Urea | Carbonyl diamide;Ureophil | 尿素 | AmBeed-信号通路专用抑制剂

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT03369561	-		Not yet recruiting	March 1, 2020	Egypt ... 展开 >> Assiut University Hospital Assiut, Egypt, Assiut University71515 收起 <<
NCT02673151	Prostate Adenocarcinoma ... 展开 >> PSA Failure Recurrent Prostate Carcinoma 收起 <<	Phase 2	Suspended(logistics)	August 2021	United States, California ... 展开 >> Stanford University, School of Medicine Palo Alto, California, United States, 94304 收起 <<
NCT02561247	Acute Kidney Injury in Pediatr... 展开 >>ic Patients 收起 <<	Not Applicable	Terminated	-	United States, California ... 展开 >> Lucile Packard Children's Hospital Stanford Stanford, California, United States, 94305 United States, Iowa University of Iowa Children's Hospital Iowa City, Iowa, United States, 52242 United States, Michigan Helen DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Texas Children's Medical Center of Dallas Dallas, Texas, United States, 75235 United States, Washington Seattle Children's Hospital - Divison of Nephrology Seattle, Washington, United States, 98105 收起 <<
NCT02488070	-		Completed	-	-
NCT02488070	Recurrent Prostate Carcinoma	Phase 1 Phase 2	Completed	-	United States, California ... 展开 >> Stanford University, School of Medicine Palo Alto, California, United States, 94304 收起 <<
NCT01735136	Helicobacter Pylori Infection	Phase 2 Phase 3	Unknown	June 2013	Korea, Republic of ... 展开 >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Recruiting Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 Contact: Seung-Ok Lee, MD., PhD 82-63-250-1289 hyangim100@gmail.com 收起 <<
NCT00669955	Helicobacter Infections	Phase 3	Completed	-	United Kingdom ... 展开 >> Dr. I. Orpen Bath, United Kingdom 收起 <<
NCT00669955	-		Completed	-	-
NCT01547221	Otomycosis	Not Applicable	Completed	-	Thailand ... 展开 >> ENT clinic KhonKaen Hospital KhonKaen, Thailand, 40000 收起 <<
NCT00155623	-		Completed	-	Taiwan ... 展开 >> Department of Internal Medicine, National Taiwan University Hospital Taipei, Taiwan, 100 收起 <<
NCT01219764	Helicobacter Infections	Phase 4	Completed	-	Lebanon ... 展开 >> American University of Beirut - Medical Center Beirut, Lebanon 收起 <<
NCT01842087	Chronic Kidney Disease	Not Applicable	Completed	-	United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32611 收起 <<
NCT03463733	Glioma Gliobl... 展开 >>astoma 收起 <<	Phase 1	Recruiting	June 2020	Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: H.M.W Verheul, MD, PhD +31 (0)20 4444321 h.verheul@vumc.nl 收起 <<
NCT00872209	Otitis Externa ... 展开 >> Otorhinolaryngologic Diseases Ear Diseases Otitis 收起 <<	Phase 1 Phase 2	Completed	-	Israel ... 展开 >> HaEmek Medical Center Afula, Israel Wolfson Medical Center Holon, Israel, 58100 Maccabi Healthcare Services Tel Aviv, Israel, 68125 Assaf Harofeh Medical Center Zerifin, Israel, 70300 收起 <<
NCT03469544	-		Not yet recruiting	March 29, 2020	-
NCT02074007	Acute Otitis Media	Phase 3	Terminated(primary outcome mea... 展开 >>sure not met) 收起 <<	-	United States, Arizona ... 展开 >> Clinical Research Consortium Arizona Phoenix, Arizona, United States, 85004 United States, California Kern Allergy and Medical Research, Inc Bakersfield, California, United States, 93301 Central California Research Fresno, California, United States, 93720 United States, Florida Pharma Research International, Inc Naples, Florida, United States, 34102 SCORE Physician Alliance, LLC St. Petersburg, Florida, United States, 33710 United States, Kentucky Kentucky Pediatric / Adult Research Bardstown, Kentucky, United States, 40004 United States, Nebraska Pioneer Clinical Research, LLC Bellevue, Nebraska, United States, 68005 Omaha ENT Clinic Omaha, Nebraska, United States, 68130 United States, New York Children's Health Center / St. Elizabeth Medical Center Utica, New York, United States, 13502 Valley Stream Pediatrics Valley Stream, New York, United States, 11580 United States, North Carolina Haywood pediatric and Adolescent Medicine Group, PA Clyde, North Carolina, United States, 39721 United States, Ohio Sterling Research Group, LTD Cinncinati, Ohio, United States, 45246 Central Ohio Clinical Research Columbus, Ohio, United States, 43207 Urgent Care Specialists Hometown Urgent Care Columbus, Ohio, United States, 43214 United States, South Carolina Carolina Ear, Nose & Throat Clinic Orangeburg, South Carolina, United States, 29118 United States, Tennessee PMG Research of Bristol Bristol, Tennessee, United States, 37620 Holston Medical Group Kingsport, Tennessee, United States, 37660 United States, Utah Tanner Clinic Layton, Utah, United States, 84041 Foothill Family Clinic South Salt Lake City, Utah, United States, 84121 Heartland Research Associates LLC - Augusta Salt Lake City, Utah, United States, 84121 United States, Virginia Van Dorn Pediatrics Alexandria, Virginia, United States, 22302 收起 <<
NCT02015013	-		Recruiting	January 1, 2020	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 <<
NCT00328289	Hypotension	Not Applicable	Completed	-	Switzerland ... 展开 >> Department of Nephrology and Hypertension, University Hospital of Berne Berne, Switzerland, 3010 收起 <<
NCT01560897	Disorder of the Urea Cycle	Phase 1 Phase 2	Unknown	-	Belgium ... 展开 >> Cliniques Saint Luc Recruiting Brussels, Belgium 收起 <<
NCT00197457	H. Pylori Infection ... 展开 >> Gastric Ulcer Duodnal Ulcer 收起 <<	Phase 2	Completed	-	Japan ... 展开 >> Hamamatsu University School of Medicine Hamamatsu, Shizuoka, Japan, 431-3192 收起 <<
NCT02044341	Acute Otitis Media	Phase 3	Completed	-	-
NCT03763656	Anemia, Sickle Cell	Phase 2	Recruiting	January 2020	Jamaica ... 展开 >> Dr Angela E Rankine- Mullings Recruiting Kingston, Jamaica Contact: Angela E Rankine- Mullings, MD 1 (876)927-2471 ext 249 angela.rankinemullings@uwimona.edu.jm 收起 <<
NCT01403220	Renal Failure, Acute	Not Applicable	Completed	-	France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 <<
NCT00636389	Chronic Kidney Disease	Not Applicable	Completed	-	United States, Minnesota ... 展开 >> DaVita Clinical Research Facility Minneapolis, Minnesota, United States, 55404 收起 <<
NCT00636389	-		Completed	-	-
NCT00004767	Amino Acid Metabolism, Inborn ... 展开 >>Errors 收起 <<	Phase 2	Completed	-	-
NCT01447017	-		Completed	-	-
NCT01722695	Renal Failure Chronic Requirin... 展开 >>g Hemodialysis 收起 <<	Not Applicable	Completed	-	Austria ... 展开 >> Dialyseinstitut Prim. Dr. W. Gießauf GmbH Graz, Austria, 8010 Medical University Graz Graz, Austria, 8036 收起 <<
NCT03026725	Tooth Sensitivity	Not Applicable	Completed	-	Syrian Arab Republic ... 展开 >> Damascus University Damascus, Syrian Arab Republic 收起 <<
NCT00843921	Inborn Errors of Metabolism	Phase 2 Phase 3	Completed	-	United States, District of Col... 展开 >>umbia Childrens Research Institute Washington, District of Columbia, United States, 20010 收起 <<
NCT03675633	-		Not yet recruiting	January 31, 2021	-
NCT01481688	Chronic Kidney Disease	Phase 4	Unknown	January 2012	United Kingdom ... 展开 >> Renal unit, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board Recruiting Bangor, Gwynedd, United Kingdom, LL57 2PW Principal Investigator: Danielle Kirkman, MSc 收起 <<
NCT01447017	Acute Otitis Externa	Phase 2	Completed	-	Sweden ... 展开 >> Hagakliniken Gothenburg, Sweden Me3+ Clinical Trials Gothenburg, Sweden Hallands Sjukhus Halmstad, Sweden, 30185 ProbarE Lund, Sweden Curakliniken Malmö, Sweden, 20037 S3 Clinical Research Center, Vällingby Stockholm, Sweden Värmdö vårdcentral Stockholm, Sweden 收起 <<
NCT00667589	Hand-foot Skin Reaction ... 展开 >> Rash 收起 <<	Phase 2	Terminated(Study was halted du... 展开 >>e to poor subject accrual.) 收起 <<	-	United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine, Department of Dermatology Chicago, Illinois, United States, 60611 收起 <<
NCT02478086	Abnormal Renal Function ... 展开 >> Malnutrition 收起 <<	Phase 2	Completed	-	Mexico ... 展开 >> Instituto Mexicano del Seguro Social León, Guanajuato, Mexico, 37200 收起 <<
NCT00808366	Onychomycosis	Not Applicable	Unknown	October 2009	France ... 展开 >> Hôpital Purpan Recruiting Toulouse, France, 31059 收起 <<
NCT02249884	Radiodermatitis	Phase 2	Completed	-	Brazil ... 展开 >> University Hospital of Brasília Brasilia, Distrito Federal, Brazil 收起 <<
NCT00622518	Acute Otitis Media	Not Applicable	Completed	-	United States, Washington ... 展开 >> University of Washington Medical Center-Roosevelt Pediatric Care Center Seattle, Washington, United States, 98105 收起 <<
NCT01157819	Otitis Externa ... 展开 >> Otorhinolaryngologic Diseases Ear Diseases Otitis 收起 <<	Phase 2	Completed	-	Israel ... 展开 >> Wolfson Medical Center Holon, Israel, 58100 Bet Roter Clinic, Clalit Health Services Holon, Israel, 58320 收起 <<
NCT02528721	Helicobacter Pylori Infection	Phase 3	Completed	-	United States, Arizona ... 展开 >> Del Sol Research Management Tucson, Arizona, United States, 85710 United States, California Ventura Clinical Trials Ventura, California, United States, 93003 United States, Colorado Innovative Clincal Research Lafayette, Colorado, United States, 80026 United States, Florida Palmetto Research Hialeah, Florida, United States, 33016 Hope Clinical Research Kissimmee, Florida, United States, 34741 United States, Maryland Metropolitan Gastro Group Chevy Chase, Maryland, United States, 20815 United States, Michigan Gasrtrenetrology Associates of Western Michigan, West Michigan Clinical Research Center Wyoming, Michigan, United States, 49519 United States, New York Digestive Disease Care New Hyde Park, New York, United States, 11040 United States, Ohio Great Lakes Medical Research Willoughby, Ohio, United States, 44094 United States, South Dakota Innovative Clinical Research Rapd City, South Dakota, United States, 57701 United States, Texas Digestive Disease Center of South Texas, P.L.L.C San Antonio, Texas, United States, 78215 Israel Barzilai Medical center Ashkelon, Israel, 7830604 Assaf Harofe Medical Center Tzrifin, Israel, 70300 收起 <<
NCT02528721	-		Completed	-	-
NCT00432679	Diabetes Mellitus, Type 2	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Kumamoto, Japan, 862-0976 GSK Investigational Site Oita, Japan, 870-0039 收起 <<
NCT00825630	-		Completed	-	-
NCT00622518	-		Completed	-	-
NCT03397680	Helicobacter Pylori Infection	Phase 1	Active, not recruiting	May 15, 2018	Thailand ... 展开 >> Thammasat University Hospital Khlong Luang, Patumthanee, Thailand, 12121 收起 <<
NCT00345605	Argininosuccinic Aciduria ... 展开 >> Amino Acid Metabolism, Inborn Errors Urea Cycle Disorders 收起 <<	Phase 2	Completed	-	United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT00825630	Helicobacter Pylori Infection	Phase 4	Completed	-	Israel ... 展开 >> Rabin Medical Center Petah Tikva, Israel, 49100 收起 <<
NCT02017873	Dentin Sensitivity	Phase 4	Completed	-	Brazil ... 展开 >> Juliana Larocca de Geus Ponta Grossa, Brazil Chile Faculty of Dentistry - University of Chile Santiago, Metropólitana, Chile 收起 <<
NCT01003210	Otitis Media	Not Applicable	Completed	-	United States, Washington ... 展开 >> Mercer Island Pediatric Associates Mercer Island, Washington, United States, 98040 Valley Children's Clinic Renton, Washington, United States, 98055 University of Washington Medical Center-Roosevelt Pediatric Care Center Seattle, Washington, United States, 98195 收起 <<
NCT00667589	-		Terminated(Study was halted du... 展开 >>e to poor subject accrual.) 收起 <<	-	-
NCT01003210	-		Completed	-	-
NCT00955123	-		Completed	-	Denmark ... 展开 >> Department of Medicine V, Aarhus University Hospital Aarhus, Denmark, 8000 收起 <<
NCT00345605	-		Completed	-	-
NCT00004307	Amino Acid Metabolism, Inborn ... 展开 >>Errors 收起 <<	Phase 1	Unknown	-	United States, Texas ... 展开 >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Susan Carter 832-822-1630 scarter@bcm.tmc.edu 收起 <<
NCT01245257	-		Completed	-	Denmark ... 展开 >> Department of Medicine V, Aarhus University Hospital Aarhus, Denmark, 8000 收起 <<
NCT01252108	Helicobacter Pylori Infection	Phase 2	Withdrawn(lack of funding)	-	-
NCT03376620	Hypertrophic Scar	Phase 3	Completed	-	-
NCT03213535	-		Recruiting	July 10, 2017	Egypt ... 展开 >> Ain Shams university Recruiting Cairo, Egypt, +20 Contact: rasha m medhat abd el hady, MD 1224448449 ext 002 RASHAMEDHAT30@GMAIL.COM 收起 <<
NCT01421888	-		Terminated	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT03763188	-		Recruiting	September 1, 2019	France ... 展开 >> Alexandre Gros Recruiting Bordeaux, Aquitaine, France, 33000 Contact: Alexandre BOYER, MD PdD 05 56 79 56 79 收起 <<
NCT00781820	Onychomycosis	Phase 3	Completed	-	-
NCT02359942	Helicobacter Pylori Infection	Not Applicable	Unknown	January 2018	Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seongnam, Korea, Republic of Contact: Nayoung Kim, Professio nayoungkim49@empas.com 收起 <<
NCT01765283	Urea Cycle Disorders, ... 展开 >> Crigler Najjar Syndrome 收起 <<	Phase 1 Phase 2	Completed	-	Belgium ... 展开 >> Saint Luc University Hospital Brussels, Belgium Universitair Ziekenhuis (UZ) Antwerpen Edegem, Belgium, 2650 France CHU Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 Hôpital Jeanne de Flandre, CHRU Lille Lille Cedex, France, 59037 Hôpital des Enfants, CHU de Toulouse Toulouse cedex 9, France, 31059 Israel Rambam Medical Center, Meyer Children's Hospital Haifa, Israel, 31096 Hadassah Ein-Kerem Medical Center Jerusalem, Israel, 91240 Schneider Children's Medical Center of israel Petach Tikva, Israel, 49202 Italy Ospedale Pediatrico Bambino Gesu di Roma Roma, Italy, 00165 United Kingdom Birmingham Children's Hospital Birmingham, United Kingdom, B4 6NH Great Ormond Street Hospital London London, United Kingdom, WC1N 3JH 收起 <<
NCT02247830	Radiodermatitis	Phase 3	Active, not recruiting	March 2019	Brazil ... 展开 >> University Hospital of Brasília Brasilia, Brazil 收起 <<
NCT00472732	-		Completed	-	-
NCT02592096	Otitis Media	Phase 1	Unknown	February 2016	China ... 展开 >> Qingdao Municipal Hospital Recruiting Qingdao, China, 266011 Contact: Weiguo XUE, MD 收起 <<
NCT03181828	Urea Cycle Disorder	Phase 1 Phase 2	Active, not recruiting	April 30, 2019	United States, District of Col... 展开 >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 收起 <<
NCT00472732	-		Completed	-	United States, District of Col... 展开 >>umbia George Washington University School of Medicine Washington, District of Columbia, United States, 20037 Georgetown University Washington, District of Columbia, United States, 20057 收起 <<
NCT01610089	Citrullinemia	Not Applicable	Completed	-	United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT00992459	Urea Cycle Disorders	Phase 3	Completed	-	-
NCT00992459	-		Completed	-	-
NCT01347073	Urea Cycle Disorders	Phase 3	Completed	-	United States, California ... 展开 >> UCLA Pediatrics/Genetics Los Angeles, California, United States, 90404 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maine Maine Medical Center Portland, Maine, United States, 04101 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT01347073	-		Completed	-	-
NCT00223730	Cancer	Phase 2	Completed	-	United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 <<
NCT01626781	-		-	-	Germany ... 展开 >> Universitätsmedizin Mannheim, III. Medizinische Klinik Mannheim, Germany, 68167 收起 <<
NCT02246218	Urea Cycle Disorder	Phase 4	Completed	-	United States, California ... 展开 >> Kaiser Permanente Regional Metabolic Center Los Angeles, California, United States, 90027 Stanford Center for Clinical & Translational Research & Education Palo Alto, California, United States, 94034 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Florida Shands at University of Florida Gainesville, Florida, United States, 32610 United States, Georgia Emory University Decatur, Georgia, United States, 30033 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maine Maine Medical Center Portland, Maine, United States, 04102 United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada The Hospital for Sick Children Toronto, Canada, M5G 1Hs 收起 <<
NCT00237315	-		Recruiting	December 2019	United States, California ... 展开 >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Rebecca Singer, MS, LCGC 310-206-7470 RSigner@mednet.ucla.edu Sub-Investigator: Stephen Cederbaum, MD Principal Investigator: Derek Wong, MD University of California San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Vimal Vimal Gunasekaran Vimal.Gunasekaran@ucsf.edu Principal Investigator: Renata C Gallagher, MD, PhD Stanford University Medical Center Recruiting Stanford, California, United States, 94305 Contact: Thu Quan, MBA, HCM 650-736-8166 tquan@stanford.edu Principal Investigator: Gregory Enns, MD United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Curtis Coughlin, MS, CGC 303-724-2310 Coughlin.Curtis@tchden.org Principal Investigator: James Weisfeld-Adams, MD Principal Investigator: Curtis Coughlin, MS, CGC United States, District of Columbia Children's National Medical Center Recruiting Washington, D.C., District of Columbia, United States, 20010 Contact: Kara Simpson, MS, CGC 202-476-6216 ksimpson@childrensnational.org Principal Investigator: Nicholas Ah Mew, MD United States, Massachusetts Children's Hospital Boston (UCDC New England Center) Recruiting Boston, Massachusetts, United States, 02115 Contact: Vera Anastasoaie 617-355-7346 Vera.Anastasoaie@childrens.harvard.edu Principal Investigator: Susan Waisbren, MD Sub-Investigator: Harvey Levy, MD United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Sara Elsbecker, MS, RN, CPNP 612-626-5275 selsbeck10@umphysicians.umn.edu Principal Investigator: Susan Berry, MD United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Luca Fierro 212-659-1477 luca.fierro@mssm.edu Principal Investigator: George A. Diaz, MD United States, Ohio Case Western Medical College Recruiting Cleveland, Ohio, United States, 44106 Contact: Audrey Lynn, PhD 216-844-7124 Audrey.Lynn@UHhospitals.org Principal Investigator: Shawn McCandless, MD United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Sondra Bloxam 503-494-4290 bloxam@ohsu.edu Principal Investigator: Cary Harding, MD United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Irma Payan, RN 215-590-6236 Payan@email.chop.edu Principal Investigator: Marc Yudkoff, MD United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Mary Mullins, RN, BSN 832-822-4263 mullins@bcm.edu Principal Investigator: Sandesh Nagamani, MD United States, Washington Children's Hospital and Regional Medical Center Recruiting Seattle, Washington, United States, 98105 Contact: Linnea Brody, BS, MPH 206-987-3694 linnea.brody@seattlechildrens.org Principal Investigator: Lawrence Merritt, MD Canada, Ontario The Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Liora Caspi 416-813-7654 ext 328027 liora.caspi@sickkids.ca Principal Investigator: Andreas Schulze, MD Germany University of Heidelberg Recruiting Heidelberg, Germany Contact: Peter Burgard, PhD ++49 [0]6221/56-32377 Peter.Burgard@med.uni-heidelberg.de Contact ++49 [0]6221/56-37733 Principal Investigator: Georg Hoffmann, MD Sub-Investigator: Peter Burgard, PhD Switzerland University Children's Hospital Recruiting Zurich, Switzerland, CH-8032 Contact: Tamar Stricker +41 44-266-7111 Tamar.stricker@kispi.uzh.ch Principal Investigator: Matthias Baumgartner, MD Sub-Investigator: Tamar Stricker, MD 收起 <<
NCT01948427	-		Recruiting	September 2026	United States, Pennsylvania ... 展开 >> United BioSource Corporation Recruiting Blue Bell, Pennsylvania, United States, 19422 Contact: THRIVE Registry Team 855-823-2595 thriveregistry@unitedbiosource.com 收起 <<
NCT02978209	Ichthyosis Vulgaris	Not Applicable	Unknown	December 2017	Denmark ... 展开 >> Department of Dermatology, Aarhus University Hospital Aarhus, Denmark, DK-8000 收起 <<
NCT02935114	Tooth Sensitivity	Phase 3	Completed	-	-
NCT01584271	Acute Otitis Externa	Phase 2	Unknown	December 2013	Israel ... 展开 >> "Maccabi" Clinic Recruiting Gedera, Israel Contact: Dan Guttman, MD 972 52 7777730 dan1966@netvision.net.il Principal Investigator: Dan Guttman, ENT MD 收起 <<
NCT00296036	Breast Cancer ... 展开 >> Drug/Agent Toxicity by Tissue/Organ Unspecified Adult Solid Tumor, Protocol Specific 收起 <<	Phase 3	Completed	-	-
NCT00296036	-		Completed	-	-
NCT00947297	-		Completed	-	-
NCT00947297	Urea Cycle Disorders	Phase 3	Completed	-	-
NCT03260036	-		Recruiting	August 21, 2021	Denmark ... 展开 >> Department of Hepatology and Gastroenterology, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Karen Louise Thomsen, MD, PhD +45 78463892 karethom@rm.dk 收起 <<
NCT02251392	Radiodermatitis	Phase 3	Unknown	December 2016	-
NCT01257737	-		Completed	-	-
NCT01301144	-		Completed	-	Mali ... 展开 >> Unviersite de Bamako Bamako, Mali 收起 <<
NCT00551200	-		Completed	-	-
NCT00551200	Urea Cycle Disorders	Phase 2	Completed	-	United States, Minnesota ... 展开 >> University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT01541722	-		Terminated(DSMB suggested clos... 展开 >>ure due to low enrollment) 收起 <<	-	United States, California ... 展开 >> University of California, Los Angeles Los Angeles, California, United States, 90095 United States, Colorado The Children's Hospital, Aurora Aurora, Colorado, United States, 80045 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio Case Western Medical College Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center Seattle, Washington, United States, 98105 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 <<
NCT01257737	Urea Cycle Disorders	Phase 4	Completed	-	United States, California ... 展开 >> UCLA Pediatrics/Genetics Los Angeles, California, United States, 90095 Stanford University School of Medicine Palo Alto, California, United States, 94305 United States, Colorado Denver Children's Hospital Aurora, Colorado, United States, 80045 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maine Maine Medical Center Portland, Maine, United States, 04102 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55454 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Pittsburg of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 <<
NCT02935283	-		Recruiting	December 2020	United States, District of Col... 展开 >>umbia Children's Research Institute Recruiting Washington, District of Columbia, United States, 20010 Contact: Andrea L. Gropman, M.D. 202-476-3511 agropman@childrensnational.org Principal Investigator: Andrea L Gropman, M.D. United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Gerard Berry, MD 617-355-6394 gerard.berry@childrens.harvard.edu Contact: Susan Waisbren, Ph.D. (617) 355-4686 susan.waisbren@childrens.harvard.edu Sub-Investigator: Susan Waisbren, PhD Principal Investigator: Gerard Berry, MD 收起 <<
NCT02484118	End Stage Renal Failure on Dia... 展开 >>lysis 收起 <<	Not Applicable	Completed	-	Canada, British Columbia ... 展开 >> University of British Columbia, Division of Nephrology Vancouver, British Columbia, Canada, V5Z 1M9 收起 <<
NCT00947544	-		Completed	-	-
NCT02111200	Urea Cycle Disorders, Inborn	Not Applicable	Completed	-	United States, Texas ... 展开 >> Children's Nutrition Research Center/Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT00947544	Urea Cycle Disorders	Phase 2	Completed	-	United States, California ... 展开 >> UCLA Los Angeles, California, United States, 90095 United States, District of Columbia The George Washington DC Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15201 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G1X8 收起 <<
NCT02905825	-		Completed	-	-
NCT02905825	Helicobacter Pylori Infection	Phase 3	Completed	-	United States, Louisiana ... 展开 >> Willis-Knighton Pediatric GI Specialist/Willis-Knighton Physician Network Shreveport, Louisiana, United States, 71118 United States, Mississippi Gastrointestinal Associates Flowood, Mississippi, United States, 39232 United States, Tennessee Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States, 10238 United States, Texas Children's Health - Children's Medical Center Dallas (UT Southwestern) Dallas, Texas, United States, 75235 Baylor College of Medicine/Texas Children's Hospital Houston, Texas, United States, 77094 Israel Assaf Harofe Medical Center Tzrifin, Israel, 70300 收起 <<
NCT00718627	Urea Cycle Disorders ... 展开 >> Carbamoylphosphate Synthetase I Deficiency Ornithine Transcarbamylase Deficiency Citrullinemia 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> University Children's Hospital, Heinrich-Heine University Düsseldorf, Germany, 40225 University Children's Hospital Heidelberg, Germany, D-69120 收起 <<
NCT02911246	-		Completed	-	-
NCT02489292	Urea Cycle Disorders	Phase 2	Unknown	March 2017	Belgium ... 展开 >> Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Françoise Smets, MD, PhD +32 2 764 19 20 Principal Investigator: Françoise Smets, MD, PhD France Hôpital Jeanne de Flandre, CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Dries Dobbelaere, MD +33 3 20 44 41 49 dries.dobbelaere@chru-lille.fr Principal Investigator: Dries Dobbelaere, MD Poland Instytut - Pomnik Centrum Zdrowia Dziecka Recruiting Warszawa, Poland Contact: Dariusz Rokicki, MD d.rokicki@czd.pl Principal Investigator: Dariusz Rokicki, MD Spain Hospital Materno Infatil de Badajoz Recruiting Badajoz, Spain, 06010 Contact: Ana Maria Marquez, MD +34 636529711 anam.maar@gmail.com Principal Investigator: Ana Maria Marquez, MD Hospital Universitari Vall d'Hebron de Barcelona Recruiting Barcelona, Spain, 08035 Contact: Jesús Quintero Bernabeu, MD +34 675 78 15 47 jquintero@vhebron.net Principal Investigator: Jesús Quintero Bernabeu, MD Hospital Materno Infantil de Málaga Recruiting Málaga, Spain, 29011 Contact: Javier Blasco Alonso, MD +34 951 292 374 javierblascoalonso@yahoo.es Principal Investigator: Javier Blasco Alonso, MD 收起 <<
NCT02311283	-		Completed	-	United States, Florida ... 展开 >> University of South Florida Tampa, Florida, United States, 33612 收起 <<
NCT01549015	Urea Cycle Disorders	Not Applicable	Completed	-	Germany ... 展开 >> CRS Clinical Research Services GmbH (Phase I Unit), Mönchengladbach, Germany, 41061 Medizinische Hochschule Hannover, Klinik für Kinderheilkunde Hannover, Germany, 30625 Universitätsklinikum Heidelberg Klinik für Kinderheilkunde I Heidelberg, Germany, D-69120 Universitätsklinikum Münster, Zentrum für Kinder- und Jugendmedizin Münster, Germany, 48149 收起 <<
NCT02111200	-		Completed	-	-
NCT02111148	Disorder of Amniotic Cavity an... 展开 >>d/or Membrane 收起 <<	Not Applicable	Recruiting	January 2019	Egypt ... 展开 >> Nesreen Abdel Fattah Abdullah Shehata Recruiting Cairo, Egypt Principal Investigator: Nesreen A Shehata, MD 收起 <<
NCT03001466	Drug Action Increased	Phase 2	Completed	-	-
NCT03335488	Urea Cycle Disorder	Phase 4	Recruiting	March 31, 2020	United States, New York ... 展开 >> Mount Sinai School of Medicine Recruiting New York, New York, United States, 10029 Contact: Dr. George Diaz, M.D., PhD. 212-241-0858 George.Diaz@mssm.edu Contact: Luca Fierro 212 659 1477 luca.fierro@mssm.edu Principal Investigator: Dr. George Diaz, M.D., PhD. United States, Ohio University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44106-6005 Contact: Dr. Jirair Bedoyan, MD 216-844-7124 Jirair.Bedoyan@UHhospitals.org Contact: Audrey Lynn 216 844 7124 audrey.lynn@UHhospitals.org United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Dr. Gerard Vockley, MD, PhD 412-692-7530 Jennifer.baker@chp.edu Contact: Jennifer Baker 412-692-7530 Jennifer.baker@chp.edu Principal Investigator: Dr. Gerard Vockley, MD, PhD United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Dr. Nicola Longo, M.D., PhD. 801-587-3605 Nicola.Longo@hsc.utah.edu Contact: Carrie Bailey 801 587 3605 Carrie.Bailey@hsc.utah.edu Principal Investigator: Dr. Nicola Longo, M.D., PhD. Belgium Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Prof. Etienne Sokal, MD 32 2 764 13 87 etienne.sokal@uclouvain.be Contact: Julia Versavau 32 2 764 19 33 julia.versavau@uclouvain.be Principal Investigator: Prof. Etienne Sokal, MD Spain Hospital Materno-Infantil (HRU Carlos Haya) Recruiting Málaga, Andalucia, Spain, 29006 Contact: Dr. Javier Blasco-Alonso, MD 34 951 29 21 91 javierblascoalonso@yahoo.es Contact: Almudena Frias 34 951 29 21 91 Principal Investigator: Dr. Javier Blasco-Alonso Hospital Clinico Universitario de Santiago Recruiting Santiago de Compostela, Galicia, Spain, 15706 Contact: Dr. Maria Luz Couce-Pico, MD 34 981 950 162 maria.luz.couce.pico@sergas.es Contact: Maria Teresa Oreiro-Garcia 34 981 955 627 maria.teresa.oreiro.garcia@sergas.es Principal Investigator: Dr. Maria Luz Couce-Pico, MD Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Contact: Dr. Luis Jose Aldamiz-Echevar Azuara, MD 34 94 600 6327 LUISJOSE.ALDAMIZ-ECHEVARAZUARA@osakidetza.net Contact: Fernando Olatz 34 94 600 6327 fernando.andradelodeiro@osakidetza.eus Principal Investigator: Dr. Luis Jose Aldamiz-Echevar Azuara, MD Switzerland Universitätsspital, Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Matthias Gautchshi,, MD 41 (0)31 632 01 47 Matthias.Gautschi@insel.ch Contact: Alexandra Nuoffer +41 (0)31 632 51 37 alexandra.nuoffer@insel.ch Principal Investigator: Dr. Matthias Gautchshi, MD University Children's Hospital Recruiting Zurich, Switzerland, 75, 8032 Contact: Prof Johannes Häberle, MD 41- 44-266-7111 johannes.haeberle@kispi.uzh.ch Contact: Ms. Doris Anzengruber 41- 44-266-7722 Doris.Anzengruber@kispi.uzh.ch Principal Investigator: Prof Johannes Häberle, MD 收起 <<
NCT01303068	Cystic Fibrosis	Not Applicable	Completed	-	United States, New Mexico ... 展开 >> University of New Mexico Albuquerque, New Mexico, United States, 87131 收起 <<
NCT03675841	Chronic Suppurative Otitis Med... 展开 >>ia 收起 <<	Phase 1	Recruiting	June 28, 2019	China, Jiangsu ... 展开 >> Jiangsu Province People's Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: lei chen, PHD 13776620807 jspent@126.com Contact: fen shao, PHD 13851691161 shaofengnj@163.com 收起 <<
NCT01195753	Urea Cycle Disorders	Phase 2	Terminated	-	United States, California ... 展开 >> Stanford University Palo Alto, California, United States, 94304 University of California San Diego, California, United States, 92103 United States, Connecticut Yale University New Haven, Connecticut, United States, 06250 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 收起 <<
NCT03324295	-		Recruiting	July 2018	Egypt ... 展开 >> Hassan Lotfy Recruiting Assiut, Egypt, 7111 Contact: Hassan Lotfy, prof. 01020833002 hassaniron57@yahoo.com 收起 <<
NCT01934829	Hepatocellular Carcinoma	Phase 2	Completed	-	China, Beijing ... 展开 >> 301 Military Hospital, Beijing, China Beijing, Beijing, China, 100039 302 Military Hospital, Beijing, China Beijing, Beijing, China, 100039 China, Fujian Union Hospital of Fujian Medical University, Fujian, China Fuzhou, Fujian, China, 350001 China, Guangdong Guangdong Provincial People's Hospital, Guangdong, China Guangzhou, Guangdong, China, 510080 The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, China Guangzhou, Guangdong, China, 510630 China, Heilongjiang Heilongjiang Provincial Cancer Hospital, Heilongjiang, China Haerbin, Heilongjiang, China, 150081 China, Jiangsu The 81 Hospital of the Chinese People's Liberation Army, Nanjing, China Nanjing, Jiangsu, China, 210002 China, Jilin Jilin Provincial Tumor Hospital, Jilin, China Changchun, Jilin, China, 130012 China, Shanghai Zhongshan Hospital, Fudan University, Shanghai Shanghai, Shanghai, China, 200032 Eastern Hepatobiliary Surgery Hospital of the Second Military Medical University, Shanghai, China Shanghai, Shanghai, China, 200438 China, Tianjin Tianjin Cancer Hospital, Tianjin, China Tianjin, Tianjin, China, 300060 收起 <<
NCT01002469	Urea Cycle Disorders	Not Applicable	Completed	-	Germany ... 展开 >> CRS Clinical Research Services Mönchengladbach GmbH Mönchengladbach, Germany, 41061 收起 <<
NCT02740153	-		Active, not recruiting	February 2019	United States, District of Col... 展开 >>umbia Childrens Research Institute Washington, District of Columbia, United States, 20010 收起 <<
NCT03212625	Hepatocellular Carcinoma	Phase 4	Active, not recruiting	January 31, 2019	Korea, Republic of ... 展开 >> Korea University Guro Hospital Seoul, Korea, Republic of, 08308 收起 <<
NCT02705664	Foot Dermatoses	Phase 4	Completed	-	Iceland ... 展开 >> Principal Investigator Reykjavik, Iceland 收起 <<
NCT03721367	-		Recruiting	August 31, 2019	United States, Texas ... 展开 >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Saima Ali 832-822-4263 saima.ali@bcm.edu 收起 <<
NCT02670889	Ornithine Transcarbamylase Def... 展开 >>iciency Argininosuccinate Synthetase Deficiency (Citrullinemia) Argininosuccinic Acid Lyase Deficiency (Argininosuccinic Aciduria) Carbamyl-Phosphate Synthase I Deficiency 收起 <<	Phase 1 Phase 2	Not yet recruiting	March 2019	-
NCT01519908	-		Completed	-	Netherlands ... 展开 >> Academic Medical Center Amsterdam, Netherlands Free University Amsterdam, Netherlands Medisch Spectrum Twente Enschede, Netherlands University Medical Center Groningen Groningen, Netherlands Maastricht University Medical Center Maastricht, Netherlands University Medical Center Utrecht Utrecht, Netherlands 收起 <<
NCT02928887	Acute Kidney Injury ... 展开 >> Inflammation 收起 <<	Not Applicable	Not yet recruiting	December 31, 2019	-
NCT01460576	-		Completed	-	United States, Tennessee ... 展开 >> Jackson Madison County General Hospital Jackson, Tennessee, United States, 38301 Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States, 37232 收起 <<
NCT03536195	-		Not yet recruiting	June 1, 2019	France ... 展开 >> CHRU de Brest Recruiting Brest, France, 29609 Contact: Cécile AUBRON cecile.aubron@chu-brest.fr 收起 <<
NCT01573000	Lymphoma, Non-Hodgkin	Phase 2	Completed	-	-
NCT03232515	Chronic Renal Failure ... 展开 >> Dialysis Dry Weight Blood Pressure 收起 <<	Not Applicable	Completed	-	Mexico ... 展开 >> Hospital General del Estado de Sonora "Dr. Ernesto Ramos Bours" Hermosillo, Sonora, Mexico, 83000 收起 <<
NCT02733120	Autism Spectrum Disorder	Not Applicable	Recruiting	October 2019	United States, Texas ... 展开 >> Texas A&M University-CTRAL Recruiting College Station, Texas, United States, 77843 Contact: Marielle Engelen, PhD 979-220-2282 mpkj.engelen@ctral.org Contact: Cindy Lieben, PhD 9793245428 ck.lieben@ctral.org 收起 <<
NCT01573000	-		Completed	-	-
NCT01403571	Diabetes Mellitus ... 展开 >> Overweight Obesity 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> Risk Factor Modification Centre, St. Michael's Toronto, Ontario, Canada, M5B1W8 收起 <<
NCT03208426	Helicobacter Pylori Infection	Phase 4	Recruiting	December 31, 2020	Taiwan ... 展开 >> Jyh-Ming Liou Recruiting Taipei, Taiwan, Taiwan, 10002 Contact: Jyh-Ming Liou jyhmingliou@gmail.com Principal Investigator: Ming-Shiang Wu Principal Investigator: Yu-Jen Fang 收起 <<
NCT03697330	Intraoperative Complications	Phase 2	Recruiting	February 15, 2019	Egypt ... 展开 >> Assiut University Hospital Recruiting Assiut, Egypt Contact: ahmed elminshawy, prof 2332278 ext 088 ethics_committee12@yahoo.com 收起 <<
NCT00533559	Diabetes Insu... 展开 >>lin Resistance 收起 <<	Phase 4	Completed	-	Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 收起 <<
NCT03228563	Chronic Kidney Disease ... 展开 >> Probiotics 收起 <<	Not Applicable	Recruiting	June 30, 2019	Taiwan ... 展开 >> China Medical University Hospital Recruiting Taichung, Taiwan, 413 Contact: I-Kuan Wang 886-4-22052121 ext 2902 ikwang@seed.net.tw Principal Investigator: I-kuan Wang, MD 收起 <<
NCT03528837	-		Not yet recruiting	August 1, 2019	Egypt ... 展开 >> Assiut university children hospital Recruiting Assiut, Egypt Contact: Mostafa Sh Khalf, Bachlear +201112110096 mostafa.tawfeek1@med.au.edu.eg 收起 <<
NCT02912611	Acute Kidney Injury	Not Applicable	Unknown	-	Bolivia ... 展开 >> Hospital Obrero #2 Recruiting Cochabamba, Bolivia Contact: Rolando Claure, MD Malawi Queen Elizabeth Central Hospital (QECH) Recruiting Blantyre, Malawi Contact: Ulla Hemmila Nepal BP Koirala Institute of Health Sciences Recruiting Dharan, Nepal Contact: Sanjib Sharma, MD 收起 <<
NCT03121989	Breast Cancer	Phase 1	Recruiting	November 2018	Canada, Ontario ... 展开 >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Julie Green, MSc 416-480-6100 ext 83655 julie.green@sunnybrook.ca Principal Investigator: Charles Cunningham, PhD 收起 <<
NCT02340325	Cicatrix Cica... 展开 >>trix, Hypertrophic Keloid 收起 <<	Phase 1	Completed	-	Canada, British Columbia ... 展开 >> BCPFF Burn & Wound Healing Lab Vancouver, British Columbia, Canada, V5Z1M9 收起 <<
NCT00643240	Leukemia	Phase 1	Terminated(Due to slow accrual... 展开 >>) 收起 <<	-	United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 <<
NCT01103128	-		Terminated	-	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT03227107	-		Recruiting	December 30, 2020	China, Hunan ... 展开 >> Xiangya hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Li Haitao, Doctor (+86)18684916132 168101013@csu.edu.cn 收起 <<
NCT03315624	Renal Failure ... 展开 >> End Stage Renal Disease 收起 <<	Not Applicable	Completed	-	Germany ... 展开 >> Georg-Haas-Dialysezentrum der PHV Gießen, Germany, 35392 收起 <<
NCT02522676	Kidney Stones	Not Applicable	Not yet recruiting	December 2020	Turkey ... 展开 >> Selcuk University, School of Medicine, Department of Urology Not yet recruiting Konya, Turkey, 42075 Contact: Murat Akand, M.D. +905327438333 drmuratakand@yahoo.com Contact: Ozcan Kilic, M.D. +905074196189 drozcankilic@yahoo.com 收起 <<
NCT00118742	Liver Transplantation	Phase 4	Completed	-	-
NCT01041482	Renal Cell Carcinoma	Phase 2	Unknown	November 2013	China, Beijing ... 展开 >> Jianhui Ma Recruiting Beijing, Beijing, China, 100730 Contact: Jianhui Ma Jianhui Ma Jianhui Ma, Doctor 01086108878 收起 <<
NCT01255332	-		Unknown	August 2012	Korea, Republic of ... 展开 >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse 82-2-3010-6378 redpin75@paran.com 收起 <<
NCT03173365	Hand-foot Syndrome	Phase 2	Recruiting	April 1, 2019	Germany ... 展开 >> Universitätsklinikum Düsseldorf, Klinik für Dermatologie Recruiting Düsseldorf, Germany, 40225 Contact: Peter Arne Gerber, PD Dr. 004921181 ext 17775 PeterArne.Gerber@med.uni-duesseldorf.de 收起 <<
NCT03202667	SIAD - Syndrome of Inappropria... 展开 >>te Antidiuresis Hyponatremia 收起 <<	Phase 2 Phase 3	Recruiting	December 2018	Switzerland ... 展开 >> University Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Julie Refardt, Dr. +41(0)61 2652525 Zentrale julie.refardt@usb.ch Contact: Mirjam Christ-Crain, Prof mirjam.christ@usb.ch 收起 <<
NCT01946360	Acute Liver Failure ... 展开 >> Acute on Chronic Liver Failure 收起 <<	Not Applicable	Completed	-	India ... 展开 >> Institute of Liver & Biliary Sciences New Delhi, Delhi, India, 110070 收起 <<
NCT01597440	Propionic Acidemia ... 展开 >> Methylmalonic Acidemia 收起 <<	Phase 2	Terminated(insufficient enroll... 展开 >>ment) 收起 <<	-	United States, California ... 展开 >> University of California Los Angeles Los Angeles, California, United States, 90095 Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 United States, Colorado The Children's Hospital of Colorado Aurora, Colorado, United States, 80045 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Ohio University Hospitals of Cleveland/Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT01906879	Helicobacter Pylori Infection	Phase 4	Recruiting	December 2017	Taiwan ... 展开 >> Chiayi Christian Hospital Recruiting Chiayi, Taiwan Contact: Po-ye Chen National Taiwan University Hospital, Hsinchu Branch Recruiting Hsinchu, Taiwan Contact: Wen Fong Hsu, MD Principal Investigator: Wen Fong Hsu, MD E- DA Hospital and I-Shou University Recruiting Kaohsiung, Taiwan Contact: Chi-Yang Chang, MD Principal Investigator: Chi Yang Chang, MD Kaohsiung Medical University Hospital Recruiting Kaohsiung, Taiwan Contact: Jeng-Yih Wu Ming-Shiang Wu Recruiting Taipei, Taiwan, 10002 Contact: Jyh-Ming Liou, MD, PhD Principal Investigator: Ming-Shiang Wu, MD, PhD Principal Investigator: Jyh-Ming Liou, MD, PhD Sub-Investigator: Mei-Jyh Chen, MD Sub-Investigator: Chien-Chun Chen, MD Mackay Memorial Hospital, Taipei Recruiting Taipei, Taiwan Contact: Wen-Hsiung Chang, MD Principal Investigator: Wen-Hsiung Chang, MD Taipei Medical University Hospital Recruiting Taipei, Taiwan Contact: Chun-Chao Chen Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Jiing-Chyuan Luo, MD Principal Investigator: Jiing-Chyuan Luo, MD Mackay Memorial Hospital, Taitung Recruiting Taitung, Taiwan Contact: Ming Chung Bair, MD Principal Investigator: Ming Chung Bair, MD National Taiwan University Hospital, Yun-Lin Branch Recruiting Yun-Lin County, Taiwan Contact: Chieh-Chang Chen, MD Principal Investigator: Chieh-Chang Chan, MD Sub-Investigator: Ji-Yuh Lee, MD Sub-Investigator: Yu-Jen Fang, MD Principal Investigator: Chi-Yang Chang, MD 收起 <<
NCT00118742	-		Completed	-	-
NCT01891591	-		Completed	-	Switzerland ... 展开 >> Clinical Research Centre, CHUV Lausanne, Switzerland, CH-1011 收起 <<
NCT01597440	-		Terminated(insufficient enroll... 展开 >>ment) 收起 <<	-	-
NCT03232619	Acute Leukemia	Phase 1 Phase 2	Recruiting	December 2020	China, Shanghai ... 展开 >> Shanghai Bioray Inc. Recruiting Shanghai, Shanghai, China, 200240 Contact: wei Li, PhD +8618621670308 adamweili@126.com Principal Investigator: Jinsong Zeng, MD 收起 <<
NCT03604042	Weight Gain	Not Applicable	Recruiting	December 9, 2018	France ... 展开 >> Hopital de la Croix Rousse Recruiting Lyon, France, 69004 Contact: Jean-Charles Picaud, Prof +33 4 72 00 41 22 jean-charles.picaud@chu-lyon.fr 收起 <<
NCT02278432	-		Completed	-	-
NCT01717989	-		Completed	-	-
NCT01375907	Diarrhea Vomi... 展开 >>t Fever Nausea Irritability 收起 <<	Phase 1	Completed	-	Vietnam ... 展开 >> Preventive Medicine Center Thanh Son, Phu Tho, Vietnam 收起 <<
NCT02316080	Dentin Hypersensitivity	Phase 4	Completed	-	Brazil ... 展开 >> University of Sao Paulo -Ribeirao Preto Campus Ribeirão Preto, São Paulo, Brazil, 14040904 收起 <<
NCT01717989	-		Completed	-	-
NCT01563484	-		Unknown	September 2012	China, Jiangsu ... 展开 >> Zhongda Hospital, Southeast University Nanjing, Jiangsu, China, 210009 收起 <<
NCT01866761	-		Completed	-	Japan ... 展开 >> Okayama University of Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama, Japan, 700-8525 收起 <<
NCT00972569	Heart Failure ... 展开 >> Renal Dysfunction 收起 <<	Phase 1 Phase 2	Enrolling by invitation	June 2019	-
NCT03527511	-		Recruiting	May 14, 2020	France ... 展开 >> Service de Néphrologie, Rhumatologie et Dermatologie Pédiatriques - Hôpital Femme Mère Enfant - Bron. Recruiting Bron, France, 69677 Contact: Justine BACCHETTA, Pr 04 27 85 61 30 ext +33 justine.bacchetta@chu-lyon.fr Principal Investigator: Justine BACCHETTA, Pr Sub-Investigator: Bruno RANCHIN, Dr Sub-Investigator: Anne-Laure SELIER-LECLERC, Dr Sub-Investigator: Aurélia BERTHOLET-THOMAS, Dr Sub-Investigator: Elodie CHEYSSAC, Dr Sub-Investigator: Corentin TANNE, Dr 收起 <<
NCT00422448	Nevi	Not Applicable	Completed	-	Austria ... 展开 >> Department of Dermatology, Medical University of Graz Graz, Austria, 8036 收起 <<
NCT03658317	Diabetic Nephropathy	Not Applicable	Not yet recruiting	September 2019	-
NCT02004197	Helicobacter Pylori [H. Pylori... 展开 >>] as the Cause of Diseases 收起 <<	Phase 2 Phase 3	Completed	-	Pakistan ... 展开 >> clinical trial was conducted in high risk areas of Pakistan such as Karachi, Bahawalpur, Islamabad and Rawalpindi at Shifa-Ul-Mulk Memorial Hospital, Hamdrad University Karachi, Bahawalpur Victoria Hospital and Nawaz Salik Hospital respectively Karachi, Pakistan Shifa Ul MUlk Memorial Hospital Karachi, Pakistan 收起 <<
NCT01062984	Acute Renal Failure	Not Applicable	Unknown	December 2017	United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 收起 <<
NCT02137863	Radiographic Contrast Agent Ne... 展开 >>phropathy 收起 <<	Phase 4	Completed	-	-
NCT02691533	Chronic Liver Failure	Not Applicable	Completed	-	India ... 展开 >> Institute of liver and Biliary Sciences New Delhi, Delhi, India, 110070 收起 <<
NCT02384902	Diabetic Nephropathy ... 展开 >> Medication Compliance 收起 <<	Not Applicable	Completed	-	Iran, Islamic Republic of ... 展开 >> Leila Azadbakht Isfahan, Iran, Islamic Republic of 收起 <<
NCT01122225	-		Unknown	June 2010	France ... 展开 >> Reanimation medicale, Hopital Saint-Andre, Bordeaux University Hospital Bordeaux, Aquitaine, France, 33000 收起 <<
NCT00190034	Cardiovascular Disease ... 展开 >> Renal Insufficiency, Acute Cardiopulmonary Bypass 收起 <<	Phase 4	Suspended(opposite result)	June 2007	Taiwan ... 展开 >> Far Eastern Memorial Hospital Pan-Chiao, Taipei, Taiwan, 220 收起 <<
NCT00576238	Atopic Eczema	Phase 3	Completed	-	Sweden ... 展开 >> Nacka hudmottagning Nacka, Sweden, 13183 Nacka närsjukhus Nacka, Sweden, 13183 Sophiahemmet Stockholm, Sweden, 11486 Hudkliniken, Danderyds sjukhus Stockholm, Sweden, 18288 Läkarhuset Vällingby Vällingby, Sweden, 16862 收起 <<
NCT02443376	-		Completed	-	Poland ... 展开 >> Medical University of Warsaw Warsaw, Mazovian, Poland, 02-091 收起 <<
NCT02884713	GASTRITIS	Not Applicable	Completed	-	-
NCT01227148	Critically Ill Patients	Phase 3	Completed	-	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 收起 <<
NCT00719420	Helicobacter Pylori Infection	Phase 3	Completed	-	Colombia ... 展开 >> Universidad del Valle Cali, Colombia 收起 <<
NCT02433210	End Stage Renal Disease (ESRD)	Not Applicable	Recruiting	May 2018	United States, Missouri ... 展开 >> Dialysis Clinic Incorporated Recruiting Columbia, Missouri, United States, 65201 Contact: Maduhkar Misra, MD 573-882-7992 misram@health.missouri.edu Contact: Harold Moore 573 882-4433 MooreH@health.missouri.edu 收起 <<
NCT00712413	Helicobacter Pylori Infection	Phase 3	Withdrawn(Sponsor's decision)	December 2008	United States, Michigan ... 展开 >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, Wisconsin Aurora Health Care Milwaukee, Wisconsin, United States, 53233 Canada, Ontario McMaster University Medical Center, Division of Gastroenterology Hamilton, Ontario, Canada, L8N 3Z5 收起 <<
NCT02474719	End-stage Renal Disease	Not Applicable	Unknown	July 2016	France ... 展开 >> Besançon University Hospital, Nephrology Department Recruiting Besançon, Franche-Comté, France, 25000 Contact: Cécile Courivaud, MCU/PH +33381219218 ccourivaud@chu-besancon.fr Contact: Stéphanie Py, PhD +33381218999 s1py@chu-besancon.fr 收起 <<
NCT02371018	Blood Pressure ... 展开 >> Kidney Failure, Chronic Dietary Modification 收起 <<	Not Applicable	Completed	-	United States, Illinois ... 展开 >> University of Illinois Urbana, Illinois, United States, 61801 收起 <<
NCT01877863	End Stage Kidney Disease	Not Applicable	Completed	-	Canada, Alberta ... 展开 >> Northwest Dialysis Centre Calgary, Alberta, Canada, T2L 2J8 收起 <<
NCT00422448	-		Completed	-	-
NCT03156855	Helicobacter	Phase 4	Recruiting	December 2019	Taiwan ... 展开 >> Chiayi Christian Hospital Recruiting Chiayi City, Taiwan Contact: Po-Yuei Chen National Taiwan University Hospital, Hsinchu Branch Recruiting Hsinchu, Taiwan Contact: Wen-Feng Hsu E-DA University Hospital Recruiting Kaohsiung, Taiwan Contact: Chi-Yang Chang, MD Jyh-Ming Liou Recruiting Taipei, Taiwan Contact: Jyh-Ming Liou, MD, PhD 886972651883 jyhmingliou@gmail.com Taipei Veteran General Hospital Recruiting Taipei, Taiwan Contact: Jing-Chuang Luo Mackay Memorial Hospital, Taitung branch Recruiting Taitung, Taiwan Contact: Ming-Chung Bair National Taiwan University Hospital, Yun-Lin Branch Recruiting Yunlin County, Taiwan Contact: Yu-Ren Fang, MD 886972655474 收起 <<
NCT03629977	-		Not yet recruiting	December 31, 2019	-
NCT00403364	Helicobacter Pylori Infection	Phase 2 Phase 3	Completed	-	Italy ... 展开 >> S.Orsola/Malpighi Teaching Hospital, University Bologna, Italy, 40138 收起 <<
NCT01273870	-		Completed	-	-
NCT01448889	Nephropathy	Not Applicable	Unknown	December 2012	Israel ... 展开 >> Intensive Cardiac Care Unit, assaf harofhe medical center Recruiting Zerifin, Israel Contact: Sahar Minha, Dr minha.saar@gmail.com Contact: Keren Doenyas, Dr 972-544-215487 kerendoenyas@gmail.com Principal Investigator: Alex Blat, Dr 收起 <<
NCT00632775	Hyponatremia	Phase 3	Completed	-	Canada, Ontario ... 展开 >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 <<
NCT01395966	Acute Otitis Media	Phase 3	Completed	-	Spain ... 展开 >> Laboratorios Salvat, S.A. Esplugues de Llobregat, Barcelona, Spain, 08950 收起 <<
NCT00005576	Disseminated Neuroblastoma ... 展开 >> Recurrent Neuroblastoma Regional Neuroblastoma 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> Children's Oncology Group Arcadia, California, United States, 91006-3776 收起 <<
NCT01404611	Acute Otitis Media	Phase 3	Completed	-	Spain ... 展开 >> Laboratorios SALVAT S.A. Esplugues de Llobregat, Barcelona, Spain, 08950 收起 <<
NCT02286206	Psychotic Disorders ... 展开 >> Schizophrenia 收起 <<	Phase 4	Active, not recruiting	December 2017	Canada, British Columbia ... 展开 >> UBC Hospital - Detwiller Pavilion Vancouver, British Columbia, Canada, V6T 2A1 收起 <<
NCT01404611	-		Completed	-	-
NCT00006380	Prostate Cancer	Phase 1	Completed	-	United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 <<
NCT01534741	Hemodialysis	Phase 4	Completed	-	Spain ... 展开 >> Hospital Clínic Barcelona, Spain, 08036 收起 <<
NCT01395966	-		Completed	-	-
NCT01981395	Hyperalgesia ... 展开 >>Allodynia 收起 <<	Phase 1	Completed	-	United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 <<
NCT01815086	AL Amyloidosis	Phase 1	Completed	-	United States, Tennessee ... 展开 >> University of Tennessee Medical Center Knoxville, Tennessee, United States, 37920 收起 <<
NCT00003082	Chronic Myeloproliferative Dis... 展开 >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Unspecified Adult Solid Tumor, Protocol Specific 收起 <<	Phase 1	Completed	-	United States, Arizona ... 展开 >> Arizona Cancer Center Tucson, Arizona, United States, 85724 收起 <<
NCT00978640	Healthy	Not Applicable	Unknown	June 2012	Denmark ... 展开 >> mikkel Holm Vendelbo Århus, Jylland, Denmark, 8000 收起 <<
NCT03077048	Renal Insufficiency, Chronic	Phase 1 Phase 2	Completed	-	Czechia ... 展开 >> Thomayer Hospital Clinical - Pharmacology Unit (CPU) Prague, Czechia, 140 59 收起 <<
NCT00723762	-		Completed	-	United States, Ohio ... 展开 >> Hattie Larlham Center for Children with Disabilities Mantua, Ohio, United States, 44255 收起 <<
NCT03207204	Tooth Bleaching ... 展开 >> Dentin Sensitivity 收起 <<	Not Applicable	Active, not recruiting	July 2, 2020	Brazil ... 展开 >> School of Dentistry of USP São Paulo, SP, Brazil, 05508-000 收起 <<
NCT02775942	Poliomyelitis	Phase 2	Completed	-	Vietnam ... 展开 >> Preventive Medicine center Thanh Son, Phu Tho, Vietnam Phu Tho Preventive Medicine Center Viet tri, Phu Tho, Vietnam 收起 <<
NCT02975089	Frail Elderly	Not Applicable	Completed	-	-
NCT02816554	Japanese Encephalitis	Phase 2	Completed	-	Vietnam ... 展开 >> District Health Center Thanh Son, Phu Tho, Vietnam Phu Tho Preventive Medicine Center Viet tri, Phu Tho, Vietnam 收起 <<
NCT03547323	End Stage Renal Disease	Not Applicable	Recruiting	January 31, 2019	China, Beijing ... 展开 >> Baxter Investigational Site Recruiting Beijing, Beijing, China, 100034 China, Guangdong Baxter Investigational Site Recruiting Guangzhou, Guangdong, China, 510515 China, Heilongjiang Baxter Investigational Site Recruiting Haerbin, Heilongjiang, China, 150001 China, Sichuan Baxter Investigational Site Recruiting Chengdu, Sichuan, China, 610041 China, Zhejiang Baxter Investigational Site Recruiting Hangzhou, Zhejiang, China, 310014 收起 <<
NCT03299725	Helicobacter Pylori Infection	Phase 4	Recruiting	November 2019	Belgium ... 展开 >> Hôpital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Samy Cadranel, MDPhD 003224773216 samy.cadranel@huderf.be Principal Investigator: Samy Cadranel, MDPhD 收起 <<
NCT01687543	Clostridium Difficile Colonisa... 展开 >>tion Impact of Enteral Probiotics on Certain Lab Parameters 收起 <<	Not Applicable	Terminated(Too low inclusion r... 展开 >>ate and several sites did not comply) 收起 <<	-	Sweden ... 展开 >> Intensive Care Unit, Helsingborg Hospital Helsingborg, Sweden, SE 251 87 Intensive Care Unit, Kristianstad Central hospital Kristianstad, Sweden, SE 291 85 Lund University Hospital Lund, Sweden, SE 22185 Dept of Anesthesia & Intensive Care, University Hospital of Norrland Umeå, Sweden, SE-901 85 收起 <<
NCT01511354	-		Completed	-	United States, Arkansas ... 展开 >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 收起 <<
NCT02760901	Cisplatin Nephrotoxicity	Phase 2	Completed	-	-
NCT02991144	Ornithine Transcarbamylase (OT... 展开 >>C) Deficiency 收起 <<	Phase 1 Phase 2	Recruiting	December 2020	United States, California ... 展开 >> Ronald Reagan University of Califonria Los Angeles Medical Center Recruiting Los Angeles, California, United States, 90095 University of California San Francisco Recruiting San Francisco, California, United States, 94158 United States, Colorado The Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029-6508 United States, Ohio University Hospital Cleveland Medical Center/Case Western Reserve University Active, not recruiting Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Canada, Alberta Alberta's Children's Hospital Recruiting Calgary, Alberta, Canada, T3B 6A8 Spain Hospital Clinico Universitario de Santiago Recruiting Santiago de Compostela, A Coruna, Spain, 15706 Hospital Universitario de Cruzes Recruiting Barakaldo, Vizcaya, Spain, 48903 United Kingdom National Hospital for Neurology & Neurosurgery Recruiting London, London City, United Kingdom, WC1N 3BG Queen Elizabeth Hospital Recruiting Birmingham, United Kingdom, B15 2TH 收起 <<
NCT01844375	Bowel; Disease, Carbohydrate A... 展开 >>bsorption Difficulty Walking Colorectal Neoplasms 收起 <<	Not Applicable	Unknown	June 2017	Thailand ... 展开 >> Siriraj hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Contact: Mingkwan Wongyingsinn, MD, MSc (02)-419-7995 minkcheerful@hotmail.com Principal Investigator: Mingkwan Wongyingsinn, MD, MSc 收起 <<
NCT03047174	Head and Neck Neoplasms	Not Applicable	Recruiting	August 2019	Germany ... 展开 >> Department of Radiotherapy (Radiooncology), Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein Campus Kiel Recruiting Kiel, Schleswig-Holstein, Germany, 24105 Contact: Jürgen Dunst, Prof. Dr. +4943150026500 juergen.dunst@uksh.de Contact: Schmalz Claudia, Dr. med. +4943150026511 claudia.schmalz@uksh.de Principal Investigator: Jürgen Dunst, Prof. Dr. Sub-Investigator: Claudia Schmalz, Dr. med. Sub-Investigator: Melica Reutemann, Dr. med. Sub-Investigator: Rene Baumann, Dr. med. Sub-Investigator: Florian Pyschny Sub-Investigator: Cornelia Setter, Dr. med. Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein Recruiting Lubeck, Germany, 23562 Contact: Dirk Rades, Prof. Dr. +49-451-500-45400 dirk.rades@uksh.de Contact: Kirsten Hakelberg, Dr. med. +49-451-500-45410 kirsten.hakelberg@uksh.de Principal Investigator: Dirk Rades, Prof. Dr. Sub-Investigator: Kirsten Hakelberg, Dr. med. Sub-Investigator: Carlos A Narvaez Sub-Investigator: Annika Panzner, Dr. med. Sub-Investigator: Michael von Staden, Dr. med. Sub-Investigator: Christian Staackmann Sub-Investigator: Liesa Dziggel, Dr. med. Sub-Investigator: Tobias Schröder Sub-Investigator: Jan-Dirk Küter, Dr. med. Sub-Investigator: Natalie Graen Sub-Investigator: Laura Motisi, Dr. med. Sub-Investigator: Maike Radtke, Dr. med. 收起 <<
NCT01877382	Advanced Solid Tumor ... 展开 >> Lymphoma 收起 <<	Phase 1	Recruiting	March 2020	United States, Michigan ... 展开 >> Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 United States, New York Columbia University College of Physicians and Surgeons Recruiting New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Mrinal Gounder 646-888-4167 gounderm@mskcc.org United States, Tennessee Tennessee Oncology Completed Nashville, Tennessee, United States, 37203 United States, Texas UT MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 <<
NCT02125045	Health Subjects With Cardiovas... 展开 >>cular Risk Factors 收起 <<	Phase 3	Completed	-	Italy ... 展开 >> Oberdan Parodi, MD Milan, Italy, 20162 收起 <<
NCT01400451	Melanoma	Phase 1	Terminated(More than 2 of 6 pa... 展开 >>tients treated experienced dose limiting toxicities.) 收起 <<	-	United States, California ... 展开 >> University Of California Los Angeles Los Angeles, California, United States, 90095 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana Farber Cancer Inst Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT01369641	-		Terminated(Poor accrual)	-	-
NCT01400451	-		Terminated(More than 2 of 6 pa... 展开 >>tients treated experienced dose limiting toxicities.) 收起 <<	-	-
NCT02674802	-		Unknown	September 2016	China, Jiangxi ... 展开 >> Affiliated Hospital of Nanchang University Recruiting Nanchang, Jiangxi, China, 330006 Contact: Nonghua Lv, MD 13707086809 lunonghua@163.com Contact: Kunhe Zhang, MD 13007202818 393467260@qq.com Principal Investigator: Nonghua Lv, MD 收起 <<
NCT01363336	-		Completed	-	Japan ... 展开 >> Many Locations, Japan 收起 <<
NCT03347461	Otorrhea Otit... 展开 >>is Media With Effusion in Children 收起 <<	Phase 4	Withdrawn(Low use of Otiprio a... 展开 >>mong otolaryngologists.) 收起 <<	June 2019	United States, Massachusetts ... 展开 >> Boston Medical Center Boston, Massachusetts, United States, 02118 收起 <<
NCT02768207	Metastatic Melanoma	Phase 2	Active, not recruiting	July 30, 2019	Belgium ... 展开 >> UZ Brussel Brussel, Belgium, 1090 Institut Jules Bordet Bruxelles, Belgium, 1000 CHIREC Edith Cavell Bruxelles, Belgium, 1180 UZ Antwerpen Edegem, Belgium, 2650 UZ Gent Gent, Belgium, 9000 Jessa Zkh (Campus Virga Jesse) Hasselt, Belgium, 3500 AZ Groeninge Kortrijk, Belgium, 8500 Clinique Ste-Elisabeth Namur, Belgium, 5000 AZ Delta (Campus Wilgenstraat) Roeselare, Belgium, 8800 AZ Nikolaas (Sint Niklaas) Sint Niklaas, Belgium, 9100 Sint Augustinus Wilrijk Wilrijk, Belgium, 2610 Poland Centrum Onkologii Instytut Klinika Nowotworow Ukladowych i Uogolnionych Krakow, Poland Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu. Poznań, Poland, 60-355 Centrum Onkologii- Instytut; im. M.Skłodowskiej-Curie Warszawa, Poland, 02-781 收起 <<
NCT01267760	Uremia	Phase 2	Completed	-	Denmark ... 展开 >> Herlev Hospital Herlev, Denmark, 2880 收起 <<
NCT01369641	Cancer	Not Applicable	Terminated(Poor accrual)	-	United States, Pennsylvania ... 展开 >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT03647813	Xerostomia Ch... 展开 >>ronic Renal Failure 收起 <<	Phase 2	Completed	-	-
NCT00725517	Chronic Kidney Disease ... 展开 >> Peritoneal Dialysis 收起 <<	Phase 4	Completed	-	-
NCT02596620	Helicobacter Pylori Infection	Not Applicable	Completed	-	-
NCT00994877	-		Unknown	May 2010	Israel ... 展开 >> Asaf Harofeh Medical Center Recruiting Beer Yaakov, Israel Contact: asaf miller asafmiller@gmail.com Principal Investigator: ASAF MILLER, MD 收起 <<
NCT00726466	Age Related Macular Degenerati... 展开 >>on AMD CNV 收起 <<	Phase 1	Withdrawn(Lack of recruitment)	-	United States, New York ... 展开 >> Vitreous Retina Macula Consultants of New York New York, New York, United States, 10022 收起 <<
NCT03594760	Prostate Cancer	Phase 3	Not yet recruiting	November 2024	Canada, Quebec ... 展开 >> Centre Hospitalier de l'université de Montréal Montréal, Quebec, Canada, H2X 0C1 收起 <<
NCT00517803	HIV Infections ... 展开 >> Cancer, Second Primary 收起 <<	Not Applicable	Completed	-	Canada, Ontario ... 展开 >> St. Joseph's Hospital London, Ontario, Canada, N6A 4V2 收起 <<
NCT02596620	-		Completed	-	-
NCT00442819	Uremia Prurit... 展开 >>us 收起 <<	Phase 4	Completed	-	Taiwan ... 展开 >> China Medical University Hospital Taichung, Taiwan, 404 收起 <<
NCT02541864	-		Completed	-	-
NCT02386657	-		Completed	-	Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 收起 <<
NCT00765401	-		Withdrawn(No participants enro... 展开 >>lled) 收起 <<	-	United States, Pennsylvania ... 展开 >> Penn State College of Medicine, Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 收起 <<
NCT03553329	-		Completed	-	France ... 展开 >> CHU DE Poitiers Poitiers, France, 86021 收起 <<
NCT00004386	Ornithine Transcarbamylase Def... 展开 >>iciency Disease 收起 <<	Phase 1	Terminated	-	-
NCT02541864	Helicobacter Pylori Infection	Not Applicable	Completed	-	-
NCT03430388	Systemic Lupus ... 展开 >> Rheumatoid Arthritis Spondyloarthritis Inflammatory Myopathy Systemic Sclerosis Mixed Connective Tissue Disease Takayasu Arteritis Granulomatosis With Polyangiitis Sjogren's Syndrome Juvenile Idiopathic Arthritis Juvenile Dermatomyositis 收起 <<	Not Applicable	Recruiting	February 24, 2019	Brazil ... 展开 >> Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo Recruiting São Paulo, Sao Paulo, Brazil, 05403-000 Contact: Eloisa Bonfa, MD, PhD 55 11 30617490 eloisa.bonfa@hc.fm.usp.br 收起 <<
NCT02796638	Heart Failure ... 展开 >> Sleep Apnea, Obstructive 收起 <<	Not Applicable	Recruiting	October 2021	United States, California ... 展开 >> VA San Diego Healthcare System Recruiting San Diego, California, United States, 92161 Contact: Alan S Maisel, M.D. 858-552-8585 ext 7344 alan.maisel@va.gov Contact: Steve Carter, BS 858-552-8585 ext 2893 steve.carter@va.gov 收起 <<
NCT03587870	Muscle Wasting in Critically I... 展开 >>ll 收起 <<	Not Applicable	Not yet recruiting	April 1, 2020	-
NCT01096095	Spinocerebellar Ataxia Type 3	Phase 2	Withdrawn(Regulatory authoriti... 展开 >>es did not allow the entrance of the study drug in the country) 收起 <<	July 2011	Brazil ... 展开 >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90.035-903 收起 <<
NCT00090545	Prostate Cancer	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 <<
NCT00805610	Liver Failure	Phase 1 Phase 2	Withdrawn(Investigator taking ... 展开 >>position at another university-0 enrolled under this protocol.) 收起 <<	June 2018	United States, Virginia ... 展开 >> Virginia Commonwealth University Health System Richmond, Virginia, United States, 23298 收起 <<
NCT01999023	Chronic Renal Disease	Not Applicable	Unknown	December 2014	Taiwan ... 展开 >> Taichung Veterans General Hospital Not yet recruiting Taichung, Taiwan, 40705 Contact: Yi-Chia Huang, PhD +886424730022 ext 12198 ych@csmu.edu.tw Principal Investigator: Cheng-Hsu Chen, MD, PhD 收起 <<
NCT01932190	Renal Replacement Therapy for ... 展开 >>Acute Kidney Injury in Intensive Care Unit 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Hôpital Louis Mourier Colombes, France, 92700 收起 <<
NCT02701452	Ovarian Hyperstimulation Syndr... 展开 >>ome Hypercoagulability 收起 <<	Not Applicable	Recruiting	October 2018	France ... 展开 >> Hôpital Jeanne de Flandres, CHRU Recruiting Lille, France Principal Investigator: Sophie Catteau-Jonard, MD,PhD 收起 <<
NCT00992992	-		Completed	-	-
NCT01149434	Cancer Neuroe... 展开 >>ndocrine Ovarian Cancer Colon Cancer 收起 <<	Phase 1 Phase 2	Terminated(Lack of drug effica... 展开 >>cy) 收起 <<	-	United States, Utah ... 展开 >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 收起 <<
NCT01362283	-		Completed	-	-
NCT00090545	-		Completed	-	-
NCT03611283	Xerostomia Sj... 展开 >>ogren's Syndrome 收起 <<	Not Applicable	Completed	-	-
NCT00992992	Lymphoma, Mantle-Cell	Phase 2	Completed	-	-
NCT00464919	Hepatocellular Carcinoma	Phase 2	Completed	-	Taiwan ... 展开 >> National Taiwan University Hospital Taipei, Taiwan, 100 收起 <<
NCT01829178	Upper GI Cancer ... 展开 >> Cisplatin Adverse Reaction 收起 <<	Phase 2 Phase 3	Completed	-	Iran, Islamic Republic of ... 展开 >> Tehran University of Medical Science Tehran, Iran, Islamic Republic of 收起 <<
NCT01769365	Helicobacter Pylori Infection	Phase 4	Completed	-	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Kaohsiung city, Taiwan, 813 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 收起 <<
NCT01149434	-		Terminated(Lack of drug effica... 展开 >>cy) 收起 <<	-	-
NCT01769365	-		Completed	-	-
NCT03678285	Acute Kidney Injury ... 展开 >> Exercise 收起 <<	Not Applicable	Recruiting	June 30, 2019	United States, Wyoming ... 展开 >> University of Wyoming Recruiting Laramie, Wyoming, United States, 82071 Contact: Evan C Johnson, PhD 307-766-5282 evan.johnson@uwyo.edu 收起 <<
NCT03537365	Growth Necrot... 展开 >>izing Enterocolitis Late-Onset Sepsis Feeding Intolerance 收起 <<	Not Applicable	Recruiting	December 1, 2022	Denmark ... 展开 >> Aarhus University Hospital Recruiting Aarhus, Denmark, 8200 Contact: Bente Hoest, MD benthoes@rm.dk Rigshospitalet (RH) Recruiting Copenhagen, Denmark, 2100 Contact: Lise Aunsholt, MD.,PhD lise.aunsholt@regionh.dk Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: Bo Moelholm Hansen, MD., PhD bo.moelholm.hansen.01@regionh.dk North Zealand Hospital Not yet recruiting Hillerød, Denmark, 3400 Contact: Mia Bjerager, MD mia.bjerager@regionh.dk Hvidovre Hospital (HH) Recruiting Hvidovre, Denmark, 2650 Contact: Heidi Smedegaard, MD heidi.smedegaard@regionh.dk Kolding Hospital Recruiting Kolding, Denmark, 6000 Contact: Anja Klamer, MD anja.klamer@rsyd.dk Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Gitte Zachariassen, MD., PhD +45 21 36 04 26 Gitte.Zachariassen@rsyd.dk Principal Investigator: Gitte Zachariassen, MD., PhD 收起 <<
NCT03649828	Metabolic Syndrome ... 展开 >> Cardiovascular Diseases Hypertension 收起 <<	Not Applicable	Completed	-	-
NCT02896517	-		Withdrawn(The investigator aba... 展开 >>ndoned the project.) 收起 <<	October 1, 2016	France ... 展开 >> Groupe Hospitalier Paris Saint Joseph Paris, Ile-de-France, France, 75014 收起 <<
NCT01042327	Chronic Kidney Disease	Phase 4	Completed	-	United Kingdom ... 展开 >> Royal Free Hospital London, United Kingdom, NW3 2QG 收起 <<
NCT00696982	Diabetes Mellitus ... 展开 >> Arterial Stiffness 收起 <<	Not Applicable	Unknown	June 2009	Israel ... 展开 >> Department of Internal Medicine A , Research & Development unit Assaf Harofeh Medical Center, Zerifin, affiliated to Sackler School of Medicine, Tel Aviv, Israel Recruiting Zrifin, Israel, 70300 Contact: Shlomit Koren, MD 972-546-888=385 shlomitks@gmail.com Contact: Shai Efrati, MD 972-577-346-364 efratishai@013.net Principal Investigator: Shlomit Koren, MD 收起 <<
NCT02378350	End Stage Renal Disease	Phase 4	Completed	-	China, Fujian ... 展开 >> The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China China, Gansu Lanzhou University Second Hospital Lanzhou, Gansu, China China, Guangdong Guangzhou Panyu Central Hospital Guangzhou City, Guangdong, China The First Affiliated Hospital , Sun Yet-Sen University Guangzhou, Guangdong, China, 510080 The Third Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China The 2nd Shenzhen Municipal People's Hospital Shenzhen, Guangdong, China China, Guizhou Guizhou Province People's Hospital Gui Yang City, Guizhou, China China, Heilongjiang The Second Affiliated Hospital of Harbin Medical University Harbin City, Heilongjiang, China China, Hubei Traditional Chinese Medicine Hospital of Wuhan Wuhan City, Hubei, China China, Hunan The Third Xiangya Hospital of Central South University Changsha, Hunan, China China, Jiangsu The Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China China, Jiangxi Jiangxi province people's hospital Nanchang, Jiangxi, China Nanchang First Affiliated Hospital Nangchang, Jiangxi, China China, Liaoning First Hospital of Affiliated of Dalian Medical University Dalian, Liaoning, China China, Ningxia General Hospital of Ningxia Medical University Yingchuan, Ningxia, China China, Shanghai Renji Hospital , Shanghai Jiaotong University , School of Medicine Shanghai, Shanghai, China, 200127 Shanghai 455 Hospital Shanghai, Shanghai, China Shanghai Tenth People's Hospital Shanghai, Shanghai, China Shanghai Xinhua Hospital Shanghai, Shanghai, China China, Sichuan Sichuan Provincial People's Hospital Chengdu, Sichuan, China China, Tianjin The First Affiliated Hospital of Tianjin University of TCM Tianjin, Tianjin, China 收起 <<
NCT02359435	Helicobacter Pylori Infection	Not Applicable	Completed	-	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 收起 <<
NCT02359435	-		Completed	-	-
NCT03060174	Postoperative Cognitive Dysfun... 展开 >>ction Postoperative Delirium 收起 <<	Not Applicable	Recruiting	June 2019	Germany ... 展开 >> Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hamburg Eppendorf, Univ.-Prof. Dr. med. Alwin E. Goetz and Prof. Dr. med. Christian Zoellner Recruiting Hamburg, Germany, 20246 Contact: Rainer Kiefmann, MD, Prof. +4915222815615 r.kiefmann@uke.de Contact: Julia Wiede, MD +4915222827380 j.wiede@klinikum-starnberg.de 收起 <<
NCT02547753	-		Completed	-	Brazil ... 展开 >> Rubens Caliento São Paulo, SP, Brazil, 05508000 University of São Paulo São Paulo, Brazil, 05508-000 收起 <<
NCT03239808	Renal Disease, End-Stage	Not Applicable	Recruiting	July 2021	Spain ... 展开 >> FundeSalud. Junta de Extremadura Recruiting Mérida, Badajoz, Spain, 06800 Contact: Jonathan Gómez Raja, PhD +34-924009306 jonathan.gomez@fundesalud.es Contact: Maria Isabel Cotilla +34-924004354 misabel.cotilla@fundesalud.es Hospital Virgen del Puerto Recruiting Plasencia, Cáceres, Spain, 10600 Contact: Miguel A Suarez Santisteban, MD +34-617426612 santisteban79@gmail.com Principal Investigator: Miguel A Suarez Santisteban, MD Hospital San Pedro de Alcántara Recruiting Cáceres, Spain, 10003 Contact: Javier L Deira Lorenzo, PhD MD +34-661374085 deiralorenzo@gmail.com Principal Investigator: Javier L Deira Lorenzo, PhD MD 收起 <<
NCT01847651	Hepatic Encephalopathy ... 展开 >> Minimal Hepatic Encephalopathy Cirrhosis 收起 <<	Phase 4	Completed	-	United Kingdom ... 展开 >> Liver unit St Mary's Hospital, 10th floor QEQM Wing, South Wharf Road London, United Kingdom, W2 1NY 收起 <<
NCT02874807	SIADH	Phase 2 Phase 3	Enrolling by invitation	April 2019	Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 <<
NCT02478242	Acute Kidney Injury	Phase 4	Completed	-	-
NCT02317445	-		Completed	-	-
NCT02037815	Brain Edema	Phase 4	Completed	-	China, Beijing ... 展开 >> Neurosurgical ICU, Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing, China, 100050 收起 <<
NCT03486886	Prostate Cancer	Not Applicable	Completed	-	Canada, Quebec ... 展开 >> Centre Hospitalier de l'Université de Montréal Montréal, Quebec, Canada 收起 <<
NCT03495271	-		Completed	-	United States, Indiana ... 展开 >> Purdue University West Lafayette, Indiana, United States, 47907 收起 <<
NCT02559388	Renal Insufficiency, Chronic	Not Applicable	Completed	-	-
NCT01278901	-		Unknown	-	Israel ... 展开 >> Department of Gastroenterology, Rabin Medical Center Not yet recruiting Petach Tikva, Israel, 49100 Contact: Vered Shabat, MD 972-3-9732798 ext 2798 veredsh3@clalit.org.il 收起 <<
NCT03066921	End Stage Renal Disease	Not Applicable	Completed	-	Taiwan ... 展开 >> Tungs' Taichung MetroHarbour Hospital Taichung, Taiwan 收起 <<
NCT00216450	Helicobacter Infections ... 展开 >> Bacterial Infections 收起 <<	Phase 4	Completed	-	-
NCT02077348	Diabetes Mellitus Type I ... 展开 >> Ketoacidosis 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Institute of Clinical Medicine Aarhus, Aarhus C, Denmark, 8000 收起 <<
NCT01612429	End Stage Renal Failure on Dia... 展开 >>lysis 收起 <<	Early Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT00507793	Kidney Transplantation	Phase 4	Completed	-	-
NCT02307903	-		Completed	-	Hong Kong ... 展开 >> The University of Hong Kong Hong Kong Island, Hong Kong 收起 <<
NCT03446196	Transplant Dysfunction	Not Applicable	Recruiting	December 31, 2018	Italy ... 展开 >> University of Padova Recruiting Padova, Veneto, Italy, 35127 Contact: Alessandro De Cassai, MD 收起 <<
NCT02979106	Hereditary Fructose Intoleranc... 展开 >>e Fructose Metabolism, Inborn Errors Glucose Metabolism Disorders 收起 <<	Not Applicable	Completed	-	-
NCT03007862	-		Recruiting	May 2019	France ... 展开 >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13005 Contact: Jeremy Bourenne 收起 <<
NCT02857387	Acute Coronary Syndrome	Not Applicable	Completed	-	France ... 展开 >> Chu Reims France, Reims, France, 51092 收起 <<
NCT03347942	Feeding Behavior ... 展开 >> Diet, Reducing Eating 收起 <<	Not Applicable	Recruiting	July 2018	Brazil ... 展开 >> Hospital de Clínicas de Porto Alegre Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035903 Contact: Milena Artifon, Nutricionist 55 54 991661416 milena.artifon@gmail.com Contact: Thaís R Moreira, Nutricionist 55 51 999161004 thaisr_moreira@hotmail.com 收起 <<
NCT02147782	-		Recruiting	-	China, Anhui ... 展开 >> Anhui Province Hospital of TCM Recruiting Hefei, Anhui, China, 230031 Contact: Shunjin Hu 0551-62838661 Principal Investigator: Shunjin Hu China, Jiangsu Jiangsu Province Hospital of TCM Suspended Nanjing, Jiangsu, China China, Shanghai Longhua hospital affiliated to Shanghai University of TCM Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiaofeng Li, PhD 86-21-64395700 lixiaofeng0409@163.com Principal Investigator: Xiaofeng Li Huadong Hospital Affiliated to Fudan University Completed Shanghai, Shanghai, China, 200040 收起 <<
NCT01496157	Prostate Cancer	Phase 1 Phase 2	Completed	-	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287 收起 <<
NCT01496157	-		Completed	-	-
NCT00516594	Hyperlipidemia ... 展开 >> Cardiovascular Disease Diet Therapy 收起 <<	Phase 2	Completed	-	Canada, Ontario ... 展开 >> Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Health Centre Toronto, Ontario, Canada, M5C 2T2 收起 <<
NCT00865150	-		Completed	-	United States, Indiana ... 展开 >> Memorial Hospital South Bend South Bend, Indiana, United States, 46601 United States, South Carolina McLeod Regional Medical Center Florence, South Carolina, United States, 29506 收起 <<
NCT02411084	Graft vs Host Disease	Phase 3	Terminated(Insufficient rate o... 展开 >>f accrual) 收起 <<	-	-
NCT03249415	-		Recruiting	July 2018	Spain ... 展开 >> IVI Barcelona Recruiting Barcelona, Spain Contact: Irene Cervelló 收起 <<
NCT00419380	-		Completed	-	-
NCT02553083	Bacterial Infection Due to Hel... 展开 >>icobacter Pylori (H. Pylori) 收起 <<	Phase 4	Recruiting	December 2021	Israel ... 展开 >> Rabin Medical Center Recruiting Petach Tikva, Israel, 49100 Contact: Yaron Niv, MD 97239377237 yniv@clalit.org.il Principal Investigator: Yaron Niv, MD 收起 <<
NCT03419923	Hemodialysis ... 展开 >>Anticoagulation 收起 <<	Not Applicable	Recruiting	March 30, 2019	China, Guangdong ... 展开 >> Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ting Lin, Ph.D.,M.D. +8615013186074 linting131@163.com 收起 <<
NCT00868062	Laparoscopic Cholecystectomy	Phase 3	Completed	-	United Kingdom ... 展开 >> Sherwood Forest Hospitals NHS Foundation Trust Mansfield, Nottinghamshire, United Kingdom, NG17 4JL 收起 <<
NCT00281047	Helicobacter Pylori	Phase 2 Phase 3	Unknown	-	Japan ... 展开 >> Oita Kouseiren Tsurumi Hospital Recruiting Beppu, Oita, Japan, 874-8585 Contact: Takayuki Nagai, MD. PhD 81-977-23-7111 ikyoku@ok-tsurumi.com Principal Investigator: Takayuki Nagai, MD, PhD Senoo Clinic for Internal Medicine and Gastroenterology Recruiting Hamamatsu, Shizuoka, Japan, 431-3125 Contact: Kazutaka Senoo, MD CBF00628@nifty.com Principal Investigator: Kazutaka Senoo, MD University Hospital of Hamamatsu University School of Medicine Recruiting Hamamatsu, Shizuoka, Japan, 431-3192 Contact: Takahisa Furuta, MD, PhD 81-53-435-2850 furuta@hama-med.ac.jp Principal Investigator: Takahisa Furuta, MD, PhD Sub-Investigator: Naohito Shirai, MD, PhD Sub-Investigator: Mitsushige Sugimoto, MD Matsushita Clinic Recruiting Hamamatsu, Shizuoka, Japan, 433-8121 Contact: Fumiaki Matsushita, MD, PhD 81-53-475-5225 fmatsushita@mail.wbs.ne.jp Principal Investigator: Fumiaki Matsushida, MD, PhD Kumagai Clinic for Internal Medicine and Gastroenterology Recruiting Hamamatsu, Shizuoka, Japan, 435-0006 Contact: Junichi Kumagai, MD, PhD 81-53-422-2588 jkuma@yr.tnc.ne.jp Principal Investigator: Junichi Kumagai, MD, PhD Nakajima Clinic Recruiting Kakegawa, Shizuoka, Japan, 436 Contact: Hiroshi Nakamura, MD, PhD 81-537-22-6819 mdnakajima@mail.wbs.ne.jp Principal Investigator: Hiroshi Nakajima, MD, PhD University Hospital of Oita University Faculty of Medicine Recruiting Oita, Japan, 879-5593 Contact: Kazunari Murakami, MD, PhD 81-97-586-6193 murakam@med.oita-u.ac.jp Principal Investigator: Kazunari Murakami, MD, PhD 收起 <<
NCT00419380	Otitis Media	Phase 4	Completed	-	United States, Colorado ... 展开 >> The Children's Hospital Denver, Colorado, United States, 80218 收起 <<
NCT02952144	Dialysis Amyloidosis	Not Applicable	Recruiting	March 2019	United States, New York ... 展开 >> The Rogosin Institute Recruiting New York, New York, United States, 10021 Contact: Jeffrey Silberzweig, MD 收起 <<
NCT00461448	Rheumatoid Arthritis	Phase 1	Completed	-	Iran, Islamic Republic of ... 展开 >> Division of Rheumatoloy, Sina Teaching Hospital, Tabriz Medical Sciences University Tabriz, East Azerbaidjan, Iran, Islamic Republic of Sheikh-ol-Raees Ultra Specialized Clinic Tabriz, East Azerbaidjan, Iran, Islamic Republic of 收起 <<
NCT00346242	Thalassemia	Phase 4	Completed	-	Greece ... 展开 >> Novartis Investigative Site Athens, Greece 收起 <<
NCT03636438	-		Enrolling by invitation	December 2024	Spain ... 展开 >> Hospital Clinico Universitario de Santiago Santiago De Compostela, Coruna, Spain, 15706 Hospital Universitario de Cruces. Servicio de Pediatria Barakaldo, Vizcaya, Spain, 48903 United Kingdom Queen Elizabeth Hospital, Department of Endocrinology Birmingham, United Kingdom, B15 2TH 收起 <<
NCT01792700	Helicobacter Infections	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi-do, Korea, Republic of 收起 <<
NCT00818935	Type 2 Diabetes ... 展开 >> Inflammation Cardiovascular Disease 收起 <<	Not Applicable	Completed	-	Jamaica ... 展开 >> University of the West Indies Kingston, Jamaica 收起 <<
NCT01867190	Critical Limb Ischemia	Phase 1 Phase 2	Completed	-	United States, Missouri ... 展开 >> Kansas City Vascular Foundation (KCV) North Kansas City, Missouri, United States, 64116 收起 <<
NCT01526798	End-Stage Renal Disease (ESRD)	Not Applicable	Completed	-	Italy ... 展开 >> Azienda Ospedaliera Garbagnate Milanese Ospedale Bollate - Divisione Nefrologia e Dialisi Bollate, Milan, Italy, 20021 收起 <<
NCT01060917	Diabetes Mellitus	Phase 1 Phase 2	Completed	-	Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 收起 <<
NCT00906516	Brain Tumors	Phase 2	Unknown	December 2010	United States, North Carolina ... 展开 >> The Preston Robert Tisch Brain Tumor Center Not yet recruiting Durham, North Carolina, United States, 27710 Contact: David A. Reardon, MD 919-668-1409 reard003@mc.duke.edu Contact: Susan T. Boulton, RN, BSN (919) 668-0896 boult001@mc.duke.edu Principal Investigator: David A. Reardon, MD 收起 <<
NCT02533414	Urolithiasis	Not Applicable	Recruiting	July 2017	Turkey ... 展开 >> Selcuk University, School of Medicine, Department of Urology Recruiting Konya, Turkey, 42075 Contact: Ozcan Kilic, M.D. +905074196189 drozcankilic@yahoo.com Contact: Murat Akand, M.D. +905327438333 drmuratakand@yahoo.com 收起 <<
NCT02472834	End Stage Renal Failure on Dia... 展开 >>lysis 收起 <<	Not Applicable	Unknown	December 2018	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Sahir Kalim, MD 617-726-5050 skalim@mgh.harvard.edu Contact: Katherine Brock, BS 617-643-9463 KBROCK2@mgh.harvard.edu Principal Investigator: Sahir Kalim, MD Fresenius Medical Centers (local affilliates) Recruiting Boston, Massachusetts, United States, 02201 收起 <<
NCT03324763	-		Completed	-	France ... 展开 >> Hôpital Saint Vincent de Paul Lille, Hauts de France, France, 59000 收起 <<
NCT03608956	-		Recruiting	December 2018	Turkey ... 展开 >> Marmara University Pendik Education and Research Hospital Recruiting Istanbul, Turkey Contact: Mustafa Kemal Arslantas, Assoc.Prof +905052242119 mkarslantas@gmail.com Contact: Pelin Corman Dincer, Ass Prof +905425270011 pelincorman@yahoo.com Principal Investigator: Gulbin Tore Altun, MD Principal Investigator: Alper Kararmaz, Prof 收起 <<
NCT00451971	Arthritis, Rheumatoid	Phase 4	Completed	-	Australia ... 展开 >> Sanofi-Aventis Sydney, Australia 收起 <<
NCT03633279	Liver Cirrhoses	Phase 4	Recruiting	August 2019	India ... 展开 >> Dyanand Medical College and Hospital Recruiting Ludhiana, Punjab, India, 141001 Contact: Sandeep Singh Sidhu, MD,DM +919814025085 sandeepsidhu1963@gmail.com Contact: Omesh Goyal, MD,DM +919914821155 goyalomesh@yahoo.co.in Principal Investigator: Sandeep Singh Sidhu, MD,DM 收起 <<
NCT03767270	Ornithine Transcarbamylase Def... 展开 >>iciency 收起 <<	Phase 1 Phase 2	Not yet recruiting	June 2022	-
NCT03440164	-		Completed	-	-
NCT02611882	Prostate Cancer	Phase 1 Phase 2	Completed	-	United States, California ... 展开 >> UCSF Imaging Center at China Basin San Francisco, California, United States, 94107 收起 <<
NCT01601327	Idiopathic Hypogonadotropic Hy... 展开 >>pogonadism 收起 <<	Phase 4	Completed	-	Turkey ... 展开 >> Gulhane School of Medicine Dep. of Endocrine and Metabolism Ankara, Turkey, 06018 Gulhane School of Medicine Dep. of Endocrinology and Metabolism Ankara, Turkey, 06018 收起 <<
NCT02854475	Dermatologic Disorders ... 展开 >> Disorder of Cholesterol Metabolism 收起 <<	Not Applicable	Completed	-	-
NCT02055079	Polycystic Kidney, Type 1 Auto... 展开 >>somal Dominant Disease Polycystic Kidney, Type 2 Autosomal Dominant Disease 收起 <<	Phase 3	Recruiting	December 2019	Austria ... 展开 >> Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Markus Riegersperger, MD 0043140400 ext 4391 markus.riegersperger@gmail.com Contact: Gere Sunder-Plassmann, MD 0043140400 ext 4391 gere.sunder-plassmann@meduniwien.ac.at Principal Investigator: Markus Riegersperger, MD Sub-Investigator: Gere Sunder-Plassmann, MD 收起 <<
NCT02668848	Stroke Dehydr... 展开 >>ation 收起 <<	Phase 2 Phase 3	Unknown	February 2018	Taiwan ... 展开 >> Chang Gung Memorial Hospital Recruiting Chiayi, Taiwan, 613 Contact: Leng C Lin, MD +886 05 3621000 ext 2805 a3456711@ms65.hinet.net Principal Investigator: Leng C Lin, MD 收起 <<
NCT01029626	Gastrointestinal Hemorrhage	Not Applicable	Completed	-	Switzerland ... 展开 >> Geneva University Hospital Geneva, Switzerland, 1211 收起 <<
NCT01881984	-		Completed	-	-
NCT02389114	Obesity Satie... 展开 >>ty Diabetes 收起 <<	Not Applicable	Completed	-	-
NCT03497377	Metastatic Prostate Cancer	Phase 1	Active, not recruiting	May 2021	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287 收起 <<
NCT03525288	Prostate Cancer	Phase 2 Phase 3	Recruiting	April 30, 2026	Canada, Quebec ... 展开 >> Centre Hospitalier de l'Université de Montréal Recruiting Montréal, Quebec, Canada Contact: Diane Trudel 514-890-8000 ext 26906 diane.dt.trudel.chum@ssss.gouv.qc.ca 收起 <<
NCT00004285	End Stage Renal Disease	Not Applicable	Completed	-	United States, New York ... 展开 >> University of Rochester School of Medicine Rochester, New York, United States, 14642 收起 <<
NCT01881984	Medium-chain Acyl-CoA Dehydrog... 展开 >>enase (MCAD) Deficiency 收起 <<	Phase 1	Completed	-	United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 收起 <<
NCT02067390	-		Recruiting	July 2020	United States, Illinois ... 展开 >> Northwestern Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Scheetz mscheetz@nmh.org Principal Investigator: Marc H Scheetz, PharmD, MSc 收起 <<
NCT02766010	Blood Pressure,	Not Applicable	Unknown	July 2016	-
NCT03206411	-		Recruiting	November 30, 2018	Egypt ... 展开 >> Assiut University Recruiting Assiut, Egypt 收起 <<
NCT03536663	Kidney Failure, Chronic	Not Applicable	Recruiting	February 1, 2019	United States, California ... 展开 >> Balboa Nephrology Med Group Recruiting Chula Vista, California, United States, 92154 Contact: Carmen Flores CFlores@balboaunited.org Principal Investigator: Jill Meyer California Institute of Renal Research Recruiting San Diego, California, United States, 92111 Contact: Lisa Burchard lburchard@balboaunited.org Principal Investigator: Dylan Steer, MD United States, Kansas Research Management Inc/ Kansas Nephrology Research Institute, LLC-J/V Recruiting Wichita, Kansas, United States, 67214 Contact: Angela Anderson aanderson@researchmgmt.com Principal Investigator: Lisa Weber, MD 收起 <<
NCT02996539	-		Completed	-	China, Yunnan ... 展开 >> Internal medicine department, Kunming First People's Hospital Kunming, Yunnan, China, 650000 收起 <<
NCT01380249	Malignant Solid Tumours	Phase 1	Completed	-	Spain ... 展开 >> Hospital Universitario La Paz Madrid, Spain, 28046 收起 <<
NCT03378817	Reperfusion Injury ... 展开 >> Hypothermic Oxygenated Machine Perfusion 收起 <<	Not Applicable	Recruiting	August 31, 2019	Germany ... 展开 >> Department of Surgery and Transplantation, University Hospital RWTH Aachen Recruiting Aachen, Germany, 52074 Contact: Georg Lurje, M.D. +492418035048 glurje@ukaachen.de 收起 <<
NCT00194688	Helicobacter Infections	Phase 2	Completed	-	United States, Washington ... 展开 >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 <<
NCT01964924	Estrogen Receptor Negative ... 展开 >> HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IV Breast Cancer Triple-Negative Breast Carcinoma 收起 <<	Phase 2	Active, not recruiting	-	United States, District of Col... 展开 >>umbia MedStar Georgetown University Hospital Washington, D.C., District of Columbia, United States, 20007 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 收起 <<
NCT03198507	Helicobacter Pylori Infection ... 展开 >> Dyspepsia 收起 <<	Phase 3	Active, not recruiting	January 2019	-
NCT00288561	Age-Related Macular Degenerati... 展开 >>on (ARMD) 收起 <<	Phase 2	Completed	-	Switzerland ... 展开 >> Novartis Basel, Switzerland 收起 <<
NCT03277911	-		Not yet recruiting	August 30, 2019	-
NCT01989585	BRAF V600E Mutation Present ... 展开 >> BRAF V600K Mutation Present Metastatic Melanoma Solid Neoplasm Stage III Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 收起 <<	Phase 1 Phase 2	Recruiting	-	United States, California ... 展开 >> University of California Davis Comprehensive Cancer Center Suspended Sacramento, California, United States, 95817 United States, Massachusetts Massachusetts General Hospital Cancer Center Withdrawn Boston, Massachusetts, United States, 02114 United States, Missouri Siteman Cancer Center at West County Hospital Suspended Creve Coeur, Missouri, United States, 63141 Washington University School of Medicine Suspended Saint Louis, Missouri, United States, 63110 Siteman Cancer Center-South County Suspended Saint Louis, Missouri, United States, 63129 Siteman Cancer Center at Christian Hospital Suspended Saint Louis, Missouri, United States, 63136 Siteman Cancer Center at Saint Peters Hospital Suspended Saint Peters, Missouri, United States, 63376 United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Site Public Contact 732-235-8675 Principal Investigator: Janice M. Mehnert United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Site Public Contact 888-275-3853 Principal Investigator: James L. Abbruzzese United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu Principal Investigator: Kari L. Kendra United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact 877-312-3961 Principal Investigator: Michael A. Davies 收起 <<
NCT03443622	Refractory Solid Tumor	Phase 1	Not yet recruiting	November 2020	-
NCT01802320	Colon Mucinous Adenocarcinoma ... 展开 >> Colon Signet Ring Cell Adenocarcinoma Rectal Mucinous Adenocarcinoma Rectal Signet Ring Cell Adenocarcinoma Recurrent Colon Carcinoma Recurrent Rectal Carcinoma Stage IIIA Colon Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer 收起 <<	Phase 2	Active, not recruiting	December 2017	United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT02948023	Corneal Injuries ... 展开 >> Corneal Burns Corneal Scars and Opacities 收起 <<	Phase 1	Recruiting	August 2019	India ... 展开 >> LV Prasad Eye Institute Recruiting Hyderabad, Telangana, India, 500034 Contact: Sayan Basu, MBBS, MS +9140 3061 2625 ext 2625 sayanbasu@lvpei.org Contact: Vivek Singh Singh, MSc PhD +9140 3061 2286 ext 2286 viveksingh@lvpei.org 收起 <<
NCT01802320	-		Active, not recruiting	-	-
NCT02109653	Non-Small Cell Lung Cancer	Phase 2	Withdrawn(Study never started ... 展开 >>- transferred to Array.) 收起 <<	November 2017	United States, Illinois ... 展开 >> University of Chicago Medical Center SC-2 Chicago, Illinois, United States, 60546 收起 <<
NCT03042312	Metastatic Castration Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 2	Active, not recruiting	April 11, 2019	United States, California ... 展开 >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 United States, Texas Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States, 77042 收起 <<
NCT02541786	Helicobacter Pylori Infection	Phase 4	Completed	-	Taiwan ... 展开 >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 收起 <<
NCT03389451	Prostate Cancer ... 展开 >> Prostatic Neoplasm Prostatic Neoplasms, Castration-Resistant Prostatic Cancer Recurrent Prostatic Cancer Metastatic 收起 <<	Phase 2 Phase 3	Enrolling by invitation	December 31, 2022	United States, Iowa ... 展开 >> The University of Iowa Hospitals & Clinics Iowa City, Iowa, United States, 52242 收起 <<
NCT03388346	Prostate Cancer ... 展开 >> Prostatic Neoplasm Prostatic Neoplasms, Castration-Resistant Prostatic Neoplasm of Uncertain Behavior 收起 <<	Phase 2 Phase 3	Enrolling by invitation	January 1, 2022	United States, Iowa ... 展开 >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 收起 <<
NCT01335334	H. Pylori Infection	Phase 4	Unknown	August 2011	United States, Texas ... 展开 >> Victor M. Cardenas Recruiting El Paso, Texas, United States, 79902 Sub-Investigator: Cesar O Salazar, MD 收起 <<
NCT02677480	Hyposalivation	Phase 1	Completed	-	Sweden ... 展开 >> Institute of odontology Gothenburg, Sweden, 41390 收起 <<
NCT01749761	Hypotension	Not Applicable	Completed	-	Canada, British Columbia ... 展开 >> St.Paul's Hospital Hemodialysis Unit Vancouver, British Columbia, Canada, V6Z1Y6 收起 <<
NCT01741857	Systemic Lupus Erythematosus	Phase 1 Phase 2	Unknown	December 2013	China, Jiangsu ... 展开 >> The Affiliated Drum Tower Hospital of Nanjing University Medical School Recruiting Nanjing, Jiangsu, China, 210008 Contact: Sun +86-25-83105209 收起 <<
NCT01481844	Optimization of Second Line Tr... 展开 >>eatment Protocol for H Pylori Eradication 收起 <<	Phase 3	Completed	-	Israel ... 展开 >> Soroca UMC Beer-Sheva, Israel 收起 <<
NCT00428077	Leukemia	Phase 2	Terminated(Withdrawn because t... 展开 >>here were no dramatic changes in the main endpoint, as well as low enrollment numbers. The data are not interpretable in terms of efficacy.) 收起 <<	-	United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 收起 <<
NCT02894268	Helicobacter Pylori Infection	Phase 4	Recruiting	December 2019	China, Zhejiang ... 展开 >> Sir Run Run Shaw Hospital,Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Weiling Hu, Attending +86153-9705-9751 ringwh@163.com Principal Investigator: Weiling Hu, Atrending 收起 <<
NCT02296112	Recurrent Melanoma ... 展开 >> Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma 收起 <<	Phase 2	Recruiting	January 2024	United States, District of Col... 展开 >>umbia Georgetown University Medical Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Bridget Haley 202-687-6871 Principal Investigator: Suthee Rapisuwon, MD United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Keith T Flaherty, MD 617-724-4000 KFLAHERTY@mgh.harvard.edu Principal Investigator: Keith T. Flaherty, MD United States, New York Memorial Sloan-Kettering Cancer Center Withdrawn New York, New York, United States, 10021 United States, Pennsylvania University of Pennsylvania Cancer Center Withdrawn Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: B. VICC Clinical Trials Information Program 800-811-8480 Principal Investigator: Douglas B. Johnson, MD United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Anna Vardeleon 713-794-4274 asreckew@mdanderson.org Principal Investigator: Michael A. Davies, MD 收起 <<
NCT03556254	Helicobacter Pylori Infection	Phase 4	Recruiting	June 30, 2022	Taiwan ... 展开 >> National Taiwan University Hospital, Yun-Lin Branch Recruiting Yun-Lin County, Taiwan Contact: Chieh-Chang Chen, MD Principal Investigator: Chieh-Chang Chan, MD Sub-Investigator: Ji-Yuh Lee, MD Sub-Investigator: Yu-Jen Fang, MD Principal Investigator: Chi-Yang Chang, MD 收起 <<
NCT00428077	-		Terminated(Withdrawn because t... 展开 >>here were no dramatic changes in the main endpoint, as well as low enrollment numbers. The data are not interpretable in terms of efficacy.) 收起 <<	-	-
NCT03361267	Helicobacter Pylori Infection ... 展开 >> Compliance, Patient Drug Resistance Antibiotics 收起 <<	Not Applicable	Recruiting	June 28, 2018	Korea, Republic of ... 展开 >> Inha University Hospital Recruiting Incheon, Korea, Republic of, 22332 Contact: Byoung WooK Bang, M.D. phD +82-32-890-2548 bangbu@inha.ac.kr 收起 <<
NCT03769948	-		Not yet recruiting	July 2020	-
NCT01650831	-		Completed	-	-
NCT01852071	ADA-SCID	Phase 1 Phase 2	Active, not recruiting	September 2018	United States, California ... 展开 >> Mattel Children's Hospital, UCLA Los Angeles, California, United States, 90095 United States, Maryland Mark O. Hatfield Clinical Research Center, NIH Bethesda, Maryland, United States, 20892 收起 <<
NCT01650831	Suspicion of Being Infected Wi... 展开 >>th H.Pylori 收起 <<	Not Applicable	Completed	-	United States, New Jersey ... 展开 >> Unimed Center East Brunswick, New Jersey, United States, 08816 收起 <<
NCT00154583	-		Unknown	-	Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Chi-An Chen, MD 886-2-2312-3456 ext 5157 cachen@ha.mc.ntu.edu.tw 收起 <<
NCT00005518	-		Completed	-	-
NCT01616303	Ovarian Neoplasms	Phase 2	Completed	-	United States, Connecticut ... 展开 >> University of Connecticut Health Center Farmington, Connecticut, United States, 06030 United States, Indiana Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 收起 <<
NCT00155792	-		Unknown	-	Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Wen-Fang Cheng, MD, PhD 886-2-2312-3456 ext 5166 wenfangcheng@yahoo.com 收起 <<
NCT02225860	Autosomal Dominant Polycystic ... 展开 >>Kidney Disease (ADPKD) 收起 <<	Phase 2 Phase 3	Completed	-	United States, Massachusetts ... 展开 >> Tufts Medical Center Boston, Massachusetts, United States, 02111 收起 <<
NCT02225860	-		Completed	-	-
NCT01191034	Metastatic Melanoma	Phase 1 Phase 2	Unknown	August 2012	Belgium ... 展开 >> Cliniques Universitaires Saint-Luc Recruiting Bruxelles, Belgium, 1200 Contact: Baurain Jean-François, MD,PhD +32 2 764 5471 jean-francois.baurain@uclouvain.be Contact: VanBaren Nicolas, MD,PhD +32 2 764 7508 nicolas.vanbaren@uclouvain.be Principal Investigator: Baurain Jean-François, MD,PhD 收起 <<
NCT02817347	Otitis Media ... 展开 >>Otorrhea 收起 <<	Phase 1 Phase 2	Active, not recruiting	December 2020	Korea, Republic of ... 展开 >> Chonnam National Universitiy Hospital Gwang-ju, Chonnam, Korea, Republic of, 501-757 收起 <<
NCT03288922	End-stage Renal Disease ... 展开 >> Hemodialysis 收起 <<	Not Applicable	Completed	-	Thailand ... 展开 >> Chulalongkorn Hospital Bangkok, Thailand, 10330 收起 <<
NCT00514514	-		Completed	-	-
NCT00850512	Diffuse Large B-Cell Lymphoma	Phase 2	Completed	-	Italy ... 展开 >> Istituto di Ematologia e Oncologia Medica Seràgnoli Bologna, BO, Italy, 40138 收起 <<
NCT03405584	Helicobacter Pylori Infection	Phase 4	Completed	-	China, Shanghai ... 展开 >> Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200127 收起 <<
NCT03413020	Helicobacter Pylori Infection	Phase 4	Completed	-	China, Shanghai ... 展开 >> Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200127 收起 <<
NCT00514514	Kidney Transplantation	Phase 3	Completed	-	Germany ... 展开 >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover Muenden, Germany, 34346 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Lubeck, Germany, 23538 Novartis Investigative Site Munchen, Germany, 81377 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Regensburg, Germany, 93053 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 收起 <<
NCT03654781	Helicobacter Pylori Infection	Phase 1	Completed	-	-
NCT01588535	Pain Otitis M... 展开 >>edia 收起 <<	Phase 2	Completed	-	United States, Arkansas ... 展开 >> Nda Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida COMMUNITY Medical Research Miami Beach, Florida, United States, 33141 United States, Iowa The Iowa Clinic, Pc West Des Moines, Iowa, United States, 50266 United States, Kentucky Kentucky Pediatric/Adult Research Bardstown, Kentucky, United States, 40004 United States, Nebraska Prairie Fields Family Medicine/Clinical Research Advantage Fremont, Nebraska, United States, 68025 United States, Nevada Clinical Research Center Las Vegas, Nevada, United States, 89104 United States, North Dakota Odyssey Research Fargo, North Dakota, United States, 58104 United States, Tennessee ACCESS CLINICAL TRIALS, Inc. / Centennial Medical Center Clarksville, Tennessee, United States, 37203 United States, Texas DiscoveReseach, Inc. Bryan, Texas, United States, 77082 Research Across America Carrollton, Texas, United States, 75010 Research Across America Dallas, Texas, United States, 75234 Dm Clinical Research Tomball, Texas, United States, 77375 United States, Utah Foothill Family Clinic Salt Lake City, Utah, United States, 84109 FIRSTMED Salt Lake City, Utah, United States, 84121 Jordon River Family Medicine South Jordan, Utah, United States, 84095 收起 <<
NCT00388323	Alcoholic Hepatitis ... 展开 >> Alcoholic Cirrhosis 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Hôpital Antoine Béclère Clamart, France, 92140 收起 <<
NCT02803658	Infertility	Not Applicable	Active, not recruiting	September 2018	France ... 展开 >> CHU Amiens Amiens, France, 80054 CHU Caen Caen, France, 14033 收起 <<
NCT02935010	Helicobacter Pylori Infection	Phase 4	Completed	-	China, Shanghai ... 展开 >> Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200001 Shanghai General Hospital, Shanghai First People's Hospital, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200001 Shanghai Tenth People's Hospital, Tongji University Shanghai, Shanghai, China, 200001 Zhongshan Hospital,Fudan University Shanghai, Shanghai, China, 200001 Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200127 收起 <<
NCT01575899	Helicobacter Pylori Infection	Phase 4	Terminated(Early termination d... 展开 >>ue to efficacy) 收起 <<	-	Taiwan ... 展开 >> Buddhist Tzu Chi General Hospital Hualien, Taiwan, 97002 收起 <<
NCT03708848	Helicobacter Pylori Infection	Phase 4	Recruiting	March 31, 2019	China, Shanghai ... 展开 >> Renji Hospital, School of Medicine, Shanghai Jiao Tong University Recruiting Shanghai, Shanghai, China, 200127 Contact: Laisheng Luo, M.D. 86+18758279101 luolaishengzju@163.com Principal Investigator: Hong Lu, M.D.,Ph.D Sub-Investigator: Laisheng Luo, M.D. Sub-Investigator: Lou Yu, M.D Sub-Investigator: Xiaohua Long, M.D. Sub-Investigator: Xiao Liang, M.D.,Ph.D 收起 <<
NCT03220542	Helicobacter Pylori Infection	Phase 4	Recruiting	December 2017	Korea, Republic of ... 展开 >> Kyung Hee University Hospital Recruiting Seoul, Korea, Republic of, 130-872 Contact: Seok Ho Dong, M.D. 82-2-958-8149 Principal Investigator: Jung-Wook Kim, M.D., Ph.D. 收起 <<
NCT00154284	Organ Transplantation, Renal T... 展开 >>ransplantation 收起 <<	Phase 3	Completed	-	-
NCT00154284	-		Completed	-	-
NCT00859001	Follicular Lymphoma	Phase 2	Completed	-	Italy ... 展开 >> Istituto di Ematologia e Oncologia Medica Seràgnoli Bologna, BO, Italy, 40138 收起 <<
NCT00550368	Infection Ach... 展开 >>lorhydria 收起 <<	Not Applicable	Completed	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT01575899	-		Terminated(Early termination d... 展开 >>ue to efficacy) 收起 <<	-	-
NCT00550368	-		Completed	-	-
NCT00371826	Renal Transplanted Recipients	Phase 4	Completed	-	Australia ... 展开 >> Royal Prince Alfred Hospital NSW, Australia Westmead Hospital NSW, Australia Princess Alexandra Hospital QLD, Australia Monash Medical Centre Sale, Australia Queen Elizabeth Hospital Sale, Australia Royal Melbourne Hospital VIC, Australia Sir Charles Gairdner Hospital WA, Australia 收起 <<
NCT03134378	Helicobacter Pylori Infection	Phase 4	Recruiting	May 12, 2017	Indonesia ... 展开 >> Cipto Mangunkusumo Hospital Recruiting Jakarta Pusat, DKI Jakarta, Indonesia, 10430 Contact: Ari F Syam, Dr. +62818706199 ari_syam@hotmail.com Contact: Ryan Herardi, dr. +6281585089087 ryanhemail@gmail.com 收起 <<
NCT03557437	Helicobacter Pylori Infection	Phase 4	Recruiting	December 1, 2018	China, Shanghai ... 展开 >> Renji Hospital, School of Medicine, Shanghai Jiao Tong University Recruiting Shanghai, Shanghai, China, 200127 Contact: Laisheng Luo, M.D 86+18758279101 luolaishengzju@163.com Principal Investigator: Hong Lu, M.D.,Ph.D Sub-Investigator: Zhijun Cao, M.D.,Ph.D Sub-Investigator: Laisheng Luo, M.D 收起 <<
NCT00742534	Bronchopulmonary Dysplasia	Phase 1	Withdrawn(Study never began)	August 2009	United States, Tennessee ... 展开 >> Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee, United States, 37232 收起 <<
NCT00371826	-		Completed	-	-
NCT01085786	Helicobacter Pylori Infection	Phase 4	Completed	-	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan 收起 <<
NCT00001830	Chronic Lymphocytic Leukemia ... 展开 >> Graft vs Host Disease Hodgkin's Disease Multiple Myeloma Non Hodgkin's Lymphoma 收起 <<	Phase 1	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT00348413	Graves Ophthalmopathy	Not Applicable	Completed	-	Singapore ... 展开 >> Singapore National Centre Singapore, Singapore, 168751 收起 <<
NCT01142375	-		Unknown	-	-
NCT01081405	HEMATOLOGIC MALIGNANCIES	Phase 2	Recruiting	November 2020	Italy ... 展开 >> A.O.U. San Giovanni Battista Recruiting Torino, Italy, 10126 Contact: Mario Boccadoro, MD +39 0116335814 gismm2001@yahoo.it Contact: Benedetto Bruno, MD +39 0116334354 benedetto.bruno@unito.it Principal Investigator: Mario Boccadoro, MD 收起 <<
NCT01170858	End Stage Renal Disease	Not Applicable	Completed	-	Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 <<
NCT01619501	-		Unknown	-	Singapore ... 展开 >> Nationa University Hospital Recruiting Singapore, Singapore Contact: Ross Soo +65 6779 5555 Principal Investigator: Ross Soo 收起 <<
NCT02709083	Chronic Myelogenous Leukemia ... 展开 >> Chronic Myeloid Leukemia Leukemia 收起 <<	Phase 2	Terminated(Original principal ... 展开 >>investigator left institution) 收起 <<	-	United States, Georgia ... 展开 >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 <<
NCT02709083	-		Terminated(Original principal ... 展开 >>investigator left institution) 收起 <<	-	-
NCT02682563	Diabetes Mellitus, Type 2 ... 展开 >> Diabetic Nephropathies 收起 <<	Phase 4	Completed	-	Netherlands ... 展开 >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1081 HV 收起 <<
NCT01544868	Energy Expenditure in Burn Chi... 展开 >>ldren Protein Turnover in Burn Children 收起 <<	Not Applicable	Completed	-	United States, Massachusetts ... 展开 >> Shriners Hospitals For Chidren Boston, Massachusetts, United States, 02446 收起 <<
NCT03485300	-		Not yet recruiting	December 2019	-
NCT00110201	Cardiovascular Disease ... 展开 >> Acute Renal Failure Death 收起 <<	Phase 3	Unknown	-	United States, Florida ... 展开 >> Shands Hospital at the University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Richard A Finlay, RN 352-273-5356 finlara@medicine.ufl.edu 收起 <<
NCT02630537	-		Completed	-	-
NCT01843348	Kidney Transplantation ... 展开 >> Renal Transplantation 收起 <<	Phase 3	Completed	-	France ... 展开 >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Dijon, France, 21079 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bochum, Germany, 44892 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Tübingen, Germany, 72076 收起 <<
NCT02399397	Sepsis System... 展开 >>ic Inflammatory Response Syndrome Septic Shock 收起 <<	Phase 4	Completed	-	Brazil ... 展开 >> Universidade Estadual Paulista Júlio de Mesquita Filho Araraquara, São Paulo, Brazil, 14801902 收起 <<
NCT01085786	-		Completed	-	-
NCT01829503	Acute Myeloid Leukemia	Phase 2	Active, not recruiting	October 2017	United States, Pennsylvania ... 展开 >> University of PIttsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 收起 <<
NCT00082238	Cystic Fibrosis ... 展开 >> Diabetes Mellitus 收起 <<	Not Applicable	Completed	-	United States, Texas ... 展开 >> University of Texas Southwestern Dallas, Texas, United States, 75390-9063 收起 <<
NCT00417105	-		Completed	-	Australia, Victoria ... 展开 >> Monash Medical Centre Clayton, Victoria, Australia, 3168 Geelong Hospital Geelong, Victoria, Australia, 3220 Belgium Virga Jesse Ziekenhuis Hasselt, Limburg, Belgium, 3500 Universitaire Ziekenhuizen Leuven Leuven, Vlaams-Brabant, Belgium, 3000 收起 <<
NCT01843348	-		Completed	-	-
NCT01531803	Hypovolemia	Phase 2 Phase 3	Terminated(Per FDA CBER letter... 展开 >> dated July 15, 2015, Kedrion SpA was released from the PMC to perform the study with Kedbumin 25 % in pediatric patients) 收起 <<	-	-
NCT00098254	Non-Small-Cell Lung Carcinoma	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01624688	Tattoo Tattoo... 展开 >> Removal 收起 <<	Not Applicable	Unknown	June 2013	United States, Massachusetts ... 展开 >> Wellman Center for Photomedicine Boston, Massachusetts, United States, 02114 收起 <<
NCT00098254	-		Completed	-	-
NCT00876642	Radiation Dermatitis	Phase 3	Completed	-	Brazil ... 展开 >> Gustavo Viani Marilia, Sao Paulo\brazil, Brazil, 17501570 收起 <<
NCT01829503	-		Active, not recruiting	-	-
NCT02644057	Cardiorenal Syndrome	Phase 2	Withdrawn(Could not enroll pat... 展开 >>ients) 收起 <<	-	United States, New York ... 展开 >> Maimonides Medical Center Brooklyn, New York, United States, 11219 收起 <<
NCT00872092	-		Completed	-	Germany ... 展开 >> University of Bonn Bonn, Germany, 53105 收起 <<
NCT02711176	Helicobacter Infection	Phase 4	Completed	-	Iran, Islamic Republic of ... 展开 >> Ilam University of Medical Scienvc Ilam, Iran, Islamic Republic of, 6939177143 收起 <<
NCT01108029	Parkinson's Disease ... 展开 >> Gait Disorders, Neurologic 收起 <<	Phase 4	Completed	-	France ... 展开 >> Devos Lille, France, 59037 收起 <<
NCT01827059	Pulmonary Arterial Hypertensio... 展开 >>n Congenital Heart Disease 收起 <<	Phase 2	Active, not recruiting	June 2018	Netherlands ... 展开 >> Academic Medical Centre Amsterdam, Noord-Holland, Netherlands, 1105AZ 收起 <<
NCT01071759	-		Unknown	-	Taiwan ... 展开 >> E-DA Hospital Recruiting Kaohsiung County, Taiwan Contact: Fu-Chen Kuo, MD, MSc 886-7-6150011 ext 2981 ed100418@edah.org.tw Principal Investigator: Fu-Chen Kuo, MD, Msc 收起 <<
NCT00978354	Acute Renal Failure	Phase 2 Phase 3	Terminated(Feasibility of targ... 展开 >>et enrollment within the context of available funding resources.) 收起 <<	-	Australia, Queensland ... 展开 >> Princess Alexandra Hospital Brisbane, Queensland, Australia, 4012 Australia, Victoria Austin Hospital Melbourne, Victoria, Australia, 3084 Canada, Alberta General Systems Intensive Care Unit, University of Alberta Edmonton, Alberta, Canada, T6G2B7 Canada, Quebec University of Laval Quebec City, Quebec, Canada, G1V 0A6 收起 <<
NCT00986063	Nevirapine Induced Rash ... 展开 >> Nevirapine Induced Hepatitis HIV Adverse Side Effects AIDS HIV Infections 收起 <<	Phase 4	Completed	-	Thailand ... 展开 >> Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok, Thailand, 10400 收起 <<
NCT02352740	Overweight Hy... 展开 >>pertriglyceridemic Waist 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Centre de Recherche sur Volontaires (CRV), Hospital Avicenne Bobigny, Ile-de-France, France, 93000 收起 <<
NCT00529139	Acute Kidney Failure	Phase 4	Completed	-	Germany ... 展开 >> Hannover Medical School Hannover, Germany, 30625 收起 <<
NCT00362063	Growth Hormone Deficiency	Not Applicable	Active, not recruiting	April 2018	United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT00815113	-		Completed	-	Israel ... 展开 >> Department of Gastroenterology, Rabin Medical Center Petach Tikva, Israel, 49100 收起 <<
NCT03091634	Qi Stagnation and Blood Stasis... 展开 >> Syndrome 收起 <<	Phase 2	Recruiting	December 1, 2018	China ... 展开 >> Guang'anmen Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, China, 100053 Contact: Jie Wang, professor 8610-88001817 wangjie0103@126.com Contact: Haoqiang He, master 8610-88001817 MyStrong@bucm.edu.cn Sub-Investigator: Jie Wang, professor Sub-Investigator: Haoqiang He, master Sub-Investigator: Guang Chen, doctor Sub-Investigator: Jialiang Gao, doctor Sub-Investigator: Qingyong He, professor Huguosi TCM Hospital Affiliated to Beijing University of CM Recruiting Beijing, China Contact: Yu Liu, master 0086-13810113116 Principal Investigator: Yu Liu, master Wangjing Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, China Contact: Chenhao Zhang, professor 0086-13671393316 Principal Investigator: Chenhao Zhang, professor 收起 <<
NCT01696448	Metabolic Syndrome	Not Applicable	Completed	-	United States, Georgia ... 展开 >> Atlanta Vascular Research Foundation Atlanta, Georgia, United States, 30342 收起 <<
NCT02868723	Stroke Transi... 展开 >>ent Ischemic Attack (TIA) 收起 <<	Not Applicable	Recruiting	December 30, 2019	Qatar ... 展开 >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Contact: YAHIA Z BASHIER IMAM, MD,MRCP,MRCPE 55246887 yimam@hamad.qa Contact: NIMA K EL KHAWAD MOHAMED AHMED, MBBS 33141880 drnima88@gmail.com Sub-Investigator: NUMAN AMIR, MB,BS Sub-Investigator: MAHER SAQQUR, FRCPC Sub-Investigator: AHMAD MUHAMMAD, MBBS Sub-Investigator: DIRK DELEU, PHD Sub-Investigator: AHMED OWN, MD Sub-Investigator: AHMED EL SOTOUHY, MD Sub-Investigator: ABDULSALIM KILIYANNI, MD Sub-Investigator: ABDUL SALAM, PHD Sub-Investigator: MOHAMED S ABDELMONEIM, MSC Sub-Investigator: PAULA BOURKE, PGC Sub-Investigator: DEBORAH MARGARET, BSC Sub-Investigator: MARK SANTOS, MAN Sub-Investigator: SUJATHA JOSEPH, MSC Sub-Investigator: pablo garcia, MD 收起 <<
NCT01251029	Chronic Kidney Diseases ... 展开 >> General Anesthesia 收起 <<	Phase 1	Unknown	January 2014	Israel ... 展开 >> Assaf Harofeh Medical Center Not yet recruiting Zerifin, Israel, 70300 Contact: Zoya Haitov, MD 972-8-9779946 ZoyaC@asaf.health.gov.il Principal Investigator: Zoya Haitov, MD 收起 <<
NCT00935012	TTR-CM	Phase 3	Active, not recruiting	December 2021	United States, Illinois ... 展开 >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, New York Clinical Cardiovascular Research Lab for the Elderly (CCRLE) Columbia Universtiy New York, New York, United States, 10034 收起 <<
NCT01846754	-		Completed	-	Taiwan ... 展开 >> National Taiwan University Hospital Taipei, Taiwan 收起 <<
NCT03666312	-		Recruiting	August 30, 2021	Italy ... 展开 >> IRCCS San Raffaele Active, not recruiting Milan, Italy, 20132 Azienda Ospedaliero, Universitaria Pisana Recruiting Pisa, Italy Contact: Paola Carrai Azienda Ospedaliera Città della Salute e della Scienza di Torino Recruiting Torino, Italy Contact: Renato Romagnoli, MD 收起 <<
NCT02084823	Neoplasms, Lung	Phase 1 Phase 2	Completed	-	China, Guangdong ... 展开 >> Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 收起 <<
NCT02074046	Neoplasms, Pancreas	Phase 1 Phase 2	Completed	-	China, Guangdong ... 展开 >> Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 收起 <<
NCT02115958	Neoplasms, Lung	Phase 1 Phase 2	Completed	-	China, Guangdong ... 展开 >> Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 收起 <<
NCT03089216	Tooth Bleaching ... 展开 >> Tooth Sensitivity 收起 <<	Phase 4	Active, not recruiting	December 31, 2018	-
NCT02089919	Neoplasms, Liver	Phase 1 Phase 2	Completed	-	China, Guangdong ... 展开 >> Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 收起 <<
NCT02176746	Neoplasms,Colorectal	Phase 1 Phase 2	Completed	-	China, Guangdong ... 展开 >> Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 收起 <<
NCT02178670	Neoplasms,Ovarian	Phase 1 Phase 2	Completed	-	China, Guangdong ... 展开 >> Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China, 510000 收起 <<
NCT02919111	Prostate Cancer	Phase 2 Phase 3	Recruiting	August 2020	United States, California ... 展开 >> UCSF Imaging Center at China Basin Recruiting San Francisco, California, United States, 94107 Contact: Raven Smith 415-353-9448 raven.smith@ucsf.edu 收起 <<
NCT00197379	Alopecia	Not Applicable	Unknown	January 2007	Japan ... 展开 >> Department of Dermatology, Hamamatsu University School of Medicine Hamamatsu, Japan, 431-3192 收起 <<
NCT02918357	Prostate Cancer	Phase 2 Phase 3	Completed	-	United States, California ... 展开 >> UCSF Imaging Center at China Basin San Francisco, California, United States, 94107 收起 <<
NCT03148366	Helicobacter	Phase 3	Recruiting	April 2019	Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Ming-Shiang Wu Contact: Jyh-Ming Liou Sub-Investigator: Chieh-Chang Chang Sub-Investigator: Jyh-MIng Liou National Taiwan University Hospital, Yunlin branch Recruiting Yunlin, Taiwan Contact: Yu-Jen Fang 收起 <<
NCT01119911	-		Unknown	June 2012	Israel ... 展开 >> Meir Medical Center Recruiting Kfar Saba, Israel, 44281 收起 <<
NCT02401165	Rheumatoid Arthritis	Not Applicable	Completed	-	-
NCT03651388	-		Completed	-	France ... 展开 >> Chu Dijon Bourogne Dijon, France, 21000 收起 <<
NCT03538990	Heart Failure NYHA Class III	Not Applicable	Recruiting	December 2019	United States, Georgia ... 展开 >> University of Georgia Clinical and Translational Research Unit Recruiting Athens, Georgia, United States, 30606 Contact: Kimberly Schmitz, MS 706-713-2721 schmitzk@uga.edu 收起 <<
NCT01916369	Peripheral Arterial Disease	Phase 1	Completed	-	United Kingdom ... 展开 >> Ninewells Hospital Dundee, Scotland, United Kingdom, DD1 4HN 收起 <<
NCT01200654	Methicillin-Resistant Staphylo... 展开 >>coccus AureuS 收起 <<	Phase 4	Completed	-	-
NCT00956748	Otitis Media ... 展开 >>Otorrhea 收起 <<	Phase 4	Not yet recruiting	June 2021	Canada, British Columbia ... 展开 >> St. Paul's Hospital BC Rotary Hearing & Balance Centre Not yet recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Contact: Rochelle Galleto, LPN 604-682-2344 ext 64217 rgalleto@providencehealth.bc.ca Principal Investigator: Brian D Westerberg, MD 收起 <<
NCT03367624	-		Recruiting	March 2018	France ... 展开 >> Baux Recruiting Nancy, France, 54000 Contact: Elisabeth Baux, MD 03 83 15 28 65 ext +33 e.baux@chru-nancy.fr 收起 <<
NCT03353740	Prostate Cancer	Phase 3	Recruiting	December 1, 2019	United States, California ... 展开 >> UCSF Imaging Center at China Basin Recruiting San Francisco, California, United States, 94107 Contact: Raven Smith 415-353-9448 raven.smith@ucsf.edu Principal Investigator: Thomas Hope, MD 收起 <<
NCT01174979	Tinnitus	Phase 3	Suspended(due to less patient ... 展开 >>the study was suspended) 收起 <<	-	Austria ... 展开 >> Landeskrankenhaus Feldkirch Feldkirch, Vorarlberg, Austria, 6800 收起 <<
NCT01985672	-		Completed	-	Belgium ... 展开 >> Centre for Reproductive Medicine UZ Brussel Brussels, Belgium, 1090 收起 <<
NCT01876017	Chronic Renal Failure	Phase 1 Phase 2	Unknown	December 2016	India ... 展开 >> Chaitanya Hospital Recruiting Pune,, Maharashtra, India, 411009 Contact: Sachin P Jamadar, D ORTHO +918888788880 sac2751982@gmail.com Principal Investigator: Anant E Bagul, MS,Ortho 收起 <<
NCT02490813	Allergy to Fish ... 展开 >> Allergy to Shrimp Allergy to Crab 收起 <<	Not Applicable	Recruiting	August 2018	Hong Kong ... 展开 >> Hong Kong Sanatorium & Hospital Recruiting Happy Valley, Hong Kong Contact: JUNE CHAN, MASTER +85228358430 junechan@hksh.com Contact: TAK LEE, DOCTOR +85228358430 thlee@hksh.com 收起 <<
NCT01582646	Postthoracotomy Pain ... 展开 >> Postthoracoscopy Neuropathic Pain 收起 <<	Phase 2	Terminated(difficulty of recru... 展开 >>itment) 收起 <<	-	France ... 展开 >> CHU de Besançon Besançon,, France, 25030 Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 收起 <<
NCT00551265	Fallopian Tube Carcinoma ... 展开 >> Primary Peritoneal Carcinoma Recurrent Ovarian Carcinoma Stage III Ovarian Cancer Stage IV Ovarian Cancer 收起 <<	Not Applicable	Withdrawn	-	United States, Pennsylvania ... 展开 >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 收起 <<
NCT02395679	Mesothelioma	Phase 1	Unknown	December 2016	Netherlands ... 展开 >> Erasmus MC, Dept. of Pulmonary Medicine Recruiting Rotterdam, Zuid-Holland, Netherlands, 3015GD Contact: Cor P. van der Leest, PhD +31 10 703 4862 k.vanderleest@erasmusmc.nl Contact: Robin Cornelissen, PhD +31 10 703 4862 r.cornelissen@erasmusmc.nl 收起 <<
NCT03345966	Oral Squamous Cell Carcinoma	Not Applicable	Not yet recruiting	November 2019	Egypt ... 展开 >> Asmaa M. Abou Gabal Cairo, Egypt 收起 <<
NCT01369849	-		Completed	-	-
NCT01877759	Liver Cirrhosis	Phase 1 Phase 2	Unknown	December 2014	India ... 展开 >> Chaitanya Hospital Not yet recruiting Pune,, Maharashtra, India, 411009 Contact: Sachin P Jamadar, D ORTHO +918888788880 sac2751982@gmail.com Contact: Smita S Bhoyar, BAMS.PGCR 9372620569 drsmitabhoyar@rediffmail.com Principal Investigator: Anant E Bagul, MS,Ortho 收起 <<
NCT00905398	Precursor B-Cell Lymphoblastic... 展开 >> Leukemia-Lymphoma Acute Lymphoblastic Leukemia 收起 <<	Phase 1 Phase 2	Terminated(The study was termi... 展开 >>nated due to excessive toxicity and low compliance to the protocol scheme.) 收起 <<	July 2015	-
NCT03206359	-		Completed	-	-
NCT00004816	Multiple Sclerosis	Phase 1	Completed	-	-
NCT01369849	Chronic Lymphocytic Leukemia ... 展开 >> Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia 收起 <<	Phase 1 Phase 2	Completed	-	-
NCT03244332	Esophageal and Gastric Varices... 展开 >> Child, Only 收起 <<	Not Applicable	Completed	-	Belgium ... 展开 >> Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 收起 <<
NCT01956006	Heart Failure	Phase 1 Phase 2	Active, not recruiting	December 2017	Australia, Victoria ... 展开 >> Alfred Hospital Melbourne, Victoria, Australia, 3004 收起 <<
NCT00656968	Helicobacter Infection	Phase 4	Completed	-	Taiwan ... 展开 >> Chung-Ho Hospital Kaohsiung, Taiwan, 807 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 收起 <<
NCT00656968	-		Completed	-	-
NCT02587598	Solid Tumors	Phase 1 Phase 2	Recruiting	January 2020	-
NCT02643706	-		Unknown	December 2016	China, Shandong ... 展开 >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Feng Xu, M.D., Ph.D. 86-18560083066 xufengsdu@126.com 收起 <<
NCT00817440	Healthy	Not Applicable	Completed	-	Denmark ... 展开 >> Aarhus sygehus Aarhus, Jylland, Denmark, 8000 收起 <<
NCT01997385	Renal Insufficiency, Chronic	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 <<
NCT01412658	Drug Safety	Phase 1	Completed	-	United States, Texas ... 展开 >> Baylor University Center for Exercise, Nutrition, and Preventive Health Research Waco, Texas, United States, 76706 收起 <<
NCT03681951	Neoplasms, Pancreatic	Phase 2	Not yet recruiting	November 1, 2022	-
NCT02839265	Non-small Cell Lung Cancer (NS... 展开 >>CLC) 收起 <<	Phase 2	Recruiting	July 2021	United States, New York ... 展开 >> Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Contact: Alyssa Asaro, BA 718-920-5636 aasaro@montefiore.org Principal Investigator: Nitin Ohri, MD Principal Investigator: Chandan Guha, MD, PhD 收起 <<
NCT00445029	-		Unknown	-	France ... 展开 >> Jean-François Nicolas Recruiting Lyon, France, 69495 收起 <<
NCT02915393	-		Not yet recruiting	December 2019	-
NCT01648140	Hepatitis C, Chronic	Phase 2	Completed	-	-
NCT03485638	-		Recruiting	November 3, 2020	Korea, Republic of ... 展开 >> Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University Recruiting Seoul, Korea, Republic of, 03722 Contact: Jungwon Park, MD +82 10 7389 3033 PARKJW@yuhs.ac 收起 <<
NCT01648140	-		Completed	-	-
NCT01619449	Acute Kidney Injury ... 展开 >> Liver Disease Chronic Kidney Disease End Stage Kidney Disease 收起 <<	Not Applicable	Withdrawn(Research never begun... 展开 >> and no subjects enrolled. Protocol term with IRB in Dec 2014) 收起 <<	-	United States, Illinois ... 展开 >> University of Chicago Medicine Chicago, Illinois, United States, 60637 收起 <<
NCT02602067	Breast Neoplasm ... 展开 >> Head and Neck Neoplasm Skin Neoplasm Respiratory Tract Neoplasm Urogenital Neoplasm Digestive System Neoplasm Pancreatic Neoplasm Connective and Soft Tissue Neoplasm Lymphoma, Non-Hodgkin 收起 <<	Phase 1	Terminated(Uptake of drug into... 展开 >> the tumour lesion was negligible) 收起 <<	-	France ... 展开 >> Institut Bergonnie Bordeaux, France, 33076 Centre Leon Berard Lyon, France, 69373 Icm Val D'Aurelle Montpellier, France, 34298 Italy Istituto Nazionale Dei Tumori Irccs - Fondazione "G. Pascale" Naples, Italy, 80131 University of Study of Pisa Pisa, Italy, 65126 S. Maria Nuova Hospital - Irccs Reggio Emilia, Italy, 42123 Humanitas Clinical Institute Rozzano Mi, Italy, 20089 收起 <<
NCT03275402	Neuroblastoma ... 展开 >> CNS Metastases Leptomeningeal Metastases 收起 <<	Phase 2 Phase 3	Recruiting	December 2022	United States, California ... 展开 >> Childrens Hospital Los Angeles Not yet recruiting Los Angeles, California, United States, 90027 United States, Florida University of Florida Not yet recruiting Gainesville, Florida, United States, 32611 United States, Indiana Riley Hospital for Children Recruiting Indianapolis, Indiana, United States, 46202 United States, New York Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 United States, Ohio Nationwide Children's Hospital Not yet recruiting Columbus, Ohio, United States, 43205 United States, Texas M.D. Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Denmark Rigshospitalet Not yet recruiting København, Denmark, 2100 Spain Hospital Sant Joan de Déu Not yet recruiting Barcelona, Spain, 08010 收起 <<
NCT03108287	Helicobacter Pylori Infection	Phase 4	Completed	-	-
NCT01378975	Malignant Melanoma	Phase 2	Completed	-	-
NCT01378975	-		Completed	-	-
NCT02238821	-		Completed	-	Italy ... 展开 >> Fondazione del Piemonte per l'Oncologia Candiolo, TO, Italy, 10060 收起 <<
NCT01922505	-		Completed	-	Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Bundang-gu, Seongnam, Gyeonggi-do, Korea, Republic of, 463-707 收起 <<
NCT02336516	Haemolytic and Uremic Syndrome	Not Applicable	Recruiting	October 2021	France ... 展开 >> Arnaud de Villeneuve Hospital Recruiting Montpellier, France, 34295 Montpellier cedex 5 Contact: Marc Fila, MD +33467336428 m-fila@chu-montpellier.fr Contact: Georges Deschenes, MD, PhD +33140031242 georges.deschenes@rdb.aphp.fr 收起 <<
NCT03041688	Acute Myeloid Leukemia ... 展开 >> Blasts 5 Percent or More of Bone Marrow Nucleated Cells Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia TP53 wt Allele Untreated Adult Acute Myeloid Leukemia 收起 <<	Phase 1	Recruiting	October 31, 2019	United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org Principal Investigator: Samer K. Khaled Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Kevin R. Kelly USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Kevin R. Kelly Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact 323-865-0451 Principal Investigator: Kevin R. Kelly University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Brian A. Jonas United States, Kentucky University of Kentucky/Markey Cancer Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Site Public Contact 859-257-3379 Principal Investigator: Reshma Ramlal United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Jonathan A. Webster United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Myrna R. Nahas Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com Principal Investigator: Myrna R. Nahas Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 617-667-9925 Principal Investigator: Myrna R. Nahas Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 877-442-3324 Principal Investigator: Myrna R. Nahas United States, Ohio Ohio State University Comprehensive Cancer Center Active, not recruiting Columbus, Ohio, United States, 43210 收起 <<
NCT02145910	Recurrent Melanoma ... 展开 >> Stage IV Melanoma Tumors Metastatic to Brain 收起 <<	Phase 1	Withdrawn(Study was never open... 展开 >>ed to accrual. There is no clinical benefit to patients.) 收起 <<	-	-
NCT02023411	Diabetic Neuropathic Arthropat... 展开 >>hy 收起 <<	Phase 2	Active, not recruiting	December 2018	India ... 展开 >> Deptt of Endocrinology Chandigarh, India, 160012 PGIMER Chandigarh, India, 160012 收起 <<
NCT01576185	-		Completed	-	United States, California ... 展开 >> Children's Oncology Group Monrovia, California, United States, 91006-3776 收起 <<
NCT02404363	Locally Advanced Pancreatic Ca... 展开 >>ncer Adenocarcinoma, Pancreas Metastatic Pancreatic Cancer 收起 <<	Phase 3	Active, not recruiting	June 26, 2018	France ... 展开 >> Service d'oncologie digestive - Institut Sainte Catherine Avignon, France, 84918 收起 <<
NCT03017521	Solid Tumor, Adult	Phase 2	Recruiting	December 2020	Korea, Republic of ... 展开 >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Contact: Minkyu Jung 收起 <<
NCT01980095	Dyspepsia Hel... 展开 >>icobacter Pylori Infection 收起 <<	Phase 3	Completed	-	United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Anaheim Clinical Trials Anaheim, California, United States, 92801 Catalina Research Institute Chino, California, United States, 91710 United States, Florida Jupiter Research, Inc. Jupiter, Florida, United States, 33458 United States, Georgia Columbus Regional Research Institute Columbus, Georgia, United States, 31904 United States, Louisiana MedPharmics Metairie, Louisiana, United States, 70006 United States, Maryland Investigative Clinical Research Annapolis, Maryland, United States, 41401 MGG Group Co. Chevy Chase Clinical Research Chevy Chase, Maryland, United States, 20815 United States, Michigan Detroit Clinical Research Center Farmington Hills, Michigan, United States, 48334 United States, Nevada Office of Dr. Stephen Miller, MD Las Vegas, Nevada, United States, 89144 United States, North Carolina Peters Medical Research High Point, North Carolina, United States, 27262 Wake Research Associates Raleigh, North Carolina, United States, 27612 收起 <<
NCT01980095	-		Completed	-	-
NCT01573975	Helicobacter Pylori Infection	Phase 4	Completed	-	Taiwan ... 展开 >> Buddhist Tzu Chi General Hospital Hualien, Taiwan, 97002 收起 <<
NCT00309660	Ulcerative Colitis	Phase 1 Phase 2	Unknown	-	Denmark ... 展开 >> Dept. Gastroenterology C, Herlev University Hospital Recruiting Herlev, Denmark, 2730 Contact: Gitte Pedersen, MD +45 44883418 gitped01@herlevhosp.kbhamt.dk Principal Investigator: Gitte Pedersen, MD 收起 <<
NCT00811889	Chronic Kidney Disease ... 展开 >> Type 2 Diabetes Diabetic Nephropathy 收起 <<	Phase 2	Completed	-	-
NCT01785355	Periodontal Disease ... 展开 >> Chronic Kidney Disease 收起 <<	Not Applicable	Unknown	June 2016	Romania ... 展开 >> CMI "Dr Slusanschi Oana" Recruiting Bucharest, Romania Contact: Oana Slusanschi, DMD +40722266279 oanciu@yahoo.com Principal Investigator: Oana Slusanschi, DMD 收起 <<
NCT02943746	Premature Infants	Not Applicable	Recruiting	December 2019	United States, Texas ... 展开 >> Baylor College of Medicine / Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Amy B Hair, MD 832-826-3719 abhair@texaschildrens.org Principal Investigator: Amy B Hair, MD 收起 <<
NCT02685995	Renal Failure Chronic Requirin... 展开 >>g Hemodialysis Chronic Renal Insufficiency 收起 <<	Not Applicable	Recruiting	December 2019	United States, Pennsylvania ... 展开 >> Hospital of the Unviersity of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kristine Lima, BS 215-898-0190 lima_krisitne@yahoo.com Contact: Gregory Nadolski, MD Gregory.Nadolski@uphs.upenn.edu Principal Investigator: Gregory Nadolski, MD Sub-Investigator: Jonas Redmond, MD Penn Presbyterian Medical Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kristine Lima, BS 215-898-0190 kristine.lima@uphs.upenn.edu Principal Investigator: Gregory Nadolski, MD Sub-Investigator: Jonas Redmond, MD 收起 <<
NCT01572597	Bacterial Infection Due to Hel... 展开 >>icobacter Pylori (H. Pylori) 收起 <<	Phase 4	Unknown	December 2012	Taiwan ... 展开 >> Buddhist Tzu Chi General Hospital Recruiting Hualien, Taiwan, 97002 Contact: Ming-Cheh CHEN, MD +886-910-521003 MingCheh_chen@tzuchi.com.tw Principal Investigator: Chi-Tan HU, PhD, MD Sub-Investigator: Wei-Yi RAY, MD 收起 <<
NCT00721773	Renal Function Disorder	Not Applicable	Completed	-	China, Guangdong ... 展开 >> The 1st Affiliated Hospital, Sun Yet-sen University GuangZhou, Guangdong, China, 510080 收起 <<
NCT01382004	Yaws Treponem... 展开 >>a Infection Neglected Tropical Disease 收起 <<	Phase 3	Completed	-	Papua New Guinea ... 展开 >> Lihir Medical Centre Kavieng, New Ireland Province, Papua New Guinea, 034 收起 <<
NCT03165253	Helicobacter Pylori Infection	Not Applicable	Completed	-	-
NCT00957086	Carcinoma, Squamous Cell of He... 展开 >>ad and Neck 收起 <<	Phase 3	Recruiting	June 2021	-
NCT01566643	Helicobacter Pylori Infection	Phase 4	Unknown	December 2012	Taiwan ... 展开 >> Buddhist Tzu Chi General Hospital Recruiting Hualien, Taiwan, 97002 Contact: Ming-Cheh CHEN, MD +886-910-521003 MingCheh_chen@tzuchi.com.tw Principal Investigator: Ming-Cheh CHEN, MD Sub-Investigator: Chi-Tan HU, PhD, MD Sub-Investigator: Wei-Yi RAY, MD 收起 <<
NCT01505127	H. Pylori Infection	Phase 3	Completed	-	Japan ... 展开 >> Abiko-shi, Chiba, Japan Kashiwa-shi, Chiba, Japan Fukui-shi, Fukui, Japan Fukuoka-shi, Fukuoka, Japan Ishikari-shi, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Kobe-shi, Hyogo, Japan Nishinomiya-shi, Hyogo, Japan Marugame-shi, Kagawa, Japan Takamatsu-shi, Kagawa, Japan Kagoshima-shi, Kagoshima, Japan Ebina-shi, Kanagawa, Japan Yokohama-shi, Kanagawa, Japan Yatsushiro-shi, Kumamoto, Japan Kyoto-shi, Kyoto, Japan Oita-shi, Oita, Japan Hirakata-shi, Osaka, Japan Osaka-shi, Osaka, Japan Sakai-shi, Osaka, Japan Suita-shi, Osaka, Japan Takatsuki-shi, Osaka, Japan Toyonaka-shi, Osaka, Japan Saga-shi, Saga, Japan Kumagaya-shi, Saitama, Japan Tokorozawa-shi, Saitama, Japan Shizuoka-shi, Shizuoka, Japan Adachi-ku, Tokyo, Japan Chiyoda-ku, Tokyo, Japan Hachioji-shi, Tokyo, Japan Kokubunji-shi, Tokyo, Japan Nishi-tokyo-shi, Tokyo, Japan Oota-ku, Tokyo, Japan Ota-ku, Tokyo, Japan Setagaya-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan 收起 <<
NCT02547025	Helicobacter Pylori Infection	Not Applicable	Recruiting	December 2019	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Recruiting Kaohsiung, Taiwan, 813 Contact: Ping I Hsu, MD 886-7346-8237 williamhsup@yahoo.com.tw Contact: Feng-Woei Chiae, Bachelor +886-7-342-2121 ext 2074 fwchiae@vghks.gov.tw Sub-Investigator: Ping I Hsu, MD 收起 <<
NCT03453047	-		Recruiting	December 20, 2018	Turkey ... 展开 >> Akdeniz University Medical Faculty Department of Anesthesiology and Reanimation Recruiting Antalya, Turkey, 07059 Contact: BORA DINC, ASSIST. PROF. +905323865600 drboradinc@gmail.com Contact: ILKER ONGUC AYCAN, ASSOC. PROF +905056702335 ilkeraycan@gmail.com Principal Investigator: BORA DINC, ASSIST. PROF Sub-Investigator: ILKER ONGUC AYCAN, ASSOC. PROF. 收起 <<
NCT02646332	Helicobacter Pylori Infection	Not Applicable	Recruiting	July 2019	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Recruiting Kaohsiung, Taiwan, 813 Contact: Ping I Hsu, MD 886-7346-8237 williamhsup@yahoo.com.tw Contact: Feng-Woei Tsay, Bachelor +886-7-342-2121 ext 2074 fwchiae@vghks.gov.tw Sub-Investigator: Ping I Hsu, MD 收起 <<
NCT01592032	Catheter-Related Infections ... 展开 >> Bacteremia. 收起 <<	Phase 4	Unknown	December 2015	Spain ... 展开 >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 收起 <<
NCT01760824	Helicobacter Pylori Infection	Not Applicable	Completed	-	Hong Kong ... 展开 >> The University of Hong Kong, Queen Mary Hospital Hong Kong SAR, Hong Kong 收起 <<
NCT03013374	-		Recruiting	June 2017	Italy ... 展开 >> NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Recruiting Milan, Italy, 20122 Contact: Laura Morlacchi, MD +39 0255032483 laura.morlacchi@mangiagalli.it Principal Investigator: Laura Morlacchi, MD Sub-Investigator: Paola Roggero, MD 收起 <<
NCT01137175	-		Unknown	-	Taiwan ... 展开 >> Kaohsiung Medical University Chung-Ho Memorial Hospital Recruiting Kaohsiung, Taiwan, 807 Contact: Jessie Jou, Assistant 886-7-3121101 ext 6361 r93445113@gmail.com 收起 <<
NCT03754179	Melanoma	Phase 1 Phase 2	Recruiting	December 1, 2020	Belgium ... 展开 >> UZ Brussel Recruiting Jette, Brabant, Belgium, 1090 Contact: Bart Neyns, Phd,Md 0032(0)2477 64 15 bart.neyns@uzbrussel.be Principal Investigator: Bart Neyns, Phd,Md 收起 <<
NCT03202407	Hyperphosphatemia	Phase 3	Not yet recruiting	December 1, 2018	-
NCT03539718	Hemodialysis Catheter Infectio... 展开 >>n Thrombosis; Dialysis Catheter 收起 <<	Phase 4	Recruiting	February 2019	Egypt ... 展开 >> Ain Shams University Hospitals Recruiting Cairo, Egypt, 002 Contact: amr m mansour, Msc 1007212824 theamr19@gmail.com Principal Investigator: magdy Mohamed Saeed El Sharkawy, MD 收起 <<
NCT02547038	Helicobacter Pylori Infection	Not Applicable	Recruiting	February 2019	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Recruiting Kaohsiung, Taiwan, 813 Contact: Ping I Hsu, MD 886-7346-8237 williamhsup@yahoo.com.tw Contact: Feng-Woei Chiae, Bachelor +886-7-342-2121 ext 2074 fwchiae@vghks.gov.tw Sub-Investigator: Ping I Hsu, MD 收起 <<
NCT03321773	Helicobacter Pylori Infection	Not Applicable	Recruiting	December 2020	Taiwan ... 展开 >> Kaohsiung Veterans General Hospital Recruiting Kaohsiung, Taiwan, 813 Contact: Feng-Woei Tsay, Bachelor 886-7346-2121 ext 2074 fwchiae@vghks.gov.tw Contact: Ping-I Hsu, MD 886-7346-8233 pihsu@vghks.gov.tw 收起 <<
NCT00657618	-		Completed	-	-
NCT00657618	Leishmaniasis	Phase 1 Phase 2	Completed	-	United States, District of Col... 展开 >>umbia Walter Reed National Military Medical Center Washington, District of Columbia, United States, 20307 收起 <<
NCT01435655	Transthyretin Familial Amyloid... 展开 >> Polyneuropathy 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> Kumamoto University Hospital/Department of Neurology Kumamoto-shi, Kumamoto, Japan, 860-8556 Shinshu University Hospital/Department of Medicine (Neurology and Reumatology) Matsumoto-shi, Nagano, Japan, 390-8621 收起 <<
NCT01179906	Patients With Stage 2-4 Chroni... 展开 >>c Kidney Disease 收起 <<	Not Applicable	Completed	-	United States, Massachusetts ... 展开 >> Springfield College Springfield, Massachusetts, United States, 01109 收起 <<
NCT01435655	-		Completed	-	-
NCT02090738	H. Pylori Infection	Phase 2	Withdrawn	-	Korea, Republic of ... 展开 >> severnace Hospital Seoul, Seodaemun-gu, Korea, Republic of, 120-752 收起 <<
NCT01922765	Gastritis, Gastric Ulcer, and ... 展开 >>Duodenal Ulcer 收起 <<	Phase 4	Unknown	February 2014	Korea, Republic of ... 展开 >> Yeouido St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 150-713 Contact: Jin Il Kim, MD,PhD 82-10-6345-9977 jikim@catholic.ac.kr Principal Investigator: Jin Il Kim, MD,PhD 收起 <<
NCT02739113	Limbal Stem Cell Deficiency	Phase 1 Phase 2	Active, not recruiting	December 2019	-
NCT03217916	-		Not yet recruiting	March 1, 2018	-
NCT00454974	Renal Failure	Phase 1	Completed	-	United Kingdom ... 展开 >> UCL Center for Nephrology London, United Kingdom, NW3 2QG 收起 <<
NCT02083484	-		-	-	-
NCT01004770	-		Completed	-	-
NCT02025491	Disseminated Leishmaniasis	Phase 3	Completed	-	Brazil ... 展开 >> HUPES Salvador, Bahia, Brazil, 40000 收起 <<
NCT03342456	Duodenal Ulcer Due to Helicoba... 展开 >>cter Pylori 收起 <<	Phase 4	Recruiting	March 20, 2019	China, Hunan ... 展开 >> Hunan Provincial People's Hospital Recruiting Changsha, Hunan, China, 410002 Contact: JIANGTAO LIAO +8613574899399 jt99399@163.com Changsha Central Hospital Not yet recruiting Changsha, Hunan, China, 410004 Contact: YA ZENG +8613637403676 The First Hospital of Changsha City Not yet recruiting Changsha, Hunan, China, 410005 Contact: LI LIU +8613975119635 Xiangya Hospital of Central South University Not yet recruiting Changsha, Hunan, China, 410008 Contact: MEIHUA XU +8613787270539 meihuaxu2001@yahoo.com.cn The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: CHUNLIAN WANG +8613973161116 The Third Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410013 Contact: CANXIA XU +8613786176248 xucanxia@163.com The First Affiliated Hospital of University of South China Not yet recruiting Hengyang, Hunan, China, 421001 Contact: AIJUN LIAO +8613973400930 liaoaj163@163.com Loudi central hospital Recruiting Loudi, Hunan, China, 417000 Contact: FENGQIAN SONG +8615873890651 Shaoyang Central Hospital Recruiting Shaoyang, Hunan, China, 422000 Contact: CHAOMIN LI +8613762857236 The Affiliated Hospital Of YongZhou Vocational Technical College Recruiting Yongzhou, Hunan, China, 425000 Contact: MING YANG +8613974621123 收起 <<
NCT01004770	Healthy	Phase 1 Phase 2	Completed	-	United States, New Jersey ... 展开 >> GE Healthcare Princeton, New Jersey, United States, 08540 收起 <<
NCT03665428	Helicobacter Pylori Infection	Phase 4	Recruiting	December 31, 2019	Korea, Republic of ... 展开 >> Chuncheon Sacred Heart hospital Recruiting Chuncheon, Gangwon-do, Korea, Republic of, 24253 Contact: Chang Seok Bang, M.D., Ph.D. +82-33-240-5000 cloudslove@naver.com Principal Investigator: Chang Seok Bang, M.D., Ph.D. 收起 <<
NCT03312244	HIV-1-infection ... 展开 >> CD4+ T Lymphocytopenia Immune Deficiency Immuno-senescence 收起 <<	Phase 2	Active, not recruiting	June 30, 2020	Mexico ... 展开 >> Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Tlalpan, Ciudad de México, Mexico, 14080 收起 <<
NCT02941159	Good Health	Phase 1	Recruiting	February 2018	Zambia ... 展开 >> Tropical Diseases Resaerch Centre Recruiting Ndola, Copperbelt, Zambia, 71769 Contact: Modest Mulenga, MD; PhD +260-212-620737 mulengam@tdrc.org.zm Contact: Shepherd Khondowe, MPH +260-212-620737 khondowes@tdrc.org.zm Principal Investigator: Ray Handema, PhD Sub-Investigator: Alasford Ngwengwe, PhD Sub-Investigator: Victor Mwanakasale, MD; PhD 收起 <<
NCT01549990	-		Completed	-	Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 <<
NCT00005665	Diabetes Mellitus, Type 1	Phase 2	Unknown	-	United States, Texas ... 展开 >> Dept. of Neurology, Rm MSB 7.044 Univ. of Texas-Houston Medical School Houston, Texas, United States, 77030 收起 <<
NCT00634595	Head and Neck Squamous Carcino... 展开 >>ma Nasopharyngeal Carcinoma 收起 <<	Phase 2	Unknown	December 2010	China, Guangdong ... 展开 >> Cancer center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Xubin Lin, MD, PhD linxubin@mail.sysu.edu.cn 收起 <<
NCT03367663	Atherosclerosis ... 展开 >> Dyslipidemias Diabetes 收起 <<	Early Phase 1	Not yet recruiting	December 2018	-
NCT03596580	-		Recruiting	June 2019	Italy ... 展开 >> Fondazione Ca' Granda Ospedale Maggiore Policlinico Recruiting Milan, Italy, 20122 Contact: Ivana Maria Rosi, Dr +390255035457 ivana.rosi@policlinico.mi.it Contact: Roberto Milos, Dr +390255032704 roberto.milos@policlinico.mi.it Principal Investigator: Ivana Maria Rosi, Dr Sub-Investigator: Roberto Milos, Dr Sub-Investigator: Loris Bonetti, Dr 收起 <<
NCT01960231	-		Recruiting	December 2017	Israel ... 展开 >> Sheba Medical Center Recruiting ramat Gan, Israel, 52621 Contact: Ayana Paster, RD 972-3-5302021 收起 <<
NCT00629018	-		Completed	-	-
NCT02493725	Gullain Barre Syndrome	Phase 2	Completed	-	Japan ... 展开 >> Nagoya University Hospital Nagoya, Aichi, Japan Hokkaido University Hospital Sapporo, Hokkaido, Japan Kobe City Medical Center General Hospital Kobe, Hyogo, Japan Kitasato University Hospital Sagamihara, Kanagawa, Japan Kindai University Hospital Osaka-sayama, Osaka, Japan National Defence Medical College Hospital Tokorozawa, Saitama, Japan Dokkyo Medical University Hospital Mibu, Tochigi, Japan Tokyo Medical and Dental University Hospital Bunkyo-ku, Tokyo, Japan Tokyo University Hospital Bunkyo-ku, Tokyo, Japan Keio University Hospital Shinjuku-ku, Tokyo, Japan Chiba University Hospital Chiba, Japan Kyushu University Hospital Fukuoka, Japan Tokushima University Hospital Tokushima, Japan 收起 <<
NCT02602808	-		Unknown	December 2016	China, Shandong ... 展开 >> Linyi People's Hospital Recruiting Dezhou, Shandong, China Contact: Juncai Liu, M.D. liujuncai1995@163.com China Changhai Hospital, Second Military Medical University Recruiting Shanghai, China, 200433 Contact: zhaoshen Li, MD 86-21-81873241 zhaoshenlismmu@gmail.com Principal Investigator: zhaoshen Li, MD Department of Gastroenterology, Shanghai First People's Hospital Recruiting Shanghai, China, 200433 Contact: Guoyong Hu, M.D. huguoyongsh@sina.com 收起 <<
NCT02082821	-		Active, not recruiting	June 2019	United States, Massachusetts ... 展开 >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 收起 <<
NCT02701543	Peripheral Artery Disease	Not Applicable	Active, not recruiting	October 2020	Germany ... 展开 >> University Clinic Leipzig Leipzig, Saxony, Germany, 04103 收起 <<
NCT02629874	Endotoxemia S... 展开 >>ystemic Inflammatory Response 收起 <<	Phase 1	Completed	-	Netherlands ... 展开 >> Intensive care, research unit, Radboud University Medical Centre Nijmegen, Gelderland, Netherlands, 6525 GA 收起 <<
NCT02646228	-		Recruiting	June 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Korea, Republic of, 135-720 Contact: yoon jeong ahn 82-2-2148-7395 Principal Investigator: Jeeyun Lee, MD, PhD 收起 <<
NCT02032082	Neurogenic Lung Edema	Not Applicable	Unknown	January 2018	Belgium ... 展开 >> CHU Mont-Godinne Yvoir, Namur, Belgium, 5530 收起 <<
NCT00629018	Dilated Cardiomyopathy	Phase 2	Completed	-	Slovenia ... 展开 >> Ljubljana University Medical Center Ljubljana, Slovenia, 1000 收起 <<
NCT01863823	Oral Helicobacter Pylori	Phase 1 Phase 2	Completed	-	China ... 展开 >> Beijing University First Hospital Beijiang, China, 1001 收起 <<
NCT01909141	Polycystic Ovary Syndrome ... 展开 >> Infertility 收起 <<	Early Phase 1	Completed	-	Egypt ... 展开 >> Cairo University Cairo, Egypt 收起 <<
NCT01909141	-		Completed	-	-
NCT02895113	Diabetes	Phase 3	Unknown	September 2018	Italy ... 展开 >> Internal and Medical Specialities Department - Policlinico Umberto I Rome, Italy, 00161 收起 <<
NCT00774774	Influenza Human	Phase 4	Completed	-	France ... 展开 >> Hopital Saint Antoine Paris, France, 75012 收起 <<
NCT01360931	-		Unknown	June 2013	Hong Kong ... 展开 >> Queen Mary Hospital Recruiting Hong Kong, Hong Kong, 0 Contact: David CL Lam, MBBS, FRCP(Edin), FCCP, FACP +852 2255 5814 dcllam@hku.hk 收起 <<
NCT02459613	Endocarditis ... 展开 >>Thrombosis 收起 <<	Phase 1 Phase 2	Recruiting	September 2019	France ... 展开 >> Bichat Hospital Recruiting Paris, France, 75018 收起 <<
NCT01637220	-		Completed	-	France ... 展开 >> Hospital BICHAT Paris, France, 75018 收起 <<
NCT00154310	-		Completed	-	-
NCT01004120	Metabolic Syndrome X	Phase 1 Phase 2	Completed	-	United Kingdom ... 展开 >> School of Chemistry, Food Biosciences and Pharmacy, The University of Reading Reading, Berkshire, United Kingdom, RG6 6AU 收起 <<
NCT00944996	Major Depression	Not Applicable	Completed	-	Israel ... 展开 >> Tirat Carmel Mental Health Center Tirat Hacarmel, Israel, 30200 收起 <<
NCT02828774	-		Not yet recruiting	June 2020	-
NCT02474251	Obstructive Sleep Apnea ... 展开 >> Alzheimer's Disease 收起 <<	Not Applicable	Active, not recruiting	March 31, 2019	United States, New York ... 展开 >> Bellevue Hospital Center New York, New York, United States, 10016 NYU Langone Medical Center New York, New York, United States, 10016 收起 <<
NCT00950391	Peripheral Nerve Injury	Phase 1 Phase 2	Withdrawn(PI unable to secure ... 展开 >>funding for the project so study was not pursued.) 收起 <<	September 2015	-
NCT00154310	Renal Transplantation	Phase 4	Completed	-	Germany ... 展开 >> Novartis Investigational Sites Nurnberg, Germany Switzerland Novartis Pharma AG Basel, Switzerland Novartis Investigational Sites Bern, Switzerland 收起 <<
NCT02329054	Ebola Virus Disease	Phase 2	Completed	-	Guinea ... 展开 >> The caregivers treatment center Conakry, Guinea MSF Ebola treatment centre Gueckedou, Guinea French Red Cross Ebola care center Macenta, Guinea ALIMA Ebola care center Nzerekore, Guinea 收起 <<
NCT00378443	Glomerulonephritis, IGA	Not Applicable	Unknown	-	-
NCT03740048	End Stage Renal Failure on Dia... 展开 >>lysis 收起 <<	Phase 3	Not yet recruiting	June 2021	United States, North Carolina ... 展开 >> Wake Forest Baptist Medical Center Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Carrie Smith 336-713-7531 suscmit@wakehealth.edu Contact: Mariana Murea, MD 3367162074 mmurea@wakehealth.edu 收起 <<
NCT01547065	-		Terminated(Enrollment lower th... 展开 >>an anticipated) 收起 <<	-	United States, New Jersey ... 展开 >> University Hospital Newark, New Jersey, United States, 07101 收起 <<
NCT01014234	Kidney Transplantation	Phase 2	Completed	-	Italy ... 展开 >> Policlinico Fondazione IRCCS "San Matteo" Pavia, Italy, 27100 收起 <<
NCT01673737	Neoplasm Malignant	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Investigational Site Number 840001 Boston, Massachusetts, United States, 02114 Investigational Site Number 840101 Boston, Massachusetts, United States, 02115 United States, Texas Investigational Site Number 840002 Houston, Texas, United States, 77054 Canada Investigational Site Number 124001 Toronto, Canada, M5G 2M9 收起 <<
NCT02273102	Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndromes Leukemia 收起 <<	Phase 1	Recruiting	December 2019	United States, Florida ... 展开 >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Justin Watts, MD 305-243-4860 jwatts@med.miami.edu Principal Investigator: Justin Watts, MD 收起 <<
NCT02565446	Obesity Fatty... 展开 >> Liver 收起 <<	Not Applicable	Recruiting	December 2019	United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 收起 <<
NCT03231995	Influenza	Not Applicable	Not yet recruiting	October 2020	France ... 展开 >> Laboratoire de Virologie Institut des Agents Infectieux - Hospices Civils de Lyon Not yet recruiting Lyon, France, 69317 Contact: Laurence Josset (0)472 071 022 ext +33 Laurence.josset@chu-lyon.fr 收起 <<
NCT02130466	Melanoma Soli... 展开 >>d Tumors 收起 <<	Phase 1 Phase 2	Recruiting	July 10, 2021	United States, Arizona ... 展开 >> Call for Information (Investigational Site 0030) Recruiting Tucson, Arizona, United States, 85719 United States, California Call for Information (Investigational Site 0001) Recruiting Los Angeles, California, United States, 90025 Call for Information (Investigational Site 0003) Recruiting Los Angeles, California, United States, 90095 United States, Indiana Call for Information (Investigational Site 0031) Recruiting Fort Wayne, Indiana, United States, 46845 United States, Massachusetts Call for Information (Investigational Site 0002) Recruiting Boston, Massachusetts, United States, 02215 United States, Pennsylvania Call for Information (Investigational Site 0007) Recruiting Philadelphia, Pennsylvania, United States, 19104 Australia Merck Sharp & Dohme Recruiting North Ryde, Australia Contact: Australian Medical Information Centre 61 2 8988 8428 Canada, Quebec Merck Canada Recruiting Kirkland, Quebec, Canada, H9H 4M7 Contact: Medical Information Centre Centre d'information medicale Merck Canada Inc. 514-428-8600 / 1-800-567-2594 收起 <<
NCT02200120	-		Completed	-	United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 收起 <<
NCT00200655	Relapsing-remitting Multiple S... 展开 >>clerosis 收起 <<	Phase 3	Completed	-	France ... 展开 >> Nantes University Hospital Nantes, France, 44093 收起 <<
NCT00512629	Cholestasis P... 展开 >>arenteral Nutrition 收起 <<	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Childrens's Hospital Boston Boston, Massachusetts, United States, 02115 收起 <<
NCT03236220	Haploidentical Hematopoietic S... 展开 >>tem Cell Transplantation 收起 <<	Phase 2	Recruiting	July 2019	China ... 展开 >> Peking University People's Hospital Recruiting Beijng, China Contact: Yuan Kong, MD,PhD 86-10-88324670 successky@163.com 收起 <<
NCT02736565	Ewing's Sarcoma	Phase 1	Recruiting	December 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Morgan Coleman colemanm@mskcc.org Principal Investigator: Emily Slotkin, MD United States, Texas Mary Crowley Cancer Research Centers Completed Dallas, Texas, United States, 75230 收起 <<
NCT03497819	Pancreatic Cancer	Early Phase 1	Active, not recruiting	October 31, 2020	China, Zhejiang ... 展开 >> First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China, 325000 收起 <<
NCT01860573	Prematurity	Not Applicable	Completed	-	United States, Rhode Island ... 展开 >> Women & Infants Hospital of Rhode Island Providence, Rhode Island, United States, 02905 收起 <<
NCT01860573	-		Completed	-	-
NCT01637688	-		Recruiting	September 2018	Thailand ... 展开 >> Faculty of Medicine Siriraj Hospital Recruiting Bangkok, Thailand, 10700 Contact: Narumon Densupsoontorn, MD 662 4197000 ext 5947 narumon.den@mahidol.ac.th Contact: Pipop Densupsoontorn, MD 662 4197000 ext 5946 pipop.jir@mahidol.ac.th Principal Investigator: Narumon Densupsoontorn, MD 收起 <<
NCT02806856	Acute Stroke	Not Applicable	Recruiting	February 2019	France ... 展开 >> Centre Hospitalier Sainte Anne Recruiting Paris, France, 75674 Contact: Martine GAVARET, PH 收起 <<
NCT01725906	Self Efficacy	Phase 4	Recruiting	December 2017	Taiwan ... 展开 >> National Taiwan Universtiy Hospital Recruiting Taipei, Taiwan Contact: Jyh-Ming Liou, MD +886972651883 dtmed046@pchome.com.tw Principal Investigator: Ming-Shiang Wu, MD National Taiwan University Hospital, Yun-Lin Branch Recruiting Yun-Lin County, Taiwan Principal Investigator: Chieh-Chang Chen, MD 收起 <<
NCT02200978	Childhood Acute Promyelocytic ... 展开 >>Leukemia 收起 <<	Phase 4	Recruiting	September 2022	China, Guangdong ... 展开 >> The First Affiliated Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Xue-Qun Luo, professor L-xuequn@126.com Principal Investigator: Xue-Qun Luo, professor 收起 <<
NCT01764880	Multiple Myeloma	Phase 1	Completed	-	Germany ... 展开 >> Manik Chatterjee Würzburg, Germany, 97080 Israel Division of Hematology, Chaim Sheba Medical Center Tel Hashomer, Israel Italy U.O. Ematologia con Trapianto, Dipartimento dell'Emergenza e dei Trapianti di Organi Bari, Italy, 70124 USC Ematologia, Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy, 24127 S.C. Ematologia, ASO S. Croce e Carle - Cuneo Cuneo, Italy, 12100 收起 <<
NCT02796859	Schizophrenia ... 展开 >> Psychotic Disorders 收起 <<	Phase 1 Phase 2	Recruiting	May 2020	United States, Georgia ... 展开 >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Brian J Miller, MD 706-721-4445 brmiller@augusta.edu Contact: Elizabeth Matznick, BS 706-721-3048 ematznick@augusta.edu Principal Investigator: Brian J Miller, MD 收起 <<
NCT02090725	Muscle Weakness	Not Applicable	Enrolling by invitation	December 2020	United States, New Hampshire ... 展开 >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03221 收起 <<
NCT00234494	Bladder Cancer	Phase 2	Completed	-	United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 AP&S Clinic Terre Haute, Indiana, United States, 47804 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 收起 <<
NCT01715636	HIV Nonoccupational Post-expos... 展开 >>ure Prophylaxis in Men Who Have Sex With Men 收起 <<	Phase 4	Completed	-	Australia, New South Wales ... 展开 >> Sydney Sexual Heatlh Centre Sydney, New South Wales, Australia, 2000 St Vincents Hospital Sydney, New South Wales, Australia, 2010 Australia, Victoria The Alfred Hospital Melbourne, Victoria, Australia, 3004 Melbourne Sexual Health Centre Melbourne, Victoria, Australia, 3053 收起 <<
NCT00234494	-		Completed	-	-
NCT02555293	Malignant Liver Disease ... 展开 >> Major Liver Resection 收起 <<	Phase 2	Recruiting	-	Germany ... 展开 >> RWTH Aachen University Recruiting Aachen, Germany, 52074 Contact: Ulf Neumann, Prof., MD uneumann@ukaachen.de 收起 <<
NCT03550729	Pulmonary Arterial Hypertensio... 展开 >>n 收起 <<	Not Applicable	Recruiting	December 2020	Spain ... 展开 >> Hospital Clínic Recruiting Barcelona, Spain, 08036 Contact: Isabel Blanco, MD, PhD +34 649539835 iblanco2@clinic.cat 收起 <<
NCT01568736	-		Withdrawn(never started)	March 2016	United States, Michigan ... 展开 >> Michigan Techinical University Houghton, Michigan, United States, 49931 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 Netherlands Radbound University of Nijmegen Medical Centre Nijmegen, Netherlands 收起 <<
NCT03682003	-		Active, not recruiting	December 1, 2019	-
NCT02613325	Pigmented Skin Lesion ... 展开 >> Melanoma 收起 <<	Phase 1	Completed	-	United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 <<
NCT00613496	Persistent Atrial Fibrillation	Phase 4	Unknown	May 2010	Germany ... 展开 >> University Hospital Magdeburg; Div. of Cardiology Recruiting Magdeburg, Germany, 39120 Contact: Veronika Raetzel 0049 391 6701 veronika.raetzel@medizin.uni-magdeburg.de 收起 <<
NCT02721953	Insulin Resistance ... 展开 >> Obesity 收起 <<	Phase 2 Phase 3	Unknown	March 2018	Italy ... 展开 >> University of Naples Federico II Recruiting Naples, Italy, 80131 Contact: Roberto Berni Canani, MD, PhD +390817462680 收起 <<
NCT02687724	Colitis	Phase 4	Recruiting	February 2020	Ireland ... 展开 >> St Vincent's University Hospital Recruiting Dublin, Ireland Contact: Glen Doherty g.doherty@st-vincents.ie Principal Investigator: Glen Doherty 收起 <<
NCT02026414	Obesity	Not Applicable	Active, not recruiting	December 2022	United States, Ohio ... 展开 >> The Ohio State University Wexner Medical Center (Davis Heart and Lung Research Institute) Columbus, Ohio, United States, 43210 收起 <<
NCT00853580	-		Completed	-	-
NCT02645201	Helicobacter Infections	Not Applicable	Withdrawn(The research protoco... 展开 >>l was completely changed.) 收起 <<	August 18, 2017	Belgium ... 展开 >> Queen Fabiola Children's Hospital Brussels, Belgium Croatia Children's Hospital Zagreb Zagreb, Croatia, 10000 Germany Dr. von Hauner Children's Hospital Munich, Germany Israel Kaplan Medical Center Rehovot, Israel Slovenia University Children's Hospital Ljubljana, Slovenia, 1000 收起 <<
NCT03670472	-		Recruiting	January 2020	France ... 展开 >> Hôpital Calmette,CHU Recruiting Lille, France Principal Investigator: Anne Prévotat, MD 收起 <<
NCT00853580	Neurofibromatosis Type 1	Phase 2	Completed	-	United States, Alabama ... 展开 >> The University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland NIH Bethesda, Maryland, United States, 20892 United States, Massachusetts Children' Hospital Boston Boston, Massachusetts, United States, 02115 United States, Missouri Washington University - St. Louis Saint Louis, Missouri, United States, 63110 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19096 United States, Texas Childrens Medical Center - Univ. of Texas SW Medical Center Dallas, Texas, United States, 75235 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Australia, New South Wales The Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 收起 <<
NCT01334255	Pigment Epithelial Detachment	Phase 1	Terminated(Sponsor decision; n... 展开 >>ot safety related) 收起 <<	-	United States, Florida ... 展开 >> Center For Retina & Macular Disease Winter Haven, Florida, United States, 33880 United States, Pennsylvania Associates in Ophthalmology West Mifflin, Pennsylvania, United States, 15122 United States, South Carolina Palmetto Retina Center West Columbia, South Carolina, United States, 29169 United States, Texas Retina Research Institute of Texas Abilene, Texas, United States, 79606 Retina Research Center Austin, Texas, United States, 78705 收起 <<
NCT01457534	-		Completed	-	Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 <<
NCT03291639	-		Not yet recruiting	September 4, 2018	-
NCT01610401	Ischemia Reperfusion Injury ... 展开 >> Endothelial Function 收起 <<	Phase 4	Completed	-	Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB 收起 <<
NCT00823290	Hepatocellular Carcinoma	Phase 1	Unknown	December 2010	Germany ... 展开 >> Department of Medicine 1, University Hospital Erlangen Recruiting Erlangen, Germany, 91054 Contact: Matthias Ocker, MD +49-6421-58 ext 68931 Matthias.Ocker@staff.uni-marburg.de Contact: Susanne Gahr, MD +49-9131-85 ext 35000 susanne.gahr@uk-erlangen.de Principal Investigator: Deike Strobel, MD 收起 <<
NCT01140360	Neurofibromatosis ... 展开 >> Neurofibromas 收起 <<	Phase 1 Phase 2	Completed	-	United States, Indiana ... 展开 >> Riley Hospital for Children Indianapolis, Indiana, United States, 46202 收起 <<
NCT01140360	-		Completed	-	-
NCT01109381	Helicobacter Pylori Infection	Phase 1 Phase 2	Terminated(Poor efficacy (2 of... 展开 >> 31 completing participants with H.pylori eradication)) 收起 <<	-	Singapore ... 展开 >> Singapore General Hospital Singapore, Singapore 收起 <<
NCT03722433	Helicobacter Pylori Infection	Phase 4	Recruiting	July 31, 2020	Taiwan ... 展开 >> Jyh-Ming Liou Recruiting Taipei, Taiwan, Taiwan, 10002 Contact: Jyh-Ming Liou jyhmingliou@gmail.com 收起 <<
NCT03193450	Helicobacter Pylori Infection	Not Applicable	Completed	-	China, Shaanxi ... 展开 >> First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710061 收起 <<
NCT03233776	Multiple Myeloma	Phase 2	Recruiting	November 2019	Netherlands ... 展开 >> Radboud university medical center Recruiting Nijmegen, Netherlands, 6525 GA Contact: Postbus Trialbureau Hematologie-Oncologie +31 24 36 14 794 trialbureauhemat-onco@radboudumc.nl Principal Investigator: Nicole Blijlevens, MD PhD 收起 <<
NCT01879267	Huntington's Disease	Not Applicable	Completed	-	Switzerland ... 展开 >> University Hospital Zurich, Division of Neurology Zurich, ZH, Switzerland, 8091 收起 <<
NCT01441453	Surgery Hepat... 展开 >>ocellular Carcinoma 收起 <<	Not Applicable	Unknown	-	Italy ... 展开 >> General Surgery and Organ Transplantation Unit, Policlinico Sant'Orsola-Malpighi Not yet recruiting Bologna, Italy, 40138 Contact: Matteo Cescon, MD, PhD matteo.cescon@unibo.it Principal Investigator: Matteo Cescon, MD, PhD 收起 <<
NCT02230917	Multiple Myeloma	Phase 2	Withdrawn	-	United States, Indiana ... 展开 >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 <<
NCT02819804	B Acute Lymphoblastic Leukemia... 展开 >> With t(9;22)(q34;q11.2); BCR-ABL1 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia 收起 <<	Phase 1	Active, not recruiting	August 2019	United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States, 60611 收起 <<
NCT01109381	-		Terminated(Poor efficacy (2 of... 展开 >> 31 completing participants with H.pylori eradication)) 收起 <<	-	-
NCT03229317	-		Recruiting	March 2020	France ... 展开 >> Armand Trousseau Hospital Recruiting Paris, France, 75012 Contact: Nicole BEYDON, MD, PhD 01 71 73 85 18 nicole.beydon@aphp.fr Necker Enfants-malades Hospital Recruiting Paris, France, 75015 Contact: Alice HADCHOUEL, MD, PhD +33 1 44 49 48 47 alice.hadchouel-duverge@aphp.fr Robert Debré Hospital Not yet recruiting Paris, France, 75019 Contact: Véronique HOUDOUIN, MD;, PhD 01 40 03 36 78 veronique.houdouin@aphp.fr 收起 <<
NCT02562898	Metastatic Pancreatic Adenocar... 展开 >>cinoma 收起 <<	Phase 1 Phase 2	Active, not recruiting	June 2019	United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94158 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 收起 <<
NCT01291407	Gastrointestinal Neoplasms ... 展开 >> Gastric Cancer 收起 <<	Phase 1	Completed	-	China ... 展开 >> Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, China, 100021 收起 <<
NCT01466322	Multiple Sclerosis, Relapsing-... 展开 >>Remitting 收起 <<	Phase 1	Completed	-	Australia, Queensland ... 展开 >> GSK Investigational Site Herston, Queensland, Australia, 4006 收起 <<
NCT03198455	Pollen; Allergy, Asthma	Not Applicable	Completed	-	-
NCT02780219	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Not Applicable	Recruiting	February 2020	United States, Texas ... 展开 >> Texas A&M University-CTRAL Recruiting College Station, Texas, United States, 77845-4253 Contact: Marielle Engelen, PhD 979-220-2282 mpkj.engelen@ctral.org Contact: Clayton Cruthirds, MS 7138280116 Cl.cruthirds@ctral.org 收起 <<
NCT02372136	Infant, Premature, Diseases ... 展开 >> Infant, Small for Gestational Age 收起 <<	Not Applicable	Active, not recruiting	January 2022	United States, Texas ... 展开 >> UT Southwestern Medical Center Dallas, Texas, United States, 75390-9063 收起 <<
NCT00421785	ESRD Peritone... 展开 >>al Dialysis 收起 <<	Not Applicable	Unknown	January 2008	Israel ... 展开 >> Dialyss unit Recruiting Zerifin, Israel, 70300 Contact: Leonid s Feldman +972-8-9779383 leonidf@asaf.health.gov.il 收起 <<
NCT02112812	Response to Levodopa ... 展开 >> Motor Outcomes Quality of Life Outcomes 收起 <<	Not Applicable	Completed	-	Malaysia ... 展开 >> UKM Medical Center Cheras, Kuala Lumpur, Malaysia, 56000 收起 <<
NCT03172403	Cancer of Digestive System	Not Applicable	Recruiting	March 1, 2021	France ... 展开 >> CHU Saint-Etienne Recruiting Saint-Étienne, France, 42055 Principal Investigator: Karine ABBOUD, MD Sub-Investigator: Olivier TIFFET, MD 收起 <<
NCT03294824	-		Recruiting	June 2018	France ... 展开 >> Hôpital Pitié Salpêtriere Recruiting Paris, France, 75651 收起 <<
NCT01315613	-		Completed	-	Belgium ... 展开 >> Erasme Hospital Brussels, Belgium, 1070 收起 <<
NCT01637792	End Stage Renal Disease ... 展开 >> Anuria Peritonitis 收起 <<	Phase 4	Completed	-	China, Shanghai ... 展开 >> Renji Hospital, Shanghai Jiao Tong University school of medicine Shanghai, Shanghai, China, 200127 收起 <<
NCT00130793	Herpes Zoster	Phase 3	Completed	-	-
NCT02477462	-		Recruiting	May 2019	United States, California ... 展开 >> University of California Davis Medical Center Recruiting Sacramento, California, United States, 95817 Contact: Sandeep Dhaliwal, MD 916-734-8696 sandhaliwal@ucdavis.edu Principal Investigator: Christopher L Bowlus, MD 收起 <<
NCT02992938	Hyperalgesia ... 展开 >>Opioid-Related Disorders 收起 <<	Phase 4	Recruiting	July 2018	Chile ... 展开 >> Faculty of Medicine, University of Chile Recruiting Santiago, Metropolitana, Chile, 7563215 Contact: Rodrigo Gutierrez, MD +56995993665 rggutierrez1@gmail.com 收起 <<
NCT01536561	Lymphoma, Non-Hodgkin	Phase 1	Completed	-	-
NCT01536561	-		Completed	-	-
NCT01306786	Helicobacter Pylori Infection	Not Applicable	Completed	-	Hong Kong ... 展开 >> The University of Hong Kong, Queen Mary Hospital Hong Kong SAR, Hong Kong 收起 <<
NCT00909948	Non Hodgkin's Lymphoma ... 展开 >> Hodgkin Disease Multiple Myeloma 收起 <<	Phase 1	Terminated(Slow Accrual)	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT00130793	-		Completed	-	-
NCT00396253	Dysfunctional Hemodialysis Cat... 展开 >>heters 收起 <<	Phase 3	Completed	-	-
NCT00673738	Lung Cancer	Phase 2	Completed	-	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 <<
NCT00673738	-		Completed	-	-
NCT01845870	-		Completed	-	China, Tianjin ... 展开 >> General Hospital of Tianjin Medical University Tianjin, Tianjin, China, 300052 收起 <<
NCT00795704	Type 2 Diabetes	Phase 2 Phase 3	Completed	-	United States, Mississippi ... 展开 >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 收起 <<
NCT00277888	Kidney Failure, Acute ... 展开 >> Critical Illness 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Medical and nephrologic Intensive Care Unit, CHU Amien Sud Amiens, France, 80000 CH Argenteuil Argenteuil, France, 95100 Medical Intensive Care Unit, CHU de Caen Caen, France, 14000 Surgical Intensive Care Unit Caen, France, 14033 CHU de Clermont Ferrand Clermont Ferrand, France CHU Raymond Pointcarré Garches, France, 92380 Hôpital Cochin Paris, France, 75679 Hôpital Lariboisière Paris, France, 75 Hôpital St Joseph Paris, France, 75 CH Saint Malo Saint Malo, France 收起 <<
NCT00396253	-		Completed	-	-
NCT01825044	Traumatic Brain Injury	Phase 2	Completed	-	Denmark ... 展开 >> Dept. of Neurosurgery, Rigshospitalet, University of Copenhagen Copenhagen, Denmark, 2100 收起 <<
NCT02386553	Spinal Muscular Atrophy	Phase 2	Active, not recruiting	January 25, 2022	United States, Colorado ... 展开 >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Florida Nemours Children's Clinic Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Columbia University Medical Center, The SMA Clinical Research Center New York, New York, United States, 10032 United States, Utah Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 Australia, Victoria Royal Children's Hospital- Melbourne Parkville, Victoria, Australia, 3052 Germany Dept. of Neuropediatrics and Muscle Disorders Universitätsklinikum Freiburg Freiburg, Baden-Württemberg, Germany, 79106 Italy Bambino Gesu' Children's Research Hospital Roma, Lazio, Italy, 165 Fondazione Serena Onlus - Centro Clinico Nemo Milano, Italy, 20162 Qatar Hamad General Hospital Doha, Qatar, 3050 Taiwan Kaohsiung Medical University Hospital Kaohsiung City, Taiwan, 806 National Taiwan University Hospital Taipei, Taiwan, 100 Turkey Hacettepe University Medical Faculty Ankara, Sihhiye, Turkey, 6100 收起 <<
NCT01230996	Locally Advanced Cervical Canc... 展开 >>er 收起 <<	Phase 1 Phase 2	Active, not recruiting	April 2018	United Kingdom ... 展开 >> Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Hammersmith Hospital London, England, United Kingdom Royal Marsden - London London, England, United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom 收起 <<
NCT02145182	Delayed Graft Function	Phase 2 Phase 3	Completed	-	-
NCT00817609	Stroke Acute ... 展开 >>Ischemic Stroke 收起 <<	Phase 2 Phase 3	Unknown	-	China, Shanghai ... 展开 >> Zhongshan Hospital of Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Dingfang Cai, MD doctorcn@hotmail.com Principal Investigator: Zhan Sun, MD Sub-Investigator: Wenwei Li, MD Sub-Investigator: Junpeng Gao, MD, PhD Sub-Investigator: Chenling Yao, MD Sub-Investigator: Zhenju Song, MD Sub-Investigator: Chaoyang Tong, MD Sub-Investigator: Yuping Tang, MD, PhD Sub-Investigator: Chunfei Jiang, MD 收起 <<
NCT01368042	-		Completed	-	Greece ... 展开 >> Site Reference ID/Investigator# 56803 Arta, Greece, 47100 Site Reference ID/Investigator# 53424 Athens, Greece, 11528 Site Reference ID/Investigator# 53425 Larissa, Greece, 41223 Site Reference ID/Investigator# 56805 Lefkada, Greece, 31100 Site Reference ID/Investigator# 56802 Melissia, Greece, 151 27 Site Reference ID/Investigator# 66291 Patras, Greece, 26225 Site Reference ID/Investigator# 56809 Patras, Greece, 26504 Site Reference ID/Investigator# 50442 Pylaia Thessaloniki, Greece, 57001 Site Reference ID/Investigator# 77554 Thessaloniki, Greece, 570 01, Site Reference ID/Investigator# 77553 Thessaloniki, Greece, 570 19 Site Reference ID/Investigator# 53422 Volos, Greece, 38221 收起 <<
NCT01921374	Other Diseases or Conditions	Not Applicable	Completed	-	Brazil ... 展开 >> University Federal of São Paulo São Paulo, Brazil, 04024001 收起 <<
NCT00543647	Healthy Volunteers	Phase 1	Completed	-	United Kingdom ... 展开 >> Site 1 London, United Kingdom 收起 <<
NCT02461329	Hemorrhage, Surgical ... 展开 >> Hip Replacement, Total Thrombocytopathy 收起 <<	Not Applicable	Unknown	December 2016	-
NCT02145182	-		Completed	-	-
NCT01154582	Physiology Nu... 展开 >>trition 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Centre de recherche sur volontaires Bobigny, France, 93 Centre de recherche sur Volontaires Nantes, France, 44 收起 <<
NCT01368042	-		Completed	-	-
NCT02947958	Prostatic Hyperplasia	Not Applicable	Unknown	April 2017	Brazil ... 展开 >> Hospital De Clinicas De Porto Alegre Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Contact: Brasil S Neto, MdPg 555133598286 bneto@hcpa.edu.br 收起 <<
NCT02940262	Prostate Adenocarcinoma ... 展开 >> PSA Progression Recurrent Prostate Carcinoma 收起 <<	Not Applicable	Recruiting	August 1, 2022	United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Johannes Czernin 310-206-3226 Principal Investigator: Johannes Czernin 收起 <<
NCT00795951	-		Completed	-	-
NCT00737711	Anemia	Phase 4	Completed	-	India ... 展开 >> Ahmedabad, India, 380007 Bangalore, India, 560034 Chennai, India, 603103 Coimbatore, India, 641004 Gujarat, India, 387 001 Hyderabad, India, 500001 Kerala, India, 682017 Kolkata, India, 700099 Ludhiana, India Mumbai, India, 400026 Mumbai, India New Delhi, India, 110 060 New Delhi, India, 110017 New Delhi, India, 110026 Vellore, India, 632 004 Vishakpatnam, India, 530002 收起 <<
NCT00737711	-		Completed	-	-
NCT00795951	Dermatitis, Contact	Phase 4	Completed	-	United States, California ... 展开 >> Rady Children's Hospital San Diego, California, United States, 92123 收起 <<
NCT01872455	Kidney Transplantation	Phase 4	Completed	-	Italy ... 展开 >> federico II Univeristy Naples, Italy, 80131 收起 <<
NCT00919126	Anaesthesia	Phase 3	Terminated(Enrollment rate)	-	France ... 展开 >> Centre Hospitalier Universitaire de Clermont-Ferrand Clermont-Ferrand, France, 63058 Groupe Hospitalier Universitaire Caremeau Nîmes, France, 30029 Germany Evangelisches Waldkrankenhaus Berlin-Spandau Berlin, Germany, D-14129 BG Kliniken-Bergmannstrost Halle, Germany, D-06112 University Hospital Schleswig-Holstein Kiel, Germany, D-24105 United Kingdom Manchester Royal Infirmary Manchester, United Kingdom, M139WL 收起 <<
NCT02203890	-		Completed	-	Guatemala ... 展开 >> Center for Studies of Sensory Impairment Aging and Metabolism Guatemala, Quetzaltenango, Guatemala, 09001 收起 <<
NCT01253811	Congenital Bleeding Disorder ... 展开 >> Congenital FXIII Deficiency 收起 <<	Phase 3	Completed	-	United States, Massachusetts ... 展开 >> Novo Nordisk Clinical Trial Call Center Boston, Massachusetts, United States, 02115 United States, Ohio Novo Nordisk Clinical Trial Call Center Columbus, Ohio, United States, 43205 Israel Petach Tikva, Israel, 49100 United Kingdom Leicester, United Kingdom, LE1 5WW 收起 <<
NCT00919126	-		Terminated(Enrollment rate)	-	-
NCT01457950	Osteoporosis, Postmenopausal	Phase 3	Completed	-	Korea, Republic of ... 展开 >> GSK Investigational Site Busan, Korea, Republic of, 602-739 GSK Investigational Site Daegu, Korea, Republic of GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Seoul, Korea, Republic of, 100-380 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 GSK Investigational Site songpa-gu, Seoul, Korea, Republic of, 138-736 GSK Investigational Site Suwon, Korea, Republic of, 443-721 收起 <<
NCT01083186	-		Completed	-	-
NCT01457950	-		Completed	-	-
NCT01083186	-		Completed	-	Greece ... 展开 >> Site Reference ID/Investigator# 47002 Arta, Greece, 47100 Site Reference ID/Investigator# 43772 Athens, Greece, 115 21 Site Reference ID/Investigator# 27492 Athens, Greece, 115 27 Site Reference ID/Investigator# 43769 Athens, Greece, 115 27 Site Reference ID/Investigator# 38257 Athens, Greece, 11526 Site Reference ID/Investigator# 47003 Athens, Greece, 11526 Site Reference ID/Investigator# 27497 Athens, Greece, 11527 Site Reference ID/Investigator# 47004 Athens, Greece, 11527 Site Reference ID/Investigator# 27489 Athens, Greece, 11528 Site Reference ID/Investigator# 27495 Athens, Greece, 16673 Site Reference ID/Investigator# 43773 Athens, Greece, 17237 Site Reference ID/Investigator# 27498 Haidari, Athens, Greece, 12462 Site Reference ID/Investigator# 38259 Ioannina, Greece, 45500 Site Reference ID/Investigator# 22121 Larissa, Greece, 411 10 Site Reference ID/Investigator# 43771 Larissa, Greece, 41223 Site Reference ID/Investigator# 43767 Maroussi Athens, Greece, 15123 Site Reference ID/Investigator# 27496 Nikaia, Greece, 18454 Site Reference ID/Investigator# 43768 North Ionia, Athens, Greece, 142 33 Site Reference ID/Investigator# 27491 Piraeus, Greece, 18536 Site Reference ID/Investigator# 27494 Thessaloniki, Greece, 546 36 Site Reference ID/Investigator# 27493 Thessaloniki, Greece, 54636 Site Reference ID/Investigator# 38255 Thessaloniki, Greece, 56403 Site Reference ID/Investigator# 43770 Thessaloniki, Greece, 570 01 Site Reference ID/Investigator# 39839 Thessaloniki, Greece 收起 <<
NCT01087840	HIV Prevention ... 展开 >> HIV Infections 收起 <<	Phase 4	Completed	-	Australia, New South Wales ... 展开 >> Sydney Sexual Health, Sydney Hospital Sydney, New South Wales, Australia, 2000 St. Vincent's Hospital, 390 Victoria Rd, Darlinghurst Sydney, New South Wales, Australia, 2010 收起 <<
NCT02273336	-		Active, not recruiting	July 22, 2020	United States, California ... 展开 >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT02505334	Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku,, Japan, 104 0061 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Hokkaido, Japan, 078-8236 Novo Nordisk Investigational Site Ichikawa-shi, Chiba, Japan Novo Nordisk Investigational Site Iruma-shi, Saitama, Japan, 358 0011 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kobe-shi, Hyogo, Japan Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan, 310-0845 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Neyagawa-shi, Osaka, Japan Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 5590012 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sappro-shi, Hokkaido, Japan, 060 8648 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 105-8471 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 169-0073 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 收起 <<
NCT01253811	-		Completed	-	-
NCT02381483	Brown Adipose Tissue	Not Applicable	Completed	-	Austria ... 展开 >> Medical University of Vienna Vienna, Austria, 1090 收起 <<
NCT01724788	Renal Failure	Phase 1	Completed	-	Canada ... 展开 >> Investigational Site Number 124002 Montreal, Canada, H1T 2M4 收起 <<
NCT03251352	-		Recruiting	March 30, 2021	China, Guangdong ... 展开 >> Shenzhen Second People's Hospital Recruiting Shenzhen, Guangdong, China, 518035 Contact: Xin Du, MD 075583366388 ext 8196 duxingz@medmail.com.cn 收起 <<
NCT02505334	-		Completed	-	-
NCT00310375	Epilepsy	Phase 3	Completed	-	-
NCT00724867	-		Completed	-	-
NCT01965990	-		Completed	-	Italy ... 展开 >> Clinical Nutrition Unit - A.O.R.N. "San Giuseppe Moscati" Avellino, Italy, 83100 收起 <<
NCT03030456	Aging Oxidati... 展开 >>ve Stress 收起 <<	Not Applicable	Enrolling by invitation	February 2017	-
NCT03462121	Mild to Moderate Dementia Due ... 展开 >>to Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease 收起 <<	Phase 2	Recruiting	April 30, 2019	Canada, Ontario ... 展开 >> Kawartha Centre - Redefining Healthy Aging Recruiting Peterborough, Ontario, Canada, K9H 2P4 Contact: Jennifer K Ingram, MD FRCPC 705-749-3906 Contact: Krista Gillis 05-930-2667 (24 Hr.) Principal Investigator: Jennifer K Ingram, MD Toronto Memory Program Recruiting Toronto, Ontario, Canada, M3B 2S7 Principal Investigator: Sharon Cohen, MD Gerontion Research Inc., The Center for Memory & Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Principal Investigator: Giovanni Marotta, MD Canada, Quebec Recherches Neuro-Hippocampe Inc. d/b/a Clinique de la Memoire de l'Outaouais Recruiting Gatineau, Quebec, Canada, J8T 8J1 Principal Investigator: Richard Bergeron, MD Diex Recherche Sherbrooke Inc. Recruiting Sherbrooke, Quebec, Canada, J1L 0H8 Principal Investigator: Marcel Germain, MD 收起 <<
NCT00732693	Premature Ovarian Failure	Phase 4	Completed	-	United Kingdom ... 展开 >> Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH16 4SA Royal Hospital for Sick Children Edinburgh, United Kingdom, EH9 1LF 收起 <<
NCT00724867	Systemic Lupus Erythematosus	Phase 3	Completed	-	-
NCT03601338	Unexplained Stillbirth	Early Phase 1	Completed	-	Iraq ... 展开 >> Hawler Medical University Erbil, Kurdistan Region, Iraq, 44001 收起 <<
NCT00920426	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 2	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Fort Lauderdale, Florida, United States, 33308 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Vero Beach, Florida, United States, 32960 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28209 收起 <<
NCT02355314	Acute Kidney Injury	Not Applicable	Completed	-	France ... 展开 >> CHU Avicenne Bobigny, France, 93000 CHU Gabriel Montpied Clermont Ferrand, France, 63000 CHU Saint-Louis Paris, France, 75010 Chu de Saint Etienne Saint Etienne, France, 42000 CHRU de Strasbourg Strasbourg, France, 67000 收起 <<
NCT00733304	Macular Degeneration	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Beverly Hills, California, United States, 90211 GSK Investigational Site Sacramento, California, United States, 95841 United States, Florida GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46280 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02111 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48105 GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Australia, New South Wales GSK Investigational Site Sydney, New South Wales, Australia, 2145 GSK Investigational Site Sydney, New South Wales, Australia, 2150 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia Australia, Western Australia GSK Investigational Site Perth, Western Australia, Australia, 6009 Italy GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Milano, Lombardia, Italy, 20157 GSK Investigational Site Torino, Piemonte, Italy, 10122 GSK Investigational Site Firenze, Toscana, Italy, 50134 GSK Investigational Site Padova, Veneto, Italy, 35128 收起 <<
NCT00920426	-		Completed	-	-
NCT00310388	-		Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 <<	-	-
NCT03446612	Anaemia	Phase 2	Not yet recruiting	December 2, 2019	United Kingdom ... 展开 >> GSK Investigational Site Not yet recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Edinburgh, United Kingdom, EH16 4TJ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00945282	-		Completed	-	-
NCT00310375	-		Completed	-	-
NCT00733304	-		Completed	-	-
NCT00310388	Epilepsy	Phase 3	Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 <<	-	-
NCT03395262	Weight Loss	Not Applicable	Active, not recruiting	December 31, 2018	United States, Texas ... 展开 >> Exercise & Sport Nutrition Lab - Human Clinical Research Facility College Station, Texas, United States, 77845 收起 <<
NCT02878317	-		Active, not recruiting	August 2022	United Kingdom ... 展开 >> Derby Hospitals NHS Foundation Trust Derby, Derbyshire, United Kingdom, DE22 3NE 收起 <<
NCT00945282	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 2	Completed	-	Argentina ... 展开 >> GSK Investigational Site Buenos Aires, Argentina, B1602DBG 收起 <<
NCT01429376	Heart Failure ... 展开 >> Pulmonary Disease, Chronic Obstructive Inflammation 收起 <<	Not Applicable	Completed	-	Netherlands ... 展开 >> Rijnstate Hospital Arnhem, Gelderland, Netherlands, 6800 TA Rijnstate Hospital Zevenaar, Gelderland, Netherlands, 6903 ZN 收起 <<
NCT01018186	Asthma	Phase 3	Completed	-	-
NCT00519376	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Berlin, Germany, 14057 收起 <<
NCT00473109	Contra-Indication to the Use o... 展开 >>f Low Molecular Weight Heparin 收起 <<	Phase 3	Completed	-	France ... 展开 >> Chu de Necker Paris, France, 75015 收起 <<
NCT01018186	-		Completed	-	-
NCT00519376	-		Completed	-	-
NCT00640328	Multiple Sclerosis	Phase 2	Completed	-	-
NCT00837655	Kidney Failure, Chronic ... 展开 >> End-Stage Renal Disease Insulin Resistance Hyperphosphatemia 收起 <<	Not Applicable	Withdrawn(PI retired)	-	Sweden ... 展开 >> Sahlgrenska University Hospital Gothenburg, Sweden, 413 45 Karolinska University Hospital Stockholm, Sweden, 14186 收起 <<
NCT00323869	-		Completed	-	-
NCT00604825	-		Completed	-	-
NCT00323869	Lung Cancer N... 展开 >>on-small Cell Lung Cancer (NSCLC) 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> VA Palo Alto Healthcare System Palo Alto, California, United States, 94304-1290 Santa Clara Valley Medical Center San Jose, California, United States, 95128 Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT01453296	Asthma	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 收起 <<
NCT00640328	-		Completed	-	-
NCT00476879	Metabolism Fa... 展开 >>tty Liver 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Medical department M, Arhus Sygehus, Region midtjylland Aarhus, Denmark, 8000 收起 <<
NCT01364623	Female Sexual Dysfunction	Phase 1	Completed	-	United States, Texas ... 展开 >> Premier Research International LLC Austin, Texas, United States, 78705 收起 <<
NCT00604825	Menopausal and Female Climacte... 展开 >>ric States 收起 <<	Phase 2	Completed	-	-
NCT00996840	Lung Injury, Acute	Phase 2	Completed	-	United States, Kentucky ... 展开 >> GSK Investigational Site Lexington, Kentucky, United States, 40536-0293 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232-7110 收起 <<
NCT02469298	-		Completed	-	-
NCT02803554	Aging	Not Applicable	Completed	-	-
NCT02496494	CYCLOSPORINE/TACROLIMUS	Phase 4	Unknown	December 2015	Korea, Republic of ... 展开 >> Kyungpook National University Hospital Recruiting Daegu, Korea, Republic of Contact: Chan-Duck Kim drcdkim@knu.ac.kr 收起 <<
NCT02469298	Virus Diseases	Phase 2	Completed	-	-
NCT01453296	-		Completed	-	-
NCT01940393	Urticaria	Phase 4	Completed	-	Colombia ... 展开 >> Medellin Medellin, Antioquia, Colombia 收起 <<
NCT03050307	Gastric Ulcer ... 展开 >> Peptic Ulcer Gastrointestinal Diseases Digestive System Diseases Lansoprazole Anti-Ulcer Agents Gastrointestinal Agents Proton Pump Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action 收起 <<	Phase 3	Recruiting	April 19, 2019	-
NCT03050359	Duodenal Ulcer	Phase 3	Recruiting	June 7, 2019	-
NCT01641692	-		Completed	-	-
NCT00515502	-		Completed	-	-
NCT00515502	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22291 收起 <<
NCT03331900	Healthy Subjects	Phase 1	Completed	-	United States, Ohio ... 展开 >> Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 收起 <<
NCT01641692	Asthma	Phase 2	Completed	-	-
NCT00996840	-		Completed	-	-
NCT01930370	Chronic Dialysis Patients	Phase 4	Completed	-	Canada, Ontario ... 展开 >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 <<
NCT02312999	Surgery	Phase 4	Completed	-	Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 Erasme Brussels, Belgium, 1070 收起 <<
NCT01597635	Lung Injury, Acute	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Sacramento, California, United States, 95817 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01199 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Greensboro, North Carolina, United States, 27403 GSK Investigational Site Winston-Salem, North Carolina, United States, 27517 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 收起 <<
NCT02344225	Retinopathy of Prematurity	Phase 2	Completed	-	United States, New York ... 展开 >> SUNY Downstate Medical Center/University Hospital of Brooklyn Brooklyn, New York, United States, 11203 收起 <<
NCT01332292	Asthma	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 收起 <<
NCT01332292	-		Completed	-	-
NCT01453023	Asthma	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Huntington Beach, California, United States, 92647 收起 <<
NCT02800135	Critical Illness ... 展开 >> Oliguria 收起 <<	Not Applicable	Recruiting	March 2019	France ... 展开 >> CHU de CLERMONT-FERRAND Not yet recruiting Clermont-ferrand, France, 63000 Contact: Bertrand SOUWEINE, MD PhD CHU de MONTPELLIER Not yet recruiting Montpellier, France, 34000 Contact: Kada KLOUCHE, MD PhD CHU de SAINT-ETIENNE Recruiting Saint-etienne, France, 42000 Contact: michael DARMON, MD PhD (0)477127793 ext +33 michael.darmon@chu-st-etienne.fr Contact: Carine LABRUYERE, CRA (0)477120469 ext +33 carine.labruyere@chu-st-etienne.fr CHRU de STRASBOURG Not yet recruiting Strasbourg, France, 67000 Contact: David SCHNELL, MD 收起 <<
NCT01597635	-		Completed	-	-
NCT02705807	Cardiovascular Disease	Phase 4	Completed	-	Japan ... 展开 >> GSK Investigational Site Okayama, Japan, 701-1192 收起 <<
NCT01453023	-		Completed	-	-
NCT02705807	-		Completed	-	-
NCT00657475	Cardiac Surgery ... 展开 >> Extracorporeal Circulation 收起 <<	Phase 4	Completed	-	France ... 展开 >> Cardiac Surgery Dpt (University Hospital) Bordeaux, France, 33000 收起 <<
NCT01370811	Sialorrhoea	Phase 2	Completed	-	United States, Michigan ... 展开 >> QUEST Research Institute Bingham Farms, Michigan, United States, 48025 收起 <<
NCT01063361	Type 2 Diabetes	Phase 2	Completed	-	Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 收起 <<
NCT01396915	-		Completed	-	United States, Indiana ... 展开 >> Purdue University W. Lafayette, Indiana, United States, 47907 收起 <<
NCT03112967	Bowel Preparation	Not Applicable	Completed	-	Korea, Republic of ... 展开 >> Department of Internal Medicine, Kyung Hee University College of Medicine Seoul, Korea, Republic of, 05278 收起 <<
NCT02793154	Diabetes Mellitus, Type 2	Phase 4	Terminated(Early termination d... 展开 >>ue to insufficient enrollment.) 收起 <<	-	United States, Kentucky ... 展开 >> GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75230 收起 <<
NCT03109561	-		Recruiting	April 30, 2020	United States, Kentucky ... 展开 >> University of Kentucky Medical Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Lance Johnson, PhD 859-323-2746 Johnson.Lance@uky.edu 收起 <<
NCT02793154	-		Terminated(Early termination d... 展开 >>ue to insufficient enrollment.) 收起 <<	-	-
NCT00566020	Bipolar Disorder	Phase 3	Completed	-	-
NCT00566020	-		Completed	-	-
NCT00732472	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Reading, Berkshire, United Kingdom, RG2 0TG GSK Investigational Site Buckshaw Village, Chorley, Lancashire, United Kingdom, PR7 7NA GSK Investigational Site Waterloo, Liverpool, Merseyside, United Kingdom, L22 0LG GSK Investigational Site Clydebank, Glasgow, United Kingdom, G81 2DR GSK Investigational Site Edgbaston, Birmingham, United Kingdom, B15 2SQ GSK Investigational Site Llanishen, United Kingdom, CF14 5GJ GSK Investigational Site Manchester, United Kingdom, M15 6SX 收起 <<
NCT02346682	Severe Major Depression Disord... 展开 >>er 收起 <<	Phase 4	Unknown	December 2017	China, Zhejiang ... 展开 >> Tongde hospital of zhejiang province Recruiting Hangzhou, Zhejiang, China, 310012 Contact: Feng Bin, bachelor +860571 89972003 fengbintd@aliyun.com Contact: Zhang jianmin, Ph.d +86057189972008 jianmin.3.zhang@kcl.ac.uk Principal Investigator: Zhang-jin Zhang, Professor Principal Investigator: Bin Feng, Professor Sub-Investigator: Jiong Chen, physician Sub-Investigator: ya-ping Li, Professor Principal Investigator: Jin-bao Pu, researcher Sub-Investigator: Wei-qing Liang, researcher Sub-Investigator: Hong-xia Zhang, Radiologist Sub-Investigator: Wen-song Chen, physician Sub-Investigator: Zheng-xin Chen, physician Sub-Investigator: Cheng-yu Gu, physician Sub-Investigator: Pei-rong Wang, physician Sub-Investigator: Yong-chun Ma, physician Sub-Investigator: Yin Zhang, physician Sub-Investigator: Chun-yu Yang, physician Sub-Investigator: Bao-ping Xing, physician Sub-Investigator: Wei-dong Jin, physician Sub-Investigator: Yuan-Yuan Zhang, physician 收起 <<
NCT02270515	ESRD	Not Applicable	Completed	-	United States, Illinois ... 展开 >> Fresenius Medical Care Chicago Westside dialysis center Chicago, Illinois, United States, 60608 University of Illinois Hospital and Health Sciences System dialysis center Chicago, Illinois, United States, 60612 收起 <<
NCT01628198	-		Terminated(recommendation by t... 展开 >>he study's DSMB due to insufficient data to determine efficacy.) 收起 <<	-	-
NCT00618696	Leukemia Myel... 展开 >>odysplastic Syndromes 收起 <<	Phase 1	Terminated(Replaced with anoth... 展开 >>er study) 收起 <<	-	United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 <<
NCT02270515	-		Completed	-	-
NCT01235689	Crohn's Disease	Phase 3	Completed	-	-
NCT01381549	Infections, Urinary Tract	Phase 2	Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90033 United States, Iowa GSK Investigational Site Council Bluffs, Iowa, United States, 51503 United States, Kansas GSK Investigational Site Topeka, Kansas, United States, 66604 United States, Texas GSK Investigational Site Corsicana, Texas, United States, 75110 Canada, Quebec GSK Investigational Site Chicoutimi, Quebec, Canada, G7H 5H6 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 France GSK Investigational Site Suresnes, France, 92151 GSK Investigational Site Toulouse cedex 9, France, 31059 Greece GSK Investigational Site Athens, Greece, 11527 GSK Investigational Site Chaidari, Greece, 12462 GSK Investigational Site Goudi, Athens, Greece, 11527 GSK Investigational Site Thessaloniki, Greece, 56429 Russian Federation GSK Investigational Site Irkutsk, Russian Federation, 664079 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Rostov-on-Don, Russian Federation, 344022 GSK Investigational Site Smolensk, Russian Federation, 214018 GSK Investigational Site St'Petersburg, Russian Federation, 194354 Spain GSK Investigational Site Alicante, Spain, 03010 GSK Investigational Site Elche (Alicante), Spain, 03203 GSK Investigational Site Getafe/Madrid, Spain, 28905 GSK Investigational Site Granada, Spain, 18003 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Murcia, Spain GSK Investigational Site Pama de Mallorca, Spain, 07010 收起 <<
NCT01235689	-		Completed	-	-
NCT00732472	-		Completed	-	-
NCT01294436	Type2 Diabetes ... 展开 >> High Blood Sugar 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Owariasahi, Aichi, Japan Research Site Toyohashi, Aichi, Japan Research Site Hirosaki, Aomori, Japan Research Site Niihama, Ehime, Japan Research Site Itoshima, Fukuoka, Japan Research Site Yukuhashi, Fukuoka, Japan Research Site Annaka, Gunma, Japan Research Site OTA, Gunma, Japan Research Site Aki-gun, Hiroshima, Japan Research Site Sapporo, Hokkaido, Japan Research Site Sanuki, Kagawa, Japan Research Site Takamatsu, Kagawa, Japan Research Site Kamakura, Kanagawa, Japan Research Site Kawasaki, Kanagawa, Japan Research Site Yokohamashi, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Zushi, Kanagawa, Japan Research Site Sendai, Miyagi, Japan Research Site Matsumoto, Nagano, Japan Research Site Suita, Osaka, Japan Research Site Otsu, Shiga, Japan Research Site Atami, Shizuoka, Japan Research Site Komatsushima, Tokushima, Japan Research Site Chiyoda, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Mitaka, Tokyo, Japan Research Site OTA, Tokyo, Japan Research Site Shibuya, Tokyo, Japan Research Site Shinjuku, Tokyo, Japan Research Site Taito, Tokyo, Japan Research Site Takaoka, Toyama, Japan Research Site UBE, Yamaguchi, Japan Research Site Fukuoka, Japan Research Site Hiroshima, Japan Research Site Kochi, Japan Research Site Osaka, Japan Research Site Shizuoka, Japan Research Site Toyama, Japan 收起 <<
NCT01628198	Uncontrolled Hypertension	Not Applicable	Terminated(recommendation by t... 展开 >>he study's DSMB due to insufficient data to determine efficacy.) 收起 <<	-	United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 <<
NCT01381549	-		Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 <<	-	-
NCT01294436	-		Completed	-	-
NCT03592524	-		Completed	-	Egypt ... 展开 >> Iman Montasser Cairo, Egypt, 11566 收起 <<
NCT00814983	-		Terminated(IND approval for na... 展开 >>ive T-cell depletion not obtained) 收起 <<	-	-
NCT02767479	H. Pylori Infection	Phase 3	Completed	-	Japan ... 展开 >> Hamamatsu University School of Medicine Hamamatsu, Shizuoka, Japan, 431-3192 收起 <<
NCT03545581	Hereditary Fructose Intoleranc... 展开 >>e 收起 <<	Not Applicable	Recruiting	April 1, 2019	Belgium ... 展开 >> Guillaume Debray Recruiting Liège, Belgium Contact: Guillaume F Debray, MD +3242249057 fg.debray@chu.ulg.ac.be 收起 <<
NCT00814983	ALL ANLL ... 展开 >> MDS NHL 收起 <<	Phase 1 Phase 2	Terminated(IND approval for na... 展开 >>ive T-cell depletion not obtained) 收起 <<	-	-
NCT03058562	Tourette Syndrome ... 展开 >> Chronic Motor Tic Disorder 收起 <<	Phase 1	Completed	-	Germany ... 展开 >> Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 收起 <<
NCT01569568	-		Completed	-	-
NCT01270958	Rhinitis, Allergic, Perennial	Phase 4	Completed	-	Vietnam ... 展开 >> GSK Investigational Site Ha Noi, Vietnam, 084 收起 <<
NCT01569568	-		Completed	-	-
NCT02655705	Psoriasis	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, KS009 收起 <<
NCT02616458	Otitis Media	Not Applicable	Completed	-	United States, Colorado ... 展开 >> Childrens Hospital Colorado Aurora, Colorado, United States, 80045 收起 <<
NCT01333735	-		Completed	-	Belgium ... 展开 >> Université Bruxelles, Belgium, 1050 France INSERM Caen, Calvados, France, 14000 CHU Caen, Calvados, France, 14033 Centre François BACLESSE Caen, Calvados, France, 14076 Hôpital Saint-Louis Paris, Ile de France, France, 75475 Hopital Pitié-Sapètrière Paris, Ile de France, France, 75651 Hopital TENON Paris, Ile de France, France, 75970 CHRU Hôpital Claude Huriez Lille, Nord, France, 59000 Hopital gériatrique des Bateliers Lille, Nord, France, 59037 Université Lille, Nord, France, 59653 CHU, Hôpital Bois Guillaume Rouen, Seine Maritime, France, 76000 CHU Rouen, Seine Maritime, France, 76000 Centre Henri BECQUEREL Rouen, Seine Maritime, France, 76038 Hôpital Charles FOIX IVRY sur SEINE, France, 94206 Hopitaux universitaires Strasbourg, France, 67091 收起 <<
NCT01668654	-		Terminated(FDA placed a clinic... 展开 >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) 收起 <<	-	-
NCT01345578	Metabolic Diseases	Phase 1	Suspended(seeking additional f... 展开 >>unding) 收起 <<	January 2019	United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15201 收起 <<
NCT03145220	Systemic Inflammatory Response... 展开 >> Syndrome Coronary Artery Bypass Grafting 收起 <<	Phase 2	Active, not recruiting	October 2018	Netherlands ... 展开 >> Intensive care, research unit, Radboud University Medical Centre Nijmegen, Gelderland, Netherlands, 6525 GA 收起 <<
NCT01270958	-		Completed	-	-
NCT01668654	Epilepsy	Phase 3	Terminated(FDA placed a clinic... 展开 >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 收起 <<
NCT01691794	-		Completed	-	-
NCT03654287	-		Not yet recruiting	October 30, 2021	China ... 展开 >> Children'S Hosptial of Fudan University Recruiting Shanghai, China Contact: LU guoping, dotor 18017590817 13788904150@163.com 收起 <<
NCT02576873	-		Completed	-	Thailand ... 展开 >> King Chulalongkorn Memorial Hospital Pathumwan, Bangkok, Thailand, 10330 收起 <<
NCT01691794	HIV, Pediatric	Phase 4	Completed	-	United States, Arizona ... 展开 >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Grady Health System Ponce Family And Youth Clinic Atlanta, Georgia, United States, 30322 United States, Texas Children'S Medical Center Of Dallas Dallas, Texas, United States, 75235 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Buenos Aires, Argentina, 1181 Local Institution Buenos Aires, Argentina, 1425 Brazil Local Institution Salvador, Bahia, Brazil, 40110-160 Local Institution Salvador, Bahia, Brazil, 40110 Local Institution Porto Alegre, RIO Grande DO SUL, Brazil, 90035-903 Local Institution Porto Alegre, Rio Grande Do Sul, Brazil, 90035 Local Institution Sao Paulo, SP, Brazil, 01416-901 Local Institution Sao Paulo, Brazil, 01246 Chile Local Institution Santiago, Metropolitana, Chile, 8207257 Local Institution Santiago, Metropolitana, Chile, 8380418 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Monterrey, Nuevo LEON, Mexico, 64000 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru, LIMA 10 Russian Federation Local Institution Moscow, Russian Federation, 129110 Local Institution St. Petersburg, Russian Federation, 190103 South Africa Local Institution Port Elizabeth, Eastern CAPE, South Africa, 6001 Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Soweto, Gauteng, South Africa, 2013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Local Institution Cape Town, Western CAPE, South Africa, 7530 收起 <<
NCT02354768	High Output Stoma	Phase 3	Terminated	-	France ... 展开 >> Hôpital Jean Minjoz - Service de Chirurgie Digestive Besançon, France, 25030 Hôpitaux Civils de Colmar - Service de Chirurgie Digestive Colmar, France, 68024 Hopital du Bocage - CHU Dijon- Service de Chirurgie Digestive Dijon, France Hôpital Emile MULLER - Service de Chirurgie Digestive Mulhouse, France, 68070 CHU Robert Debré Service de chirurgie générale, digestive et endocrinienne Reims, France, 51100 Hôpital de Hautepierre-Service de Chirurgie Digestive Strasbourg, France, 67098 收起 <<
NCT03444233	Non-Alcoholic Fatty Liver Dise... 展开 >>ase Obesity 收起 <<	Phase 4	Completed	-	-
NCT01222949	Malaria, Falciparum	Phase 1	Completed	-	Australia ... 展开 >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Nucleus Network Limited Melbourne, Australia, VIC 3004 收起 <<
NCT02355704	Renal Insufficiency	Phase 3	Completed	-	Mexico ... 展开 >> Western Medical Center, Mexican Institute of Social Security Guadalajara, Jalisco, Mexico, 44340 收起 <<
NCT01222962	Malaria, Falciparum	Phase 1	Completed	-	Australia ... 展开 >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 收起 <<
NCT02020889	Churg-Strauss Syndrome	Phase 3	Completed	-	-
NCT02020889	-		Completed	-	-
NCT03105219	Diabetic Kidney Disease	Phase 3	Recruiting	May 30, 2021	China, Jiangsu ... 展开 >> Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210006 Contact: Junjie Zhang, PHD 86-25-52271350 jameszll@163.com Contact: Xiaofei Gao, MD 86-25-52271350 gaoxiaofei2014@163.com 收起 <<
NCT00516139	-		Completed	-	-
NCT03549923	Cardiogenic Shock	Phase 4	Not yet recruiting	April 2022	China ... 展开 >> Beijing Anzhen Hospital Not yet recruiting Beijing, China, 100029 Contact: Jianzeng Dong, PhD., Md. 86 13911828375 jz_dong@126.com Contact: Xiaotong Hou, PhD., Md. 86 18911662932 xt.hou@ccmu.edu.cn 收起 <<
NCT01568892	HIV Infections	Phase 3	Completed	-	-
NCT00750633	Acute Otitis Externa	Phase 3	Completed	-	-
NCT01806064	Renal Cell Carcinoma	Phase 1 Phase 2	Active, not recruiting	June 2019	-
NCT01568892	-		Completed	-	-
NCT02261376	Healthy	Phase 1	Completed	-	United Kingdom ... 展开 >> Hammersmith Medicines Research Ltd London, United Kingdom, NW10 7EW 收起 <<
NCT00787137	Arthritis, Psoriatic	Phase 1	Terminated(poor recruitment)	-	Serbia ... 展开 >> Professor Nemanja Damjanov Belgrade, Serbia 收起 <<
NCT02014467	-		Completed	-	-
NCT00516139	Epilepsy	Phase 3	Completed	-	-
NCT01316887	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	-
NCT02759731	Chronic Graft vs Host Disease ... 展开 >> Chronic Graft-Versus-Host Disease 收起 <<	Phase 1 Phase 2	Recruiting	June 1, 2020	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 <<
NCT01316887	-		Completed	-	-
NCT02014467	Osteoporosis, Postmenopausal	Phase 3	Completed	-	China, Sichuan ... 展开 >> GSK Investigational Site Chengdu, Sichuan, China, 610041 GSK Investigational Site Chengdu, Sichuan, China, 610072 China GSK Investigational Site Beijing, China, 100035 GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chengdu, China, 610083 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200233 收起 <<
NCT00812929	Asthma	Phase 2	Completed	-	United States, Colorado ... 展开 >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 收起 <<
NCT00787137	-		Terminated(poor recruitment)	-	-
NCT02716194	-		Completed	-	-
NCT03320538	Peptic Ulcer Disease	Not Applicable	Recruiting	July 1, 2019	China, Jiangxi ... 展开 >> Jiangxi University of Traditional Chinese Medicine Recruiting Nanchang, Jiangxi, China, 330004 Contact: Xu Zhou, Ph.D. +8618780085060 zhouxu_ebm@hotmail.com Contact: Xiaofan Chen, Ph.D. +86079187118012 841347982@qq.com 收起 <<
NCT01494610	Asthma	Phase 2	Completed	-	Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Wellington, New Zealand, 6021 收起 <<
NCT02716194	Hemophilia A	Phase 1	Completed	-	Bulgaria ... 展开 >> UMHAT "Sv. Georgi", EAD Plovdiv, Bulgaria, 4000 Germany Werlhof-Institut Hannover, Niedersachsen, Germany, 30159 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Vivantes Klinikum im Friedrichshain - Landsberger Allee Berlin, Germany, 10249 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Universitaetsklinikum Gießen Marburg, Germany, 35043 Hungary Semmelweis Egyetem AOK I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Presidio Ospedaliero di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy, 31033 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 Policlinico Umberto I di Roma-Università di Roma La Sapienza Roma, Italy, 00144 Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6525 GA Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 AA Poland Instytut Hematologii i Transfuzjologii Warszawa, Poland, 02-776 Russian Federation FSBI "Kirov SR Institute of Hematology and Blood Transfusion FMBA" Kirov, Russian Federation, 610027 FSBI "Hematological Research Center" MoH of RF Moscow, Russian Federation, 125167 SBEI HPE "Samara State Medical University" of the MoH of the RF Samara, Russian Federation, 443099 Spain Complejo Hospitalario Universitario A Coruña A Coruña, La Coruña, Spain, 15006 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Regional Universitario de Malaga Malaga, Spain, 29010 Hospital Universitario Son Espases Palma de Mallorca, Spain, 07120 United Kingdom Royal Cornwall Hospital Truro, Cornwall, United Kingdom, TR1 3LJ Royal London Hospital London, Greater London, United Kingdom, E1 1BB Royal Free Hospital London, Greater London, United Kingdom, NW3 2QG St Thomas' Hospital Centre for Haemostasis & Thrombosis London, Greater London, United Kingdom, SE1 7EH Manchester Royal Infirmary Manchester, Greater Manchester, United Kingdom, M13 9WL University Hospital of Wales Cardiff, West Glamorgan, United Kingdom, CF14 4XW 收起 <<
NCT00812929	-		Completed	-	-
NCT01086410	Asthma	Phase 3	Completed	-	United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73103 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Hamburg, Germany, 20253 Poland GSK Investigational Site Bialystok, Poland, 15-010 GSK Investigational Site Gdansk, Poland, 80-405 GSK Investigational Site Gidle, Poland, 97-540 GSK Investigational Site Krakow, Poland, 31-023 GSK Investigational Site Lodz, Poland, 93-513 GSK Investigational Site Olsztyn, Poland, 10-357 GSK Investigational Site Warszawa, Poland, 01-138 收起 <<
NCT01086410	-		Completed	-	-
NCT01494610	-		Completed	-	-
NCT00603382	Asthma	Phase 2	Completed	-	-
NCT00603278	Asthma	Phase 2	Completed	-	-
NCT00603278	-		Completed	-	-
NCT00603746	Asthma	Phase 2	Completed	-	-
NCT02299375	-		Completed	-	-
NCT01243528	-		Completed	-	Germany ... 展开 >> Schoen Clinic Bad Aibling Bad Aibling, Bavaria, Germany, 83043 收起 <<
NCT01602549	Gastroparesis	Phase 2	Completed	-	Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53105 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 13088 Sweden GSK Investigational Site Uppsala, Sweden, SE-751 85 United Kingdom GSK Investigational Site Cambridge, United Kingdom, C2B 2PY GSK Investigational Site Newcastle Upon Tyne, United Kingdom, NE4 5PL GSK Investigational Site Norwich, United Kingdom, NR4 7UY 收起 <<
NCT00603382	-		Completed	-	-
NCT00603746	-		Completed	-	-
NCT01602549	-		Completed	-	-
NCT01262898	Gastroparesis	Phase 2	Completed	-	-
NCT01585948	-		Active, not recruiting	December 2017	Greece ... 展开 >> Cardiology Department, University Hospital of Ioannina Ioannina, Greece, 45110 收起 <<
NCT03398681	Heart Failure ... 展开 >> Iron-deficiency 收起 <<	Phase 4	Recruiting	May 2018	Spain ... 展开 >> Hospital General de Castellón Recruiting Castellón De La Plana, Castellón, Spain Contact: Patricia Palau, MD PhD patripalau@gmail.com Sub-Investigator: Patricia Palau, MD PhD Hospital de Manises Recruiting Manises, Valencia, Spain Contact: Pau Llacer, MD PhD paullaceriborra@gmail.com Sub-Investigator: Pau Llacer, MD PhD ERESA Recruiting Valencia, Spain, 46010 Contact: Maria Pilar Lopez Lereu, MD PhD plereu@eresa.com Contact: Jose Vicente Monmeneu, MD PhD jmonmeneu@eresa.com Fundación Investigación Hospital Clínico Universitario de Valencia. Instituto de Investigación Sanitaria INCLIVA. Recruiting Valencia, Spain, 46010 Contact: Julio Nuñez, MD PhD 652856689 yulnunez@gmail.com Contact: Ingrid Cardells, MD 660619422 ingridcb88@hotmail.com Principal Investigator: Julio Nuñez, MD PhD Sub-Investigator: Gema Miñana, MD PhD Sub-Investigator: Ingrid Cardells, MD Sub-Investigator: Ernesto Valero, MD Sub-Investigator: Enrique Santas, MD PhD Sub-Investigator: Sergio García-Blas, MD PhD Sub-Investigator: Anna Mollar, PhD Sub-Investigator: Amparo Villaescusa, Nurse Sub-Investigator: Silvia Rodriguez, Nurse Sub-Investigator: Rafael De la Espliella, MD Hospital General de Valencia Recruiting Valencia, Spain Contact: Lorenzo Fácila, MD PhD lfacila@gmail.com Sub-Investigator: Lorenzo Fácila, MD PhD Hospital la Fe Recruiting Valencia, Spain Contact: Luis Almenar, MD PhD Sub-Investigator: Luis Almenar, MD PhD 收起 <<
NCT02299375	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	-
NCT01910402	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 3	Active, not recruiting	December 31, 2020	-
NCT00263302	Heart Failure, Congestive	Phase 1	Suspended	-	China, Hebei ... 展开 >> Kunshen Liu Shijiazhuang, Hebei, China, 050031 The First Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050031 收起 <<
NCT01452958	Inflammation ... 展开 >>Glucose Metabolism Disorders 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Medical Department MEA, NBG, Aarhus University Hospital Aarhus, Denmark, 8000 收起 <<
NCT01910402	-		Active, not recruiting	-	-
NCT02294682	Gonorrhea	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Fountain Valley, California, United States, 92708 GSK Investigational Site Los Angeles, California, United States, 90028 GSK Investigational Site Los Angeles, California, United States, 90069 GSK Investigational Site Palm Springs, California, United States, 92262 GSK Investigational Site San Francisco, California, United States, 94103 United States, Florida GSK Investigational Site Orlando, Florida, United States, 32806 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Louisiana GSK Investigational Site New Orleans, Louisiana, United States, 70119 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68114 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44109 United States, Pennsylvania GSK Investigational Site Jenkintown, Pennsylvania, United States, 19046 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 United Kingdom GSK Investigational Site London, United Kingdom, SW10 9NH 收起 <<
NCT02294682	-		Completed	-	-
NCT01788358	-		Completed	-	-
NCT01788358	Hypertension	Phase 3	Completed	-	-
NCT01262898	-		Completed	-	-
NCT03385369	Safety Health... 展开 >>y Subjects 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> Research Site Anaheim, California, United States, 92801 收起 <<
NCT00350727	Glioma	Phase 2	Completed	-	-
NCT01729728	Postoperative Pain ... 展开 >> Acute Pain 收起 <<	Phase 2	Completed	-	United States, Utah ... 展开 >> Jean Brown Research Salt Lake City, Utah, United States, 84124 收起 <<
NCT02045797	Infections, Bacterial	Phase 2	Completed	-	-
NCT02045797	-		Completed	-	-
NCT03665948	Nutrition Ket... 展开 >>ogenic Dieting Low Glycemic Index Diet Sport Crossfit 收起 <<	Not Applicable	Completed	-	Poland ... 展开 >> Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences Poznań, Poland, 60-624 收起 <<
NCT01271218	Knee Osteoarthritis	Phase 4	Completed	-	United States, Texas ... 展开 >> Exercise & Sport Nutrition Lab College Station, Texas, United States, 78843 收起 <<
NCT02880852	-		Completed	-	-
NCT00350727	-		Completed	-	-
NCT03435276	Healthy Volunteers	Phase 1	Completed	-	United Kingdom ... 展开 >> Research Site Harrow, United Kingdom, HA1 3UJ 收起 <<
NCT02880852	Systemic Lupus Erythematosus	Phase 1	Completed	-	China ... 展开 >> GSK Investigational Site Shanghai, China GSK Investigational Site Suzhou, China, 215004 收起 <<
NCT01729728	-		Completed	-	-
NCT03771170	Peritonitis I... 展开 >>ntoxication 收起 <<	Phase 4	Recruiting	January 31, 2020	Georgia ... 展开 >> "Unimedi Adjara" LLC Recruiting Batumi, Georgia Contact: Kahaber Kishibadje, MD Principal Investigator: Kahaber Kishibadje, MD Kutaisi Referral Hospital Recruiting Kutaisi, Georgia Contact: David Tevdoradze Principal Investigator: David Tevdoradze JSC EVEX/LTD Traumatology Recruiting Tbilisi, Georgia Contact: Jano Vashadze, MD Principal Investigator: Jano Vashadze, MD Moldova, Republic of Institute of Ambulance Recruiting Chisinau, Moldova, Republic of Contact: Adrian Beliy, MD Principal Investigator: Adrian Beliy, MD Municipal Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Silvia Agop, MD Principal Investigator: Silvia Agop, MD Republican Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Victor Cojocaru, MD Principal Investigator: Viktor Kogokaru Ukraine Institute of General and Urgent Surgery of the National Academy of Medical Sciences of Ukraine Recruiting Kharkov, Ukraine Contact: Peev Stanislav, MD Principal Investigator: Peev Stanislav, MD Kyiv City Clinical Hospital No.4; National Medical University named after O.O. Bogomolets Recruiting Kyiv, Ukraine Contact: Igor Kolosovich, MD Principal Investigator: Igor Kolosovich, MD HSEE of Ukraine "Ukrainian Medical Stomatological Academy"; Poltava Central District Hospital Recruiting Poltava, Ukraine Contact: Alexey Ligonenko, MD Principal Investigator: Alexey Ligonenko, MD Vinnytsa Regional Clinical Hospital Active, not recruiting Vinnitsa, Ukraine Uzbekistan Republic Centre of Ambulance Recruiting Tashkent, Uzbekistan Contact: Visolat Sharipova, MD Principal Investigator: Visolat Sharipova, MD 收起 <<
NCT01328054	Cancer	Phase 4	Completed	-	United States, Michigan ... 展开 >> GSK Investigational Site Detroit, Michigan, United States, 48202 United States, New Hampshire GSK Investigational Site Lebanon, New Hampshire, United States, 03756 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112 收起 <<
NCT02564042	-		Completed	-	-
NCT01328054	-		Completed	-	-
NCT03400488	Coronary Artery Disease	Phase 1	Completed	-	United States, California ... 展开 >> Research Site Glendale, California, United States, 91206 收起 <<
NCT02564042	Psoriasis	Phase 2	Completed	-	-
NCT03436316	Asthma	Phase 1	Recruiting	January 16, 2019	Germany ... 展开 >> Research Site Recruiting Berlin, Germany, 14050 收起 <<
NCT02382874	Focal Segmental Glomeruloscler... 展开 >>osis 收起 <<	Phase 1	Unknown	October 2017	Iran, Islamic Republic of ... 展开 >> Royan Institute Recruiting Tehran, Iran, Islamic Republic of Contact: Nasser Aghdami, MD,PhD (+98)2123562000 ext 516 nasser.aghdami@royaninstitute.org Contact: Leila Arab, MD (+98)2123562000 ext 414 Leara91@gmail.com Principal Investigator: Reza Moghadasali, PhD 收起 <<
NCT03593785	Hypercholesterolemia	Phase 1	Recruiting	July 23, 2019	United States, California ... 展开 >> Research Site Recruiting Glendale, California, United States, 91206 收起 <<
NCT03563898	Fluid Overload ... 展开 >> Peritoneal Dialysis Complication 收起 <<	Not Applicable	Recruiting	June 11, 2018	Mexico ... 展开 >> Hosptal Civil Fray Antonio Alcalde Recruiting Guadalajara, Jalisco, Mexico Contact: JONATHAN CHAVEZ 513313299609 收起 <<
NCT02497937	Heart Failure	Phase 2	Completed	-	United States, Minnesota ... 展开 >> GSK Investigational Site Minneapolis, Minnesota, United States, 55415 GSK Investigational Site Rochester, Minnesota, United States, 55905 收起 <<
NCT00502996	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT02497937	-		Completed	-	-
NCT01667679	Migraine Head... 展开 >>aches 收起 <<	Phase 3	Completed	-	United States, California ... 展开 >> San Francisco Clinical Research Center San Francisco, California, United States, 94109 California Medical Clinic for Headache Santa Monica, California, United States, 90404 United States, Connecticut Associated Neurologists of Southern CT, P.C. Fairfied, Connecticut, United States, 06824 United States, Florida Premiere Research Institute West Palm Beach, Florida, United States, 33407 United States, Massachusetts MedVadis Watertown, Massachusetts, United States, 02472 United States, Michigan Michigan Head and Pain Institute Ann Arbor, Michigan, United States, 48104-5199 United States, Missouri ClinVest Springfield, Missouri, United States, 65807 Mercy Health Research St. Louis, Missouri, United States, 63141 United States, New York DENT Neurologic Institute Amherst, New York, United States, 14226 United States, North Carolina Headache Welness Center Greensboro, North Carolina, United States, 27405 PMG Research of Winston Salem, LLC Winston Salem, North Carolina, United States, 27103 United States, Pennsylvania Jefferson Headache Center Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina Coastal Carolina Research Center Mt. Pleasant, South Carolina, United States, 29464 收起 <<
NCT01791205	-		Completed	-	Italy ... 展开 >> Reggio Calabria, Calabria, Italy, 89133 Napoli, Campania, Italy, 80131 Telese Terme, Campania, Italy, 82037 Bologna, Emilia-Romagna, Italy, 40138 Roma, Lazio, Italy, 00133 Roma, Lazio, Italy, 00152 Roma, Lazio, Italy, 00161 Roma, Lazio, Italy, 00189 Legnano, Lombardia, Italy, 20025 Milano, Lombardia, Italy, 20157 Milano, Lombardia, Italy, 20162 Monza, Lombardia, Italy, 20052 Pavia, Lombardia, Italy, 27100 Ancona, Marche, Italy, 60020 Jesi, Marche, Italy, 60035 Torino, Piemonte, Italy, 10126 Torino, Piemonte, Italy, 10128 Bari, Puglia, Italy, 70124 Martina Franca, Puglia, Italy, 74015 Sassari, Sardegna, Italy, 07100 Firenze, Toscana, Italy, 50139 Pisa, Toscana, Italy, 56100 Prato, Toscana, Italy, 59100 Siena, Toscana, Italy, 53100 Perugia, Umbria, Italy, 06122 Cona (Ferrara), Veneto, Italy, 44124 Padova, Veneto, Italy, 35128 Verona, Veneto, Italy, 37126 收起 <<
NCT01791205	-		Completed	-	-
NCT00502996	-		Completed	-	-
NCT02064985	Stable Coronary Heart Disease ... 展开 >>(CHD) 收起 <<	Phase 4	Completed	-	China ... 展开 >> Research Site Beijing, China 收起 <<
NCT02064985	-		Completed	-	-
NCT01839578	Septic Shock	Not Applicable	Unknown	April 2015	France ... 展开 >> Service de Réanimation - Pavillon P, Hôpital Edouard Herriot Recruiting Lyon, France, 69003 Contact: Thomas Rimmelé, Dr 4 72 11 02 13 ext +33 th.rimmele@gmail.com Contact: Bernard Allaouchiche, Pr 4 72 11 02 13 ext +33 bernard.allaouchiche@chu-lyon.fr Principal Investigator: Thomas Rimmelé, Dr Sub-Investigator: Bernard Allaouchiche, Pr Sub-Investigator: Charles-Eric Ber, Dr Sub-Investigator: Jullien Crozon, Dr Sub-Investigator: Mathieu Page, Dr Sub-Investigator: Johanne Prothet, Dr Sub-Investigator: Jean-Jacques Baillon, Dr Sub-Investigator: Françoise Christin, Dr Sub-Investigator: Bernard Floccard, Dr Sub-Investigator: Christian Guillaume, Dr Sub-Investigator: Olivier Martin, Dr Sub-Investigator: Guillaume Marcotte, Dr Sub-Investigator: Etienne Hautin, Dr Sub-Investigator: Alexandre Faure, Dr Sub-Investigator: Thomas Geffriaud, Dr Sub-Investigator: François Malavieille, Dr 收起 <<
NCT03384290	Healthy Subjects	Phase 1	Active, not recruiting	November 2018	Australia, Victoria ... 展开 >> Nucleus Network Limited Melbourne, Victoria, Australia, 3004 收起 <<
NCT01899768	Cough	Phase 2	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7AB 收起 <<
NCT01667679	-		Completed	-	-
NCT02462421	Diabetes Mellitus ... 展开 >> Gout Hyperuricemia 收起 <<	Phase 4	Enrolling by invitation	September 2019	-
NCT03574805	Asthma	Phase 1	Recruiting	October 20, 2019	Australia, South Australia ... 展开 >> CMAX Recruiting Adelaide, South Australia, Australia, 500 Contact: Kate Richardson 61 8 7088 7900 Kathryn.Richardson@cmax.com.au Principal Investigator: Thomas Polasek, MD Australia, Victoria Nucleus Network Limited Recruiting Melbourne, Victoria, Australia, 3004 Contact: Jessica Faggian 61 3 9076 8900 j.faggian@nucleusnetwork.com.au Principal Investigator: Oscar Walsh, MD Australia Linear Recruiting Perth, Australia Contact: Nicola Norton, RN 61 0 414 416 034 nnorton@linear.org.au Contact: Simon Scott, BSc, MPharmMed 61 0 432 149 680 sscott@linear.org.au Principal Investigator: Lara Hatchuel, MD 收起 <<
NCT01899768	-		Completed	-	-
NCT00696657	-		Completed	-	-
NCT00570492	-		Completed	-	-
NCT00696657	Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 <<	Phase 2	Completed	-	-
NCT00713648	Congenital Bleeding Disorder ... 展开 >> Congenital FXIII Deficiency 收起 <<	Phase 3	Completed	-	-
NCT00713648	-		Completed	-	-
NCT03663582	Short Bowel Syndrome	Phase 3	Recruiting	July 12, 2019	Japan ... 展开 >> Hyogo College of Medicine Hospital Recruiting Hyogo, Japan, 663-8501 Contact: Site Contact +81-79-845-6372 Principal Investigator: Hiroki Ikeuchi Tohoku University Hospital Recruiting Miyagi-Ken, Japan, 980-8574 Contact: Site Contact +81-22-717-7000 Principal Investigator: Motoshi Wada Osaka University Hospital Recruiting Osaka, Japan, 565-0871 Contact: Site Contact +81-6-6210-8290 Principal Investigator: Tsunekazu Mizushima Yokohama Municipal Citizen's Hospital Recruiting Yokohama, Japan, 240-8555 Contact: Site Contact +81-45-331-1961 Principal Investigator: Akira Sugita 收起 <<
NCT00570492	Rhinitis, Allergic, Perennial	Phase 4	Completed	-	-
NCT01160224	Asthma	Phase 2	Completed	-	Canada, Alberta ... 展开 >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 收起 <<
NCT03596164	Short Bowel Syndrome	Phase 3	Enrolling by invitation	June 25, 2021	Japan ... 展开 >> Hyogo College of Medicine Hospital Hyogo, Japan, 663-8501 Tohoku University Hospital Miyagi-Ken, Japan, 980-8574 Osaka University Hospital Osaka, Japan, 565-0871 Yokohama Municipal Citizen's Hospital Yokohama, Japan, 240-8555 收起 <<
NCT02140918	Healthy Volunteers	Phase 2	Completed	-	France ... 展开 >> Rennes University Hospital Rennes, France, 35033 收起 <<
NCT01808313	Vascular Disease	Phase 3	Completed	-	China, Heilongjiang ... 展开 >> GSK Investigational Site Harbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Hunan, Hunan, China, 410008 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Shaanxi GSK Investigational Site Xian, Shaanxi, China, 710032 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250012 China GSK Investigational Site Beijing, China, 100032 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100037 GSK Investigational Site Beijing, China, 100038 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200433 收起 <<
NCT01808313	-		Completed	-	-
NCT02105987	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 3	Completed	-	-
NCT02523885	-		Completed	-	France ... 展开 >> Centre Hospitalier Victor Dupouy Argenteuil, France, 95100 Louis Mourier Hospital Colombes, France, 92700 Hôpital Max Fourestier Nanterre, France, 92000 Tenon Hospital Paris, France, 75020 收起 <<
NCT00005889	Infant, Low Birth Weight ... 展开 >> Hyperglycemia 收起 <<	Not Applicable	Unknown	-	United States, Texas ... 展开 >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Agneta L. Sunehag 713-798-6725 asunehag@bcm.tmc.edu 收起 <<
NCT00737464	Anemia	Phase 4	Completed	-	India ... 展开 >> Indraprastha Apollo Hospitals New Delhi, Delhi, India, 110076 Manipal Institute of Nephrology and Urology; Nephrology Bangalore, India, 560017 Columbia Asia Medical Centre - Hebbal; Nephrology Bangalore, India, 560024 Tanker Foundation Chennai, India, 600 037 MIOT Institute of Nephrology ; Nephrology Chennai, India, 6000089 Madras Medical Mission Hospital Chennai, India, 600037 International Hospital Guwahati, India, 781005 Kamineni Hospitals; Nephrology Hyderabad, India, 500068 Nizam's Institute of Medical Sciences; Nephrology Hyderabad, India, 500082 Regency Hospital Ltd.; Nephrology Kanpur, India, 208005 Wockhardt Hospital and Kidney Institute; Nephrology Kolkata, India, 700029 Meerut Kidney Hospital Meerut, India, 250001 Silver Oaks Hospital; Nephrology Mohali, India, 160 063 Apex Kidney Care Mumbai, India, 400080 Lancelot Dialysis Center Mumbai, India, 400092 Fortis Flt. Lt. Rajan Dhall Hospital; Nephrology New Delhi, India, 110070 Ruby Hall Clinic Pune, India, 411 001 收起 <<
NCT00737464	-		Completed	-	-
NCT02106624	Critically Ill	Phase 4	Recruiting	August 2018	China, Shanghai ... 展开 >> Division of Critical Care Medicine: Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Wei Wu, MD 8602164041990 ext 2324 wu.wei@zs-hospital.sh.cn Principal Investigator: Ming Zhong, MD 收起 <<
NCT00655824	Arthritis, Rheumatoid	Phase 2	Terminated(The clinical develo... 展开 >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33334 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, Pennsylvania GSK Investigational Site Duncansville, Pennsylvania, United States, 16635 Denmark GSK Investigational Site Glostrup, Denmark, 2600 GSK Investigational Site Hellerup, Denmark, 2900 GSK Investigational Site Koebenhavn, Denmark, 2100 Hungary GSK Investigational Site Szombathely, Hungary, 9700 Poland GSK Investigational Site Warszawa, Poland, 02-256 United Kingdom GSK Investigational Site Ipswich, United Kingdom, IP4 5PD 收起 <<
NCT02105987	-		Completed	-	-
NCT02931929	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 1 Phase 2	Unknown	October 2017	-
NCT02701855	-		Unknown	December 2017	France ... 展开 >> Unité de prévention des maladies cardiovasculaires Pôle Cardiologie/Métabolisme Hôpital Pitié-Salpétriêre, APHP, 83 bd de l'hôpital, Recruiting Paris, France, 75013 Contact: David Rosenbaum, Dr 收起 <<
NCT01777256	Systemic Lupus Erythematosus	Phase 2	Terminated(This study met a pr... 展开 >>otocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.) 收起 <<	-	-
NCT03405818	Onychomycosis ... 展开 >> Tinea Unguium 收起 <<	Phase 4	Completed	-	United States, California ... 展开 >> Madera Family Medical Group Madera, California, United States, 93637 Stanford University School of Medicine Palo Alto, California, United States, 94304 United States, District of Columbia MedStar Health Research Institute - MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20016 United States, Florida Doctors Research Network South Miami, Florida, United States, 33143 United States, New York University Hospital, SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 Skin Specialty Dermatology New York, New York, United States, 10155 United States, Oregon Cyn3rgy Research Gresham, Oregon, United States, 97030 Oregon Dermatology & Research Center Portland, Oregon, United States, 97210 United States, Texas West Houston Clinical Research Services LLC Houston, Texas, United States, 77055 Texas Dermatology and Laser Specialists San Antonio, Texas, United States, 78218 United States, Utah Jordan Valley Dermatology Center West Jordan, Utah, United States, 84088 United States, Virginia PI Coor Clinical Research, LLC Burke, Virginia, United States, 22015 收起 <<
NCT00655824	-		Terminated(The clinical develo... 展开 >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) 收起 <<	-	-
NCT03495362	Pre-diabetic	Not Applicable	Recruiting	March 2019	China, Hubei ... 展开 >> Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Liegang Liu, MD, PhD +86-27-83650522 liegangliu@gmail.com Principal Investigator: Shufang Xu, PhD Principal Investigator: Liangkai Chen, MD Principal Investigator: Xiaoli Hu, MD Principal Investigator: Qiang Wang, MD 收起 <<
NCT03405818	-		Completed	-	-
NCT02617732	Type 2 Diabetes Mellitus	Not Applicable	Unknown	February 2018	China, Beijing ... 展开 >> Peking Union Medical College Hospital traditional Chinese medicine department Not yet recruiting Beijing, Beijing, China, 100730 Contact: Qian Zhang, Doctor （86+）13810387388 qianqian0409@163.com Contact: Zhen Tang, Master （86+）18810941269 1225530172@qq.com 收起 <<
NCT00678769	Malignant Neoplasm	Phase 1	Completed	-	United States, Michigan ... 展开 >> Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT01602562	Herpes Simplex	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 446-8602 GSK Investigational Site Aichi, Japan, 453-8511 GSK Investigational Site Aichi, Japan, 466-8560 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Hyogo, Japan, 650-0047 GSK Investigational Site Hyogo, Japan, 654-0081 GSK Investigational Site Kagoshima, Japan, 890-8520 GSK Investigational Site Kanagawa, Japan, 259-1143 GSK Investigational Site Osaka, Japan, 594-1101 GSK Investigational Site Saitama, Japan, 339-8551 GSK Investigational Site Tokyo, Japan, 162-8655 收起 <<
NCT02464345	Binge Eating Disorder ... 展开 >> Bulimia Nervosa Eating Disorder 收起 <<	Phase 2 Phase 3	Unknown	December 2018	Brazil ... 展开 >> Universidade Federal de Sao Paulo (UNIFESP) Recruiting Sao Paulo, SP, Brazil Contact: Angelica Claudino, MD, Ph.D 50842187 收起 <<
NCT01602562	-		Completed	-	-
NCT01321281	Osteoarthritis	Phase 2	Completed	-	Ireland ... 展开 >> Cork University Hospital Cork, Ireland 收起 <<
NCT02546037	-		Completed	-	-
NCT01290887	Eosinophilic Asthma	Phase 3	Terminated(Business decision)	-	-
NCT01290887	-		Terminated(Business decision)	-	-
NCT03539926	Cystinuria	Not Applicable	Active, not recruiting	February 2019	Spain ... 展开 >> Fundacio Puigvert Barcelona, Spain, 08025 收起 <<
NCT03761368	Remote Ischemic Preconditionin... 展开 >>g Contrast Induced - Acute Kidney Injury 收起 <<	Not Applicable	Completed	-	Poland ... 展开 >> Intensive Cardiac Therapy Clinic Lodz, Poland, 92-213 收起 <<
NCT01774994	Healthy	Not Applicable	Completed	-	-
NCT01304992	Hypercholesterolemia	Not Applicable	Completed	-	Germany ... 展开 >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 收起 <<
NCT02405416	Liver Neoplasms ... 展开 >> Liver Cirrhosis 收起 <<	Not Applicable	Unknown	June 2017	China, Hubei ... 展开 >> Tongji Hospital Recruiting Wuhan, Hubei, China, 430030 Contact: Xiaoping Chen, M.D. +86 27 83662851 chenxp@medmail.com.cn Contact: Chao Wu, M.M. +86 18986136006 dr_wuchao@hust.edu.cn 收起 <<
NCT03155919	Athletic Proteinuria	Not Applicable	Completed	-	Brazil ... 展开 >> Flavia Giolo de Carvalho Ribeirão Preto, Sao Paulo, Brazil 收起 <<
NCT01437540	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 3	Completed	-	-
NCT01378767	Effects of Krill Oil on Human ... 展开 >>Health 收起 <<	Not Applicable	Completed	-	United States, Tennessee ... 展开 >> Cardiorespiratory/Metabolic Laboratory Memphis, Tennessee, United States, 38152 收起 <<
NCT02797119	Pregnancy Complications ... 展开 >> Hemorrhage 收起 <<	Phase 4	Recruiting	February 2019	France ... 展开 >> Hôpital Jeanne de Flandre - CHRU de Lille Recruiting Lille, France Contact: Anne-Sophie Ducloy-Bouthors, MD anne-sophie.ducloy@chru-lille.fr Principal Investigator: Alexandre Turbelin, MD Hospices civils de Lyon CHU-Lyon Croix Rousse Not yet recruiting Lyon, France Principal Investigator: Françoise Broisin, MD Assistance Publique Hôpitaux Paris Hôpital Louis Mourier Recruiting Paris, France Principal Investigator: Hawa Keita-Meyer, MD Assistance Publique Hôpitaux Paris Hôpital Trousseau Recruiting Paris, France Principal Investigator: Agnès Rigouzzo, MD Centre Hospitalier Maternité Monaco Valenciennes Recruiting Valenciennes, France Principal Investigator: Laurent Chonow, MD 收起 <<
NCT00444587	Breast Cancer	Phase 2	Completed	-	Bulgaria ... 展开 >> Sofia, Bulgaria, 1527 Estonia Tallinn, Estonia, 13419 Hungary Budapest, Hungary, 1082 Budapest, Hungary, 1115 Budapest, Hungary, 1122 Budapest, Hungary, 1125 Budapest, Hungary, 1135 Budapest, Hungary, 1145 Debrecen, Hungary, 4032 Gyor, Hungary, 9023 Gyula, Hungary, 5700 Nyíregyháza, Hungary, 4400 Szeged, Hungary, 6725 Szekesfehervar, Hungary, 8000 Szombathely, Hungary, 9700 Israel Haifa, Israel, 31096 Holon, Israel, 58100 Petach Tikva, Israel, 49100 Ramat Gan, Israel, 52621 Rehovot, Israel, 76100 Safed, Israel, 13110 Tel Aviv, Israel, 6423906 Zerifin, Israel, 70300 Lithuania Kaunas, Lithuania, 50009 Vilnius, Lithuania, 08660 Macedonia, The Former Yugoslav Republic of Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Slovakia Bratislava, Slovakia, 812 50 Kosice, Slovakia, 041 90 Turkey Adana, Turkey, 01330 Ankara, Turkey, 06590 收起 <<
NCT00442572	-		Completed	-	-
NCT02000219	Primary Hyperoxaluria	Phase 2	Active, not recruiting	February 2020	Germany ... 展开 >> Universitätsklinikum Bonn, Department of Paediatric Nephrology Bonn, Germany, DE-53113 收起 <<
NCT03093766	-		Completed	-	Netherlands ... 展开 >> Medisch Centrum Leeuwarden Leeuwarden, Netherlands 收起 <<
NCT00444587	-		Completed	-	-
NCT00442572	Hepatitis B, Chronic	Phase 2	Completed	-	Bulgaria ... 展开 >> Mhat St. Ivan Rilski; Clinic of Gastroenterology Sofia, Bulgaria, 1612 收起 <<
NCT01437540	-		Completed	-	-
NCT02130635	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 14050 收起 <<
NCT03686969	Dermatomyositis	Phase 3	Recruiting	June 2020	Russian Federation ... 展开 >> I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY Rheumatology Department Of, Clinici Of Nephrology Recruiting Moscow, Russian Federation, 119992 收起 <<
NCT02130635	-		Completed	-	-
NCT02280005	End Stage Renal Disease	Not Applicable	Completed	-	United States, Washington ... 展开 >> University of Washington Seattle, Washington, United States, 98195U 收起 <<
NCT01572792	-		Completed	-	-
NCT01566578	Plaque Psoriasis	Phase 1	Unknown	November 2012	Switzerland ... 展开 >> University Hospital Zurich, Dermatology Clinic Recruiting Zurich, Switzerland, 8091 Contact: Michael Weisskopf, MD michael.weisskopf@usz.ch Sub-Investigator: Michael Weisskopf, MD 收起 <<
NCT01289132	Essential Hypertension	Phase 2	Completed	-	-
NCT01405794	Healthy	Phase 1 Phase 2	Completed	-	United States, Utah ... 展开 >> University of Utah Salt Lake City, Utah, United States, 84112-5820 收起 <<
NCT00299091	HIV	Phase 4	Completed	-	Spain ... 展开 >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 收起 <<
NCT03033953	Healthy Young... 展开 >> Elderly 收起 <<	Not Applicable	Completed	-	Norway ... 展开 >> Norwegian School of Sport Sciences Oslo, Norway, 0863 收起 <<
NCT01405794	-		Completed	-	-
NCT01613404	-		Completed	-	Canada, Nova Scotia ... 展开 >> Halifax, Nova Scotia, Canada Sydney, Nova Scotia, Canada Canada, Ontario Kingston, Ontario, Canada London, Ontario, Canada Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada Point Claire, Quebec, Canada Canada, Saskatchewan Regina, Saskatchewan, Canada Canada Greenfield Park, Canada Montreal, Canada Saskatoon, Canada St. John, Canada Toronto, Canada Verdun, Canada 收起 <<
NCT01572792	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 3	Completed	-	-
NCT01513902	-		Completed	-	-
NCT02612051	Idiopathic Pulmonary Fibrosis	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, SE1 1YR 收起 <<
NCT01568424	Right Ventricular Failure	Not Applicable	Completed	-	United States, Arizona ... 展开 >> Mayo Clinic Hospital Arizona Phoenix, Arizona, United States, 85054 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York New York Columbia Presbyterian Hospital New York, New York, United States, 10032 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Texas St. Luke's Episcopal Medical Center Houston, Texas, United States, 77030 United States, Utah Intermountain Medical Center Murray, Utah, United States, 84107 University of Utah Salt Lake City, Utah, United States, 84132 收起 <<
NCT02031224	Chronic Kidney Disease	Phase 4	Completed	-	Romania ... 展开 >> "Dr Carol Davila" Teaching Hospital of Nephrology Bucharest, Romania, 010731 收起 <<
NCT03385395	Alpha 1-Antitrypsin Deficiency	Phase 2	Withdrawn(IND has been closed.... 展开 >>) 收起 <<	December 2019	-
NCT01513902	Juvenile Idiopathic Arthritis	Phase 1	Completed	-	United States, Minnesota ... 展开 >> Explorer Clinic, University of Minnesota Children's Hospital Minneapolis, Minnesota, United States, 55454 Clinical and Translational Science Institute Masonic Clinical Research Unit (Administration Only) Minneapolis, Minnesota, United States, 55455 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Randall Children's Hospital at Legacy Emanuel Portland, Oregon, United States, 97227 Germany PRI - Pediatric Rheumatology Research Institute GmbH Bad Bramstedt, Germany, 24576 Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek Hamburg, Germany, 22081 Asklepios Klinik Sankt Augustin Gmbh St. Augustin, Germany, 53757 Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Krakow, Poland, 31-503 Klinika Kardiologii i Reumatologii Dzieciecej Lodz, Poland, 91-738 Slovakia Narodny ustav reumatickych chorob Piestany, Slovakia, 921 12 收起 <<
NCT00950755	Lymphoma, Non-Hodgkin	Phase 2	Completed	-	-
NCT01653808	Chronic Kidney Disease	Not Applicable	Completed	-	France ... 展开 >> University Hospital Center Montpellier, France, 34295 收起 <<
NCT02002585	Arterial Hypertension ... 展开 >> Chronic Renal Insufficiency 收起 <<	Phase 2	Unknown	December 2018	Czech Republic ... 展开 >> Charles University in Prague Recruiting Prague, Czech Republic, 12808 Contact: Jean Claude Lubanda, Ass.Prof.MD +420224962692 Jean-Claude.Lubanda@vfn.cz Contact: Martina Striteska, Mgr. +224962605 Martina.Striteska@vfn.cz Principal Investigator: Jean-Claude Lubanda, Ass.Prof.MD 收起 <<
NCT00764179	Intra-uterine Growth Delay	Not Applicable	Terminated(difficulties of rec... 展开 >>ruitment, high number of patients lost to follow-up) 收起 <<	-	France ... 展开 >> Universitary Hospital Nantes, France, 44093 收起 <<
NCT01568424	-		Completed	-	-
NCT00410410	Ulcerative Colitis	Phase 3	Completed	-	-
NCT03450759	Healthy Volunteers	Phase 1	Completed	-	United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 <<
NCT00410410	-		Completed	-	-
NCT02217943	Diabetes Obes... 展开 >>ity 收起 <<	Not Applicable	Active, not recruiting	July 1, 2021	China ... 展开 >> Beijing Shijitan Hospital Beijing, China China-Japan Union Hospital of Jilin University Changchun, China Guangzhou Overseas Chinese Hospital Guangzhou, China Jiangsu Province Hospital Jiangsu, China Shanghai East Hospital Shanghai, China Shanghai No. 6 People's Hospital Shanghai, China 收起 <<
NCT02925611	Postoperative Delirium	Phase 4	Unknown	June 2017	India ... 展开 >> Postgraduate Institute of Medical Education and Research Recruiting Chandigarh, India, 160012 Contact: Steve Joys, MBBS 7087617352 ext 91 stevejoys@gmail.com 收起 <<
NCT00950755	-		Completed	-	-
NCT03420092	Coronary Artery Disease	Phase 1	Completed	-	United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 <<
NCT03687476	Niemann-Pick Disease, Type C	Phase 2	Not yet recruiting	October 30, 2022	-
NCT03437538	Chronic Kidney Failure ... 展开 >> Uremia Dialysis 收起 <<	Not Applicable	Recruiting	January 30, 2019	Sweden ... 展开 >> Skane University Hospital Recruiting Malmö, Sweden Contact: Christensson anders.christensson@med.lu.se Contact +41 40-3331559 收起 <<
NCT03268460	-		Not yet recruiting	January 2019	-
NCT03672786	Genetic Change ... 展开 >> Athlete 收起 <<	Not Applicable	Completed	-	Spain ... 展开 >> Universidad de Granada Granada, Spain, 18071 收起 <<
NCT03704337	Healthy	Not Applicable	Completed	-	United States, Texas ... 展开 >> Exercise & Sport Nutrition Lab - Human Clinical Research Facility College Station, Texas, United States, 77845 收起 <<
NCT02838979	Cardiovascular Disease ... 展开 >> Sarcopenia Endothelial Dysfunction Muscle Mitochondrial Function Kidney Disease 收起 <<	Phase 2	Unknown	September 2017	United States, Washington ... 展开 >> Kidney Research Institute, University of Washington Recruiting Seattle, Washington, United States, 98104 Contact: Bob Roshanravan, MD MS MSPH 206-744-3948 broshanr@uw.edu Principal Investigator: Jonathan Himmelfarb, MD Sub-Investigator: Bryan Kestenbaum, MD MS Sub-Investigator: Bob Roshanravan, MD MS MSPH 收起 <<
NCT01375920	Depression	Phase 3	Completed	-	United Kingdom ... 展开 >> Stockton Affective Disorders Service Newcastle upon Tyne, Teesside, United Kingdom, TS17 6SD Newcastle Community Mental Health Team Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP Regional Affective Disorders Service Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP North Tyneside Community Mental Health Team Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE28 7PD Newcastle Magnetic Resonance Centre Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 5PL Bradford District Care Trust Bradford, United Kingdom Leeds Community Mental Health Team Leeds, United Kingdom, LS12 3QE Affective Disorders Service Manchester, United Kingdom, M13 9PT Manchester Community Mental Health Team Manchester, United Kingdom, M30 0GT Manchester Magnetic Resonance Centre Manchester, United Kingdom Northumberland, Tyne and Wear NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE3 3XT 收起 <<
NCT03440216	Pharmacokinetics ... 展开 >> Anti-Bacterial Agents Infection, Bacterial Infections, Respiratory Infection Drug Monitoring 收起 <<	Not Applicable	Recruiting	October 15, 2020	Belgium ... 展开 >> Cliniques universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Pierre F. Laterre, MD pierre-francois.laterre@uclouvain.be 收起 <<
NCT00933335	Lymphoma, Non-Hodgkin	Phase 2	Completed	-	-
NCT03649165	Neurofibromatosis Type 1 (NF1)... 展开 >>-Related Plexiform Neurofibromas (PNs) Healthy Participants 收起 <<	Phase 1	Completed	-	United States, Maryland ... 展开 >> Research Site Baltimore, Maryland, United States, 21225 收起 <<
NCT00933335	-		Completed	-	-
NCT00697593	-		Terminated(The study was termi... 展开 >>nated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 <<	-	-
NCT00697593	Chronic Plaque Psoriasis	Phase 4	Terminated(The study was termi... 展开 >>nated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 <<	-	Canada, Ontario ... 展开 >> Probity Medical Research City Waterloo, Ontario, Canada, N2J 1C4 收起 <<
NCT03397888	Hepatic Impairment	Phase 1	Completed	-	United States, Florida ... 展开 >> Clinical Pharmacology of Miami Hialeah, Florida, United States, 33014 收起 <<
NCT03769532	Acute Myeloid Leukemia	Phase 2	Not yet recruiting	December 2021	-
NCT01403233	Healthy	Phase 1	Completed	-	Canada, Ontario ... 展开 >> KGK Synergize Inc London, Ontario, Canada, N6A 5R8 收起 <<
NCT01399944	-		Completed	-	United States, Pennsylvania ... 展开 >> Monell Chemical Senses Center Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT01628302	Hypertension	Not Applicable	Completed	-	-
NCT03706690	Carcinoma, Non-Small-Cell Lung	Phase 3	Recruiting	January 31, 2025	-
NCT02118766	Dermatitis, Atopic	Phase 3	Completed	-	United States, Georgia ... 展开 >> Anacor Investigational Site Stockbridge, Georgia, United States 收起 <<
NCT03735420	Healthy	Phase 1	Not yet recruiting	August 2021	-
NCT03732820	Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 3	Recruiting	August 17, 2022	-
NCT00774163	Healthy	Phase 1	Completed	-	Peru ... 展开 >> Community of Santa Clara Iquitos, Loreto, Peru 收起 <<
NCT01865526	Chronic Kidney Disease	Not Applicable	Completed	-	Italy ... 展开 >> federico II university, department of nephrology Naples, Italy, 80129 收起 <<
NCT00434304	Parkinson Disease	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 455-8530 GSK Investigational Site Aichi, Japan, 460-0008 GSK Investigational Site Chiba, Japan, 279-0021 GSK Investigational Site Ehime, Japan, 791-0295 GSK Investigational Site Hokkaido, Japan, 070-0901 GSK Investigational Site Iwate, Japan, 020-0878 GSK Investigational Site Kanagawa, Japan, 251-0038 GSK Investigational Site Kyoto, Japan, 600-8811 GSK Investigational Site Osaka, Japan, 570-8507 GSK Investigational Site Saitama, Japan, 343-0032 GSK Investigational Site Tokyo, Japan, 113-8431 GSK Investigational Site Tokyo, Japan, 136-0075 收起 <<
NCT02458157	Acute Kidney Injury ... 展开 >> Fluid Overload Critical Illness 收起 <<	Phase 4	Terminated(Very low recruitmen... 展开 >>t rates) 收起 <<	-	Denmark ... 展开 >> Aalborg Universitetshospital, Anæstesi og intensiv afdeling Aalborg, Denmark, 9000 Nordsjællands Hospital. Dept. of Anaesthesiology and Intensive Care. Hillerød, Denmark, 3400 Rigshospitale. ITA 4131 / Dept. of intensive care København Ø, Denmark, 2100 收起 <<
NCT00774163	-		Completed	-	-
NCT03612856	End Stage Renal Disease ... 展开 >> Thrombosis 收起 <<	Phase 2	Recruiting	May 2020	United States, Florida ... 展开 >> Orlando Clinical Research Center Recruiting Orlando, Florida, United States, 32809 Contact: Charles Johnson 407-240-7876 收起 <<
NCT00434304	-		Completed	-	-
NCT03207295	Congenital Heart Disease ... 展开 >> Total Cavo-pulmonary Connection 收起 <<	Not Applicable	Recruiting	December 1, 2020	China, Beijing ... 展开 >> Fuwai hospital Recruiting Beijing, Beijing, China Contact: Yan Jun, MD,PhD yanjun.1112@aliyun.com 收起 <<
NCT02482402	Chronic Left Ventricular Failu... 展开 >>re Pulmonary Hypertension 收起 <<	Phase 2	Withdrawn(Delay in recruitment... 展开 >>) 收起 <<	-	Germany ... 展开 >> Klinik für Thorax- und Kardiovaskularchirurgie Bad Oeynhausen, Germany, 32545 Thoraxclinic at the University of Heidelberg Heidelberg, Germany, 69126 收起 <<
NCT01849237	Septic Shock ... 展开 >>Nonchemotherapy Drug-induced Neutropenia Neutropenia After Chemotherapy in Oncohematological Patients Neutropenia in Patients With Aplastic Anemia 收起 <<	Phase 1 Phase 2	Unknown	May 2015	Russian Federation ... 展开 >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Gennady M Galstyan, MD PhD +7(495)6124859 gengalst@gmail.com Principal Investigator: : Gennady M. Galstyan, , MD PhD Principal Investigator: Elena N. Parovichnikova, MD,PhD Sub-Investigator: Polina M. Makarova, MD Sub-Investigator: Vyacheslav A. Novikov, MD Sub-Investigator: Irina V. Kolosova, MD Sub-Investigator: Stanislav A. Keselman, MD Sub-Investigator: Alexandr Y. Mashkov, MD Sub-Investigator: Anna V. Krechetova, MD, PhD Sub-Investigator: Dmitri Tihomirov, PhD Sub-Investigator: Tatiana A. Garanzha, PhD Sub-Investigator: Larisa A. Kuzmina, MD, PhD 收起 <<
NCT03620812	Health, Subjective	Not Applicable	Recruiting	June 2019	Germany ... 展开 >> Martin-Luther-University Institute of Agriculture and Nutritional Science Recruiting Halle, Saxony Anhalt, Germany, 06120 Contact: Ulf Schlegelmilch, Dipl.Troph. (0)-49-345-5522723 收起 <<
NCT02118766	-		Completed	-	-
NCT03308565	Spinal Cord Injuries ... 展开 >> Paralysis 收起 <<	Phase 1	Recruiting	November 2023	United States, Minnesota ... 展开 >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 收起 <<
NCT03438617	Type 2 Diabetes Mellitus	Not Applicable	Active, not recruiting	July 31, 2018	China, Shanghai ... 展开 >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China 收起 <<
NCT01524159	Cardiovascular Disease.	Not Applicable	Completed	-	China, Beijing ... 展开 >> Hebei Yiling Hospital Shijiazhuang, Beijing, China, 050091 收起 <<
NCT02801890	Ultra Filtration Failure	Phase 1 Phase 2	Completed	-	Iran, Islamic Republic of ... 展开 >> Royan Institute Tehran, Iran, Islamic Republic of 收起 <<
NCT02398201	Mitochondrial Diseases	Phase 2	Completed	-	United Kingdom ... 展开 >> Clinical Research Facility, Royal Victoria Infirmary Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP 收起 <<
NCT03688711	Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 <<	Phase 3	Recruiting	April 18, 2019	United States, California ... 展开 >> ProSciento, Inc. Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD AMCR Institute Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey, MD United States, Washington Rainier Clinical Research, Inc. Recruiting Renton, Washington, United States, 98057 Contact: Leslie Klaff, MD, PhD 收起 <<
NCT03644485	Kidney Transplant	Phase 4	Recruiting	March 2020	China ... 展开 >> Site CN08602 Recruiting Wuhan, China Site CN08605 Recruiting Xi'an, China 收起 <<
NCT02311790	Insulin Sensitivity	Not Applicable	Completed	-	United States, Massachusetts ... 展开 >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 收起 <<
NCT00996996	Lymphoma, Non-Hodgkin	Phase 2	Completed	-	-
NCT03377283	Organ Preservation Solutions	Phase 4	Completed	-	-
NCT00376948	Pancreatic Cancer	Phase 2	Completed	-	United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 收起 <<
NCT00996996	-		Completed	-	-
NCT00376948	-		Completed	-	-
NCT01067313	Septic Shock	Phase 2 Phase 3	Completed	-	France ... 展开 >> Edouard Herriot Hospital, P Reanimation Lyon, France, 69003 收起 <<
NCT02205476	Hypertrophic Scars Resulting F... 展开 >>rom Prior Breast Scar Revision Surgery 收起 <<	Phase 2	Terminated(B5301001 study did ... 展开 >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) 收起 <<	-	United States, Florida ... 展开 >> Stephan Baker MD PA Coral Gables, Florida, United States, 33146 Bayside Ambulatory Center Miami, Florida, United States, 33133 United States, Georgia Kavali Plastic Surgery and Skin Renewal Center Atlanta, Georgia, United States, 30328 Primeter outpatient surgery center Atlanta, Georgia, United States, 30328 United States, Missouri Body Aesthetic Research Center Saint Louis, Missouri, United States, 63141 收起 <<
NCT02999152	Bone Metastasis ... 展开 >> Malignant Hemopathy 收起 <<	Not Applicable	Recruiting	December 31, 2019	France ... 展开 >> Institut de Cancérologie Lucien Neuwirth Recruiting Saint-Priest en Jarez, France, 42270 Principal Investigator: Nicolas Magné, PhD Sub-Investigator: Guy De Laroche, MD Sub-Investigator: Grégoire Pigne, MD Sub-Investigator: Denis Guyotat, PhD Sub-Investigator: Jérôme Cornillon, MD Institut Gustave Roussy Not yet recruiting Villejuif, France, 94800 Contact: Valentine Martin, MD Principal Investigator: Valentine Martin, MD Sub-Investigator: Angela Boros, MD 收起 <<
NCT01527760	Hypertension	Not Applicable	Completed	-	India ... 展开 >> Fr Muller Homoeopathic Medical College Hospital Mangalore, Karnataka, India, 575018 收起 <<
NCT02205476	-		Terminated(B5301001 study did ... 展开 >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) 收起 <<	-	-
NCT02028676	Human Immunodeficiency Virus	Phase 4	Completed	-	Uganda ... 展开 >> MRC /UVRI Uganda Research Unit on AIDS Entebbe, Uganda Joint Clinical Research Centre Kampala, Uganda Baylor College of Medicine Children's Foundation Mulago, Uganda Zimbabwe University of Zimbabwe Medical School Harare, Zimbabwe 收起 <<
NCT03052062	Obese	Phase 1 Phase 2	Completed	-	France ... 展开 >> Centre d'Investigation Clinique Clermont-Ferrand, France, 63000 收起 <<
NCT03746002	Fluid Overload ... 展开 >> Heart Failure Acute 收起 <<	Phase 4	Not yet recruiting	August 1, 2019	United States, Maryland ... 展开 >> University of Maryland Medical Center Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Mallory Mouradjian 401-248-3433 mmouradjian@rx.umaryland.edu 收起 <<
NCT00168831	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	-
NCT02028676	-		Completed	-	-
NCT02210156	Respiratory Tract Infection	Not Applicable	Completed	-	Mexico ... 展开 >> Omnilife Guadalajara, Jalisco, Mexico, 44500 收起 <<
NCT00168831	-		Completed	-	-
NCT01569698	-		Active, not recruiting	January 2019	Canada ... 展开 >> Pediatric intensive care - Centre mère enfants Sainte-Foy, Canada, G1V 4G2 Pediatric intensive care - Sherbrooke, Canada, J1H 5N4 France Angers University Hospital Angers, France Besançon University Hospital Besançon, France Pediatry - Bordeaux University Hospital Bordeaux, France, 33076 Reanimation pediatric - Morvan Hospital Brest, France, 29609 Pediatry - Cote De Nacre University Hospital Caen, France, 14000 Pediatric nephrology - Hôpital Couple-enfants Grenoble, France, 38043 Bicêtre University Hospital Le Kremlin Bicêtre, France Pediatry - Hopital de la Mère et de l'Enfant Limoges, France, 87000 Anesthesy-Pediatric reanimation - Nord University Hospital Marseille, France, 13920 Pediatric Nephrology and dianetology - Arnaud de Villeneuve Hospital Montpellier, France Pediatric reanimation - Hôpital mère-enfant Nantes, France, 44093 Réanimation et Surveillance - Robert Debre Hospital Paris, France, 75007 Pediatry - Reims University Hospital Reims, France, 51092 Nephrology - Hôpital des enfants Toulouse, France, 31059 Nephrology - Pediatric emergency - Clocheville University Hospital Tours, France, 37044 Pediatric reanimation - Brabois Hospital Vandoeuvre Les Nancy, France, 54511 Réunion Groupe hospitalier Sud Reunion Reunion, Réunion 收起 <<
NCT02515461	Diabetic Nephropathies	Not Applicable	Recruiting	January 2020	Denmark ... 展开 >> Odense Universitetshospital Recruiting Odense, Denmark, 5000 Contact: Sune M Skov-Jeppesen, MD 0045 51210911 sune.jeppesen@rsyd.dk Contact: Lars Lund, Professor lars.lund@rsyd.dk 收起 <<
NCT03437525	Type 2 Diabetes Treated With I... 展开 >>nsulin 收起 <<	Not Applicable	Active, not recruiting	April 30, 2018	China, Shanghai ... 展开 >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China 收起 <<
NCT00608491	Heart Failure	Phase 3	Completed	-	United States, Arizona ... 展开 >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murray, Utah, United States, 84107 United States, Vermont University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T - 1C8 收起 <<
NCT00168844	-		Completed	-	-
NCT00608491	-		Completed	-	-
NCT02706834	Dose Finding Study	Phase 1	Completed	-	United States, Maryland ... 展开 >> Baltimore, Maryland, United States United States, Texas Austin, Texas, United States 收起 <<
NCT00168844	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	-
NCT02587156	Protein Utilization ... 展开 >> Dietary Protein 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Institute of Sports Medicine Copenhagen Copenhagen, Denmark, 2400 收起 <<
NCT01899703	Cholestasis, Intrahepatic	Phase 2	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Birmingham, West Midlands, United Kingdom, B15 2WB GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 <<
NCT02706834	-		Completed	-	-
NCT03682627	Kidney Transplantation	Not Applicable	Not yet recruiting	December 2020	Germany ... 展开 >> Division of Visceral Transplantation, Department of General, Visceral and Transplantation Surgery, University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 收起 <<
NCT02345759	-		Recruiting	December 2020	Romania ... 展开 >> Spitalul Clinic de Nefrologie "Dr Carol Davila" Recruiting Bucuresti, Romania, 010731 Contact: Liliana Garneata, MD, PhD 0722619358 lilianagarna@yahoo.com Contact: Cristina Drugau, MD cristina.drugau@yahoo.com Sub-Investigator: Cristina Drugau, MD Sub-Investigator: Gabriel Stefan, MD Sub-Investigator: Paula Larisa Luca, MD Sub-Investigator: Alexandra Stancu, MD 收起 <<
NCT03764085	Sepsis Intoxi... 展开 >>cation; Septic 收起 <<	Phase 4	Recruiting	October 31, 2019	Georgia ... 展开 >> "Unimedi Adjara" LLC Recruiting Batumi, Georgia Contact: Sophio Beridze Kutaisi Referral Hospital Recruiting Kutaisi, Georgia Contact: Nino Babunashvili "Unimedi Kakheti" Ltd Recruiting Telavi, Georgia Contact: Maya Makkhetelashvili Kazakhstan Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan Recruiting Astana, Kazakhstan Contact: Nasrulla Shanazarov Moldova, Republic of Institute of Ambulance Recruiting Chisinau, Moldova, Republic of Contact: Adrian Belyy State Clinical Hospital of Traumatology and Orthopedy Recruiting Chisinau, Moldova, Republic of Contact: Octavian Cherempey State Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Victor Cojocaru Ukraine Dnipro`s Medical Academy of Ministry of Health of Ukraine Recruiting Dnipro, Ukraine, 49005 Contact: Yurii Kobelyatsky Zaicev's Institute of general and urgent surgery NMA Ukraine Recruiting Kharkiv, Ukraine, 61018 Contact: Stanislav Peev HSEE of Ukraine "Ukrainian Medical Stomatological Academy"; Poltava Central District Hospital Recruiting Poltava, Ukraine Contact: Alexey Lyhonenko Zaporizka Medical Academy of postgraduate education, Zaporizkyi Clinical Hospital N9 Recruiting Zaporizhzhya, Ukraine, 69065 Contact: Volodymyr Koshlya Uzbekistan Republic Centre of Ambulance Recruiting Tashkent, Uzbekistan Contact: Vіsolat Sharipova 收起 <<
NCT03319680	Hemodialysis-Induced Symptom	Not Applicable	Recruiting	December 2017	Spain ... 展开 >> Hospital General de Castellón Recruiting Castelló de la Plana, Castellón, Spain, 12004 Contact: Ramón Pons joserapons@gmail.com Sub-Investigator: Alba Segarra Sub-Investigator: Alejandro Pérez-Alba Principal Investigator: Ramón Pons Hospital del Henares Recruiting Coslada, Madrid, Spain, 28822 Contact: Blanca Bueno blanca.bueno@salud.madrid.org Sub-Investigator: Jose Luis Merino Sub-Investigator: Patricia Domínguez Sub-Investigator: Vicente Paraiso Principal Investigator: Blanca Bueno Hospital Universitario Infanta Sofía Recruiting San Sebastian de los Reyes, Madrid, Spain, 28702 Contact: Rocio Echarri rocio.echarri@salud.madrid.org Sub-Investigator: Yesica Amezquita Sub-Investigator: Antonio Cirugeda Sub-Investigator: Vicente Barrio Principal Investigator: Rocío Echarri Hospital Universitario Santa Lucía Recruiting Cartagena, Murcia, Spain, 30202 Contact: Gracia Alvarez alvarez.gracia@gmail.com Sub-Investigator: Manuel Molina Principal Investigator: Gracia Álvarez Hospital de Basurto Recruiting Bilbao, Vizcaya, Spain, 48013 Contact: Iñigo Moina INIGO.MOINAEGUREN@osakidetza.eus Sub-Investigator: Javier Arrieta Principal Investigator: Iñigo Moina Hospital de Galdakao Recruiting Usansolo, Vizcaya, Spain, 48960 Contact: Rosa Inés Muñoz ROSAINES.MUNOZGONZALEZ@osakidetza.eus Sub-Investigator: Isabel Martínez Principal Investigator: Rosa Inés Muñoz Hospital Universitario de Guadalajara Recruiting Guadalajara, Spain, 19002 Contact: Gabriel De Arriba garribad@gmail.com Sub-Investigator: Marta Sánchez Sub-Investigator: Maria Angeles Basterrechea Sub-Investigator: Luis Alberto Blazquez Sub-Investigator: Ruth Alexandra Fiallos Sub-Investigator: Paola Milena Villabon Principal Investigator: Gabriel De Arriba Universitary Hospital Infanta Leonor Recruiting Madrid, Spain, 28030 Contact: Patricia de Sequera, PhD 0034911918592 patricia.desequera@salud.madrid.org Principal Investigator: Patricia de Sequera, PhD Sub-Investigator: Rafael Pérez Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Eva Mérida evameridaherrero@hotmail.com Sub-Investigator: Claudia Yuste Principal Investigator: Eva Mérida Complexo Hospitalario Universitario de Ourense Recruiting Ourense, Spain, 32205 Contact: Alfoso Otero Alfonso.Otero.Gonzalez@sergas.es Sub-Investigator: Beatriz Ferreiro Sub-Investigator: Elena Iglesias Sub-Investigator: Maria Jesús Camba Sub-Investigator: María Paz Borrajo Principal Investigator: Alfoso Otero Hospital Universitario Virgen de la Macarena Recruiting Sevilla, Spain, 41009 Contact: Rocío Valverde rociovalor84@hotmail.com Sub-Investigator: Clotilde Ríos Sub-Investigator: Rocío Molas Principal Investigator: Rocío Valverde Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Contact: Luis Gil luisgilsacaluga@gmail.com Sub-Investigator: Amelia Dueñas Sub-Investigator: María Aguilar Principal Investigator: Luis Gil 收起 <<
NCT02786849	Kidney Diseases ... 展开 >> Chronic Kidney Diseases Chronic Kidney Insufficiency Chronic Renal Insufficiency Chronic Renal Diseases Renal Dialysis Hemodialysis 收起 <<	Not Applicable	Unknown	November 2016	Brazil ... 展开 >> Ana Karla Vieira Brüggemann Recruiting Santo Amaro da Imperatriz, SC - Santa Catarina, Brazil, 88140-000 Contact: Ana Karla Brüggemann, graduation +554896658289 anakarla_vb@hotmail.com Contact: Elaine Paulin, doctor +554836648602 lainepaulin@gmail.com 收起 <<
NCT01368328	Type 2 Diabetes	Phase 3	Unknown	September 2011	Brazil ... 展开 >> Goiania Municipal Health Departament Goiânia, Goiás, Brazil, 74000000 收起 <<
NCT01778192	Colorectal Cancer ... 展开 >> Colon Adenoma 收起 <<	Phase 3	Completed	-	Korea, Republic of ... 展开 >> Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine Seoul, Korea, Republic of, ASI\|KR\|KS013\|SEOUL 收起 <<
NCT01817036	Vitamin D Deficiency	Phase 1	Completed	-	China, Shanghai ... 展开 >> Institute for Nutritional Sciences, Chinese Academy of Sciences Shanghai, Shanghai, China, 200031 收起 <<
NCT02530359	Acute Kidney Injury ... 展开 >> Sepsis 收起 <<	Phase 4	Unknown	July 2016	-
NCT03287466	Critical Illness ... 展开 >> Respiratory Failure 收起 <<	Not Applicable	Recruiting	May 2020	United Kingdom ... 展开 >> Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Contact: Margaret McNeil 020 7794 0500 ext 24534 margaret.mcneil@nhs.net 收起 <<
NCT00619801	Allergic Rhinitis ... 展开 >> Chronic Urticaria 收起 <<	Phase 3	Completed	-	-
NCT00628108	Allergic Rhinitis ... 展开 >> Chronic Urticaria 收起 <<	Phase 3	Completed	-	United States, Alabama ... 展开 >> Birmingham, Alabama, United States United States, Arkansas Hot Springs, Arkansas, United States Jonesboro, Arkansas, United States Little Rock, Arkansas, United States United States, California Bakersfield, California, United States Crescent City, California, United States Huntington Beach, California, United States Los Angeles, California, United States Orange, California, United States Roseville, California, United States Stockton, California, United States United States, Georgia Albany, Georgia, United States Gainesville, Georgia, United States United States, Illinois Normal, Illinois, United States United States, Missouri Bridgeton, Missouri, United States United States, Nebraska Omaha, Nebraska, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, South Carolina Barnwell, South Carolina, United States Spartanburg, South Carolina, United States United States, Tennessee Kingsport, Tennessee, United States United States, Texas Austin, Texas, United States Dallas, Texas, United States El Paso, Texas, United States San Antonio, Texas, United States Sugarland, Texas, United States United States, Virginia Richmond, Virginia, United States 收起 <<
NCT00628108	-		Completed	-	-
NCT02653443	Healthy	Phase 2	Terminated	-	United States, New Hampshire ... 展开 >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03766 United States, Ohio Hoxworth Blood Center Cincinnati, Ohio, United States, 45267 收起 <<
NCT02157155	Ketoacidosis ... 展开 >>Diabetes Mellitus Type 1 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Aarhus University Hospital Aarhus, Denmark, 8000 收起 <<
NCT02103205	Health of Formula-fed Children... 展开 >> Infant Infections in Formula-fed Children Iron Status of Formula-fed Children 收起 <<	Not Applicable	Active, not recruiting	December 2023	Sweden ... 展开 >> Umeå University, Department of Clinical Sciences Umeå, Sweden, SE-901 87 收起 <<
NCT02108951	-		Terminated(Study was terminate... 展开 >>d because of slow recruitment) 收起 <<	-	-
NCT02978430	Major Abdominal Surgery	Phase 2	Completed	-	Belgium ... 展开 >> Erasme University Hospital Brussels, Belgium, 1070 收起 <<
NCT00619801	-		Completed	-	-
NCT03211676	End Stage Renal Disease ... 展开 >> Dialysis Related Complication Dialysis Amyloidosis 收起 <<	Not Applicable	Recruiting	December 14, 2017	France ... 展开 >> CHU DE Poitiers Recruiting Poitiers, France, 86021 Contact: Mohamed BELMOUAZ 05.49.44.40.78 收起 <<
NCT02108951	Philidelphia Positive Chronic ... 展开 >>Myeloid Leukaemia 收起 <<	Phase 3	Terminated(Study was terminate... 展开 >>d because of slow recruitment) 收起 <<	-	Australia, Australian Capital ... 展开 >>Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia, 2605 Australia, New South Wales Novartis Investigative Site Kingswood, New South Wales, Australia, 2747 Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Novartis Investigative Site Liverpool, New South Wales, Australia, 2170 Novartis Investigative Site St. Leonards, New South Wales, Australia, 2065 Australia, Queensland Novartis Investigative Site Douglas, Queensland, Australia, 4810 Novartis Investigative Site Nambour, Queensland, Australia, 4560 Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Fitzroy, Victoria, Australia, 3065 Novartis Investigative Site Geelong, Victoria, Australia, 3220 Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Australia, Western Australia Novartis Investigative Site Murdoch, Western Australia, Australia, 6150 Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 收起 <<
NCT01027494	-		Completed	-	United States, Texas ... 展开 >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 收起 <<
NCT00547521	Rheumatoid Arthritis (RA)	Phase 3	Completed	-	-
NCT01071902	Acute Otitis Media	Phase 3	Terminated(Management decision... 展开 >>) 收起 <<	-	United States, Texas ... 展开 >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 收起 <<
NCT02643147	Heart Failure	Phase 4	Completed	-	Spain ... 展开 >> Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 收起 <<
NCT02654678	Heart Failure ... 展开 >> Dilated Cardiomyopathy Congenital Heart Disease 收起 <<	Phase 2 Phase 3	Unknown	April 2018	Austria ... 展开 >> Medical University of Vienna Not yet recruiting Vienna, Austria, 1090 Contact: Christoph Male, Prof,MD,PhD + 43 1 40400 32320 christoph.male@meduniwien.ac.at Contact: Vanessa Swoboda, MD + 43 1 40400 32320 v.swoboda@live.at Principal Investigator: Christoph Male, Prof,MD,PhD Sub-Investigator: Vanessa Swoboda, MD Hungary Hungarian Paediatric Heart Centre,Göttsegen Gyorgy Hungarian Institute of Cardiology Not yet recruiting Budapest, Hungary, 1095 Contact: András Szatmári, Prof,MD,PhD +36 1 215 1220 szatmari@kardio.hu Contact: Laszlo Ablonczy, MD +36 1 215 1220 'Laszlo Ablonczy' Principal Investigator: András Szatmári, Prof,MD,PhD Sub-Investigator: Laszlo Ablonczy, MD Netherlands Sophia Children's Hospital Erasmus MC Not yet recruiting Rotterdam, Netherlands, 3015 CN Contact: Saskia N. de Wildt, MD,PhD +31 10 7040704 s.dewildt@erasmusmc.nl Contact: Tjitske van der Zanden +31 10 7040704 t.vanderzanden@erasmusmc.nl Principal Investigator: Michiel Dalinghaus, MD,PhD Sub-Investigator: Marijke Van der Meulen, MD,PhD Wilhelmina Children's Hospital, University Medical Center Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX Contact: J.M.P. J. Breur, MD,PhD + 31 8875 540 02 h.breur@umcutrecht.nl Principal Investigator: J.M.P. J. Breur, MD,PhD Serbia Univerzitetska Dečja Klinika Not yet recruiting Belgrade, Serbia, 11129 Contact: Milica Bajcetic, Prof,MD,PhD +38 1112060716 milica.bajcetic@udk.bg.ac.rs Contact: Ida Jovanovic, Prof,MD,PhD + 38 1112060716 idaj@rcub.bg.ac.rs Principal Investigator: Ida Jovanovic, Prof,MD,PhD United Kingdom Great Ormond Street Hospital for Children NHS Trust Not yet recruiting London, United Kingdom, WC1N 3JH Contact: Michael Burch, Prof,MD,PhD +44 020 7405 9200 michael.burch@gosh.nhs.uk Principal Investigator: Michael Burch, Prof,MD,PhD 收起 <<
NCT01838265	-		Withdrawn(Unlikely to Accrue)	-	United States, Florida ... 展开 >> University of Miami Miami, Florida, United States, 33136 收起 <<
NCT01209078	-		Completed	-	-
NCT00124982	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT00547521	-		Completed	-	-
NCT01665651	Renal Insufficiency, Chronic ... 展开 >> Renal Osteodystrophy 收起 <<	Phase 2	Withdrawn(Hard to enroll parti... 展开 >>cipants) 收起 <<	-	China, Anhui ... 展开 >> The first affiliated hospital of Anhui University of TCM Hefei, Anhui, China, 230031 China, Shanghai Huadong hospital affiliated to Fudan University Shanghai, Shanghai, China, 200000 Longhua Hospital affiliated to Shanghai Uni of TCM Shanghai, Shanghai, China, 200032 收起 <<
NCT00578773	Acute Otitis Media	Phase 2	Completed	-	-
NCT01209078	Skin Infections, Bacterial	Phase 2	Completed	-	United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, California GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Oceanside, California, United States, 92056 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96813 United States, Pennsylvania GSK Investigational Site West Reading, Pennsylvania, United States, 19611 收起 <<
NCT01793701	Locally Advanced Cervical Canc... 展开 >>er 收起 <<	Phase 1 Phase 2	Active, not recruiting	April 2018	United Kingdom ... 展开 >> Barts Health NHS Trust London, United Kingdom Hammersmith Hospital London, United Kingdom Royal Marsden London, United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom 收起 <<
NCT00579189	Acute Otitis Media	Phase 3	Completed	-	-
NCT02562963	Non-small Cell Lung Cancer ... 展开 >> Gastric Cancer Hepatocellular Carcinoma Colorectal Cancer 收起 <<	Phase 1 Phase 2	Recruiting	December 2018	China ... 展开 >> Hua Xin Hosptial First Hosptial of Tsinghua University Recruiting Beijing, China, 100016 Contact: Minghui Zhang, PhD 0086-10-62799520 mh-zhang@tsinghua.edu.cn Principal Investigator: Minghui Zhang, PhD Shanghai Public Health Clinical Center Recruiting Shanghai, China, 201508 Contact: Xiaoyan Zhang, MD, PhD 0086-21-37990333 ext 7310 zhangxiaoyan@shaphc.org Principal Investigator: Xiaoyan Zhang, MD, PhD 收起 <<
NCT03177395	Paracetamol Overdose	Phase 1	Enrolling by invitation	December 31, 2018	United Kingdom ... 展开 >> Royal Infirmary of Edinburgh Edinburgh, City Of Edinburgh, United Kingdom, EH16 4SA 收起 <<
NCT01473498	Septic Shock ... 展开 >>Acute Kidney Injury 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Reanimation Chirurgicale - Hôpital Kremlin Bicêtre Kremlin Bicêtre, France, 94275 收起 <<
NCT00124982	-		Completed	-	-
NCT01550445	Disorder Related to Renal Tran... 展开 >>splantation 收起 <<	Phase 4	Unknown	July 2012	Korea, Republic of ... 展开 >> Ajou University Hospital Recruiting Suwon, Korea, Republic of, 443-749 Contact: chang-kwon oh, M.D. 82-10-91657281 OHCK@ajou.ac.kr Principal Investigator: chang kwon oh, M.D 收起 <<
NCT01914263	Hepatocellular Carcinoma ... 展开 >> Renal Cell Carcinoma Lung Cancer 收起 <<	Phase 1	Unknown	June 2016	China, Hainan ... 展开 >> Hannan BOAO Life infinity international anti-aging medical center Recruiting Qionghai, Hainan, China, 571434 China, Liaoning The 210 Hospital of Chinese People's Liberation Army Recruiting Dalian, Liaoning, China, 116021 Contact: Dayue Han, MD 86-13387854002 tc210dl@hotmail.com Principal Investigator: Dayue Han, MD China, Shaanxi The 323 Hospital of Chinese People's Liberation Army Recruiting Xi'an, Shaanxi, China, 710054 Contact: Liming wang, MD 86-29-84756502 wanglm@fmmu.edu.cn Principal Investigator: Liming Wang, MD 收起 <<
NCT02014584	Alopecia	Phase 3	Completed	-	Chile ... 展开 >> GSK Investigational Site Santiago, Región Metro De Santiago, Chile, 7580206 Hong Kong GSK Investigational Site Pokfulam, Hong Kong GSK Investigational Site Shatin, Hong Kong Korea, Republic of GSK Investigational Site Chungcheongnam-do, Korea, Republic of GSK Investigational Site Daejeon, Korea, Republic of, 301-721 GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Gyeonggi-do, Korea, Republic of, 463-707 GSK Investigational Site Incheon, Korea, Republic of, 400-711 GSK Investigational Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 GSK Investigational Site Kangwon-Do, Korea, Republic of, 220-701 GSK Investigational Site Pusan, Korea, Republic of, 602-739 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 134-090 GSK Investigational Site Seoul, Korea, Republic of, 143-729 GSK Investigational Site Seoul, Korea, Republic of, 156-755 Singapore GSK Investigational Site Singapore, Singapore, 169608 Taiwan GSK Investigational Site Taipei, Taiwan, 106 GSK Investigational Site Taipei, Taiwan 收起 <<
NCT01481584	Men	Not Applicable	Completed	-	Germany ... 展开 >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany, 07743 收起 <<
NCT03141619	-		Recruiting	June 2020	Canada, Ontario ... 展开 >> Kingston General Hospital Recruiting Kingston, Ontario, Canada, K7L3V7 Contact: John G Boyd, MD, PhD 613-549-6666 ext 6228 2jgb1@queensu.ca 收起 <<
NCT02014584	-		Completed	-	-
NCT01928940	-		Completed	-	-
NCT01928940	Solid Tumours	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 收起 <<
NCT00478738	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 14050 South Africa GSK Investigational Site Bloemfontein, South Africa, 9301 GSK Investigational Site George, South Africa, 6530 GSK Investigational Site Mowbray, South Africa, 7700 收起 <<
NCT02724605	Red Blood Cells Transfusion	Phase 2	Completed	-	Egypt ... 展开 >> Assiut university faculty of medicine Assiut, Egypt 收起 <<
NCT00530790	Restless Legs Syndrome	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 802-0084 GSK Investigational Site Fukuoka, Japan, 810-0044 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Hiroshima, Japan, 733-0031 GSK Investigational Site Kanagawa, Japan, 210-0024 GSK Investigational Site Osaka, Japan, 550-0004 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 599-8263 GSK Investigational Site Tochigi, Japan, 321-0293 GSK Investigational Site Tokyo, Japan, 151-0053 GSK Investigational Site Tokyo, Japan, 187-0041 收起 <<
NCT02469402	Overweight	Not Applicable	Completed	-	Germany ... 展开 >> Evangelisches Waldkrankenhaus Spandau Berlin, Germany, 13589 收起 <<
NCT03460795	Liver Cirrhosis	Phase 1 Phase 2	Not yet recruiting	September 1, 2020	China, Jiangsu ... 展开 >> Nanjing Medical University Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Ling Lu, M.D, PH. D. 86-025-68136053 lvling@njmu.edu.cn 收起 <<
NCT00530790	-		Completed	-	-
NCT02012985	Primary Hyperoxaluria	Phase 1 Phase 2	Completed	-	France ... 展开 >> Hôpital Robert-Debré, Néphrologie Pédiatrique Paris, Cedex 19, France, 75945 Hôpital des Enfants, Centre de référence maladies rénales rares du Sud-Ouest (SORARE), CHU de Bordeaux Bordeaux, France, 33076 Hôpital Femme Mère Enfant, Lyon - Paediatric Dept Lyon, France, 69677 Bron Hôpital Necker-Enfants Malades,Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA) Paris, France, 75015 Germany Universitätsklinikum Bonn, Dept of Paediatric Nephrology Bonn, Germany, DE-53113 United Kingdom Birmingham Children's Hospital NHS Foundation Trust - Dept of Nephrology Birmingham, United Kingdom, B4 6NH Royal Free Hospital -UCL Centre for Nephrology London, United Kingdom, NW3 2QG Great Ormond Street Hospital for Children NHS Trust London, United Kingdom, WCIN 3JH 收起 <<
NCT02813031	Healthy Volunteers	Not Applicable	Completed	-	Spain ... 展开 >> IMDEA-Food Madrid, Spain, 28049 收起 <<
NCT03031496	Hypertension	Phase 1	Completed	-	South Africa ... 展开 >> GSK Investigational Site Bloemfontein, South Africa, 9301 收起 <<
NCT01242904	End Stage Renal Disease	Phase 2	Completed	-	Canada, Ontario ... 展开 >> London Health Sciences Centre, South Street Hospital, Peritoneal Dialysis Unit London, Ontario, Canada, N6A 5W9 收起 <<
NCT02882386	Healthy Participants	Not Applicable	Completed	-	-
NCT00263328	Kidney Transplantation	Phase 2	Completed	-	United States, California ... 展开 >> Multi Organ Transplant Center Los Angeles, California, United States, 90057 St. Vincent Medical Center Los Angeles, California, United States, 90057 Transplant Research Institute Los Angeles, California, United States, 90057 Stanford School of Medicine Palo Alto, California, United States, 94304 Balboa Institute of Transplantation San Diego, California, United States, 92123 California Institute of Renal Research San Diego, California, United States, 92123 Sharp Memorial Hospital San Diego, California, United States, 92123 California Pacific Medical Center San Francisco, California, United States, 94115 University of California, San Francisco, Kidney Transplant Unit San Francisco, California, United States, 94143 Stanford University Medical Center Stanford, California, United States, 94305 United States, Colorado University of Colorado Health Sciences Center Renal Clinical Trials Office Aurora, Colorado, United States, 80045 University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Northwestern University-Feinberg School of Medicine, Division of Organ Transplantation Chicago, Illinois, United States, 60611 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Jack J Dreyfus Clinic New York, New York, United States, 10021 Recanati/Miller Transplantation Institute New York, New York, United States, 10029 New York Presbyterian Hospital / Weill Cornell Medical Center New York, New York, United States, 10065 United States, Oregon Legacy Good Samaritan Hospital Portland, Oregon, United States, 97210 Legacy Transplant Services Portland, Oregon, United States, 97210 Northwest Renal Clinic Portland, Oregon, United States, 97210 United States, Texas Dallas Transplant Institute Dallas, Texas, United States, 75204 Annette C & Harold C Simmons Transplant Institute Dallas, Texas, United States, 75246 Baylor University Medical Center Dallas, Texas, United States, 75246 Baylor All Saints Medical Center Fort Worth, Texas, United States, 76104 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 <<
NCT00795600	Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 <<	Phase 4	Completed	-	Spain ... 展开 >> Málaga, Spain, 29009 收起 <<
NCT03031496	-		Completed	-	-
NCT00904488	-		Terminated(Difficult recruitme... 展开 >>nt) 收起 <<	-	-
NCT02377427	Asthma	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92123 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7310 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792-9988 Japan GSK Investigational Site Fukuoka, Japan, 811-1394 GSK Investigational Site Hiroshima, Japan, 720-8520 GSK Investigational Site Hiroshima, Japan, 721-8511 GSK Investigational Site Wakayama, Japan, 646-8558 Poland GSK Investigational Site Lodz, Poland, 90-329 GSK Investigational Site Tarnow, Poland, 33-100 GSK Investigational Site Wroclaw, Poland, 53-201 United Kingdom GSK Investigational Site Glasgow, United Kingdom, G514TF GSK Investigational Site Leicester, United Kingdom, LE27LX GSK Investigational Site Liverpool, United Kingdom, L12 2AP GSK Investigational Site London, United Kingdom, SE5 9RS GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site Oxford, United Kingdom, OX3 9DU GSK Investigational Site Sheffield, United Kingdom, S10 2TH 收起 <<
NCT03242473	Pancreatitis	Not Applicable	Recruiting	June 2018	United States, District of Col... 展开 >>umbia Children's National Health System Recruiting Washington, D.C., District of Columbia, United States, 20010 Contact: Sona Sehgal, MD 888-884-2327 SSehgal@childrensnational.org United States, Virginia Children's Hospital of The King's Daughters Recruiting Norfolk, Virginia, United States, 23507 Contact: Peter R Farrell, MD 917-696-5731 peter.farrell@cchmc.org 收起 <<
NCT00795600	-		Completed	-	-
NCT00904488	Acute Decompensated Heart Fail... 展开 >>ure 收起 <<	Phase 4	Terminated(Difficult recruitme... 展开 >>nt) 收起 <<	-	United States, North Carolina ... 展开 >> UNC_Chapel Hill Chapel Hill, North Carolina, United States, 27599 收起 <<
NCT00263328	-		Completed	-	-
NCT01954160	-		Terminated(DSMB decision based... 展开 >> upon noted lack of efficacy in manufacturers pivotal trials.) 收起 <<	-	-
NCT00050375	Ovarian Cancer	Phase 3	Terminated(Study closed by spo... 展开 >>nser) 收起 <<	-	-
NCT02798978	Cancer	Phase 1	Completed	-	Germany ... 展开 >> GSK Investigational Site Berlin, Germany, 14050 收起 <<
NCT01669408	Stroke	Phase 2	Unknown	September 2013	Germany ... 展开 >> Rescue service, Dept. of Anesthesiology, University Hospital Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Sven Poli, Dr. med. 0049 6221 56 ext 0 sven.poli@med.uni-heidelberg.de Contact: Erik Popp, PD Dr. med. 0049 6221 56 ext 0 erik.popp@med.uni-heidelberg.de Principal Investigator: Sven Poli, Dr. med. Principal Investigator: Erik Popp, PD Dr. med. Sub-Investigator: Christian Hametner, Dr. med. Sub-Investigator: Jan Purrucker, Dr. med. Sub-Investigator: Miriam Priglinger, Dr. med. Sub-Investigator: Maxim Bartz 收起 <<
NCT02377427	-		Completed	-	-
NCT02723981	Stable Angina ... 展开 >> Unstable Angina STEMI NSTEMI Coronary Disease 收起 <<	Phase 4	Withdrawn(Regulatory authority... 展开 >> approval for the initial study design could not be obtained) 收起 <<	December 2018	Germany ... 展开 >> MVZ am Kuechwald GmbH Chemnitz, Germany Elisabeth Krankenhaus Essen, Germany Universitaetsmedizin Mainz Mainz, Germany Theresienkrankenhaus und St. Hedwig GmbH Mannheim, Germany Universitaetsmedizin Mannheim Mannheim, Germany St. Franziskus, Kliniken Maria Hilf GmbH Moenchengladbach, Germany Evangelisches Krankenhuas Muehlheim a.d. Ruhr GmbH Muehlheim an der Ruhr, Germany Diakonissen-Stiftungs-Krankenhaus Speyer, Germany Herzklinik Ulm GbR Ulm, Germany Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Germany 收起 <<
NCT01954160	Heart Failure	Phase 2	Terminated(DSMB decision based... 展开 >> upon noted lack of efficacy in manufacturers pivotal trials.) 收起 <<	-	United States, Georgia ... 展开 >> Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02130 Tufts Medical Center Boston, Massachusetts, United States, 02153 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio Metro Health System Cleveland, Ohio, United States, 44115 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 United States, Vermont The University of Vermont - Fletcher Allen Health Care Burlington, Vermont, United States, 05401 收起 <<
NCT03774615	Heart Failure, Left Sided ... 展开 >> Anemia, Iron Deficiency 收起 <<	Phase 4	Not yet recruiting	June 30, 2020	-
NCT03014232	Sepsis Acute ... 展开 >>Kidney Injury 收起 <<	Not Applicable	Completed	-	-
NCT00369278	Renal Transplantation	Phase 3	Completed	-	Germany ... 展开 >> Novartis Investigational Site Various Cities, Germany 收起 <<
NCT02819219	Healthy	Not Applicable	Completed	-	-
NCT01111877	-		Terminated(Management Decision... 展开 >>) 收起 <<	-	United States, Texas ... 展开 >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 收起 <<
NCT02861222	Malignant Glioma	Phase 1	Completed	-	France ... 展开 >> Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France CHU, Hôpital d'Enfants de la Timone Marseille, France Institut Curie Paris, France Unité d'Hémato-Oncologie, CHU, Hôpital des enfants Toulouse, France CHU, Hôpital d'Enfants Vandoeuvre les Nancy, France Institut Gustave-Roussy Villejuif, France 收起 <<
NCT03593707	Healthy Volunteers	Phase 1	Suspended(Sponsor elected to v... 展开 >>oluntarily pause study.) 收起 <<	February 12, 2019	Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT02680847	-		Terminated(The trial was termi... 展开 >>nated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.) 收起 <<	-	-
NCT00119678	Systemic Lupus Erythematosus	Phase 2	Completed	-	-
NCT03598153	-		Not yet recruiting	December 31, 2019	-
NCT03231332	Human Microbiome	Phase 4	Enrolling by invitation	December 31, 2025	Latvia ... 展开 >> University of Latvia Riga, Latvia, LV 1586 收起 <<
NCT00369278	-		Completed	-	-
NCT00119678	-		Completed	-	-
NCT02680847	Moderate-severe Pain	Phase 4	Terminated(The trial was termi... 展开 >>nated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.) 收起 <<	-	United States, California ... 展开 >> Research Center For Clinical Studies-West, Inc. Lancaster, California, United States, 93534 Children's Hopsital Los Angeles Los Angeles, California, United States, 90027 Children's Hospital Of Los Angeles - University Of Southern California School Of Medicine Los Angeles, California, United States, 90027 Shriners Hospitals For Children Northern California Sacramento, California, United States, 95817 UC Davis Health Attn: Peter Trovitch, PharmD Sacramento, California, United States, 95817 University of California Davis Sacramento, California, United States, 95817 United States, Illinois University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences Systems Chicago, Illinois, United States, 60612 University of Illinois Hospital at the Medical Center Chicago, Illinois, United States, 60612 United States, North Carolina East Carolina University Brody School of Medicine(ECU) Greenville, North Carolina, United States, 27834 Leo Jenkins Cancer Center Pharmacy Greenville, North Carolina, United States, 27834 United States, South Carolina Medical University of South Carolina Children's Hospital Charleston, South Carolina, United States, 29425 Medical University of South Carolina, Investigational Drugs Services Charleston, South Carolina, United States, 29425 Medical University of South Carolina, Rutledge Tower, Pediatric Clinic Charleston, South Carolina, United States, 29425 Medical University of South Carolina, SCTR Research Nexus Charleston, South Carolina, United States, 29425 United States, Texas Road Runner Research, Ltd San Antonio, Texas, United States, 78249 收起 <<
NCT03642405	-		Active, not recruiting	January 1, 2022	Denmark ... 展开 >> Herlev Hospital Herlev, Denmark, 2730 收起 <<
NCT03416192	Chronic Kidney Diseases ... 展开 >> Uremia 收起 <<	Not Applicable	Not yet recruiting	December 2019	-
NCT01556633	-		Completed	-	-
NCT01288872	Schistosomiasis [Bilharziasis]	Phase 1	Completed	-	Philippines ... 展开 >> Research Institute for Tropical Medicine - Health Compound Muntinlupa City, National Capital Region, Philippines, 1781 收起 <<
NCT00299975	Constipation	Phase 2	Completed	-	China ... 展开 >> Hong Kong Baptist University Chinese Medicine Clinic Hong Kong, China 收起 <<
NCT01556633	Healthy Volunteer	Phase 1	Completed	-	New Zealand ... 展开 >> Christchurch, New Zealand, 8011 Grafton, New Zealand, 1010 收起 <<
NCT02368015	Hepatic Cyst	Not Applicable	Completed	-	Netherlands ... 展开 >> Radboud University Nijmegen Medical Center; Department of Gastroenterology & Hepatology Nijmegen, Gelderland, Netherlands, 6500 HB 收起 <<
NCT00773708	HIV Infections	Phase 4	Completed	-	Spain ... 展开 >> H.U. Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 收起 <<
NCT00379171	Obesity Metab... 展开 >>olic Syndrome Growth Blood Pressure Cardiovascular Disease 收起 <<	Not Applicable	Completed	-	-
NCT00741936	Functional Gastrointestinal Di... 展开 >>sorders Constipation 收起 <<	Phase 2	Completed	-	China ... 展开 >> Hong Kong Baptist University Mr. & Mrs. Chan Hon Yin Chinese Medicine Specialty Clinic and Good Clinical Practice Centre Hong Kong, China 收起 <<
NCT00205556	End-stage Renal Disease ... 展开 >> Cardiovascular Disease 收起 <<	Not Applicable	Completed	-	Canada, New Brunswick ... 展开 >> Dr Georges-L. Dumont Regional Hospital Moncton, New Brunswick, Canada Canada Centre Hospitalier de L'Université de Montreal, Hopital Notre Dame Montreal, Canada, H2L 4M1 Netherlands Jeroen Bosch Ziekenhuis 's Hertogenbosch, Netherlands, 5200 ME Medisch Centrum Alkmaar Alkmaar, Netherlands, 1815 JD Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081 HV Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1090 HM Academical Medical Center Amsterdam, Netherlands, 1100 DD Ziekenhuis Rijnstate Arnhem, Netherlands, 6800 TA Dialyse Kliniek Noord Beilen, Netherlands, 9411 SE Haga Ziekenhuis (locatie Leyenburg) Den Haag, Netherlands, 2545 CH Slingeland Ziekenhuis Doetinchem, Netherlands, 7009 BL Ziekenhuis Gelderse Vallei Ede, Netherlands, 6710 HN Catharina Ziekenhuis Eindhoven, Netherlands, 5602 ZA Oosterscheldeziekenhuis Goes, Netherlands, 4460 BB Groene Hart Ziekenhuis Gouda, Netherlands Martini Ziekenhuis Groningen, Netherlands, 9700 RM Rijnland Ziekenhuis Leiderdorp, Netherlands University Medical Center St Radboud Nijmegen, Netherlands, 6500 HB Franciscus Ziekenhuis Roosendaal, Netherlands, 4700 AZ Sint Franciscus Gasthuis Rotterdam, Netherlands, 3045 PM Medisch Centrum Rijnmond Zuid - locatie Clara Rotterdam, Netherlands, 3075 EA Orbis Medisch en Zorgcentrum Sittard, Netherlands, 6130 MB Ziekenhuis Zeeuws-Vlaanderen Terneuzen, Netherlands, 4535 PA St Elisabeth Ziekenhuis Tilburg, Netherlands, 5000 LC Stichting Dianet Utrecht, Netherlands, 3524 BN University Medical Center Utrecht Utrecht, Netherlands, 3584 CX VieCuri Medisch Centrum Venlo, Netherlands, 5912 BL Isala Klinieken Zwolle, Netherlands, 8000 GM Norway Haukeland Universitetssykehus Bergen, Norway, 5021 收起 <<
NCT00623597	HIV Infections	Phase 2	Completed	-	Argentina ... 展开 >> Buenos Aires, Argentina, 1202 Buenos Aires, Argentina, 1425 Santa Fe, Argentina, 3000 Spain Madrid, Spain, 28046 Madrid, Spain, 28905 Valencia, Spain, 46009 Thailand Bangkok, Thailand, 10400 Khon Kaen, Thailand, 40002 Pathumwan, Thailand, 10330 Payathai, Thailand, 10400 收起 <<
NCT00299975	-		Completed	-	-
NCT01113346	Viral Gastroenteritis	Phase 2 Phase 3	Unknown	February 2011	Russian Federation ... 展开 >> Arhangelsk Regional Children's Clinical Hospital named after P.G. Vizshletsov Recruiting Arhangelsk, Arhangelskaya oblast, Russian Federation, 163062 Contact: Larisa Titova, MD, PhD +7-8182-280433 irina-bul@yandex.ru Contact: Olga Samodova, MD, DrSc +7-8182-22-95-42 samodova@atknet.ru Principal Investigator: Larisa Titova, MD, PhD Sub-Investigator: Olga Samodova, MD, DrSc St. Vladimir Children's Moscow Clinical Hospital Recruiting Moscow, Russian Federation, 107014 Contact: Elena Meskina, MD, DrSc +7-916-1216172 meskinaelena@mail.ru Contact: Lyudmila Feklisova, MD, DrSc +7-495-2682226 vespamen@yandex.ru Sub-Investigator: Lyudmila Feklisova, MD, DrSc Principal Investigator: Elena Meskina, MD, DrSc 收起 <<
NCT00623597	-		Completed	-	-
NCT02048800	-		Unknown	March 2017	United Kingdom ... 展开 >> Great Ormond Street Hospital for Children Recruiting London, United Kingdom, WC1N 3JH Contact: Robert Chiesa, MD 02078138434 ext 8434 robert.chiesa@gosh.nhs.uk Contact: Praseeda Thaikaloor 02079052346 praseeda.thaikalloor@gosh.nhs.uk Great North Childrens Hospital Recruiting Newcastle Upon Tyne, United Kingdom, NE1 4LP Contact: Mary Slatter, MD 01912823767 mary.slatter@nuth.nhs.uk 收起 <<
NCT03118739	Hyperuricemia ... 展开 >> Albuminuria Type 2 Diabetes 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Research Site Canyon Country, California, United States, 91351 Research Site Chula Vista, California, United States, 91911 Research Site Corona, California, United States, 92882 Research Site Escondido, California, United States, 92025 Research Site Lakewood, California, United States, 90805 Research Site Lincoln, California, United States, 95648 Research Site Los Angeles, California, United States, 90017 Research Site Los Angeles, California, United States, 90022 Research Site Los Angeles, California, United States, 90036 Research Site North Hollywood, California, United States, 91606 Research Site Oceanside, California, United States, 92056-4510 Research Site Orange, California, United States, 92868 Research Site Sacramento, California, United States, 95821 United States, Texas Research Site Houston, Texas, United States, 77058 Research Site Houston, Texas, United States, 77070 Research Site Pearland, Texas, United States, 77584 Research Site Sugar Land, Texas, United States, 77478 Research Site Webster, Texas, United States, 77598 收起 <<
NCT00741936	-		Completed	-	-
NCT01745042	-		Completed	-	Brazil ... 展开 >> Optics Group from Physics Institute of São Carlos (IFSC), University of São Paulo (USP) São Carlos, São Paulo, Brazil, 676 收起 <<
NCT00128492	Cystic Fibrosis	Phase 3	Completed	-	-
NCT01222078	Diabetes Mellitus, Type 1	Phase 2	Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 <<	-	France ... 展开 >> GSK Investigational Site Paris Cedex 18, France, 75877 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 <<
NCT00937326	Diabetes Mellitus, Type 2	Phase 2	Completed	-	-
NCT01308073	-		Completed	-	Germany ... 展开 >> Intensivstation ZOM1 Klinik für Anästhesiologie Universitätsklinikum Düsseldorf Duesseldorf, Germany, 40225 收起 <<
NCT00583362	Systemic Lupus Erythematosus	Phase 2	Completed	-	-
NCT00583362	-		Completed	-	-
NCT03563846	Lactose Intolerance	Phase 1	Completed	-	United States, Florida ... 展开 >> Syneos Health Miami, Florida, United States, 33136 收起 <<
NCT00128492	-		Completed	-	-
NCT01736033	Benign Prostate Hyperplasia	Phase 4	Unknown	June 2017	Korea, Republic of ... 展开 >> Chungbuk National University Hospital Cheongju, Chungbuk, Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan, Chungnam, Korea, Republic of Hallym University Sacred Heart Hospital Anyang, Gyeoggi, Korea, Republic of Bucheon St. Mary's Hospital Bucheon, Gyeonggi, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Bucheon, Gyeonggi, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of Ajou University Hospital Suwon, Gyeonggi, Korea, Republic of Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of Pusan National University Hospital Busan, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Eulji General Hospital Seoul, Korea, Republic of 收起 <<
NCT01222078	-		Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 <<	-	-
NCT00937326	-		Completed	-	-
NCT01106352	Bone Metastases ... 展开 >> Castration-Resistant Prostate Cancer 收起 <<	Phase 1 Phase 2	Completed	-	United States, California ... 展开 >> San Francisco, California, United States, 94115 United States, Illinois Evanston, Illinois, United States, 60201 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02115-6013 United States, New York New York, New York, United States, 10065 United States, Washington Seattle, Washington, United States, 98109 France Villejuif Cedex, France, 94805 收起 <<
NCT01725126	-		Completed	-	-
NCT01725126	Obesity	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT00879814	Meningitis, Meningococcal	Phase 1	Completed	-	United States, Florida ... 展开 >> Miami Research Associates, Inc. South Miami, Florida, United States, 33143 收起 <<
NCT02516501	Neoplasms	Phase 1	Recruiting	December 2020	Germany ... 展开 >> Department of Radiotherapy and Radiation Oncology Recruiting Schweinfurt, Bavaria, Germany, 97421 Contact: Reinhart A Sweeney, MD +49 9721 7206420 rsweeney@leopoldina.de Principal Investigator: Rainer J Klement, PhD 收起 <<
NCT00879814	-		Completed	-	-
NCT03093688	Non-small Cell Lung Cancer ... 展开 >> Small Cell Lung Cancer Pancreas Cancer Hepatocellular Carcinoma Gastric Cancer Renal Cell Carcinoma 收起 <<	Phase 1 Phase 2	Recruiting	December 31, 2019	China, Shanghai ... 展开 >> Shanghai Public Health Clinical Center Recruiting Shanghai, Shanghai, China, 201508 Contact: Yan X Zhang, M.D. 0086-021-37990333 ext 7310 zhangxiaoyan@shaphc.org 收起 <<
NCT00742508	Heart Failure, Congestive	Phase 1	Completed	-	Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 296-8602 GSK Investigational Site Ehime, Japan, 794-0006 GSK Investigational Site Hiroshima, Japan, 737-0023 GSK Investigational Site Hokkaido, Japan, 060-0033 GSK Investigational Site Hokkaido, Japan, 063-0005 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 238-8558 GSK Investigational Site Mie, Japan, 511-0068 GSK Investigational Site Nagano, Japan, 397-8555 GSK Investigational Site Nagasaki, Japan, 859-3615 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Saga, Japan, 843-0393 GSK Investigational Site Saitama, Japan, 364-8501 GSK Investigational Site Shizuoka, Japan, 410-2295 GSK Investigational Site Shizuoka, Japan, 411-8611 GSK Investigational Site Shizuoka, Japan, 427-8502 GSK Investigational Site Shizuoka, Japan, 430-8502 GSK Investigational Site Tokyo, Japan, 141-0001 GSK Investigational Site Tokyo, Japan, 142-8666 GSK Investigational Site Tokyo, Japan, 153-8515 GSK Investigational Site Tokyo, Japan, 196-0003 GSK Investigational Site Wakayama, Japan, 640-8158 收起 <<
NCT03727282	Cardiogenic Shock ... 展开 >> Heart Failure 收起 <<	Not Applicable	Not yet recruiting	January 2, 2021	-
NCT01106352	-		Completed	-	-
NCT01663714	Lymphoma, Non-Hodgkin	Phase 2	Completed	-	-
NCT00742508	-		Completed	-	-
NCT00712933	Systemic Lupus Erythematosus	Phase 3	Completed	-	-
NCT01663714	-		Completed	-	-
NCT00712933	-		Completed	-	-
NCT01313312	Nervous System Disorders	Phase 3	Completed	-	-
NCT01586364	-		Completed	-	-
NCT00255190	-		Completed	-	-
NCT01586364	Atrophy Vagin... 展开 >>al Diseases 收起 <<	Phase 3	Completed	-	-
NCT01313312	-		Completed	-	-
NCT02613910	-		Terminated(Novartis has acquir... 展开 >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) 收起 <<	-	-
NCT00255190	Gastroesophageal Reflux Diseas... 展开 >>e 收起 <<	Phase 3	Completed	-	-
NCT02613910	Pemphigus	Phase 3	Terminated(Novartis has acquir... 展开 >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90045 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48103 收起 <<
NCT01251367	Post-stroke Spasticity ... 展开 >> Spasticity Post-Traumatic Brain Injury 收起 <<	Phase 3	Completed	-	-
NCT00048581	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT01251367	-		Completed	-	-
NCT01059760	Cardiovascular Disease	Not Applicable	Completed	-	United States, Utah ... 展开 >> Intermountain Medical Center Murray, Utah, United States, 84107-5701 收起 <<
NCT01059760	-		Completed	-	-
NCT02434497	Homozygous Familial Hyperchole... 展开 >>sterolemia (HoFH) 收起 <<	Phase 3	Completed	-	Belgium ... 展开 >> Research Site Brussels (Woluwé-St-Lambert), Belgium, 1200 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Denmark Research Site Copenhagen, Denmark, DK-2100 Israel Research Site Halfa, Israel, 31096 Malaysia Research Site Kubang Kerian, Malaysia, 16150 Taiwan Research Site Taipei City, Taiwan, 11217 收起 <<
NCT00710164	Acute Ischemic Stroke	Phase 2 Phase 3	Unknown	-	China, Chengdu ... 展开 >> Department of Nuerology, Kunming General Hospital of Chengdu Military Command Recruiting Kunming, Chengdu, China, 650032 Contact: Shixiang Liu, MD China, Guangdong Department of Nuerology, The Second People's Hospital of Foshan city Recruiting Foshan, Guangdong, China, 528000 Contact: Qingkun Zhou, MD Department of Nuerology, The Second People's Hospital of Jiangmen city Recruiting Jiangmen, Guangdong, China, 529030 Contact: Qiong Zheng, MD China, Guangxi Department of Nuerology, Liuzhou Hospital of Traditional Chinese Medicine Recruiting Liuzhou, Guangxi, China, 545001 Contact: Changjun Lu, MD China, Hebei Department of Nuerology, Cangzhou Central Hospistal Recruiting Cangzhou, Hebei, China, 060001 Contact: Junling Zhang, MD China, Hubei Department of Nuerology, Hubei Hospital of Traditional Chinese Medicine Recruiting Wuhan, Hubei, China, 430061 Contact: Mengjiu Dong, MD China, Hunan Department of Nuerology, The First People's Hospital of Changsha city Recruiting Changsha, Hunan, China, 410005 Contact: Shenhui Zhu, MD China, Shanghai Department of Neurology, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200001 Contact: Yansheng Li Department of Nuerology, Changzheng Hospital Affiliated to the Second Military Medical University Recruiting Shanghai, Shanghai, China, 200003 Contact: Zhongxin Zhao, MD Department of Integrative Medicine, Zhongshan hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200021 Contact: Dingfang Cai Department of Nuerology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Not yet recruiting Shanghai, Shanghai, China, 200021 Contact: Zhenglong Fang, MD Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Shengdi Chen, MD Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 200032 Contact: Canxing Yuan, MD Department of Nuerology, Zhongshan hospital, Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Wei Fan, MD Department of Neurology, Huashan hospital, Fudan University Not yet recruiting Shanghai, Shanghai, China, 200040 Contact: Qiang Dong, MD Department of Nuerology, Tongji Hospital of Tongji University Recruiting Shanghai, Shanghai, China, 200065 Contact: Qing Zhan, MD Department of Neurology, Shanghai First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200081 Contact: Shaoshi Wang, MD Department of Nuerology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Zhenguo Liu, MD Department of Nuerology, Shanghai Sixth People＇s Hospital Affiliated to Shanghai Jiaotong University School of Medicine Active, not recruiting Shanghai, Shanghai, China, 200233 Department of Neurology, Changhai Hospital Affiliated to the Second Military Medical University Recruiting Shanghai, Shanghai, China, 200433 Contact: Yangtai Guan, MD 收起 <<
NCT01047553	-		Completed	-	-
NCT01387633	Diabetes Mellitus	Not Applicable	Unknown	-	Brazil ... 展开 >> Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Recruiting Ribeirão Preto, São Paulo, Brazil, 14048-900 Contact: Ana Emilia Pace, Principal Investigator (55) 16 3602-3401 aepace@eerp.usp.br Principal Investigator: Ana Emilia Pace, Principal Investigator 收起 <<
NCT01936246	Perinatal Stroke ... 展开 >> Hypoxic-ischemic Encephalopathy White Matter Injury 收起 <<	Not Applicable	Completed	-	United States, Ohio ... 展开 >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 收起 <<
NCT00048581	-		Completed	-	-
NCT01047553	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Akita-shi, Akita, Japan Research Site Chitose, Hokkaido, Japan Research Site Obihiro, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site AKO, Hyogo, Japan Research Site Kobe-shi, Hyogo, Japan Research Site Hitachi, Ibaraki, Japan Research Site Tsukuba, Ibaraki, Japan Research Site Kanazawa, Ishikawa, Japan Research Site Sakaide, Kagawa, Japan Research Site Fujisawa, Kanagawa, Japan Research Site Kawasaki-shi, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Koshi, Kumamoto, Japan Research Site Nagaoka, Niigata, Japan Research Site Saiki-shi, Oita, Japan Research Site Moriguchi, Osaka, Japan Research Site Matsue, Shimane, Japan Research Site Bunkyo, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Katsushika-ku, Tokyo, Japan Research Site Kodaira, Tokyo, Japan Research Site Setagaya, Tokyo, Japan Research Site Tosima-ku, Tokyo, Japan Research Site Fukuoka, Japan Research Site Kyoto, Japan 收起 <<
NCT02462759	Spinal Muscular Atrophy	Phase 2	Active, not recruiting	April 9, 2019	United States, California ... 展开 >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095-8344 United States, Connecticut Connecticut Childrens Medical Hartford, Connecticut, United States, 06106 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Minnesota Gillette Children's Specialty Healthcare Saint Paul, Minnesota, United States, 55101 United States, Texas The University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 United States, Washington Seattle Children's Research Institute Seattle, Washington, United States, 98105 Germany LMU-Campus Innenstadt Muenchen, Germany, 80337 收起 <<
NCT01070784	-		Completed	-	-
NCT00331708	Malaria	Not Applicable	Terminated(Lack of suitable pa... 展开 >>rticipants) 收起 <<	-	Mozambique ... 展开 >> Ndlavela Health Centre Ndlavela, Maputo, Mozambique 收起 <<
NCT03685084	Healthy	Phase 1	Completed	-	-
NCT02434497	-		Completed	-	-
NCT01945801	Obstructive Sleep Apnea	Phase 4	Completed	-	Brazil ... 展开 >> Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-903 收起 <<
NCT02964260	Hepatocellular Carcinoma, Adul... 展开 >>t 收起 <<	Not Applicable	Recruiting	December 2022	China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jinhua Huang, Ph.D 0086-20-87343447 Principal Investigator: Jinhua Huang, Ph.D 收起 <<
NCT01070784	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Toyota, Aichi, Japan Research Site Yanagawa, Fukuoka, Japan Research Site Asahikawa, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site Itami, Hyogo, Japan Research Site Hitachi, Ibaraki, Japan Research Site Tsukuba, Ibaraki, Japan Research Site Sakaide, Kagawa, Japan Research Site Fujisawa, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Koshi, Kumamoto, Japan Research Site Shibata, Miyagi, Japan Research Site Chuo, Tokyo, Japan Research Site Setagaya, Tokyo, Japan Research Site Hiroshima, Japan Research Site Kyoto, Japan 收起 <<
NCT03146143	Congenital Cardiac Disorders	Not Applicable	Completed	-	Egypt ... 展开 >> Kasr Alainy Hospital , Faculty of Medicine Cairo, Egypt 收起 <<
NCT01868035	Lymphoma, Non-Hodgkin	Phase 2	Completed	-	-
NCT03613649	Electrocardiogram Repolarisati... 展开 >>on Abnormality Gonococcal Infection 收起 <<	Phase 1	Active, not recruiting	January 6, 2019	United States, Kansas ... 展开 >> Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 收起 <<
NCT01868035	-		Completed	-	-
NCT00380146	Malaria	Not Applicable	Completed	-	Mozambique ... 展开 >> Ndlavela Health Centre Ndlavela, Maputo, Mozambique 收起 <<
NCT00508625	Non-Small Cell Lung Cancer	Phase 2	Completed	-	-
NCT01460797	Obesity	Not Applicable	Completed	-	Brazil ... 展开 >> School of Health Sciences, University of Brasília Brasília, DF, Brazil, 70910-900 收起 <<
NCT01861054	Breast Cancer	Phase 2	Terminated(Enrollment target n... 展开 >>ot reached) 收起 <<	-	United States, Indiana ... 展开 >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Kansas University of Kansas Cancer Center, 4350 Shawnee Mission Pkwy, Suite 1500, Mailstop 6004 Fairway, Kansas, United States, 66205 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 Montefiore Medical Center, MMC Medical Park at Eastchester The Bronx, New York, United States, 10461 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Magee-Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Sara Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas The Methodist Hospital Research Institute Houston, Texas, United States, 77030 收起 <<
NCT03685591	Hormone Receptor Positive Adva... 展开 >>nced Breast Cancer Metastatic Breast Cancer Human Epidermal Receptor 2 Negative Advanced Breast Cancer Castration Resistant Prostate Cancer 收起 <<	Phase 1	Recruiting	August 24, 2023	United States, Texas ... 展开 >> The University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030-4009 The University of Texas - MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 NEXT Oncology Recruiting San Antonio, Texas, United States, 78240 收起 <<
NCT02289027	Ebola Vaccines	Phase 1 Phase 2	Completed	-	Switzerland ... 展开 >> Clinical Trial Unit Lausanne Lausanne, Switzerland, 1011 收起 <<
NCT01068717	-		Completed	-	-
NCT01598649	Hypercholesterolemia	Not Applicable	Completed	-	Germany ... 展开 >> Friedrich Schiller University Jena, Department of Nutritional Physiology Jena, Thuringia, Germany 收起 <<
NCT03368547	Prostate Adenocarcinoma ... 展开 >> Stage IIB Prostate Cancer AJCC v7 Stage III Prostate Cancer AJCC v7 Stage IV Prostate Cancer AJCC v7 收起 <<	Not Applicable	Recruiting	February 1, 2022	United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Johannes Czernin 310-206-3226 Principal Investigator: Johannes Czernin 收起 <<
NCT03723993	Lactic Acidosis	Not Applicable	Recruiting	December 15, 2018	Egypt ... 展开 >> Mohamed Hamed Recruiting Fayoum, Egypt, 63511 Contact: mohadme a hamed, MD 01118560065 ext +20 dhamed81@yahoo.com Principal Investigator: mohamed a hamed, MD 收起 <<
NCT01068717	Type 2 Diabetes Mellitus	Phase 1	Completed	-	United States, Texas ... 展开 >> Ppd Development, Lp Austin, Texas, United States, 78744 收起 <<
NCT03547336	End Stage Renal Disease	Not Applicable	Recruiting	January 31, 2019	China, Anhui ... 展开 >> Baxter Investigational Site Not yet recruiting Hefei, Anhui, China, 230601 China, Guangdong Baxter Investigational Site Not yet recruiting Guangzhou, Guangdong, China, 510515 China, Heilongjiang Baxter Investigational Site Not yet recruiting Haerbin, Heilongjiang, China, 150001 China, Henan Baxter Investigational Site Not yet recruiting Zhengzhou, Henan, China, 450052 China, Hubei Baxter Investigational Site Recruiting Wuhan, Hubei, China, 430060 China, Shanghai Baxter Investigational Site Recruiting Shanghai, Shanghai, China, 200011 China, Sichuan Baxter Investigational Site Not yet recruiting Chengdu, Sichuan, China, 610041 China, Zhejiang Baxter Investigational Site Not yet recruiting Hangzhou, Zhejiang, China, 310014 China Baxter Investigational Site Not yet recruiting Beijing, China, 100034 Baxter Investigational Site Recruiting Beijing, China, 100034 收起 <<
NCT00593606	-		Completed	-	-
NCT01243320	Healthy	Phase 1 Phase 2	Completed	-	United States, Utah ... 展开 >> University of Utah Hospital and Clinics Salt Lake City, Utah, United States, 84132 收起 <<
NCT00664521	-		Completed	-	-
NCT03701074	Patent Ductus Arteriosus ... 展开 >> Preterm Infant Bronchopulmonary Dysplasia 收起 <<	Phase 2	Not yet recruiting	December 2020	United States, Alabama ... 展开 >> University of South Alabama Not yet recruiting Mobile, Alabama, United States, 36607 Contact: Ramachandra Bhat, MD 251-415-1055 rbhat@health.southalabama.edu 收起 <<
NCT01353638	End Stage Renal Disease	Phase 1 Phase 2	Terminated(Primary endpoint (H... 展开 >>SP) could not be analyzed with the specified method in the planned interim analysis; a method of increased sensitivity had to be established.) 收起 <<	-	Austria ... 展开 >> Department of Internal Medicine III; Clinical Division of Nephrology and Dialysis; Medical University of Vienna Vienna, Austria, 1090 收起 <<
NCT01243320	-		Completed	-	-
NCT00664521	Rheumatoid Arthritis	Phase 2	Completed	-	France ... 展开 >> Research Site Nice, France Research Site Paris, France Research Site Strasbourg, France Netherlands Research Site Amsterdam, Netherlands Sweden Research Site Malmö, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Newcastle, United Kingdom Research Site Norwich, United Kingdom 收起 <<
NCT01831791	Alopecia	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 GSK Investigational Site Osaka, Japan, 530-0057 GSK Investigational Site Osaka, Japan, 532-0003 GSK Investigational Site Tokyo, Japan, 103-0028 GSK Investigational Site Tokyo, Japan, 160-0022 收起 <<
NCT01831791	-		Completed	-	-
NCT03580226	-		Completed	-	-
NCT00593606	Parkinson's Disease	Phase 3	Completed	-	-
NCT03672552	Dysphagia Res... 展开 >>piratory Tract Infections 收起 <<	Not Applicable	Not yet recruiting	September 12, 2019	Canada, Newfoundland and Labra... 展开 >>dor Eastern Health-Pleasant View Towers Not yet recruiting Saint John's, Newfoundland and Labrador, Canada, A1A 0L7 Contact: Mona Elliott 709-468-5247 mona.elliott@easternhealth.ca 收起 <<
NCT02345161	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	-
NCT01233869	Polycystic Kidney, Autosomal D... 展开 >>ominant 收起 <<	Phase 2	Completed	-	-
NCT01817673	Healthy Persons	Not Applicable	Completed	-	Brazil ... 展开 >> Univsersity of Sao Paulo Sao Paulo, Brazil, 05508-030 收起 <<
NCT00208026	Netherton Syndrome	Phase 1 Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT01495000	-		Completed	-	-
NCT02345161	-		Completed	-	-
NCT00208026	-		Completed	-	-
NCT01495000	Osteoporosis, Postmenopausal	Phase 3	Completed	-	India ... 展开 >> GSK Investigational Site Ahmedabad, India, 380015 GSK Investigational Site Bangalore, India, 560043 GSK Investigational Site Bangalore, India, 560052 GSK Investigational Site Bangalore, India, 560054 GSK Investigational Site Delhi, India, 110060 GSK Investigational Site Mangalore, India, 575002 GSK Investigational Site Nagpur, India, 440010 GSK Investigational Site Nagpur, India, 440012 GSK Investigational Site Pune, India, 411030 GSK Investigational Site Trivandrum, India, 695011 GSK Investigational Site Vadodra, India, 390007 收起 <<
NCT03766399	Asthma	Phase 1	Recruiting	December 5, 2019	United Kingdom ... 展开 >> Research Site Recruiting Harrow, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9GP 收起 <<
NCT03619564	-		Recruiting	January 2021	Taiwan ... 展开 >> Hualien Tzu Chi Hospital Recruiting Hualien City, Hualien County, Taiwan, 970 Kaohsiung Chang Gung Memorial Hospital Not yet recruiting Kaohsiung, Kaohsiung County, Taiwan, 833 Keelung Chang Gung Memorial Hospital Not yet recruiting Keelung, Keeluing City, Taiwan, 204; Taipei Tzu Chi Hospital Recruiting Taipei, New Taipei City, Taiwan, 231 Shuang Ho Hospital Recruiting Taipei, New Taipei City, Taiwan, 235 Taichung Veterans General Hospital Not yet recruiting Taichung, Taichung City, Taiwan, 407 National Cheng Kung University Hospital Not yet recruiting Tainan, Tainan County, Taiwan, 704 Chi Mei Medical Center Not yet recruiting Tainan, Tainan County, Taiwan, 710 National Taiwan University Hospital Not yet recruiting Taipei, Taipei City, Taiwan, 100 Taipei Veterans General Hospital Not yet recruiting Taipe, Taipei City, Taiwan, 112 Linkou Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 收起 <<
NCT02292212	Kidney Failure, Chronic	Not Applicable	Completed	-	-
NCT02292212	-		Completed	-	-
NCT01493141	-		Completed	-	United Kingdom ... 展开 >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom, S5 7AU 收起 <<
NCT01233869	-		Completed	-	-
NCT03431363	-		Recruiting	June 2020	United States, New York ... 展开 >> Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Contact: Alyssa Asaro, BA 718-920-5636 aasaro@montefiore.org 收起 <<
NCT00765661	Kidney Failure ... 展开 >> Renal Failure 收起 <<	Phase 2	Completed	-	United States, Ohio ... 展开 >> University of Cincinnati Cincinnati, Ohio, United States, 45267 收起 <<
NCT00765661	-		Completed	-	-
NCT01817959	Islet Transplantation in Diabe... 展开 >>tes Mellitus Type 1 收起 <<	Phase 3	Completed	-	United States, Illinois ... 展开 >> The University of Chicago Medical Center, Department of Surgery, Division of Abdominal Organ Transplantation Chicago, Illinois, United States, 60637 Czechia Institute for Clinical and Experimental Medicine (IKEM), Diabetes Centre; Department of Diabetes. Praha, Czechia, 14021 Italy Dipartimento di Medicina Interna e Specialistica; IRCCS Ospedale San Raffaele Milan, Italy, 20132 S.S.D. Diabetologia, Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Piazza Ospedale Maggiore 3 Milan, Italy, 20162 Sweden Transplant Institute - Sahlgrenska University Hospital Göteborg, Sweden, 41345 Department of Nephrology and Transplantation; Skane University Hospital Malmö, Sweden, 20502 Department of Transplantation Surgery; The Karolinska University Hospital Stockholm, Sweden, 14186 Division for Transplantation and Liver Surgery; Department of Surgery; Uppsala University Hospital Uppsala, Sweden, 75185 United Kingdom Institute of Transplantation, Newcastle upon Tyne Hospitals - NHS Foundation Trust, Freeman Hospital Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<
NCT00101101	Lymphoma	Phase 2	Active, not recruiting	March 2019	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 收起 <<
NCT00101101	-		Active, not recruiting	-	-
NCT01234506	Oxidative Stress ... 展开 >> Inflammation Aging Dementia Pain 收起 <<	Phase 2	Completed	-	Canada, Saskatchewan ... 展开 >> Saskatoon Health Region Saskatoon, Saskatchewan, Canada, S7K 5T6 收起 <<
NCT00044278	Epilepsy	Phase 2	Completed	-	-
NCT00708552	-		Completed	-	-
NCT02198703	Moderate Hypercholesterolemia	Not Applicable	Completed	-	France ... 展开 >> Naturalpha Lille, France, 59020 Biofortis Saint-Herblain, France, 44800 收起 <<
NCT00708552	Alzheimer's Disease	Phase 2	Completed	-	-
NCT03768245	Obesity Diabe... 展开 >>tes Mellitus, Type 2 Cardiovascular Function Kidney Diseases Liver Diseases Physical Fitness 收起 <<	Not Applicable	Completed	-	Mexico ... 展开 >> Hospital Regional Adolfo Lopez Matelos Mexico City, Distrito Federal, Mexico, 01620 收起 <<
NCT01172301	Cystic Fibrosis	Not Applicable	Completed	-	United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 收起 <<
NCT01223365	-		Completed	-	-
NCT01173354	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Not Applicable	Active, not recruiting	June 2018	United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 收起 <<
NCT02649205	-		Completed	-	Hungary ... 展开 >> Velencei-tavi Kistérségi Járóbeteg Szakellátó Közhasznú Nonprofit Kft Velence, Hungary, 2481 收起 <<
NCT01223365	Chronic Pain	Phase 3	Completed	-	-
NCT02756520	-		Completed	-	China, Beijing ... 展开 >> Prof. Xiangmei Beijing, Beijing, China 收起 <<
NCT03217604	Healthy Volunteers	Phase 1	Completed	-	Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT00976820	Influenza	Phase 2	Completed	-	-
NCT02968888	Healthy Young... 展开 >> Elderly 收起 <<	Not Applicable	Completed	-	Norway ... 展开 >> Norwegian School of Sport Sciences Oslo, Norway, 0863 收起 <<
NCT00298272	-		Terminated(Sponsor decided to ... 展开 >>end long term extension phase for business reasons unrelated to safety.) 收起 <<	-	-
NCT00976820	-		Completed	-	-
NCT00378859	Growth Disorders ... 展开 >> Metabolic Syndrome 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Institute of Human Nutrition, Rolighedsvej 30 Frederiksberg C, Denmark, 1958 收起 <<
NCT02746133	-		Active, not recruiting	December 2018	Russian Federation ... 展开 >> Moscow, Russian Federation Saint Petersburg, Russian Federation 收起 <<
NCT03674957	-		Active, not recruiting	March 2019	Canada, Manitoba ... 展开 >> University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 收起 <<
NCT01085071	Thoracic Surgery ... 展开 >> Cardiac Surgery Critically Ill 收起 <<	Phase 4	Completed	-	Netherlands ... 展开 >> University Medical Center Groningen, University of Groningen Groningen, Netherlands, 9700RB 收起 <<
NCT00298272	Rheumatoid Arthritis	Phase 2	Terminated(Sponsor decided to ... 展开 >>end long term extension phase for business reasons unrelated to safety.) 收起 <<	-	United States, Alabama ... 展开 >> Research Site Huntsville, Alabama, United States, 35801 United States, Arizona Research Site Paradise Valley, Arizona, United States, 85253 United States, California Research Site Palm Desert, California, United States, 92260 United States, Florida Research Site Jupiter, Florida, United States, 33458 Research Site Sarasota, Florida, United States, 34239 United States, Idaho Research Site Boise, Idaho, United States, 83702 United States, Michigan Research Site Kalamazoo, Michigan, United States, 49048 United States, Missouri Research Site St. Louis, Missouri, United States, 63141 United States, Ohio Research site Chardon, Ohio, United States, 44024 Research Site Mayfield Village, Ohio, United States, 44143 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73103 Research Site Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Dallas, Texas, United States, 75231 Research Site Houston, Texas, United States, 77074 Research Site San Antonio, Texas, United States, 78217 United States, Utah Research Site Salt Lake City, Utah, United States, 84132 United States, Vermont Research Site Burlington, Vermont, United States, 05401 收起 <<
NCT00711789	Acute Renal Failure ... 展开 >> Sepsis Septic Shock 收起 <<	Phase 2	Unknown	-	Australia, Victoria ... 展开 >> Northern Hospital Recruiting Epping, Victoria, Australia, 3074 Contact: Michael C Reade, MBBS DPhil +61394964838 michael.reade@austin.org.au Contact: Graeme Duke, MD FJFICM +613 8405 8000 graeme.duke@nh.org.au Principal Investigator: Michael C Reade, MBBS DPhil Sub-Investigator: Graeme Duke, MD FJFICM Sub-Investigator: Mary Park, RN The Western Hospital Recruiting Footscray, Victoria, Australia, 3011 Contact: Forbes McGain, MBBS FJFICM +613 8345 6639 forbes.mcgain@wh.org.au Contact: Craig French, MBBS FJFICM +613 8345 6639 craig.french@wh.org.au Principal Investigator: Forbes McGain, MBBS FJFICM Sub-Investigator: Craig French, MBBS FJFICM Sub-Investigator: John Mulder, MBBS FJFICM Sub-Investigator: Sathyajith Velandy-Koottayi, MBBS FJFICM Sub-Investigator: Heike Raunow, RN 收起 <<
NCT02000817	Diabetes Mellitus, Type 1	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Brussels, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 收起 <<
NCT03453060	Thrombosis	Phase 1	Active, not recruiting	November 2018	United States, Arizona ... 展开 >> Celerion Tempe, Arizona, United States, 85283 收起 <<
NCT02550912	Autism	Phase 2	Completed	-	Egypt ... 展开 >> Faculty of Pharmacy AinShams University Cairo, Egypt, 02 收起 <<
NCT00488514	-		Completed	-	-
NCT00438698	Type 2 Diabetes ... 展开 >> Cardiovascular Disease 收起 <<	Not Applicable	Completed	-	Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 <<
NCT03683225	Idiopathic Parkinson Disease	Phase 2	Not yet recruiting	March 1, 2020	-
NCT00646776	-		Completed	-	-
NCT00972517	Influenza	Phase 3	Completed	-	Germany ... 展开 >> GSK Investigational Site Kehl, Baden-Wuerttemberg, Germany, 77694 GSK Investigational Site Pforzheim, Baden-Wuerttemberg, Germany, 75172 GSK Investigational Site Schwaebisch-Hall, Baden-Wuerttemberg, Germany, 74523 GSK Investigational Site Stuttgart, Baden-Wuerttemberg, Germany, 70469 GSK Investigational Site Bindlach, Bayern, Germany, 95463 GSK Investigational Site Cham, Bayern, Germany, 93413 GSK Investigational Site Muenchen, Bayern, Germany, 81241 GSK Investigational Site Noerdlingen, Bayern, Germany, 86720 GSK Investigational Site Frankenthal, Rheinland-Pfalz, Germany, 67227 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Worms, Rheinland-Pfalz, Germany, 67547 收起 <<
NCT02927210	Healthy Men M... 展开 >>ale Contraception 收起 <<	Phase 1	Recruiting	October 2019	United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han 310-222-1865 xhan@labiomed.org Principal Investigator: Christina Wang, MD United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Kathy Winter 206-616-0484 klwinter@uw.edu Principal Investigator: Stephanie Page, MD, PhD 收起 <<
NCT00972517	-		Completed	-	-
NCT00488514	Migraine Disorders	Phase 3	Completed	-	-
NCT00197145	-		Terminated	-	-
NCT03234036	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Completed	-	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 <<
NCT01617525	Hypercholesterolemia	Not Applicable	Completed	-	United States, Maryland ... 展开 >> USDA Beltsville Human Nutrition Research Center Beltsville, Maryland, United States, 20705 收起 <<
NCT00533897	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT00197145	Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 <<	Phase 3	Terminated	-	-
NCT00355251	HIV Infections	Phase 4	Terminated(On the basis of pub... 展开 >>lished results of SMART study, it has been observed that the results are worse in patients who have interrupted their treatments.) 收起 <<	-	Spain ... 展开 >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 收起 <<
NCT00261443	Bipolar Disorder	Phase 4	Completed	-	-
NCT00646776	Antivirals/HIV	Phase 1	Completed	-	United States, New Jersey ... 展开 >> Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States, 08690 收起 <<
NCT01376388	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 590-0064 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 <<
NCT01424514	Rhinitis	Phase 2	Completed	-	Canada, Ontario ... 展开 >> GSK Investigational Site Mississauga, Ontario, Canada, L4W 1N2 收起 <<
NCT00533897	-		Completed	-	-
NCT01301456	-		Completed	-	-
NCT01301456	Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Nebraska ICON Clinical Pharmacology, LLC Omaha, Nebraska, United States, 68154 United States, Pennsylvania CRI Worldwide, LLC Philadelphia, Pennsylvania, United States, 19139 United States, Texas Healthcare Discoveries LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 收起 <<
NCT01702363	-		Completed	-	-
NCT01424514	-		Completed	-	-
NCT01702363	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 811-1347 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 530-0001 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 153-8934 GSK Investigational Site Tokyo, Japan, 192-0903 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 <<
NCT01376388	-		Completed	-	-
NCT00573794	Ulcerative Colitis	Phase 3	Completed	-	-
NCT00261443	-		Completed	-	-
NCT00573794	-		Completed	-	-
NCT02187029	Gout	Phase 1	Terminated(B7911002 was premat... 展开 >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) 收起 <<	-	United States, Florida ... 展开 >> MRA Clinical Research, LLC Miami, Florida, United States, 33143 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 United States, Kansas Vince and Associates Clinical Research Inc. Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research, Inc. Overland Park, Kansas, United States, 66212 收起 <<
NCT03298373	Healthy Men M... 展开 >>ale Contraception 收起 <<	Phase 1	Recruiting	December 2018	United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Christina Wang, MD 310-222-2503 wang@labiomed.org United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD 206-616-1818 page@uw.edu 收起 <<
NCT02187029	-		Terminated(B7911002 was premat... 展开 >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) 收起 <<	-	-
NCT01588678	Advanced Solid Tumor ... 展开 >> Lymphoma 收起 <<	Phase 1	Completed	-	United States, Texas ... 展开 >> South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 收起 <<
NCT01244984	Asthma	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 277-0863 GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Fukuoka, Japan, 816-0813 GSK Investigational Site Gifu, Japan, 501-6062 GSK Investigational Site Gunma, Japan, 373-0021 GSK Investigational Site Hiroshima, Japan, 730-0844 GSK Investigational Site Hiroshima, Japan, 732-0062 GSK Investigational Site Hiroshima, Japan, 739-0402 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0046 GSK Investigational Site Hyogo, Japan, 672-8064 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Kanagawa, Japan, 231-8682 GSK Investigational Site Kanagawa, Japan, 253-0041 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 983-8520 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-8510 GSK Investigational Site Okayama, Japan, 700-0862 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Okayama, Japan, 714-0081 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 569-1192 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Toyama, Japan, 937-0066 收起 <<
NCT01362244	Nasal Polyps	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1105 AZ United Kingdom GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SE1 1YR GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site London, United Kingdom, WC1X 8DA 收起 <<
NCT01244984	-		Completed	-	-
NCT03183024	Chronic Idiopathic Urticaria	Phase 4	Recruiting	December 31, 2018	United States, Ohio ... 展开 >> Bernstein Clinical Research Center Recruiting Cincinnati, Ohio, United States, 45231 Contact: Karen Murphy, BS, CCRC 513-354-1746 kmurphy@bernsteincrc.com Principal Investigator: Jonathan Bernstein, MD 收起 <<
NCT01205451	-		Completed	-	-
NCT01362244	-		Completed	-	-
NCT00536471	Major Depressive Disorder	Phase 4	Completed	-	-
NCT01382212	-		Completed	-	-
NCT00536471	-		Completed	-	-
NCT00224484	Herpes Simplex	Phase 3	Completed	-	-
NCT03693612	Neoplasms	Phase 1 Phase 2	Recruiting	June 16, 2022	United States, Massachusetts ... 展开 >> GSK Investigational Site Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Not yet recruiting New York, New York, United States, 10016- Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, Oklahoma GSK Investigational Site Not yet recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, Pennsylvania GSK Investigational Site Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Recruiting San Antonio, Texas, United States, 78240 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Principal Investigator: Anthony Tolcher Australia, New South Wales GSK Investigational Site Not yet recruiting Darlinghurst, New South Wales, Australia, 2010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Australia, Victoria GSK Investigational Site Not yet recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Not yet recruiting Ottawa, Ontario, Canada, K1H 8L Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Toronto, Ontario, Canada, M5G 2M Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00224484	-		Completed	-	-
NCT03013322	Shock, Septic ... 展开 >> Sepsis Perioperative Period 收起 <<	Not Applicable	Completed	-	Germany ... 展开 >> University Hospital Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 收起 <<
NCT01205451	Spasticity, Post-Stroke	Phase 3	Completed	-	China, Guangdong ... 展开 >> GSK Investigational Site Guangzhou, Guangdong, China China, Heilongjiang GSK Investigational Site Haerbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430060 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Shenyang, Liaoning, China, 110001 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100068 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200040 收起 <<
NCT03076580	-		Recruiting	December 31, 2021	China, Beijing ... 展开 >> Beijing Institute of heart, lung and blood vessel diseases Recruiting Beijing, Beijing, China Contact: Jie Du jiedubj@126.com Contact: Yulin Li lyllyl_1111@163.com Sub-Investigator: Yang Li, PhD Sub-Investigator: Hongzhao You, MS Beijing Institute of heart, lung and blood vessel diseases Recruiting Beijing, Beijing, China Contact: Jie Du jiedubj@126.com Contact: Yulin Li lyllyl_1111@163.com Sub-Investigator: Yang Li, PhD Sub-Investigator: Hongzhao You, MS Principal Investigator: Yongqiang Lai, MD China Shijie You Enrolling by invitation Beijing, China 收起 <<
NCT01466062	Respiratory Syncytial Virus In... 展开 >>fection 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> Site Reference ID/Investigator# 56847 Hyogo, Japan Site Reference ID/Investigator# 56845 Shimotsuke, Japan Site Reference ID/Investigator# 56842 Tokyo, Japan Site Reference ID/Investigator# 56844 Tokyo, Japan Site Reference ID/Investigator# 56846 Tokyo, Japan Site Reference ID/Investigator# 56843 Yokohama, Japan 收起 <<
NCT01382212	End-Stage Renal Disease ... 展开 >> Secondary Hyperparathyroidism 收起 <<	Phase 3	Completed	-	-
NCT01494584	-		Terminated(Terminated after pl... 展开 >>acing the study on hold at the request of the FDA) 收起 <<	-	-
NCT01087944	Hepatitis C, Chronic	Phase 1	Completed	-	United States, California ... 展开 >> Los Angeles, California, United States, 90045 United States, Florida Bradenton, Florida, United States, 34209 Orlando, Florida, United States, 32803 United States, Georgia Marietta, Georgia, United States, 30060 United States, Massachusetts Framingham, Massachusetts, United States, 01702 United States, New Jersey Newark, New Jersey, United States, 07102 Vineland, New Jersey, United States, 08360 United States, New York New York, New York, United States, 10016 Poughkeepsie, New York, United States, 12601 United States, North Carolina Asheville, North Carolina, United States, 28801 United States, South Carolina Columbia, South Carolina, United States, 29204 United States, Texas San Antonio, Texas, United States, 78215 收起 <<
NCT01494584	Epilepsy	Phase 2	Terminated(Terminated after pl... 展开 >>acing the study on hold at the request of the FDA) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 收起 <<
NCT00620282	Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 <<	Phase 3	Completed	-	United States, Minnesota ... 展开 >> Novo Nordisk Investigational Site Rochester, Minnesota, United States, 55905 收起 <<
NCT01087944	-		Completed	-	-
NCT03194243	-		Recruiting	October 2023	France ... 展开 >> CH Marie-Madeleine FORBACH - Service des Urgences Recruiting Forbach, Lorraine, France, 57604 Contact: Caroline HLADNIK, MD Principal Investigator: Caroline HLADNIK, MD CH LUNEVILLE - Service des Urgences Recruiting Lunéville, Lorraine, France, 54 301 Contact: Julie THISSE, MD Principal Investigator: Julie THISSE, MD CHR METZ-THIONVILLE- Hôpital de Mercy- Service des Urgences Recruiting Metz, Lorraine, France, 57085 Contact: Elies ANDRE, MD Principal Investigator: Elies ANDRE, MD CHRU Nancy - Service des Urgences Recruiting Nancy, Lorraine, France, 54000 Contact: Tahar CHOUIHED, MD +33 3 83 85 14 96 t.chouihed@chru-nancy.fr Contact: Adrien BASSAND, MD + 33 3 83 85 14 96 a.bassand@chru-nancy.fr Principal Investigator: Tahar CHOUIHED, MD Sub-Investigator: Adrien BASSAND, MD CH PONT A MOUSSON- Service des Urgences Recruiting Pont-à-Mousson, Lorraine, France, 54 701 Contact: Alexandre GROSJEAN, MD Principal Investigator: Alexandre GROSJEAN, MD CH REMIREMONT - Service des Urgences Recruiting Remiremont, Lorraine, France, 88204 Contact: Marie BREFFA, MD Principal Investigator: Marie BREFFA, MD CH SAINT-DIE-DES-VOSGES - Service des Urgences Recruiting Saint-Dié-des-Vosges, Lorraine, France, 88100 Contact: Patrice THIRION, MD Principal Investigator: Patrice THIRION, MD CHR METZ-THIONVILLE- Hôpital Bel-Air- Service des Urgences Recruiting Thionville, Lorraine, France, 57100 Contact: Phillippe SATTONNET, MD Principal Investigator: Phillippe SATTONNET, MD CH EPINAL - Service des Urgences Recruiting Épinal, Lorraine, France, 88021 Contact: Céline HOMEL, MD Principal Investigator: Céline HOMEL, MD Sub-Investigator: Jean-Dominique RISSER, MD 收起 <<
NCT03431805	Postpartum Hemorrhage	Phase 3	Recruiting	June 30, 2020	France ... 展开 >> CHU Angers Recruiting Angers, France, 49033 Contact: Guillaume Legendre, MD guillaume.legendre@chu-angers.fr CHU Jean Minjoz Recruiting Besançon, France, 25000 Contact: Didier Riethmuller, MD,PhD didier.riethmuller@univ-fcomte.fr CHU Bordeaux Recruiting Bordeaux, France, 33076 Contact: Loic Sentilhes, MD,PhD loic.sentilhes@chu-bordeaux.fr Contact: Olivier delorme olivier.delorme@chu-bordeaux.fr CHU Hôpital Femme Mère Enfant Not yet recruiting Bron, France, 69677 Contact: Muriel Doret, MD,PhD muriel.doret-dion@chu-lyon.fr CHRU Côte de Nacre Recruiting Caen, France, 14033 Contact: Delphine Vardon, MD +336 66 93 52 86 vardon-d@chu-caen.fr CHU Estain Recruiting Clermont Ferrand, France, 63001 Contact: Denis Gallot, MD,PhD dgallot@chu-clermontferrand.fr Centre Hospitalier Intercommunal de Créteil Recruiting Créteil, France Contact: Bassam Haddad, MD bassam.haddad@chicreteil.fr Hôpital Saint Joseph Marseille Recruiting Marseille, France, 13008 Contact: Raoul Desbrières, MD raoul.desbriere@orange.fr Hopital Nord Recruiting Marseille, France, 13915 Contact: Florence Bretelle, MD,PhD florence.bretelle@ap-hm.fr CHU de Montpellier Recruiting Montpellier, France, 34295 Contact: Florent Fuchs, MD f-fuchs@chu-montpellier.fr CHRU de Nancy Recruiting Nancy, France, 54000 Contact: Olivier Morel, MD,PhD olivier.morel@chru-nancy.fr CHU Nantes Recruiting Nantes, France, 44093 Contact: Norbert Winer, MD,PhD norbert.winer@chu-nantes.fr CHU Nice Not yet recruiting Nice, France, 06202 Contact: André Bongain, MD,PhD bongain.a@chu-nice.fr CHU Nîmes Recruiting Nîmes, France, 30900 Contact: Vincent Letouzey, MD,PhD vincent.letouzey@chu-nimes.fr Hôpital Trousseau Recruiting Paris, France, 75012 Contact: Gilles Kayem, MD,PhD gkayem@gmail.com Hôpital Saint Joseph Paris Recruiting Paris, France, 75014 Contact: Elie Azria, MD eazria@hpsj.fr Maternité de Port-Royal Paris Recruiting Paris, France, 75014 Contact: François Goffinet, MD,PhD francois.goffinet@aphp.fr Hôpital universitaire Necker-Enfants malades Recruiting Paris, France, 75015 Contact: Laurent Salomon, MD,PhD laurentsalomon@gmail.com Hôpital universitaire Robert Debré Recruiting Paris, France, 75019 Contact: Thomas Schmitz, MD,PhD thomas.schmitz@aphp.fr Hôpital Lariboisière Paris Recruiting Paris, France, 75475 Contact: Jeremy Sroussi, MD jeremy.sroussi@aphp.fr Hôpital universitaire Kremlin-Bicètre Recruiting Paris, France, 94270 Contact: Marie Victoire Senat, MD,PhD marie-victoire.senat@aphp.fr CH de Pau Recruiting Pau, France Contact: Caroline BOHEC, MD caroline.bohec@ch-pau.fr Centre Hospitalier Intercommunal Poissy-Saint Germain Recruiting Poissy, France, 78303 Contact: Patrick Rozenberg, MD,PhD prozenberg@chi-poissy-st-germain.fr CHU Rennes Recruiting Rennes, France, 35033 Contact: Hélène Isly, MD,PhD helene.isly@chu-rennes.fr Principal Investigator: Maela Le Lous, MD CHU Charles Nicolle Recruiting Rouen, France, 76000 Contact: Eric Verspyck, MD,PhD Eric.Verspyck@chu-rouen.fr CHU Saint Etienne Recruiting Saint Etienne, France, 42270 Contact: Céline Chauleur, MD,PhD celine.chauleur@chu-st-etienne.fr CHU Strasbourg Recruiting Strasbourg, France, 67098 Contact: Nicolas Sananes, MD Nicolas.SANANES@chru-strasbourg.fr Contact: Bruno Langer, MD, PhD Bruno.Langer@chru-strasbourg.fr Hôpital Paule de Viguier CHU Toulouse Recruiting Toulouse, France, 31059 Contact: Paul Guerby, MD guerby.p@chu-toulouse.fr CHU Tours Recruiting Tours, France, 37044 Contact: Franck Perrotin, MD,PhD franck.perrotin@med.univ-tours.fr 收起 <<
NCT01728701	Malaria Plasm... 展开 >>odium Falciparum 收起 <<	Phase 1	Completed	-	Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB 收起 <<
NCT00620282	-		Completed	-	-
NCT02314208	Spastic Paraplegia, Hereditary	Phase 2	Completed	-	France ... 展开 >> Pitié-Salpêtrière Hospital Paris, France 收起 <<
NCT01310413	-		Completed	-	-
NCT01466062	-		Completed	-	-
NCT01721317	-		Terminated(After reevaluation ... 展开 >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) 收起 <<	-	-
NCT01348568	Type 2 Diabetes	Phase 2	Completed	-	Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5C2T2 收起 <<
NCT01721317	Seizures	Phase 4	Terminated(After reevaluation ... 展开 >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Fresno, California, United States, 93710 GSK Investigational Site Newport Beach, California, United States, 92658 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Santa Monica, California, United States, 90404 United States, Colorado GSK Investigational Site Colorado Springs, Colorado, United States, 80907 United States, Florida GSK Investigational Site Pensacola, Florida, United States, 32514 GSK Investigational Site Port Charlotte, Florida, United States, 33952 United States, Illinois GSK Investigational Site Peoria, Illinois, United States, 61637 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20817 United States, Minnesota GSK Investigational Site Golden Valley, Minnesota, United States, 55422 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 GSK Investigational Site Livingston, New Jersey, United States, 07039 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76017 GSK Investigational Site Dallas, Texas, United States, 75251 GSK Investigational Site Kingwood, Texas, United States, 77339 GSK Investigational Site San Antonio, Texas, United States, 78229 GSK Investigational Site Temple, Texas, United States, 76508 United States, Washington GSK Investigational Site Spokane, Washington, United States, 99204 Greece GSK Investigational Site Athens, Greece, 10676 GSK Investigational Site Thessaloniki, Greece, 57010 收起 <<
NCT01213485	-		Completed	-	France ... 展开 >> Neuilly-sur-seine, France, 92521 收起 <<
NCT01310413	Influenza	Phase 3	Completed	-	United States, California ... 展开 >> GSK Investigational Site Paramount, California, United States, 90723 GSK Investigational Site Sacramento, California, United States, 95816 United States, Kansas GSK Investigational Site Newton, Kansas, United States, 67114 United States, Kentucky GSK Investigational Site Bardstown, Kentucky, United States, 40004 United States, Louisiana GSK Investigational Site Metairie, Louisiana, United States, 70006 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63141 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68134 United States, Nevada GSK Investigational Site Henderson, Nevada, United States, 89014 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44121 United States, Texas GSK Investigational Site Fort Worth, Texas, United States, 76135 GSK Investigational Site San Angelo, Texas, United States, 76904 Canada, British Columbia GSK Investigational Site Coquitlam, British Columbia, Canada, V3K 3P4 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 5G8 GSK Investigational Site Sudbury, Ontario, Canada, P3E 1H5 Canada, Quebec GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 1Z1 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 2G2 Thailand GSK Investigational Site Khon Kaen, Thailand, 40002 收起 <<
NCT01736475	-		Completed	-	-
NCT01622231	Rhinitis	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 272-0143 GSK Investigational Site Chiba, Japan, 277-0882 GSK Investigational Site Gifu, Japan, 501-3247 GSK Investigational Site Saitama, Japan, 355-0062 GSK Investigational Site Tokyo, Japan, 160-0017 GSK Investigational Site Tokyo, Japan, 170-0005 收起 <<
NCT01622231	-		Completed	-	-
NCT01736475	Hemophilia A	Phase 2 Phase 3	Completed	-	-
NCT01808261	Cerebrovascular Accident	Phase 2	Terminated(This study was term... 展开 >>inated for futility.) 收起 <<	-	-
NCT00281632	-		Completed	-	-
NCT00281632	Peritoneal Cancer ... 展开 >> Ovarian Cancer Neoplasms, Ovarian Fallopian Tube Cancer 收起 <<	Phase 2	Completed	-	United States, Georgia ... 展开 >> GSK Investigational Site Atlanta, Georgia, United States, 30342 United States, Texas GSK Investigational Site Austin, Texas, United States, 78731 GSK Investigational Site Bedford, Texas, United States, 76022 GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Fort Worth, Texas, United States, 76104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4029 Australia GSK Investigational Site Melbourne, Australia, 3084 Singapore GSK Investigational Site Singapore, Singapore, 119074 GSK Investigational Site Singapore, Singapore, 229899 收起 <<
NCT00550459	Hyponatremia	Phase 3	Completed	-	United States, California ... 展开 >> Sarah. S. Olelewe, MD Hawthorne, California, United States, 90250 Progressive Clinical Research Vista, California, United States, 92083 United States, Colorado Pikes Peak Cardiology Colorado Springs, Colorado, United States, 80907 United States, Florida Innovative Research of West FL Largo, Florida, United States, 33770 Coastal Nephrology Assoc. Research Center Punta Gorda, Florida, United States, 33950 United States, Georgia Rockdale Medical Research Associates Conyers, Georgia, United States, 30094 United States, Louisiana Otis Barnum, DO Natchitoches, Louisiana, United States, 71457 United States, North Dakota Lillestol Research, LLC Fargo, North Dakota, United States, 58106 United States, South Carolina Carolina Research Associates Columbia, South Carolina, United States, 29201 United States, Tennessee Wayne O. Wells, MD Lebanon, Tennessee, United States, 37087 United States, Texas Memorial Clinical Associates Houston, Texas, United States, 77043 United States, Virginia Mitchell Rosner, MD Charlottesville, Virginia, United States, 22908 收起 <<
NCT02030314	Resistant Hypertension in Kidn... 展开 >>ey Transplant Patients 收起 <<	Phase 4	Withdrawn(The patient populati... 展开 >>on changed. Unable to find patients that meet study criteria) 收起 <<	-	United States, Virginia ... 展开 >> Virginia Commonwealtlh University Richmond, Virginia, United States, 23298 收起 <<
NCT01808261	-		Terminated(This study was term... 展开 >>inated for futility.) 收起 <<	-	-
NCT03603665	Botulism	Phase 1	Recruiting	September 7, 2019	United States, North Carolina ... 展开 >> Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit Recruiting Durham, North Carolina, United States, 27710-4000 收起 <<
NCT01453049	-		Terminated(US FDA/EMA/SFDA dec... 展开 >>isions to rosiglitazone-containing medicines, ethic) 收起 <<	-	-
NCT00550459	-		Completed	-	-
NCT01934192	Gastroparesis	Phase 2	Terminated	-	United States, Colorado ... 展开 >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30909 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40202 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Southport, Queensland, Australia, 4215 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 GSK Investigational Site Woodville, South Australia, Australia, 5011 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T1Y 6J4 GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 2X2 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Ottawa, Ontario, Canada, K1Y 4E9 GSK Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 3J4 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Canada GSK Investigational Site Quebec, Canada, G1J 1Z4 收起 <<
NCT00576420	-		Completed	-	-
NCT01453049	Diabetes Mellitus, Type 2	Phase 3	Terminated(US FDA/EMA/SFDA dec... 展开 >>isions to rosiglitazone-containing medicines, ethic) 收起 <<	-	China, Hubei ... 展开 >> GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Dalian, Liaoning, China, 116027 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400016 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shenyang, China, 110003 GSK Investigational Site Tianjin, China, 300052 GSK Investigational Site Wuhan, China, 430022 收起 <<
NCT03526588	Congenital Diaphragmatic Herni... 展开 >>a 收起 <<	Phase 1	Recruiting	November 1, 2027	United States, Texas ... 展开 >> The University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Matthew T. Harting, MD, MS 855-566-6273 收起 <<
NCT00892957	Hemostasis in Participants Rec... 展开 >>eiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses 收起 <<	Phase 3	Completed	-	-
NCT02091414	Heart Transplantation	Phase 3	Completed	-	China ... 展开 >> Beijing, China, 100029 Fuzhou, China, 350001 Shanghai, China, 200032 收起 <<
NCT00576420	Adjunct to Hemostasis in Vascu... 展开 >>lar Surgery (Synthetic Vascular Grafts) 收起 <<	Phase 2	Completed	-	United States, Alabama ... 展开 >> Birmingham, Alabama, United States United States, Arizona Tucson, Arizona, United States United States, California Long Beach, California, United States United States, Florida Jacksonville, Florida, United States United States, Kentucky Lexington, Kentucky, United States United States, Louisiana Baton Rouge, Louisiana, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Utah Salt Lake City, Utah, United States United States, Virginia Charlottesville, Virginia, United States Virginia Beach, Virginia, United States United States, Washington Seattle, Washington, United States 收起 <<
NCT02091414	-		Completed	-	-
NCT01134315	-		Terminated(Terminated after FD... 展开 >>A agreement.) 收起 <<	-	United States, Alabama ... 展开 >> Site Reference ID/Investigator# 37082 Birmingham, Alabama, United States, 35255 United States, Florida Site Reference ID/Investigator# 26762 Gainesville, Florida, United States, 32610 Site Reference ID/Investigator# 28529 Orlando, Florida, United States, 32801 United States, Georgia Site Reference ID/Investigator# 26748 Atlanta, Georgia, United States, 30322 United States, Louisiana Site Reference ID/Investigator# 37582 New Orleans, Louisiana, United States, 70118 United States, Maryland Site Reference ID/Investigator# 39973 Baltimore, Maryland, United States, 21287 United States, Massachusetts Site Reference ID/Investigator# 26769 Boston, Massachusetts, United States, 02115 United States, Michigan Site Reference ID/Investigator# 26768 Detroit, Michigan, United States, 48201 United States, Missouri Site Reference ID/Investigator# 26747 Kansas City, Missouri, United States, 64108 United States, Ohio Site Reference ID/Investigator# 26749 Akron, Ohio, United States, 44308 Site Reference ID/Investigator# 26751 Cincinnati, Ohio, United States, 45229 Site Reference ID/Investigator# 26765 Columbus, Ohio, United States, 43205 United States, Oklahoma Site Reference ID/Investigator# 28528 Oklahoma City, Oklahoma, United States, 73104 United States, Oregon Site Reference ID/Investigator# 26763 Portland, Oregon, United States, 97227 United States, Virginia Site Reference ID/Investigator# 28526 Charlottesville, Virginia, United States, 22908 United States, Washington Site Reference ID/Investigator# 26758 Seattle, Washington, United States, 98105 United States, Wisconsin Site Reference ID/Investigator# 40382 Madison, Wisconsin, United States, 53792 Site Reference ID/Investigator# 26759 Wauwatosa, Wisconsin, United States, 53226 收起 <<
NCT02564055	Dermatitis, Atopic	Phase 2	Completed	-	-
NCT00892957	-		Completed	-	-
NCT01134315	-		Terminated(Terminated after FD... 展开 >>A agreement.) 收起 <<	-	-
NCT00711009	Human Immunodeficiency Virus I... 展开 >>nfection 收起 <<	Phase 3	Completed	-	-
NCT01702740	Lupus Erythematosus, Cutaneous... 展开 >> Lupus Erythematosus, Systemic 收起 <<	Phase 1	Completed	-	-
NCT01934192	-		Terminated	-	-
NCT00413699	Arthritis, Rheumatoid	Phase 3	Completed	-	-
NCT02634073	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 4	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT00711009	-		Completed	-	-
NCT02634073	-		Completed	-	-
NCT01623453	-		Terminated(Difficulty recruiti... 展开 >>ng subjects) 收起 <<	-	Korea, Republic of ... 展开 >> DaeHang Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of 收起 <<
NCT02589730	Diabetes Mellitus	Not Applicable	Unknown	October 2016	China, Shanghai ... 展开 >> Shanghai Six People`s Hospital Recruiting Shanghai, Shanghai, China, 200233 Contact: Lei Zhang, MM +86-18930173806 stonez78@hotmail.com 收起 <<
NCT01715051	Cocaine Dependence	Phase 2	Withdrawn(Funding was not rece... 展开 >>ived) 收起 <<	September 2019	United States, Ohio ... 展开 >> Maryhaven, Inc Columbus, Ohio, United States, 43207 收起 <<
NCT00413699	-		Completed	-	-
NCT03481894	Malnutrition	Phase 4	Recruiting	March 2021	United States, Illinois ... 展开 >> The University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Timothy Sentongo, MD United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Joel D Lim, MD 收起 <<
NCT01286610	Respiratory Failure ... 展开 >> Sepsis Brain Injury 收起 <<	Not Applicable	Completed	-	Germany ... 展开 >> Charite University, Berlin, Germany Berlin, Germany, 13353 收起 <<
NCT02564055	-		Completed	-	-
NCT02554630	-		Recruiting	January 2020	United States, Florida ... 展开 >> UF Health Recruiting Gainesville, Florida, United States, 32610 Contact: Shawn Larson, MD 352-273-8761 shawn.larson@surgery.ufl.edu Contact: Joy Perkins, RN 352-294-5687 joy.perkins@surgery.ufl.edu Principal Investigator: Shawn Larson, MD Sub-Investigator: Brittany Mathias, MD Sub-Investigator: Lyle Moldawer, MD 收起 <<
NCT02635945	Asthma	Phase 2	Recruiting	November 2019	Spain ... 展开 >> Unitat de Pneumologia Experimental Recruiting Barcelona, Spain, 08025 Principal Investigator: David Ramos Barbón, MD, PhD 收起 <<
NCT00972725	AIDS	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 收起 <<
NCT01540903	Malaria	Phase 1	Completed	-	Tanzania ... 展开 >> Bagamoyo Research and Training Center, Ifakara Health Institute Bagamoyo, Tanzania 收起 <<
NCT00972543	-		Terminated(The study was termi... 展开 >>nated after the European Medicines Evaluation Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 <<	-	-
NCT00532948	Glioma	Phase 1	Completed	-	United States, California ... 展开 >> San Francisco, California, United States, 94143-0780 United States, District of Columbia Washington, District of Columbia, United States, 20010 United States, Illinois Chicago, Illinois, United States, 60614 United States, Massachusetts Boston, Massachusetts, United States, 02115-6084 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Pittsburgh, Pennsylvania, United States, 15261 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98105 收起 <<
NCT01132846	-		Completed	-	-
NCT03010514	-		Recruiting	October 2019	China ... 展开 >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Contact: ke-xu Yang 86-010-64426153 EC@anzhenGCP.com 收起 <<
NCT00532948	-		Completed	-	-
NCT00972725	-		Completed	-	-
NCT02929498	Myelodysplastic Syndrome	Phase 2	Recruiting	May 15, 2019	United States, Pennsylvania ... 展开 >> GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00756145	Chronic Kidney Disease	Phase 4	Completed	-	Belgium ... 展开 >> University Hospital Ghent Ghent, Belgium, 9000 收起 <<
NCT03563222	Malnutrition, Child	Phase 4	Not yet recruiting	November 2020	-
NCT01132846	Acute Heart Failure	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Minnesota Heart Failure Network Minneapolis, Minnesota, United States, 55415 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Health Sciences Center Murry, Utah, United States, 84107 United States, Vermont University of Vermont- Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Canada, Quebec Montreal Heart Institute Montreal, Quebec, Canada, H1T- 1C8 收起 <<
NCT02467413	Alzheimer's Disease ... 展开 >> Vascular Dementia 收起 <<	Phase 2	Not yet recruiting	December 2021	Taiwan ... 展开 >> National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Contact: Ming-Chyi Pai, PhD +886-6-2353535 ext 5534 pair@mail.ncku.edu.tw Principal Investigator: Ming-Chyi Pai, MD, PhD 收起 <<
NCT01700816	Delirium	Not Applicable	Terminated(Low incidence of de... 展开 >>lirium.) 收起 <<	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT02177812	Leukaemia, Myelocytic, Acute	Phase 1	Terminated(The risk benefit in... 展开 >> relapsed refractory AML does not favor continuation of the study.) 收起 <<	-	United States, Georgia ... 展开 >> GSK Investigational Site Augusta, Georgia, United States, 30912 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 GSK Investigational Site Bronx, New York, United States, 10467 GSK Investigational Site New York, New York, United States, 10065 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia, 3004 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 GSK Investigational Site Toronto, Ontario, Canada, M5G 2M 收起 <<
NCT03024827	Epileptic Encephalopathy	Phase 1	Recruiting	December 2019	Canada, British Columbia ... 展开 >> University of British Columbia Recruiting Vancouver, British Columbia, Canada, V6T1Z4 Contact: Vesna Popovska vpopovska@cw.bc.ca Principal Investigator: Linda Huh Canada, Manitoba University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3T 2N2 Contact: Lise Bourrier LBourrier@chrim.ca Principal Investigator: Edward Leung Canada, Quebec Universite de Montreal Recruiting Montreal, Quebec, Canada, H3T1J4 Contact: Jonathan Bitton jonathan.bitton@umontreal.ca Principal Investigator: Philippe Major Canada, Saskatchewan University of Saskatchewan Recruiting Saskatoon, Saskatchewan, Canada, S7N5C5 Contact: Doris Newmeyer 306-844-1208 doris.newmeyer@usask.ca Principal Investigator: Richard Huntsman Sub-Investigator: Blair Seifert Sub-Investigator: Jose Tellez-Zentino Sub-Investigator: Jane Alcorn Sub-Investigator: Bryan Acton Sub-Investigator: Andrew Lyon Sub-Investigator: June Lim Sub-Investigator: Simona Hasal 收起 <<
NCT01521611	Acute Leukaemia ... 展开 >> Chronic Leukaemia Myeloma Lymphoma 收起 <<	Phase 1 Phase 2	Recruiting	December 2018	United Kingdom ... 展开 >> Southampton University Hospitals NHS Trust Recruiting Southampton, Hampshire, United Kingdom, SO16 6YD Contact: Kim H Orchard, MBBS PhD 0044(0)2380794163 kho@soton.ac.uk Principal Investigator: Kim Orchard, MBBS PhD Sub-Investigator: Deborah Richardson, MA ChirB MD Sub-Investigator: Matthew Jenner, MBBS Royal Free Hospital and University College London Recruiting London, United Kingdom Contact: Stephen MacKinnon, MBBS PhD Contact: Ronjon Chakraverty, MBBS PhD 收起 <<
NCT02739854	-		Completed	-	Thailand ... 展开 >> Khon Kaen University Khon Kaen, Thailand, 40002 收起 <<
NCT02937298	Diet Induced Thermogenesis ... 展开 >> Obesity Control 收起 <<	Not Applicable	Completed	-	United Kingdom ... 展开 >> Rowett Institute of Nutrition and Health, Human Nutrition Unit Aberdeen, United Kingdom, AB25 2ZD 收起 <<
NCT03043131	Cardiopulmonary Bypass	Phase 3	Not yet recruiting	September 2017	-
NCT01081392	Inflammation	Not Applicable	Unknown	May 2010	Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 收起 <<
NCT03107858	Renal Transplant	Phase 2 Phase 3	Recruiting	November 1, 2019	Egypt ... 展开 >> Assiut University Hospital Recruiting Assiut, Egypt, 71515 Contact: Ahmed Elkadi 01007485190 收起 <<
NCT00972543	Chronic Plaque Psoriasis	Phase 4	Terminated(The study was termi... 展开 >>nated after the European Medicines Evaluation Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 <<	-	-
NCT01474200	Heart Failure ... 展开 >> Cardiac Failure Acute Decompensated Heart Failure (ADHF) 收起 <<	Not Applicable	Terminated(Closed due to patie... 展开 >>nt recruitment challenges. No interim analyses were completed; study closure was not related to any concerns about safety or futility.) 收起 <<	-	-
NCT02294292	Diastolic Dysfunction ... 展开 >> Chronic Liver Disease 收起 <<	Not Applicable	Completed	-	India ... 展开 >> Institute of Liver & Biliary Sciences New Delhi, Delhi, India, 110070 收起 <<
NCT01474200	-		Terminated(Closed due to patie... 展开 >>nt recruitment challenges. No interim analyses were completed; study closure was not related to any concerns about safety or futility.) 收起 <<	-	-
NCT01258439	HIV Cardiovas... 展开 >>cular Disease 收起 <<	Phase 4	Completed	-	Australia, New South Wales ... 展开 >> Holdsworth House Medical Practice Sydney, New South Wales, Australia, 2010 St Vincent Hospital, Clinical Research Program Sydney, New South Wales, Australia, 2010 收起 <<
NCT00004498	Ornithine Transcarbamylase Def... 展开 >>iciency Disease 收起 <<	Phase 1	Terminated	-	-
NCT01148771	Healthy	Phase 4	Completed	-	United States, Connecticut ... 展开 >> Hartford Hospital Hartford, Connecticut, United States, 06102 收起 <<
NCT02880761	Arteriovenous Fistulae	Not Applicable	Recruiting	May 2019	China, Beijing ... 展开 >> Peking University International Hospital Recruiting Beijing, Beijing, China, 102206 Contact: Dongliang Zhang, Doctor +86-10-69006549 zhangdongliang@pkuih.edu 收起 <<
NCT02122146	-		Terminated(The study was prema... 展开 >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) 收起 <<	-	-
NCT01148771	-		Completed	-	-
NCT01992900	Malaria,Falciparum	Phase 2	Completed	-	Burkina Faso ... 展开 >> Centre Muraz Bobo Dioulasso, Burkina Faso Centre National de Recherche et de Formation en Paludisme Ouagadougou, Burkina Faso Congo, The Democratic Republic of the Kinshasa School of Public Health, School of Medicine, University of Kinshasa Kinshasa, Congo, The Democratic Republic of the Gambia Medical Research Council Fajara, Gambia Mozambique Manica's Health Research Centre Manica, Mozambique Tanzania Bagamoyo Research center, Ifakara Heath Institute Bagamoyo, Tanzania National Insititute for Medical Research Tanga, Tanzania 收起 <<
NCT03323359	Hepatectomy C... 展开 >>ancer, Metastatic Hemostasis 收起 <<	Not Applicable	Recruiting	March 17, 2019	Italy ... 展开 >> Policlinico Universitario Agostino Gemelli Recruiting Rome, Italy, 00168 Contact: Pacelli 00390630155133 ext 4477 fabio.pacelli@policlinicogemelli.it Principal Investigator: Fabio FP Pacelli, MD 收起 <<
NCT01700816	-		Terminated(Low incidence of de... 展开 >>lirium.) 收起 <<	-	-
NCT03404167	Gonorrhoea	Phase 1	Completed	-	United States, Kansas ... 展开 >> Quintiles Phase I Services - Overland Park Overland Park, Kansas, United States, 66211-1553 收起 <<
NCT02122146	Neoplasms	Phase 1	Terminated(The study was prema... 展开 >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) 收起 <<	-	United States, California ... 展开 >> Keck Hospital of USC Los Angeles, California, United States, 90033 LAC&USC Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver CTO (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 <<
NCT02980393	Congenital Heart Disease ... 展开 >> Pediatric Obesity 收起 <<	Not Applicable	Completed	-	-
NCT02275429	Metabolic Diseases	Not Applicable	Completed	-	France ... 展开 >> Reunion Island University Hospital Saint Denis, Reunion Island, France, 97410 收起 <<
NCT00095173	Juvenile Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT03348592	Chronic Kidney Diseases	Not Applicable	Active, not recruiting	June 2018	United States, District of Col... 展开 >>umbia The George Washington University Medical Faculty Associates Washington, District of Columbia, United States, 20037 收起 <<
NCT00095173	-		Completed	-	-
NCT00374907	Type 2 Diabetes	Phase 3	Completed	-	United States, California ... 展开 >> Va San Diego Healthcare System San Diego, California, United States, 92161 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, Texas Diabetes & Glandular Disease Research Assoc,, Inc. San Antonio, Texas, United States, 78229 收起 <<
NCT02197130	Huntington's Disease	Phase 2	Completed	-	-
NCT00374907	-		Completed	-	-
NCT02418065	Chronic Kidney Failure	Phase 3	Unknown	April 2017	France ... 展开 >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr Sub-Investigator: Dorothée BAZIN KARA Sub-Investigator: Didier DUCLOUX Sub-Investigator: Anne-Elizabeth HENG Sub-Investigator: Fitsum GUEBREEGZIABHE Sub-Investigator: Denis FOUQUE Sub-Investigator: Christophe MARIAT Sub-Investigator: Atman HADDJELMRABET Sub-Investigator: Didier AGUILERA Sub-Investigator: Eric LARUELLE Sub-Investigator: Charles CHAZOT Sub-Investigator: Abdallah GUERRAOUI Sub-Investigator: Myriam ISNARD Sub-Investigator: Prisca MUTINELLI Sub-Investigator: Hélène DE PRENEUF Sub-Investigator: François MAURICE Sub-Investigator: Pedro PALACIN Sub-Investigator: Daniel TETA Sub-Investigator: Marie ESSIG 收起 <<
NCT01263691	Bacillus Anthracis (Anthrax) I... 展开 >>nfection 收起 <<	Phase 1	Completed	-	United States, Florida ... 展开 >> Miami Research Associates Miami, Florida, United States, 33143 United States, North Carolina North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 United States, Utah Jean Brown Research Salt Lake City, Utah, United States, 84124 收起 <<
NCT02197130	-		Completed	-	-
NCT02163070	Chronic Kidney Disease	Phase 2	Completed	-	-
NCT01874106	Inflammation ... 展开 >>Malnutrition Protein Energy Wasting Syndrome Oxidative Stress Diet Therapy 收起 <<	Not Applicable	Completed	-	Iran, Islamic Republic of ... 展开 >> Shiraz University of Medical Sciences, Department of Nutrition Shiraz, Fars, Iran, Islamic Republic of 收起 <<
NCT02398279	Schizophrenia ... 展开 >> Schizoaffective Disorder 收起 <<	Not Applicable	Completed	-	Turkey ... 展开 >> Hacettepe University Faculty of Medicine Department of Psychiatry Ankara, Turkey, 06100 收起 <<
NCT02936362	Dietary Modification ... 展开 >> Bread Gastrointestinal Microbiome Hematologic Tests Body Weight Changes 收起 <<	Not Applicable	Completed	-	Israel ... 展开 >> Weizmann Institute of Science Rehovot, Israel Department of Gastroentherology Tel Aviv, Israel, 64239 收起 <<
NCT01263691	-		Completed	-	-
NCT03318731	Muscle Damage ... 展开 >> Inflammation 收起 <<	Not Applicable	Recruiting	September 2018	United States, Texas ... 展开 >> UMHB Human Performance Lab Recruiting Belton, Texas, United States, 76513 Contact: Stacie L Urbina, MsEd 254-295-4280 ext 4280 surbina@umhb.edu Contact: Lem W Taylor, PhD 254-295-4895 ext 4895 ltyalor@umhb.edu Sub-Investigator: Katelyn B Villa, B.S. Sub-Investigator: Allyson K Bermea Sub-Investigator: Torrey Boggs Sub-Investigator: Matthias R Tinnin, B.S. Sub-Investigator: Javier A Zaragoza Sub-Investigator: Seth M Bates Sub-Investigator: Colin D Wilborn, PhD Sub-Investigator: Cliffa Foster, EdD 收起 <<
NCT01142726	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT01777295	Hepatitis B	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Antwerpen, Belgium, 2060 收起 <<
NCT01172314	Non-small Cell Lung Cancer	Not Applicable	Active, not recruiting	February 2019	United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 收起 <<
NCT02467530	End Stage Renal Disease (ESRD)	Not Applicable	Completed	-	United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 <<
NCT02302287	Chronic Renal Insufficiency	Phase 4	Unknown	July 2017	Italy ... 展开 >> UOC Nefrologia Solofra, Avellino, Italy, I-83029 收起 <<
NCT03124420	Helicobacter Pylori Infection	Phase 4	Completed	-	Taiwan ... 展开 >> Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan Taipei, Taiwan, 10449 收起 <<
NCT03520361	Colonoscopy	Phase 4	Enrolling by invitation	June 30, 2019	Korea, Republic of ... 展开 >> Kangwon National University Hospital Chuncheon, Gangwon-do, Korea, Republic of, 24289 收起 <<
NCT02245399	Type 2 Diabetes ... 展开 >> Obesity Overweight Cardiovascular Diseases 收起 <<	Not Applicable	Completed	-	Canada, Manitoba ... 展开 >> Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute of Nutraceuticals and Functional Foods, Laval University Quebec City, Quebec, Canada, G1V 4G2 收起 <<
NCT03508895	Hypertension	Not Applicable	Recruiting	March 2020	Canada, Manitoba ... 展开 >> Richarson Centre for Funtional Foods and Nutraceuticals Recruiting Winnipeg, Manitoba, Canada, R3T 6C5 Contact: Peter JH Jones, PhD 204-474-8883 peter.jones@umanitoba.ca Principal Investigator: Peter JH Jones, PhD 收起 <<
NCT02948244	Facio-Scapulo-Humeral Dystroph... 展开 >>y FSHD2 FSHD1 收起 <<	Phase 2	Recruiting	December 2018	Australia, Victoria ... 展开 >> The Royal Children's Hospital Recruiting Melbourne, Victoria, Australia, 3052 Contact: Ian R Woodcock, MBBS, MSc +61 (0) 3 9345 5661 ian.woodcock@rch.org.au Contact: Daniella Villano, BN +61 (0) 3 9345 5661 daniella.villano@rch.org.au Principal Investigator: Ian R Woodcock, MBBS, MSc Sub-Investigator: Katy de Valle, BSc Physio 收起 <<
NCT01812629	Growth and Tolerance Infant St... 展开 >>udy 收起 <<	Not Applicable	Completed	-	United States, District of Col... 展开 >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 收起 <<
NCT02815527	-		Completed	-	Netherlands ... 展开 >> VU Medical Center Amsterdam, Noord Holland, Netherlands 收起 <<
NCT01142726	-		Completed	-	-
NCT01438034	Delayed Puberty ... 展开 >> Kallmann Syndrome Hypogonadotropic Hypogonadism GnRH Deficiency 收起 <<	Phase 1	Recruiting	November 2020	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Yee-Ming Chan, MD, PhD 617-726-9260 ymchan@partners.org Principal Investigator: Stephanie B Seminara, MD Sub-Investigator: Yee-Ming Chan, MD, PhD 收起 <<
NCT03523455	Iron-deficiency	Not Applicable	Terminated(Unable to recruit q... 展开 >>ualified participants) 收起 <<	-	United States, Texas ... 展开 >> UMHB Human Performance Lab Belton, Texas, United States, 76513 收起 <<
NCT00338689	Infant Development	Not Applicable	Unknown	September 2015	Belgium ... 展开 >> CHC St. Vincent, Liège / Universite Libre de Bruxelles Liège, Belgium, BE-4000 Germany Ludwig-Maximilians-Universitaet Muenchen, Germany, D 80337 Italy Universita degli Studi di Milano Milan, Italy, I-20122 Poland Children´s Memorial Healzj Institute Warsaw, Poland, P 04736 Spain Universitat Rovira i Virgili Tarragona, Spain, S 43003 收起 <<
NCT03674177	Respiratory Syncytial Virus In... 展开 >>fections 收起 <<	Phase 1	Recruiting	September 19, 2019	United States, California ... 展开 >> GSK Investigational Site Withdrawn Glendale, California, United States, 91206 GSK Investigational Site Withdrawn San Diego, California, United States, 92108 United States, Illinois GSK Investigational Site Withdrawn Peoria, Illinois, United States, 61602 United States, Kansas GSK Investigational Site Recruiting Lenexa, Kansas, United States, 66219 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Principal Investigator: Casey Johnson United States, New York GSK Investigational Site Recruiting Rochester, New York, United States, 14609 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Principal Investigator: Matthew G Davis United States, Texas GSK Investigational Site Withdrawn Austin, Texas, United States, 78705 Belgium GSK Investigational Site Withdrawn Leuven, Belgium, 3000 Finland GSK Investigational Site Not yet recruiting Helsinki, Finland, 00260 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Tampere, Finland, FI-331 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Turku, Finland, 20100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Turku, Finland, 20540 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Germany GSK Investigational Site Not yet recruiting Wuerzburg, Bayern, Germany, 97070 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Withdrawn Neu-Isenburg, Hessen, Germany, 63263 GSK Investigational Site Not yet recruiting Hannover, Niedersachsen, Germany, 30159 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Withdrawn Essen, Nordrhein-Westfalen, Germany, 45355 GSK Investigational Site Not yet recruiting Goch, Nordrhein-Westfalen, Germany, 47574 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Mainz, Rheinland-Pfalz, Germany, 55116 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Hamburg, Germany, 22143 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02539576	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> GSK Investigational Site Glendale, California, United States, 91206 收起 <<
NCT02644603	Carcinoma, Hepatocellular	Not Applicable	Active, not recruiting	June 2017	China, Shanghai ... 展开 >> Zhongshan Hospital Shanghai, Shanghai, China, 200032 收起 <<
NCT01201720	Liver Cirrhosis ... 展开 >> Liver Failure 收起 <<	Phase 4	Completed	-	Spain ... 展开 >> Hospital Clínic of Barcelona Barcelona, Spain, 08028 收起 <<
NCT01438073	Hypogonadotropic Hypogonadism ... 展开 >> Healthy Postmenopausal Women Primary Gonadal Insufficiency in Men Hypergonadotropic Hypogonadism in Men Klinefelter Syndrome 收起 <<	Phase 1	Recruiting	September 2023	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Stephanie B Seminara, MD Sub-Investigator: Yee-Ming Chan, MD, PhD Sub-Investigator: Margaret Lippincott, MD 收起 <<
NCT02652741	Heart Failure ... 展开 >> Congenital Heart Disease 收起 <<	Phase 2 Phase 3	Unknown	June 2017	Austria ... 展开 >> Medical University of Vienna Not yet recruiting Vienna, Austria, 1090 Contact: Christoph Male, MD,PhD + 43 1 40400 32320 christoph.male@meduniwien.ac.at Contact: Vanessa Swoboda, MD + 43 1 40400 32320 v.swoboda@live.at Principal Investigator: Christoph Male, Prof,MD,PhD Sub-Investigator: Vanessa Swoboda, MD Hungary Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology Not yet recruiting Budapest, Hungary, 1095 Contact: Andras Szatmari, Prof,MD,PhD +36 1 215 1220 szatmari@kardio.hu Contact: Laszlo Ablonczy, MD +36 1 215 1220 ablonczyl@gmail.com Principal Investigator: Andras Szatmari, Prof,MD,Phd Sub-Investigator: Laszlo Ablonczy, MD Netherlands Sophia Children's Hospital, Erasmus MC Not yet recruiting Rotterdam, Netherlands, 3015 CN Contact: Michiel Dalinghaus, MD,PhD +3110-7040704 m.dalinghaus@erasmusmc.nl Contact: Tjitske van der Zanden +3110-7040704 t.vanderzanden@erasmusmc.nl Sub-Investigator: Marijke Van der Meulen, MD,PhD Wilhelmina Children's Hospital, University Medical Center Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX Contact: J.M.P. Breur J. Breur, MD,PhD + 31 8875 540 02 h.breur@umcutrecht.nl Principal Investigator: J.M.P. J. Breur, MD,PhD Serbia Univerzitetska Dečja Klinika Not yet recruiting Belgrade, Serbia, 11129 Contact: Milica Bajcetic, Prof,MD,PhD 38 1112060716 milica.bajcetic@udk.bg.ac.rs Contact: Ida Jovanovic, Prof,MD,PhD 38 1112060716 idaj@rcub.bg.ac.rs Principal Investigator: Ida Jovanovic, Prof,MD,PhD United Kingdom Great Ormond Street Hospital for Children NHS Trust Not yet recruiting London, United Kingdom, WC1N 3JH Contact: Michael Burch, Prof,MD,PhD +44 020 7405 9200 michael.burch@gosh.nhs.uk Principal Investigator: Michael Burch, Prof,MD,PhD 收起 <<
NCT02652728	Heart Failure ... 展开 >> Dilated Cardiomyopathy 收起 <<	Phase 2 Phase 3	Unknown	June 2017	Austria ... 展开 >> Medical University of Vienna Not yet recruiting Vienna, Austria, 1090 Contact: Christoph Male, Prof,MD,PhD + 43 1 40400 32320 christoph.male@meduniwien.ac.at Contact: Vanessa Swoboda, MD + 43 1 40400 32320 v.swoboda@live.at Principal Investigator: Christoph Male, Prof,MD,PhD Sub-Investigator: Vanessa Swoboda, MD Hungary Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology Not yet recruiting Budapest, Hungary, 1095 Contact: András Szatmári, Prof,MD,PhD +36 1 215 1220 szatmari@kardio.hu Contact: Laszlo Ablonczy, MD +36 1 215 1220 ablonczyl@gmail.com Principal Investigator: András Szatmári, Prof,MD,PhD Sub-Investigator: Laszlo Ablonczy, MD Netherlands Sophia Children's Hospital, Erasmus MC Not yet recruiting Rotterdam, Netherlands, 3015 CN Contact: Michiel Dalinghaus, MD,PhD +3110-7040704 'Michiel Dalinghaus' Contact: Tjitske van der Zanden +3110-7040704 t.vanderzanden@erasmusmc.nl Principal Investigator: Michiel Dalinghaus, MD,PhD Sub-Investigator: Marijke Van der Meulen, MD,PjD Wilhelmina Children's Hospital, University Medical Center Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX Contact: J.M.P. J. Breur, MD,PhD + 31 8875 540 02 h.breur@umcutrecht.nl Principal Investigator: J.M.P. J. Breur, MD,PhD Serbia Univerzitetska Dečja Klinika Not yet recruiting Belgrade, Serbia, 11129 Contact: Milica Bajcetic, Prof,MD,PhD + 38 1112060716 milica.bajcetic@udk.bg.ac.rs Contact: Ida Jovanovic, Prof,MD,PhD + 38 1112060716 idaj@rcub.bg.ac.rs Principal Investigator: Ida Jovanovic, Prof,MD,PhD United Kingdom Great Ormond Street Hospital for Children NHS Trust Not yet recruiting London, United Kingdom, WC1N 3JH Contact: Michael Burch, Prof,MD,PhD +44 020 7405 9200 michael.burch@gosh.nhs.uk Principal Investigator: Michael Burch, Prof,MD,PhD 收起 <<
NCT01952782	Hypogonadotropic Hypogonadism	Phase 1	Recruiting	December 2022	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Stephanie B Seminara, MD Sub-Investigator: Yee-Ming Chan, MD, PhD Sub-Investigator: Maragret Lippincott, MD 收起 <<
NCT00365274	-		Terminated	-	-
NCT03151837	Diabetes Mellitus, Type 2	Not Applicable	Completed	-	Taiwan ... 展开 >> Chung Shan Medical University Hospital Taichung, Taiwan, 40201 收起 <<
NCT02795390	Constipation	Phase 2	Completed	-	Hong Kong ... 展开 >> Caritas Medical Centre Hong Kong, Hong Kong Hong Kong Buddhist Hospital Hong Kong, Hong Kong Our Lady of Maryknoll Hospital Hong Kong, Hong Kong 收起 <<
NCT02109445	Metastatic Cancer Pancreas	Phase 2	Terminated(The study was termi... 展开 >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) 收起 <<	-	United States, Colorado ... 展开 >> Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 Drug Shipment: Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Cancer Center Aurora, Colorado, United States, 80045 University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States, 80045 United States, New York University of Rochester Investigational Drug Pharmacy Rochester, New York, United States, 14642 University of Rochester Rochester, New York, United States, 14642 收起 <<
NCT01862679	End Stage Renal Disease	Not Applicable	Completed	-	United Kingdom ... 展开 >> NHS Greater Glasgow andClyde Glasgow, United Kingdom, G12 0XH 收起 <<
NCT02865369	-		Not yet recruiting	December 2022	Korea, Republic of ... 展开 >> Soonchunhyang University Cheonan Hospital Recruiting Cheonan, Chungcheongnam-do, Korea, Republic of, 31151 Contact: SaeHwan Lee, Professor Principal Investigator: SaeHwan Lee, Professor Soon Chun Hyang University Bucheon Hospital Recruiting Bucheon, Gyeonggi do, Korea, Republic of, 14584 Contact: Sang Gyune Kim, Professor 82-32-621-5079 mcnulty@schmc.ac.kr Principal Investigator: Sang Gyune Kim Korea University Ansan Hospital Recruiting Ansan, Gyeonggi-do, Korea, Republic of, 15355 Contact: Young Kul Jung, Professor Principal Investigator: Young Kul Jung, Professor Inha University Hospital Recruiting Jung-gu, Incheon, Korea, Republic of, 22332 Contact: Jin-Woo Lee, Professor Principal Investigator: Jin-Woo Lee, Professor Gachon University Gil Medical Center Recruiting Incheon, Korea, Republic of, 21565 Contact: Oh Sang Kwon, Professor Principal Investigator: Oh Sang Kwon, Professor Severance hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Jun Yong Park, Professor Principal Investigator: Jun Yong Park, Professor Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of, 04401 Contact: Jae Young Jang, Professor Principal Investigator: Jae Young Jang, Professor Hanyang university hospital Recruiting Seoul, Korea, Republic of, 04763 Contact: Dae Won Jun, Professor Principal Investigator: Dae Won Jun, Professor Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of, 07985 Contact: Tae Hun Kim, Professor Principal Investigator: Tae Hun Kim, Professor Wonju severance christian hospital Recruiting Wonju, Korea, Republic of, 26426 Contact: Moon young Kim, Professor Principal Investigator: Moon young Kim, Professor 收起 <<
NCT03251014	Thrombosis	Not Applicable	Completed	-	-
NCT00365274	Anaplastic Large Cell Lymphoma	Phase 2	Terminated	-	United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT03615040	COPD Exacerbation	Phase 2	Recruiting	August 31, 2020	United Kingdom ... 展开 >> Biomedical Research Centre- Respiratory, Glenfield Hospital Recruiting Leicester, Leicestershire, United Kingdom, LE3 9QP Contact: Ahmed Yousuf, Dr 0116 258 3692 ajy7@leicester.ac.uk Contact: Sarah Parker 0116 258 3277 sarah.e.parker@uhl-tr.nhs.uk Principal Investigator: Chris Brightling, Prof 收起 <<
NCT02769611	Heart Failure	Phase 1 Phase 2	Recruiting	December 2019	United States, Ohio ... 展开 >> The Lindner Center for Research and Education at The Christ Hospital Recruiting Cincinnati, Ohio, United States, 45219 Contact: Gregory Egnaczyk, MD 513-585-1777 Principal Investigator: Gregory Egnaczyk, MD 收起 <<
NCT03682952	Chronic Renal Disease	Phase 4	Active, not recruiting	April 30, 2019	China, Jiangsu ... 展开 >> The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China, 221000 收起 <<
NCT02467296	Heart Failure	Not Applicable	Recruiting	April 2018	United States, New York ... 展开 >> Stony Brook University Recruiting Stony Brook, New York, United States, 11794 收起 <<
NCT02109445	-		Terminated(The study was termi... 展开 >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) 收起 <<	-	-
NCT02119260	-		Completed	-	-
NCT02536729	-		Unknown	-	-
NCT02335723	Septic Shock	Not Applicable	Terminated(Problem to find eli... 展开 >>gible patients to include) 收起 <<	-	Finland ... 展开 >> Kuopio University Hospital Kuopio, Finland, 70210 Tampere University Hospital Tampere, Finland, 33521 Norway Haukeland Universitetssykehus Bergen, Norway, 5021 Oslo Universitetssykehus Oslo, Norway, 0372 Sweden Linköping University Hospital Linköping, Sweden, SE-58185 Uppsala University Hospital Uppsala, Sweden, SE-751 81 收起 <<
NCT03602937	Chronic Kidney Diseases ... 展开 >> Renal Disease 收起 <<	Not Applicable	Recruiting	April 17, 2019	United Kingdom ... 展开 >> Southampton Children's Hospital Recruiting Southampton, Hampshire, United Kingdom, S016 6YD Contact: Caroline Anderson 02380776072 Caroline.Anderson@uhs.nhs.uk Contact: Natasha Chigbo 023 8120 5369 natasha.chigbo@uhs.nhs.uk Alder Hey Children's Hospital Recruiting Liverpool, Merseyside, United Kingdom, L12 2AP Contact: Alison Holmes 0151 525 5231 Alison.holmes@alderhey.nhs.uk Contact: Edward Staunton 0151 252 5570 Edward.Staunton@alderhey.nhs.uk Birmingham Children's Hospital Recruiting Birmingham, West Midlands, United Kingdom, B4 6NH Contact: Sara Janes 0121 333 8803 Sara.Janes@BCH.NHS.UK Contact: Peter Price 0121 333 8748 peter.price6@nhs.net 收起 <<
NCT02119260	Oedema, Pulmonary	Phase 2	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site London, United Kingdom, NW10 7EW 收起 <<
NCT02581345	-		Completed	-	-
NCT03627494	Muscular Dystrophies	Phase 1	Recruiting	June 30, 2019	United States, Maryland ... 展开 >> GSK Investigational Site Recruiting Baltimore, Maryland, United States, 21225 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02581345	Chronic Plaque Psoriasis ... 展开 >> Psoriasis 收起 <<	Phase 3	Completed	-	-
NCT03574987	Physical Activity ... 展开 >> Diet Modification 收起 <<	Not Applicable	Recruiting	September 1, 2021	United Kingdom ... 展开 >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: Aaron Hengist, BSc +44 (0) 1225 385434 A.Hengist@bath.ac.uk Contact: Javier T Gonzalez, PhD +44 (0) 1225 385518 J.T.Gonzalez@bath.ac.uk Sub-Investigator: Russell Davies, BSc Sub-Investigator: Francoise Koumanov, PhD Sub-Investigator: Dylan Thompson, PhD Sub-Investigator: James A Betts, PhD 收起 <<
NCT02815007	Advanced EGFR-TKI-resistant No... 展开 >>n-Small Cell Lung Cancer 收起 <<	Phase 2	Unknown	June 2018	-
NCT02133079	Liver Cancer ... 展开 >>Pancreatic Adenocarcinoma 收起 <<	Phase 1 Phase 2	Active, not recruiting	November 2019	China ... 展开 >> Cancer Insititute and Hospital,Chinese Academy of Medical Sciences Beijing, China, 100021 收起 <<
NCT00644904	Multiple Sclerosis	Phase 1 Phase 2	Completed	-	Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 收起 <<
NCT02222493	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT02222493	-		Completed	-	-
NCT03327389	Kidney Transplantation	Not Applicable	Recruiting	December 31, 2020	Korea, Republic of ... 展开 >> Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Jin Ha Park, MD 82-2-2228-2420 ext 82-2-2227-7897 realsummer@yuhs.ac 收起 <<
NCT00411359	Angina Pectoris ... 展开 >> Coronary Disease 收起 <<	Phase 3	Completed	-	United Kingdom ... 展开 >> National Heart and Lung Institute, Imperial College London London, United Kingdom, SW3 6LY 收起 <<
NCT01856595	Diabetes Mellitus, Type 2	Phase 1	Completed	-	United States, California ... 展开 >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida MRA Clinical Research, LLC South Miami, Florida, United States, 33143 收起 <<
NCT03414294	Healthy	Phase 1	Recruiting	February 27, 2020	Australia, South Australia ... 展开 >> CMAX, Clinical Research Pty Ltd Recruiting Adelaide, South Australia, Australia, 5000 收起 <<
NCT00434512	AIDS	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 收起 <<
NCT02568696	-		Active, not recruiting	December 31, 2018	Finland ... 展开 >> Helsinki University and Helsinki University Hospital Helsinki, Finland, 00029 收起 <<
NCT00219791	Neoplasms	Phase 2	Completed	-	Germany ... 展开 >> Charite - Universitätsmedizin Berlin Berlin, Germany, 12200 收起 <<
NCT03009292	Solid Tumor	Phase 1	Recruiting	December 2019	China, Beijing ... 展开 >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Lin Shen 86100881211226561 China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China Contact: Yuxian Bai 8645186298694 收起 <<
NCT02512900	Asthma	Phase 1	Completed	-	Poland ... 展开 >> Research Site Kielce, Poland, 25-040 Research Site Wrocław, Poland, 51-162 Research Site Wrocław, Poland, 53-201 Research Site Łódź, Poland, 71-329 收起 <<
NCT03480971	Mucositis Nep... 展开 >>hrotoxicity Ototoxicity 收起 <<	Phase 2	Not yet recruiting	October 2019	United States, Maryland ... 展开 >> University Maryland School of Medicine Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Robert Malyapa, MD 410-328-6080 Principal Investigator: Robert Malyapa, MD 收起 <<
NCT02512900	-		Completed	-	-
NCT00815737	Lung Infection ... 展开 >> Cerebral Hemorrhage Pneumonia 收起 <<	Phase 2 Phase 3	Unknown	-	China, Shanghai ... 展开 >> Zhongshan hospital of Fudan University Shanghai, Shanghai, China, 200032 收起 <<
NCT00789269	Pneumonia Acu... 展开 >>te Stroke 收起 <<	Phase 2	Unknown	-	China, Shanghai ... 展开 >> Department of Integrative Medicine, Zhongshan hospital, Fudan University Shanghai, Shanghai, China, 200032 收起 <<
NCT02425020	Dietary Modification	Not Applicable	Completed	-	-
NCT01856595	-		Completed	-	-
NCT02168075	Supratentorial Neoplasms	Not Applicable	Unknown	-	Korea, Republic of ... 展开 >> Seoul National University of Hospital Recruiting Seoul, Korea, Republic of, 110-799 Contact: Hee Pyung Park, MD PhD 82-2-2072-2466 hppark@snu.ac.kr Contact: Eugene Kim, MD 82-2-2072-3108 tomomie@hanmail.net Principal Investigator: Eugene Kim, MD 收起 <<
NCT00661349	HIV Infections	Phase 4	Terminated(It has been impossi... 展开 >>ble to achieve the number of patients defined by protocol) 收起 <<	-	Spain ... 展开 >> Hospital Son Dureta Palma de Mallorca, Baleares, Spain, 07014 H.U. Germans Trias i Pujol - Unitat VIH, Fundació Lluita contra la Sida Badalona, Barcelona, Spain, 08916 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario Príncipe de Asturias Madrid, Spain, 28005 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario la Paz Madrid, Spain, 28046 Hospital Clínico de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Valme Sevilla, Spain, 41014 收起 <<
NCT01318486	Chronic Kidney Disease ... 展开 >> Patients Requiring Heparin Free Dialysis Treatments 收起 <<	Not Applicable	Completed	-	Belgium ... 展开 >> Erasme Hospital Brussels, Belgium UZ Brussels Brussels, Belgium Canada, New Brunswick George Dumont Hospital Moncton, New Brunswick, Canada France CHU Edouard Herriot Lyon, France CHU Brabois Nancy, France CHU de Saint-Étienne - Hôpital Nord Saint-Priest en Jarez, France, 42270 Netherlands UMCG Groningen, Netherlands Poland Gdanski Uniwersytet Medyczny Gdansk, Poland Spain Hospital Universitary German Trias i Pujol Badalona, Spain, 08916 Vall d'Hebron Hospital Barcelona, Spain United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom 收起 <<
NCT02680600	Antimicrobial Treatment	Not Applicable	Completed	-	-
NCT00734474	Diabetes Mellitus, Type 2	Phase 2 Phase 3	Completed	-	-
NCT03153774	Sarcopenia Ch... 展开 >>ronic Heart Failure 收起 <<	Not Applicable	Recruiting	December 2018	France ... 展开 >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, Auvergne, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr Contact: Romain ESCHALIER 0033 473 751 410 reschalier@chu-clermontferrand.fr 收起 <<
NCT02121327	Ischemic Stroke	Not Applicable	Completed	-	Japan ... 展开 >> Hiroshima University Hiroshima city, Hiroshima, Japan, 734-8553 收起 <<
NCT03732690	Type 2 Diabetes	Not Applicable	Not yet recruiting	December 30, 2020	France ... 展开 >> Hôpital PITIE SALPETRIERE - APHP Not yet recruiting Paris, France, 75013 Contact: Karine CLEMENT, MD, PhD 收起 <<
NCT02288663	Renal Function	Not Applicable	Unknown	September 2017	France ... 展开 >> Hôpitaux Universitaires de Strasbourg Not yet recruiting Strasbourg, France, 67098 Contact: Fabrice HUBELE, MD 3 88 12 75 47 ext 0033 fabrice.hubele@chru-strasbourg.fr 收起 <<
NCT00734474	-		Completed	-	-
NCT01416571	Influenza	Phase 2	Completed	-	United States, Arizona ... 展开 >> GSK Investigational Site Mesa, Arizona, United States, 85213 收起 <<
NCT03515577	Recurrent Prostate Carcinoma	Phase 2	Active, not recruiting	March 2, 2020	United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 收起 <<
NCT03720288	Heart Failure ... 展开 >> Acute Heart Failure 收起 <<	Phase 3	Recruiting	October 1, 2020	Brazil ... 展开 >> Instituto do Coração - HMFMUSP Recruiting São Paulo, Brazil, 05403000 Contact: Alexandre Soeiro, MD 5511-2661-5299 alexandre.soeiro@bol.com.br 收起 <<
NCT02511860	Hypertension	Not Applicable	Unknown	February 2016	-
NCT03342183	Chronic Kidney Disease	Not Applicable	Recruiting	January 1, 2021	Canada, Ontario ... 展开 >> London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5W9 Contact: Chris McIntyre, MD 519-685-8500 ext 58502 christopher.mcintyre@lhsc.on.ca Contact: Jarrin Penny 519-685-8500 ext 58765 jarrin.penny@lhsc.on.ca Principal Investigator: Christopher W McIntyre, MD 收起 <<
NCT01416571	-		Completed	-	-
NCT02090621	Hepatic Insufficiency	Phase 2	Completed	-	Spain ... 展开 >> Jose Antonio Pons, MD Murcia, El Palmar, Spain, 30120 收起 <<
NCT02342548	Huntington's Disease	Phase 2	Terminated(Study terminated on... 展开 >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) 收起 <<	-	-
NCT00378820	Metabolic Syndrome ... 展开 >> Obesity 收起 <<	Not Applicable	Unknown	-	Denmark ... 展开 >> Institute of Human Nutrition, Rolighedsvej 30 Frederiksberg C, Denmark, 1958 收起 <<
NCT02966418	Hypoxic Preconditioning ... 展开 >> Carotid Artery Stenosis Ischemic Cerebrovascular Disease 收起 <<	Not Applicable	Completed	-	China, Tianjin ... 展开 >> Tianjin HuanHu Hospital Tianjin, Tianjin, China, 300350 收起 <<
NCT02342548	-		Terminated(Study terminated on... 展开 >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) 收起 <<	-	-
NCT00048932	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT00992758	Lymphoma, Non-Hodgkin	Phase 1	Completed	-	-
NCT03314727	Hypertension ... 展开 >>Sodium Excess Oxidative Stress Inflammation 收起 <<	Not Applicable	Completed	-	Turkey ... 展开 >> Koc University Hospital Istanbul, Turkey, 34010 收起 <<
NCT01819636	Hypertriglyceridemia	Not Applicable	Completed	-	France ... 展开 >> OPTIMED Gières, France, 38610 Naturalpha Lille, France, 59020 Biofortis Saint Herblain, France, 44800 收起 <<
NCT00048932	-		Completed	-	-
NCT01627561	Infections, Papillomavirus	Phase 3	Completed	-	Colombia ... 展开 >> GSK Investigational Site Bogota, Colombia, 38007 GSK Investigational Site Yopal, Casanare, Colombia Mexico GSK Investigational Site Mexico, Mexico, 04530 Panama GSK Investigational Site Panama, Panama 收起 <<
NCT00981981	Hypercholesterolemia	Phase 2	Completed	-	Australia, New South Wales ... 展开 >> SUGiRS Human Nutrition Unit, School of Molecular & Microbial Biosciences, Unviersity of Sydney Sydney, New South Wales, Australia, 2006 Canada, Ontario Human Nutraceutical Research Unit, Department of Human Health and Nutritional Sciences, University of Guelph Guelph, Ontario, Canada, N1G 2W1 Glycemic Index Laboratories, Inc. Toronto, Ontario, Canada, M5C 2X3 Canada, Quebec Nutraceuticals and Functional Foods Institute, Faculte des science de l'agriculture et de l'alimentation, Universite Laval Laval, Quebec, Canada United Kingdom Reading Scientific Services, Ltd (RSSL) Reading, Berkshire, United Kingdom, RG6 6LA 收起 <<
NCT03354507	Epilepsy Meta... 展开 >>bolic Acidosis Tubular Acidosis; Renal 收起 <<	Not Applicable	Not yet recruiting	December 2018	Canada, Ontario ... 展开 >> McMaster Children's Hospital Not yet recruiting Hamilton, Ontario, Canada, L8N 3Z5 Contact: Mandeep Sidhu, MD 9055212100 ext 6924 mandeep.sidhu@medportal.ca Contact: Surejini Tharmaradinam, MD 9055212100 ext 6760 surejini.tharmaradinam@medportal.ca Principal Investigator: Vladimir Belostotsky, MD Sub-Investigator: Brandon Meaney, MD 收起 <<
NCT02778477	Normal Healthy	Phase 1	Terminated(Preliminary analysi... 展开 >>s of accrued data failed to indicate any meaningful pharmacodynamic response.) 收起 <<	-	Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT02213770	-		Completed	-	Norway ... 展开 >> OUS- Rikshospitalet Oslo, Norway, 0424 收起 <<
NCT01627561	-		Completed	-	-
NCT03560180	-		Recruiting	September 30, 2018	Italy ... 展开 >> UOC Chirurgia Generale - Jesi - AV5 - ASUR Marche Recruiting Jesi, AN, Italy, 60035 Contact: ROBERTO CAMPAGNACCI, MD rcampagnacci@libero.it Sub-Investigator: ANGELA MAURIZI, MD UOC Chirurgia Generale - Ospedale Montichiari (BS) - ASST Spedali Civili di Brescia Recruiting Brescia, BS, Italy, 25018 Contact: NEREO VETTORETTO, MD nereovet@gmail.com Clinica Chirurgica, Università di Brescia - UOC Chirurgia Generale 3, ASST Spedali Civili di Brescia - Brescia Recruiting Brescia, BS, Italy, 25121 Contact: GIAN LUCA BAIOCCHI, MD gianluca.baiocchi@unibs.it Sub-Investigator: SARAH MOLFINO, MD S.C. Chirurgia Generale e Oncologica - Azienda Ospedaliera S. Croce e Carle - Cuneo, Italia Recruiting Cuneo, CN, Italy, 12100 Contact: FELICE BORGHI borghi.f@ospedale.cuneo.it Sub-Investigator: DESIREE' CIANFLOCCA, MD UOC di Chirurgia Addominale IRCCS Casa Sollievo della Sofferenza - San Giovanni Rotondo - Foggia Recruiting San Giovanni Rotondo, FG, Italy, 71013 Contact: FELICE PIROZZI, MD f.pirozzi@operapadrepio.it Sub-Investigator: ANTONIO SCIUTO, MD UOC Chirurgia Generale e Oncologica - Ospedale S. Stefano - Prato (FI) - ASL Toscana Centro Recruiting Prato, FI, Italy, 59100 Contact: MARCO SCATIZZI, MD marcoscatizzi60@gmail.com Sub-Investigator: MADDALENA BARAGHINI, MD UOC Chirurgia Generale ad Indirizzo Oncologico - IRCCS San Martino IST - Genova Recruiting Genova, GE, Italy, 16121 Contact: STEFANO SCABINI, MD stefanoscabini@libero.it Sub-Investigator: ANTONIO MARTINO SOC Chirurgia Generale, Oncologica e Vascolare - Azienda Ospedaliera Marche Nord - Pesaro Recruiting Pesaro, PU, Italy, 61121 Contact: ALBERTO PATRITI, MD albertopatriti@gmail.com Sub-Investigator: MARGHERITA LAMBERTINI, MD UOC Chirurgia Generale - Ospedale "Regina Apostolorum" Albano Laziale (RM) Recruiting Albano Laziale, RM, Italy, 00041 Contact: ANDREA LIVERANI andliverani@libero.it Sub-Investigator: TATIANA DI CESARE, MD U.O. di Chirurgia Generale e d'Urgenza - Policlinico Casilino - Roma Recruiting Roma, RM, Italy, 00100 Contact: GRAZIANO LONGO, MD grazianolongo@mac.com Sub-Investigator: FEDERICO TOMASSINI, MD UOC Chirurgia Generale e Oncologica - Ospedale San Filippo Neri - ASL Roma1 Recruiting Roma, RM, Italy, 00100 Contact: STEFANO MANCINI, MD stef.mancini@virgilio.it Sub-Investigator: RICCARDO ANGELONI, MD UOS Chirurgia Geriatrica - Policlinico Campus BioMedico - Roma Recruiting Roma, RM, Italy, 00100 Contact: MARCO CARICATO, MD m.caricato@unicampus.it UOC Chirurgia Generale, Laparoscopica, Toracica -Ospedale "Ceccarini" di Riccione - Area Vasta Romagna Recruiting Riccione, RN, Italy, 47921 Contact: GIANLUCA GARULLI, MD lucagarulli@gmail.com Sub-Investigator: ANDREA LUCCHI, MD UOC Chirurgia Generale 1 - Ospedale S. Chiara - APSS Trento Recruiting Trento, TN, Italy, 38121 Contact: ALESSANDRO CARRARA, MD Alessandro.Carrara@apss.tn.it Sub-Investigator: MICHELE MOTTER, MD UOC Chirurgia Generale - Ospedale "E. Agnelli" di Pinerolo (TO) - ASL TO3 Recruiting Pinerolo, TO, Italy, 10064 Contact: ANDREA MURATORE, MD amuratore@aslto3.piemonte.it Sub-Investigator: PATRIZIA MARSANIC, MD UOC Chirurgia Generale - Ospedale Sacro Cuore Don Calabria Negrar Verona Recruiting Negrar, VR, Italy, 37024 Contact: GIACOMO RUFFO, MD giacomo.ruffo@sacrocuore.it Sub-Investigator: ELISA BERTOCCHI, MD UOC Chirurgia Generale Oncologica - Azienda Ospedaliera Belcolle - Viterbo Recruiting Viterbo, VT, Italy, 01100 Contact: RAFFAELE MACARONE PALMIERI, MD raf.macaronepalmieri@libero.it Sub-Investigator: PIETRO P AMODIO, MD SOC Chirurgia Colorettale - Istituto Nazionale dei Tumori - IRCCS Fondazione "G.Pascale" - Napoli Recruiting Napoli, Italy, 80100 Contact: PAOLO DEL RIO, MD p.delrio@istitutotumori.na.it Sub-Investigator: UGO PACE, MD 收起 <<
NCT02917278	End-Stage Renal Disease ... 展开 >> Meals Hemodialysis 收起 <<	Not Applicable	Completed	-	United States, Indiana ... 展开 >> Purdue University West Lafayette, Indiana, United States, 47907 收起 <<
NCT02988258	Haematological Malignancies ... 展开 >> CMV Infection 收起 <<	Phase 1	Suspended(Protocol being re-wr... 展开 >>itten to allow inclusion of more patients) 收起 <<	August 2019	United Kingdom ... 展开 >> University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2TH University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom, BS2 8ED University College London Hospital London, United Kingdom, NW1 2PG Nottingham University Hospital Nottingham, United Kingdom, NG5 1PB 收起 <<
NCT00761267	-		Completed	-	-
NCT00320190	-		Terminated(Terminated due to s... 展开 >>low participant accrual) 收起 <<	-	-
NCT01896648	-		Unknown	June 2016	Italy ... 展开 >> IRCCS Policlinico S. Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD giuseppe.derosa@unipv.it Contact: Pamela Maffioli, MD pamelamaffioli@hotmail.it Principal Investigator: Giuseppe Derosa, MD, PhD Sub-Investigator: Pamela Maffioli, MD 收起 <<
NCT00761267	Candidemia	Phase 3	Completed	-	-
NCT03283683	-		Active, not recruiting	September 2018	United Kingdom ... 展开 >> Royal Surrey County Hospital Guildford, Surrey, United Kingdom, GU2 7XX 收起 <<
NCT00320190	Leukemia, Myeloid, Chronic	Phase 2	Terminated(Terminated due to s... 展开 >>low participant accrual) 收起 <<	-	Belgium ... 展开 >> Local Institution Antwerpen, Belgium, 2060 Local Institution Charleroi, Belgium, 6000 Finland Local Institution Helsinki, Finland, 00029 Local Institution Tampere, Finland, 33380 France Local Institution Lyon Cedex 03, France, 69437 Local Institution Marseille Cedex 9, France, 13273 Local Institution Montpellier Cedex 5, France, 34295 Local Institution Paris Cedex 10, France, 75475 Local Institution Rennes, France, 35033 Local Institution Strasbourg Cedex, France, 67091 Local Institution Toulouse Cedex 09, France, 31059 Germany Local Institution Leipzig, Germany, 04103 Italy Local Institution Orbassano (To), Italy, 10043 Norway Local Institution Oslo, Norway, 0027 Local Institution Trondheim, Norway, 7006 Portugal Local Institution Lisboa, Portugal, 1649-035 Russian Federation Local Institution Moscow, Russian Federation, 125167 Local Institution Saint-Petersburg, Russian Federation, 191024 Local Institution St.Petersburg, Russian Federation, 197022 Spain Local Institution Murcia, Spain, 30008 Sweden Local Institution Lund, Sweden, 221 85 Local Institution Orebro, Sweden, 70185 Local Institution Uppsala, Sweden, 751 85 United Kingdom Local Institution Glasgow, Central, United Kingdom, G31 2ER Local Institution London, Greater London, United Kingdom, SE5 9RS Local Institution London, Greater London, United Kingdom, W12 ONN Local Institution Leeds, North Yorkshire, United Kingdom, LS9 7FT 收起 <<
NCT01893918	-		Unknown	July 2013	Italy ... 展开 >> Azienda Ospedaliero-Universitaria di Modena Recruiting Modena, Italy, 41100 Contact: Bianca Beghé, MD PhD +39 059 4225814 bianca.beghe@unimore.it Contact: Alessia Verduri, MD PhD +39 059 4225769 alessia.verduri@unimore.it 收起 <<
NCT02650336	-		Completed	-	China, Guangdong ... 展开 >> Xiaodong Zhaung Guangzhou, Guangdong, China, 510080 收起 <<
NCT01977430	Chronic Kidney Insufficiency ... 展开 >> Hemodialysis Treatment Diuresis Preserved 收起 <<	Phase 4	Unknown	March 2015	Spain ... 展开 >> Corporació Sanitària Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Contact: Mabel - Bolos-Contador, MD 0034937231010 ext 25010 mabeline17@hotmail.com 收起 <<
NCT01114386	-		Completed	-	Italy ... 展开 >> Azienda Ospedaliero-Universitaria di Modena Modena, Italy, 41124 收起 <<
NCT02477163	-		Unknown	April 2018	India ... 展开 >> P D Patel Ayurveda Hospital Recruiting Nadiad, Gujarat, India, 387001 Contact: Manishkumar V Patel, MD(Ayurveda) 9979589865 manishayu97@yahoo.com 收起 <<
NCT02808013	Lower Urinary Tract Symptoms	Phase 2	Unknown	-	-
NCT03183375	Thalassemia, Beta	Phase 2	Recruiting	June 30, 2018	Pakistan ... 展开 >> Omair Sana Foundation Recruiting Karachi, Sindh, Pakistan, 75300 Contact: Saqib H Ansari, MBBS, DCH, DPGN, Mphil, PhD 03002118018 muddasirsaqib@yahoo.com Contact: Salima M Ali, BScN, MS 03322696554 sohanisalima@gmail.com 收起 <<
NCT02351934	-		Completed	-	-
NCT02351934	Colorectal Disorders	Phase 4	Completed	-	United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 <<
NCT01121354	Infection	Phase 1	Completed	-	United States, Maryland ... 展开 >> PAREXEL Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 收起 <<
NCT02216526	-		Completed	-	-
NCT00656253	Parkinson's Disease	Phase 2 Phase 3	Completed	-	China, Beijing ... 展开 >> Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences Beijing, Beijing, China, 100053 China, Shanghai Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200025 Department of Integrative Medicine, Zhongshan hospital, Fudan University Shanghai, Shanghai, China, 200032 Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200032 Tongji Hospital of Tongji University Shanghai, Shanghai, China, 200065 Shanghai Chinese Medical Hospital Shanghai, Shanghai, China, 200071 Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China, 200127 The Sixth People＇s Hospital, Shanghai Jiaotong University Shanghai, Shanghai, China, 200233 Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200437 China, Zhejiang Department of Neurology, The second people's hospital of Wenzhou Wenzhou, Zhejiang, China, 325000 收起 <<
NCT01228305	Congenital Heart Disease ... 展开 >> Cardiopulmonary Bypass 收起 <<	Not Applicable	Completed	-	United States, Tennessee ... 展开 >> Vanderbilt University Nashville, Tennessee, United States, 37232 收起 <<
NCT00819780	Colon Cancer ... 展开 >>Colorectal Cancer Rectal Cancer Metastatic Colorectal Cancer 收起 <<	Phase 2	Completed	-	-
NCT01121536	Depression	Phase 3	Terminated(Business decision r... 展开 >>elated to efficacy rather than tolerability limitations, not stopped for any safety reasons.) 收起 <<	-	-
NCT01909284	Low Back Pain	Not Applicable	Unknown	March 2014	Korea, Republic of ... 展开 >> Daegu Catholic University Medical Center Recruiting Daegu, Kyungsangbukdo, Korea, Republic of 收起 <<
NCT00432913	Adenomatous Polyps	Phase 2 Phase 3	Completed	-	Italy ... 展开 >> S. Orsola Hospital Bologna, Italy, 40138 United Kingdom St. George's Hospital Medical School London, United Kingdom, SW17 0RE 收起 <<
NCT00819780	-		Completed	-	-
NCT01415895	Back Pain Low... 展开 >>er Back Pain Cervical Pain 收起 <<	Phase 2	Completed	-	United States, Florida ... 展开 >> Annette C. Toledano MD North Miami, Florida, United States, 33181 收起 <<
NCT03682848	HIV Infections	Phase 3	Not yet recruiting	December 29, 2023	-
NCT02216526	Xerosis Cutis	Not Applicable	Completed	-	Germany ... 展开 >> Charité - Universitätsmedizin Berlin Berlin, Germany, 10117 收起 <<
NCT00464399	De Novo Renal Transplantation	Phase 3	Completed	-	Norway ... 展开 >> Novartis Investigative Site, Oslo, Norway 收起 <<
NCT01121536	-		Terminated(Business decision r... 展开 >>elated to efficacy rather than tolerability limitations, not stopped for any safety reasons.) 收起 <<	-	-
NCT00555321	Immunosuppression in Solid Org... 展开 >>an Transplant 收起 <<	Phase 2	Terminated	-	-
NCT00703755	Patients With Metabolic Syndro... 展开 >>me 收起 <<	Phase 2	Completed	-	-
NCT02635386	Polycystic Ovary Syndrome ... 展开 >> Obesity 收起 <<	Phase 3	Recruiting	August 2019	United States, Louisiana ... 展开 >> Woman's Hospital Recruiting Baton Rouge, Louisiana, United States, 70815 Contact: Karen Elkind-Hirsch, PhD. 225-231-5278 Contact: Ericka Seidemann, MS 225-231-5275 ericka.seidemann@womans.org Principal Investigator: Karen Elkind-Hirsch, Ph.D. Sub-Investigator: Renee Harris, M.D. 收起 <<
NCT00975884	Influenza	Phase 3	Completed	-	France ... 展开 >> GSK Investigational Site Clermont-Ferrand, France, 63003 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Paris Cedex 18, France, 75877 GSK Investigational Site Paris, France, 75679 GSK Investigational Site Poitiers, France, 86000 收起 <<
NCT00240422	Diabetes Mellitus, Type 2 ... 展开 >> Hypertension 收起 <<	Phase 4	Completed	-	France ... 展开 >> Boehringer Ingelheim Investigational Site Lyon, France Boehringer Ingelheim Investigational Site Montpellier, France Germany Friedrich-Alexander-Universität Erlangen, Germany, 91054 Boehringer Ingelheim Investigational Site Nürnberg, Germany, 90402 Universität Erlangen-Nürnberg Nürnberg, Germany, 90471 Spain Edificio de Medicina Comunitaria Madrid, Spain, 28041 收起 <<
NCT00555321	-		Terminated	-	-
NCT01362296	-		Completed	-	-
NCT01154101	Psoriasis	Phase 2	Completed	-	United States, Missouri ... 展开 >> GSK Investigational Site Saint Louis, Missouri, United States, 63117 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10065 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97223 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19103 United States, Rhode Island GSK Investigational Site Johnston, Rhode Island, United States, 02919 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98101 收起 <<
NCT01362296	Lung Cancer, Non-Small Cell	Phase 2	Completed	-	-
NCT03315091	Solid Tumours	Phase 1	Completed	-	France ... 展开 >> Research Site Bordeaux Cedex, France, 33075 Research Site Saint Herblain, France, 44805 Netherlands Research Site Amsterdam, Netherlands, 1066 CX Research Site Amsterdam, Netherlands, 1081 HV Research Site Maastricht, Netherlands, 6229 HX United Kingdom Research Site Glasgow, United Kingdom, G12 0YN Research Site Manchester, United Kingdom, M20 4BX 收起 <<
NCT01154101	-		Completed	-	-
NCT03330847	Metastatic Triple Negative Bre... 展开 >>ast Cancer 收起 <<	Phase 2	Recruiting	January 20, 2021	-
NCT02909959	Autism Spectrum Disorder ... 展开 >> Autistic Disorder Neurodevelopmental Disorder Childhood Developmental Disorders, Pervasive 收起 <<	Phase 2	Recruiting	November 2019	United States, North Carolina ... 展开 >> Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine Recruiting Carrboro, North Carolina, United States, 27510 Contact: Laura Politte, M.D. 919-445-4160 laura.politte@cidd.unc.edu Contact: Morgan Parlier, MSW 919-843-8122 morgan.parlier@cidd.unc.edu 收起 <<
NCT01396187	Diabetes Mellitus, Type 2	Phase 1	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 收起 <<
NCT00320359	Lung Cancer, Small Cell	Phase 3	Completed	-	-
NCT02571088	Sickle Cell Hemoglobin C Disea... 展开 >>se Hemoglobin S Disease 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Hopital Avicenne Bobigny, France, 93000 Centre hospitalier sud francilien Corbeil-essonnes, France, 91100 CHU Henri MONDOR Creteil, France, 94010 CHU Kremlin-Bicêtre Le Kremlin Bicetre, France, 93270 Hopital Europeen Georges POMPIDOU Paris, France, 75015 Hopital Necker Paris, France, 75015 Hopital Tenon Paris, France, 75020 Centre hospitalier de Saint-Denis Saint-denis, France, 93200 CHU de SAINT-ETIENNE Saint-etienne, France, 42000 收起 <<
NCT01492634	Hypotension During Dialysis	Not Applicable	Completed	-	Spain ... 展开 >> Dialysis Units, Hospital Clínic Barcelona, Spain, 08036 收起 <<
NCT00611455	Arthritis, Rheumatoid	Phase 3	Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 <<	-	-
NCT00814489	Streptococcus Pneumoniae ... 展开 >> Haemophilus Influenzae 收起 <<	Phase 1	Completed	-	Sweden ... 展开 >> GSK Investigational Site Karlskrona, Sweden, SE-371 41 收起 <<
NCT00603525	-		Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 <<	-	-
NCT00611455	-		Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 <<	-	-
NCT02634749	Infant Development ... 展开 >> Body Composition, Beneficial Dietary Modification 收起 <<	Not Applicable	Active, not recruiting	January 2020	Sweden ... 展开 >> Paediatrics, Department of Clinical Sciences Umeå, Sweden, 90185 收起 <<
NCT01380366	Short Bowel Syndrome	Phase 4	Completed	-	United States, Illinois ... 展开 >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 收起 <<
NCT01380366	-		Completed	-	-
NCT03455075	Healthy Men ... 展开 >> Male Contraception 收起 <<	Phase 2	Recruiting	June 2020	United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han 310-222-1865 xhan@labiomed.org Principal Investigator: Christina Wang United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD 206-616-1818 page@uw.edu 收起 <<
NCT01370564	Heart Failure	Phase 2	Completed	-	United States, Ohio ... 展开 >> Ohio State University Columbus, Ohio, United States, 43210 United States, Oklahoma Oklahoma Cardiovascular Research Oklahoma City, Oklahoma, United States, 73120 United States, Virginia Sentara Cardiovascular Norfolk, Virginia, United States, 23507 收起 <<
NCT00814489	-		Completed	-	-
NCT03728764	Preterm Infant	Not Applicable	Recruiting	March 2020	Czechia ... 展开 >> University Hospital in Pilsen Not yet recruiting Pilsen, Czechia, 304 60 Contact: Jiri Dort, MD, PhD +420 377 105 498 dortj@fnplzen.cz Principal Investigator: Jiri Dort, MD, PhD Poland Children's University Hospital Not yet recruiting Cracovia, Poland, 30-663 Contact: Przemko Kwinta, MD, PhD +48 (12) 658 0256 klinchdz@cm-uj.krakow.pl Principal Investigator: Przemko Kwinta Slovakia University Hospital in Martin Recruiting Martin, Slovakia, 03659 Contact: Mirko Zibolen, MD +421 43 4203 759 zibolen@jfmed.uniba.sk Principal Investigator: Mirko Zibolen, MD Fakultná nemocnica s poliklinikou Not yet recruiting Nové Zámky, Slovakia, 941 52 Contact: Klaudia Demova +421 356 91 2202 klaudia.demova@nspnz.sk Principal Investigator: Klaudia Demova, MD 收起 <<
NCT01370564	-		Completed	-	-
NCT00397215	Influenza	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Dour, Belgium, 7370 GSK Investigational Site Gozée, Belgium, 6534 GSK Investigational Site Libramont, Belgium, 6800 GSK Investigational Site Mont-Godinne, Belgium, 5530 GSK Investigational Site Sprimont, Belgium, 4140 GSK Investigational Site Tessenderlo, Belgium, 3980 GSK Investigational Site Watermael-Boitsfort, Belgium, 1170 Italy GSK Investigational Site Genova, Liguria, Italy, 16132 GSK Investigational Site Milano, Lombardia, Italy, 20127 GSK Investigational Site Monserrato Cagliari, Sardegna, Italy, 09042 GSK Investigational Site Sassari, Sardegna, Italy, 07100 GSK Investigational Site Ragusa, Sicilia, Italy, 97100 收起 <<
NCT00603525	Arthritis, Rheumatoid	Phase 3	Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 <<	-	-
NCT03739710	Neoplasms	Phase 2	Not yet recruiting	February 9, 2022	-
NCT00397215	-		Completed	-	-
NCT02493140	Weight Loss	Not Applicable	Unknown	February 2016	France ... 展开 >> Clinical Nutrition Center Naturalpha (CNCN) Recruiting Lille, France, 59020 Contact: CNCN +33(0)320877575 cncn@naturalpha.com Principal Investigator: Xavier Deplanque 收起 <<
NCT03537898	Critical Illness ... 展开 >> Acidosis, Metabolic 收起 <<	Phase 3	Recruiting	March 2, 2019	United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Ryan M Brown, MD 收起 <<
NCT03441984	HIV Infections	Phase 1	Completed	-	United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 <<
NCT01236833	Intestinal Disease ... 展开 >> Feeding Disorder Neonatal 收起 <<	Phase 2	Unknown	September 2012	Canada, Quebec ... 展开 >> McGill University Health Center Montreal, Quebec, Canada, H3H 2R9 Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 收起 <<
NCT01220843	Chronic Renal Failure	Phase 3	Completed	-	France ... 展开 >> CHU Amiens service de nephrologie Amiens, France, 8000 CHU de Bordeaux Service de néphrologie Bordeaux, France, 33076 CHU Caen service de néphrologie Caen, France, 14033 CHU Lyon service de néphrologie Lyon, France, 69437 CHU Marseille Service de néphrologie Marseille, France, 13385 CHU de Montpellier Hôpital Lapeyronie Service de Néphrologie Montpellier, France, 34295 CHU de Nice Service de néphrologie Nice, France, 06002 Hôpital Tenon Service de Nephrologie Paris, France, 75020 Hôpital Européen Georges Pompidou Service de Nephrologie Paris, France, 75098 CHU Reims service de néphrologie Reims, France, 51092 Clinique du Landy Centre de dialyse Saint Ouen, France, 93400 CHU St Etienne Hopital Nord Service de néphrologie St Etienne, France, 42055 Néphrologie - Dialyse Centre de Rein Artificiel TASSIN la Demi Lune, France, 69160 CH Valenciennes hémodialyse Valenciennes, France, 59322 CHU de Nancy service de néphrologie Vandeuvre les Nancy, France, 54511 收起 <<
NCT01373606	Hepatorenal Syndrome Type 1	Phase 1 Phase 2	Completed	-	Japan ... 展开 >> Investigational site Kansai, Japan Investigational site Kanto, Japan 收起 <<
NCT01735097	Arsenical Keratosis	Not Applicable	Completed	-	Bangladesh ... 展开 >> Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh 收起 <<
NCT00455013	Disorder Related to Renal Tran... 展开 >>splantation 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Ucsf San Francisco, California, United States, 94143 United States, Colorado Denver Nephrology, Pc Denver, Colorado, United States, 80218 University Of Colorado Health Sciences Center Denver, Colorado, United States, 80262 United States, Georgia Medical College Of Georgia Augusta, Georgia, United States, 30912 United States, Illinois Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States, 60611 United States, Michigan Henry Ford Hospital Detriot, Michigan, United States, 48202 United States, New York Albany Medical College Albany, New York, United States, 12208 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Ohio University Of Cincinnati Cincinnati, Ohio, United States, 45267 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Italy Local Institution Bologna, Italy, 40138 Local Institution Brescia, Italy, 25123 Local Institution Padova, Italy, 35128 Local Institution Roma, Italy, 00168 Spain Local Institution Barcelona, Spain, 08907 Local Institution Sevilla, Spain, 41013 收起 <<
NCT01396187	-		Completed	-	-
NCT02500186	Diabetes Melltius, Type 2	Not Applicable	Completed	-	-
NCT02314936	Functional Constipation	Phase 2	Completed	-	Canada, Ontario ... 展开 >> KGK Synergize Inc. London, Ontario, Canada, N6A 5R8 收起 <<
NCT03700424	Acute Coronary Syndrome	Phase 2	Not yet recruiting	December 2019	-
NCT00455013	-		Completed	-	-
NCT02314936	-		Completed	-	-
NCT00985088	Influenza	Phase 2	Completed	-	United States, Alabama ... 展开 >> GSK Investigational Site Huntsville, Alabama, United States, 35802 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32216 GSK Investigational Site Miami, Florida, United States, 33143 United States, Idaho GSK Investigational Site Meridian, Idaho, United States, 83642 United States, Kansas GSK Investigational Site Lenexa, Kansas, United States, 66219 United States, Montana GSK Investigational Site Missoula, Montana, United States, 59801 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89104 United States, New Jersey GSK Investigational Site Edison, New Jersey, United States, 08817 United States, New York GSK Investigational Site Rochester, New York, United States, 14609 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44122 Canada, British Columbia GSK Investigational Site Surrey, British Columbia, Canada, V3R 8P8 Canada, Nova Scotia GSK Investigational Site Truro, Nova Scotia, Canada, B2N 1L2 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M9W 4L6 Canada, Quebec GSK Investigational Site Pointe-Claire, Quebec, Canada, H9R 4S3 收起 <<
NCT03645434	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 2	Recruiting	September 23, 2019	Germany ... 展开 >> Research Site Not yet recruiting Berlin, Germany, 14050 Research Site Withdrawn Frankfurt, Germany, 60596 Research Site Not yet recruiting Grosshansdof, Germany, 22927 Research Site Not yet recruiting Wiesbaden, Germany, 65187 United Kingdom Research Site Recruiting London, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9QZ 收起 <<
NCT02776033	Psoriasis	Phase 2	Completed	-	Canada, Ontario ... 展开 >> GSK Investigational Site Markham, Ontario, Canada, L3P1X2 GSK Investigational Site Peterborough, Ontario, Canada, K9J 5K2 GSK Investigational Site Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 收起 <<
NCT03567499	Amyloidosis	Phase 1	Withdrawn(The decision to end ... 展开 >>the study was made for GSK portfolio reasons. No subjects were randomised into the study.) 收起 <<	May 3, 2019	United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 <<
NCT03004846	Psoriasis	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Hamburg, Germany, 20095 收起 <<
NCT02293161	Autoimmune Diseases	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 <<
NCT02590887	Healthy Volunteers	Phase 1 Phase 2	Unknown	-	Spain ... 展开 >> Hospital Universitario Virgen del Rocío Seville, Spain, 41013 收起 <<
NCT03568942	Infections, Bacterial	Phase 2	Recruiting	December 14, 2018	United States, California ... 展开 >> GSK Investigational Site Recruiting La Mesa, California, United States, 91942 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00124137	Congestive Heart Failure	Not Applicable	Completed	-	United States, Illinois ... 展开 >> Midwest Heart Institute Lombard, Illinois, United States, 60148 收起 <<
NCT00855465	Pulmonary Hypertension	Phase 3	Completed	-	-
NCT03296098	Contraception ... 展开 >> Healthy Female 收起 <<	Phase 2	Not yet recruiting	December 2020	United States, California ... 展开 >> Essential Access Not yet recruiting Los Angeles, California, United States, 90010 Contact: Anita L. Nelson, MD 213-386-5614 ext 4403 nelsona@cfhc.org Contact: Kieumai Vo 213-386-5614 ext 4592 kvo@essentialaccess.org Principal Investigator: Anita L. Nelson, MD Principal Investigator: Ron Freizeres University of California, Davis Not yet recruiting Sacramento, California, United States, 95817 Contact: Mitchell D Creinin, MD 916-734-6886 Contact: Courtney Overstreet 916-734-6227 cboverstreet@ucdavis.edu University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94110 Contact: Abby Sokoloff, MPH 415-206-8715 abby.sokoloff@ucsf.edu Principal Investigator: Phillip Darney, MD United States, Colorado University of Colorado Not yet recruiting Denver, Colorado, United States, 80045 Contact: Ines Crato 303-724-5559 ines.crato@ucdenver.edu Principal Investigator: Stephanie Teal, MD United States, Hawaii University of Hawaii Not yet recruiting Honolulu, Hawaii, United States, 96826 Contact: Bliss Kaneshiro Contact: Tiana Fontanilla, MPH 808-203-6598 United States, Illinois University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Sadia Haider Contact: Kate Lewis 773-834-5437 klewis2@uchicago.edu United States, Maryland Johns Hopkins Bayview Medical Center Not yet recruiting Baltimore, Maryland, United States, 21224 Contact: Anne E. Burke, MD, MPH 410-550-0335 aburke@jhmi.edu Contact: Katrina Thaler, MPH 410-550-8506 kstouff3@jhmi.edu Principal Investigator: Anne E. Burke, MD, MPH United States, Massachusetts Planned Parenthood League of Massachusetts Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer Fortin jfortin@pplm.org Principal Investigator: Alisa Goldberg, MD United States, New York New York University, School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Treasure Walker Contact: Anna Davis 212-263-6253 anna.davis@nyumc.org Columbia University Not yet recruiting New York, New York, United States, 10032 Contact: Carolyn Westhoff, MD 212-305-4805 clw3@columbia.edu Contact: Claudia Roca 212-342-2986 cr479@mail.cumc.columbia.edu Principal Investigator: Carolyn Westhoff, MD United States, Ohio University of Cincinnati Not yet recruiting Cincinnati, Ohio, United States, 45267 Contact: Michael Thomas, MD 513-584-4130 Contact: Tiffany Rupert 513-584-4130 rupertts@ucmail.uc.edu University Hospitals of Cleveland MacDonald Women's Hospital Not yet recruiting Cleveland, Ohio, United States, 44106 Contact: James H. Liu, MD 440-720-3250 james.liu@uhhs.com Contact: Bridget Ermlich 216-844-8091 bridget.ermlich@uhhospitals.org Principal Investigator: James H. Liu, MD United States, Oregon Oregon Health & Science University Not yet recruiting Portland, Oregon, United States, 97239 Contact: Jeffrey Jensen Contact: Sumi Maristany 503-494-0585 maristan@ohsu.edu United States, Pennsylvania University of Pennsylvania Medical Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kurt T. Barnhart, MD 215-662-2974 kbarnhart@obgyn.upenn.edu Contact: Andrea Morley 215-615-4202 andrea.morley@uphs.upenn.edu Principal Investigator: Kurt T. Barnhart, MD Univeristy of Pittsburgh School of Medicine Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Beatrice Chen, MD 412-641-5496 chenba@upmc.edu Contact: Jenelle Mock 412-641-4791 mockj@upmc.edu Principal Investigator: Beatrice Chen, MD United States, Rhode Island Women & Infants Hospital of Rhode Island Not yet recruiting Providence, Rhode Island, United States, 02905 Contact: Rebecca Allen Contact: Mindy Marshall mamarshall@wihri.org United States, Utah University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84106 Contact: David Turok, MD 801-213-2774 Contact: Amy Orr 801-213-2774 amy.orr@hsc.utah.edu United States, Virginia Eastern Virginia Medical School (EVMS) Not yet recruiting Norfolk, Virginia, United States, 23507 Contact: David E Archer, MD 757-446-7422 Contact: Erin Maple, MPH 757-446-7971 mapleel@evms.edu 收起 <<
NCT02987530	HIV-1 Infection	Phase 3	Active, not recruiting	December 2019	France ... 展开 >> All The Regions Of The Country (40 Centers), France 收起 <<
NCT00985088	-		Completed	-	-
NCT00855465	-		Completed	-	-
NCT02432066	Tobacco Use Disorder	Phase 2	Not yet recruiting	December 29, 2020	United States, Florida ... 展开 >> Neurocognitive Lab, University of Florida, Department of Psychiatry Not yet recruiting Gainesville, Florida, United States, 32610 Contact: Robert A Prather, BA 352-294-4942 rprather@ufl.edu Contact: Ben Lewis, PhD 3522944920 benlewis@ufl.edu Principal Investigator: Sara J Nixon, PhD 收起 <<
NCT01132781	Rhinosinusitis ... 展开 >> Asthma Allergic Rhinitis 收起 <<	Phase 2	Completed	-	United Kingdom ... 展开 >> University of East Anglia Norwich, Norfolk, United Kingdom, NR47TJ 收起 <<
NCT03452111	Healthy Men ... 展开 >> Male Contraception 收起 <<	Phase 2	Recruiting	September 2021	United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han 310-222-1865 xhan@labiomed.org Principal Investigator: Christina Wang United States, Kansas University of Kansas Recruiting Kansas City, Kansas, United States, 66160 Contact: Katie Glavin 913-588-8721 kglavin@kumc.edu Principal Investigator: Ajay Nangia, MBBS, FACS United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD 206-616-1818 page@uw.edu Chile Chilean Institute of Reproductive Medicine Not yet recruiting Santiago, Chile Contact: Veronica Reyes vreyes@icmer.org Principal Investigator: Gabriela Noe, MS Italy University of Bologna Not yet recruiting Bologna, Italy Contact: Giulia Gava gava.giulia@hotmail.it Principal Investigator: Cristina Meriggiola Kenya Kenyatta National Hospital Not yet recruiting Nairobi, Kenya Contact: Sheila Eshiwani seshiwanin@gmail.com Principal Investigator: John Kinuthia, MBChB, MPH Sweden Karolinska Institutet Not yet recruiting Stockholm, Sweden Contact: Eva Broberg 46(8)517 721 28 eva.k.broberg@karolinska.se Principal Investigator: Kristina Gemzell Danielsson, MD United Kingdom University of Edinburgh Not yet recruiting Edinburgh, United Kingdom Contact: Anne Saunderson 0131 242 2669 A.Saunderson@ed.ac.uk Principal Investigator: Richard Anderson, MD, PhD University of Manchester Not yet recruiting Manchester, United Kingdom Contact: Kate Barugh 0161 27 66201 Kate.Barugh@cmft.nhs.uk Principal Investigator: Cheryl Fitzgerald, MD 收起 <<
NCT00964015	Coronary Artery Bypass Surgery	Not Applicable	Unknown	-	Canada, Ontario ... 展开 >> London Health Sciences Centre London, Ontario, Canada, N6A 5A5 收起 <<
NCT03485365	Pain, Inflammatory	Phase 1	Recruiting	November 27, 2019	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03432416	Healthy Women ... 展开 >> Female Contraception 收起 <<	Phase 2	Recruiting	June 20, 2020	United States, California ... 展开 >> Essential Access Health Recruiting Los Angeles, California, United States, 30010 Contact: Kieumai Vo 213-386-5614 ext 4592 KVo@essentialaccess.org Contact: Ron Frezeries 213-386-5614 ext 4403 RFrezieres@essentialaccess.org Principal Investigator: Anita Nelson University of California, Davis Recruiting Sacramento, California, United States, 95817 Contact: Courtney Overstreet 916-734-6846 cboverstreet@ucdavis.edu Contact: Aubrey Blanton 916-734-6846 akblanton@ucdavis.edu Principal Investigator: Mitchell Creinin United States, Colorado University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Ines Crato 303-724-5559 INES.CRATO@UCDENVER.EDU Contact: Rebecca Seale 303-724-2013 REBECCA.SEALE@UCDENVER.EDU Principal Investigator: Stephanie Teal United States, Maryland Johns Hopkins Bayview Medical Center Recruiting Baltimore, Maryland, United States, 21224 Contact: Katrina Thaler 410-550-8506 kstouff3@jhmi.edu Contact: Lauren Beal 410-550-4825 lbeal2@jhu.edu Principal Investigator: Anne Burke United States, New York Bellevue Hospital Center Recruiting New York, New York, United States, 10016 Contact: Anna Davis 212-263-6253 anna.davis@nyumc.org Principal Investigator: Treasure Walker Columbia University Recruiting New York, New York, United States, 10032 Contact: Subrina Bisnauth 212-305-8031 Snb2147@cumc.columbia.edu Contact: Connie Colon 212-305-6098 cc3238@cumc.columbia.edu Principal Investigator: Carolyn Westhoff United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Deborah Boerschig 513-584-4100 BOERSCDA@UCMAIL.UC.EDU Contact: Tiffany Rupert 513-584-4100 tiffany.rupert@uc.edu Principal Investigator: Michael Thomas United States, Oregon Oregon Health Science University Recruiting Portland, Oregon, United States, 97239 Contact: Ariela Schnyer 503-494-3173 schnyer@ohsu.edu Contact: Alison Edelman 503-494-5949 edelmana@ohsu.edu Principal Investigator: Jeffrey Jensen United States, Pennsylvania University of Pennsylvania School of Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Andrea Morley 215-615-4202 Andrea.morley@uphs.upenn.edu Contact: Kieran Alessi 215-615-3664 Kieran.Alessi@uphs.upenn.edu Principal Investigator: Kurt Barnhart United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Jasmin Alcantra 801-213-3796 jasmin.alcantara@hsc.utah.edu Contact: Amy Orr 801-213-2774 amy.orr@hsc.utah.edu Principal Investigator: David Turok United States, Virginia Eastern Virginia Medical School Recruiting Norfolk, Virginia, United States, 23507 Contact: Jackie Rocccazella 757-446-7161 roccazj@evms.edu Contact: Kim Pitts 757-446-8925 pittska@evms.edu Principal Investigator: David Archer 收起 <<
NCT00672334	Cardiac Surgery ... 展开 >> Cardiopulmonary Bypass 收起 <<	Phase 2 Phase 3	Terminated	-	Australia, Victoria ... 展开 >> Austin Health Melbourne, Victoria, Australia, 3084 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G 2B7 Germany Charité University Medicine Berlin, Germany, 13353 Ireland University Clinic Dublin, School of Medicine and Medical Science Dublin, Ireland 收起 <<
NCT01489410	Hepatocellular Carcinoma	Not Applicable	Withdrawn(Insufficient staff)	-	United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 <<
NCT02584283	Liver Failure ... 展开 >> End Stage Liver Disease Biliary Tract Diseases 收起 <<	Phase 3	Recruiting	October 2019	Belgium ... 展开 >> Ghent University Hospital Not yet recruiting Gent, De Pintelaan 185, Belgium, 9000 Contact: Roberto I Troisi, MD, PhD +3293325519 roberto.troisi@ugent.be University Hospitals Leuven Recruiting Leuven, Herestraat 49, Belgium, 3000 Contact: Diethard Monbaliu, MD, PhD +3216348727 diethard.monbaliu@uzleuven.be Netherlands Leiden Universtiy Medical Center Not yet recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Bart van Hoek, MD, PhD +31715299756 b.van_hoek@lumc.nl University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Rianne van Rijn, MD +31652724616 r.van.rijn@umcg.nl Contact: Robert J Porte, MD, PhD +31503619027 r.j.porte@umcg.nl Erasmus Medical Center Recruiting Rotterdam, Netherlands, 3015 CE Contact: Jeroen de Jonge, MD, PhD +31633330449 j.dejonge.1@umcg.nl 收起 <<
NCT02857010	Acute on Chronic Hepatic Failu... 展开 >>re 收起 <<	Phase 1	Recruiting	February 2020	Spain ... 展开 >> Hospital Clinic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: PERE GINES, MD PhD 0034932275400 ext 1713 PGINES@clinic.ub.es Contact: Javier Fernandez, MD PhD 00342275400 ext 3329 Jfdez@clinic.cat 收起 <<
NCT02122211	Men Carrying 2 Minor Alleles f... 展开 >>or Choline Dehydrogenase rs12676 Male Infertility 收起 <<	Phase 1	Completed	-	United States, North Carolina ... 展开 >> UNC Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 收起 <<
NCT02972905	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 <<
NCT02226354	Healthy	Phase 1	Completed	-	Canada, New Brunswick ... 展开 >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 收起 <<
NCT01843062	Differentiated Thyroid Cancer	Phase 3	Active, not recruiting	April 29, 2019	-
NCT03583554	Healthy	Phase 1 Phase 2	Recruiting	March 31, 2019	United States, Texas ... 展开 >> Michael E. DeBakey VA Medical Center Recruiting Houston, Texas, United States, 77030 Contact: Marijn Lijffijt, PhD 713-798-5642 marijn.lijffijt@bcm.edu Sub-Investigator: Sanjay J. Mathew, MD Sub-Investigator: Alan C. Swann, MD 收起 <<
NCT02989753	Hypercholesterolemia ... 展开 >> Hypertriglyceridemia 收起 <<	Phase 1 Phase 2	Completed	-	France ... 展开 >> Biofortis Mérieux NutriSciences Clinical Investigation Center Saint Herblain, France, 44800 收起 <<
NCT03395405	Gastroenteritis Norovirus	Phase 2	Recruiting	May 22, 2021	United States, Alabama ... 展开 >> University of Alabama Hospital - Infectious Diseases Not yet recruiting Birmingham, Alabama, United States, 35249-0001 United States, Illinois Northwestern University - Comprehensive Transplant Center Recruiting Chicago, Illinois, United States, 60611-2927 United States, Kansas University of Kansas Medical Center - Infectious Diseases Recruiting Kansas City, Kansas, United States, 66160-8500 United States, Maryland Johns Hopkins Hospital - Medicine - Infectious Diseases Not yet recruiting Baltimore, Maryland, United States, 21287-0005 United States, Michigan University of Michigan - Infectious Disease Clinic at Taubman Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 United States, Nebraska University of Nebraska Medical Center - Infectious Diseases Not yet recruiting Omaha, Nebraska, United States, 68198-5400 United States, Ohio Cincinnati Children's Hospital Medical Center - Infectious Diseases Not yet recruiting Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania University of Pittsburgh - Medicine - Infectious Diseases Recruiting Pittsburgh, Pennsylvania, United States, 15213-3403 Children's Hospital of Pittsburgh of UPMC - Pediatric Infectious Diseases Recruiting Pittsburgh, Pennsylvania, United States, 15224-1529 United States, Texas University of Texas Southwestern Medical Center - Internal Medicine Subspecialties Clinic Recruiting Dallas, Texas, United States, 75390-8884 United States, Washington Fred Hutchinson Cancer Research Center - Vaccine and Infectious Diseases Recruiting Seattle, Washington, United States, 98109-4433 University of Washington - Medicine Recruiting Seattle, Washington, United States, 98195-7110 收起 <<
NCT00492544	-		Completed	-	-
NCT03207243	Asthma	Phase 1 Phase 2	Active, not recruiting	May 23, 2019	-
NCT01962233	Hypoxic Ischemic Encephalopath... 展开 >>y 收起 <<	Phase 1	Unknown	December 2014	China, Hebei ... 展开 >> the First Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050031 Contact: Ping Gu, Doctor 86-311-85917297 gpwh2000@126.com 收起 <<
NCT01059617	Influenza	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> GSK Investigational Site Milford, Massachusetts, United States, 01757 United States, North Carolina GSK Investigational Site Salisbury, North Carolina, United States, 28144 GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 收起 <<
NCT01059617	-		Completed	-	-
NCT02427880	Nephrotic Syndrome ... 展开 >> Edema 收起 <<	Phase 4	Completed	-	-
NCT00492544	Infections, Papillomavirus	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Saitama, Japan, 360-0812 GSK Investigational Site Saitama, Japan, 360-0846 GSK Investigational Site Tokyo, Japan, 136-0073 GSK Investigational Site Tokyo, Japan, 154-0024 收起 <<
NCT02100202	Chronic Smokers ... 展开 >> Hyperlipidemia 收起 <<	Not Applicable	Unknown	July 2014	India ... 展开 >> Sreenivasa Clinic Diabetic Research Center Not yet recruiting Bangalore, Karnataka, India, 560050 Contact: Venkateshwarlu K, MD (Ayur) 919945232107 drvenkatesh64@gmail.com Contact: Raveendra K R, MD 919448134587 drkrraveendra@gmail.com Sub-Investigator: Raveendra K R, MD Principal Investigator: Venkateshwarlu K, MD 收起 <<
NCT01762878	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 <<
NCT02540759	Healthy	Phase 1	Completed	-	Canada, New Brunswick ... 展开 >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 收起 <<
NCT02663089	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 <<
NCT01072175	Cancer	Phase 2	Completed	-	United States, California ... 展开 >> Novartis Investigative Site Los Angeles, California, United States, 90025 Novartis Investigative Site San Francisco, California, United States, 94115 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site New Haven, Connecticut, United States, 06520 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Maryland Novartis Investigative Site Lutherville-Timonium, Maryland, United States, 21093 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Novartis Investigative Site Nashville, Tennessee, United States, 37232 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 收起 <<
NCT02203227	Chronic Smokers ... 展开 >> Hyperlipidemia 收起 <<	Not Applicable	Unknown	February 2015	India ... 展开 >> Sreenivasa Clinic Diabetic Research Center Not yet recruiting Bangalore, Karnataka, India, 560050 Contact: Venkateshwarlu K, MD (Ayur) 919945232107 drvenkatesh64@gmail.com Contact: Raveendra K, MD 919448134587 drkrraveendra@gmail.com Principal Investigator: Venkateshwarlu K, MD (Ayur) Sub-Investigator: Raveendra K, MD 收起 <<
NCT01173120	Rheumatoid Arthritis (RA)	Phase 3	Completed	-	-
NCT02981953	Tricuspid Valve Insufficiency ... 展开 >> Tricuspid Regurgitation Tricuspid Valve Regurgitation Cardiovascular Diseases Heart Valve Diseases Heart Diseases Cardiac Valve Annuloplasty 收起 <<	Not Applicable	Recruiting	October 2019	France ... 展开 >> Bichat hospital Recruiting Paris, France, 18 75877 Contact: Alec Vahanian, MD +33140256735/60 Principal Investigator: Alec Vahanian, Prof Germany Bonn University Recruiting Bonn, Germany Contact: George Nickenig, Prof. Dr. MD Asklepios Klinik, St. Georg Recruiting Hamburg, Germany, 5 20099 Contact: Karl-Heinz Kuck, Prof k.kuck@asklepios.com Contact +49401818852305 Principal Investigator: Karl-Heinz Kuck, Prof Medizinisches Versorgungszentrum, Hamburg Not yet recruiting Hamburg, Germany, D-22527 Contact: Joachim Schofer, Prof. schofer@herz-hh.de Principal Investigator: Joachim Schofer, Prof. Koln, Universitätsklinikum Not yet recruiting Koln, Germany Contact: Stephan Baldus, Prof.Dr.med Universitatsmedizin Mainz Not yet recruiting Mainz, Germany Contact: Ralph Stephan von Bardeleben, Dr. med München, LMU Klinikum der Universität München Not yet recruiting Munich, Germany Contact: Jörg Hausleiter, Prof.Dr.med Italy Hospital san raffaele Not yet recruiting Milano, Italy, 20132 Contact: Azeem Latib, MD Contact: , MD 收起 <<
NCT02522117	Renal Insufficiency	Phase 3	Completed	-	Mexico ... 展开 >> Western Medical Center, Mexican Institute of Social Security Guadalajara, Jalisco, Mexico, 44340 收起 <<
NCT03191383	Respiratory Syncytial Virus In... 展开 >>fections 收起 <<	Phase 2	Withdrawn(Study was canceled d... 展开 >>ue to instability of the PreF antigen during manufacturing. No safety concern has been identified in past or ongoing studies.) 收起 <<	-	United States, Kansas ... 展开 >> GSK Investigational Site Newton, Kansas, United States, 67114 United States, New York GSK Investigational Site Syracuse, New York, United States, 13210 United States, Washington GSK Investigational Site Ellensburg, Washington, United States, 98926 Finland GSK Investigational Site Oulu, Finland, 90220 GSK Investigational Site Seinajoki, Finland, 60100 Spain GSK Investigational Site Aravaca, Spain, 28023 GSK Investigational Site Burgos, Spain, 09006 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Majadahonda (Madrid), Spain, 28222 GSK Investigational Site Santiago de Compostela, Spain, 15706 GSK Investigational Site Santiago, Spain, 15705 GSK Investigational Site Sevilla, Spain, 41014 收起 <<
NCT02187757	Hyperlipidemia	Phase 3	Completed	-	India ... 展开 >> Division of Clinical & Preventive Cardiology, Heart Institute Gurgaon, Delhi, India, 122001 Life Care Institute of Medical Science & Research Ahmedabad, Gujarat, India, 380014 Bhatia Hospital Medical Research Society Mumbai, Maharashtra, India, 400007 Dr. Vikas Govind Pai Clinical Research Foundation Pune, Maharashtra, India, 411005 Fortis Escorts Hospital Jaipur, Rajasthan, India, 302017 Pace Clinical Research Center Bangalore, Tamil Nadu, India, 560043 Singvi Health Centre Chennai, Tamil Nadu, India, 600079 Rangammal Hospital Tiruvannamalai, Tamil Nadu, India, 606003 收起 <<
NCT03625284	Non Alcoholic Fatty Liver	Not Applicable	Not yet recruiting	December 10, 2019	-
NCT02937961	Cirrhotics With Septic Shock a... 展开 >>nd Acute Kidney Injury 收起 <<	Not Applicable	Recruiting	December 1, 2018	India ... 展开 >> Institute of Liver and Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 收起 <<
NCT03048487	-		Completed	-	United States, Pennsylvania ... 展开 >> Geisinger Medical Center Danville, Pennsylvania, United States, 17822 Geisinger Community Medical Center, Scranton, PA Scranton, Pennsylvania, United States, 18510 Geisinger Wyoming Valley Medical Center Wilkes-Barre, Pennsylvania, United States, 18711 收起 <<
NCT01410448	-		Completed	-	-
NCT01001832	-		Completed	-	-
NCT03343340	Septic Shock and Acute Kidney ... 展开 >>Injury 收起 <<	Not Applicable	Recruiting	September 25, 2018	India ... 展开 >> Institute of Liver and Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 收起 <<
NCT01001832	Rheumatoid Arthritis	Phase 2 Phase 3	Completed	-	Japan ... 展开 >> Local Institution Narita-Shi, Chiba, Japan, 2868523 Local Institution Fukuoka-Shi, Fukuoka, Japan, 8108563 Local Institution Kitakyushu-Shi, Fukuoka, Japan, 8078555 Local Institution Kurume-Shi, Fukuoka, Japan, 8308543 Local Institution Maebashi-Shi, Gunma, Japan, 3718511 Local Institution Takasaki-Shi, Gunma, Japan, 3700053 Local Institution Higashi-Hiroshima-Shi, Hiroshima, Japan, 7390002 Local Institution Sapporo-Shi, Hokkaido, Japan, 0608604 Local Institution Sapporo-Shi, Hokkaido, Japan, 0608648 Local Institution Sapporo-Shi, Hokkaido, Japan, 0630811 Local Institution Sapporo, Hokkaido, Japan, 0630005 Local Institution Kanzaki-Gun, Hyogo, Japan, 6792414 Local Institution Kato-Shi, Hyogo, Japan, 6731462 Local Institution Kobe-Shi, Hyogo, Japan, 6500001 Local Institution Hitachi-Shi, Ibaraki, Japan, 3160035 Local Institution Kagoshima-Shi, Kagoshima, Japan, 8900067 Local Institution Sagamihara-Shi, Kanagawa, Japan, 2520392 Local Institution Yokohama-Shi, Kanagawa, Japan, 2220036 Local Institution Yokohama-Shi, Kanagawa, Japan, 2360037 Local Institution Nagano-Shi, Nagano, Japan, 3808582 Local Institution Kurashiki-Shi, Okayama, Japan, 7128044 Local Institution Hannan-Shi, Osaka, Japan, 5990212 Local Institution Iruma-Gun, Saitama, Japan, 3500495 Local Institution Kawagoe-Shi, Saitama, Japan, 3508550 Local Institution Kitamoto-Shi, Saitama, Japan, 3640026 Local Institution Tokorozawa-Shi, Saitama, Japan, 3591111 Local Institution Hamamatsu-Shi, Shizuoka, Japan, 4308558 Local Institution Shizuoka-Shi, Shizuoka, Japan, 4208623 Local Institution Shimotsuke-Shi, Tochigi, Japan, 3290498 Local Institution Utsunomiya-Shi, Tochigi, Japan, 3291193 Local Institution Bunkyo-Ku, Tokyo, Japan, 1138519 Local Institution Nakano-Ku, Tokyo, Japan, 1648541 Local Institution Shinjuku-Ku, Tokyo, Japan, 1608582 收起 <<
NCT02834026	Chronic Renal Disease ... 展开 >> Renal Dialysis 收起 <<	Not Applicable	Unknown	January 2018	Brazil ... 展开 >> Vera Lúcia dos Santos Alves Recruiting São Paulo, SP, Brazil Contact: Vera Lúcia Santos Alves, PhD +55 11 999707013 fisioterapiasc@uol.com.br 收起 <<
NCT01072175	-		Completed	-	-
NCT01173120	-		Completed	-	-
NCT01822808	Acute Heart Failure ... 展开 >> Left Ventricular Dysfunction 收起 <<	Phase 3	Unknown	July 2016	South Africa ... 展开 >> Hatter Institute for Cardiovascular Research in Africa Cape Town, Western Cape, South Africa, 7925 收起 <<
NCT01410448	Kidney Transplantation	Phase 3	Completed	-	Italy ... 展开 >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Coppito, AQ, Italy, 67100 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Brescia, BS, Italy, 25123 Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Firenze, FI, Italy, 50139 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Milano, MI, Italy, 20162 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Palermo, PA, Italy, 90127 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00144 Novartis Investigative Site Roma, RM, Italy, 00152 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Salerno, SA, Italy, 84131 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Novara, Italy, 28100 收起 <<
NCT02191202	-		Completed	-	-
NCT02933827	Moderate to Severe Chronic Kid... 展开 >>ney Disease 收起 <<	Phase 1 Phase 2	Recruiting	December 2019	Taiwan ... 展开 >> Taipei Medical University Shuang Ho Hospital Recruiting New Taipei City, Taiwan, 235 Contact: Eva Chen Principal Investigator: Mai-Szu Wu, PhD 收起 <<
NCT00256750	Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 <<	Phase 3	Completed	-	-
NCT00415857	Leukemia	Phase 2	Terminated(Vaccine sponsor cea... 展开 >>sed operations.) 收起 <<	-	United States, Texas ... 展开 >> UT MD . Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT03327857	Steroid-refractory Acute Graft... 展开 >>-versus-Host Disease 收起 <<	Phase 1	Recruiting	June 2020	United States, California ... 展开 >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Roxanne Garcia roxgarcia@coh.org Contact: Golnaz Namdar 626-218-0061 gnamdar@coh.org Principal Investigator: Haris Ali United States, Georgia Emory University Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Shantoria Mayes 404-778-6547 shantoria.mayes@emory.edu Principal Investigator: Edmund Waller United States, Illinois University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Principal Investigator: Michael Bishop United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Lynne Bischoff 734-615-5939 lloisros@med.umich.edu Principal Investigator: Sarah Anand, MD United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Amy Hays 612-626-0461 hays0024@umn.edu Principal Investigator: Shernan Holtan, MD United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Delia Darst 615-343-7190 delia.h.darst@vumc.org Principal Investigator: Madan Jagasia, MD United States, Washington Fred Hutchinson Recruiting Seattle, Washington, United States, 98109 Contact: Lisa Grimm 206-667-2353 lgrimm@fredhutch.org Principal Investigator: Paul Martin, MD Sub-Investigator: Marco Mielcarek United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Kaylee Meisinger 414-805-8926 kmeisinger@mcw.edu Principal Investigator: Sameem Abedin, MD Sub-Investigator: Mehdi Hamadani, MD 收起 <<
NCT01845701	Malaria	Phase 3	Completed	-	Cameroon ... 展开 >> L'Hopital de District Ngong, Garoua, Garoua, North, Cameroon Baptist Hospital Mutengene, South West, Cameroon 收起 <<
NCT00415857	-		Terminated(Vaccine sponsor cea... 展开 >>sed operations.) 收起 <<	-	-
NCT03415074	CKD Stage 4	Not Applicable	Not yet recruiting	March 31, 2022	Romania ... 展开 >> "Dr Carol Davila" Teaching Hospital of Nephrology Not yet recruiting Bucharest, Romania, 010731 Contact: Liliana Garneata, Assoc Prof +40722619358 lilianagarna@yahoo.com Contact: Gabriel Stefan, MD +40724906188 gabriel_stefan@rocketmail.com 收起 <<
NCT01342042	Type 2 Diabetes	Phase 2	Unknown	December 2011	China, Beijing ... 展开 >> Peking University First Hospital Recruiting Peking, Beijing, China, 010 Contact: Cui Yi Min, MD 86-10-88325988 Principal Investigator: Cui Yi Min, MD 收起 <<
NCT00736476	-		Completed	-	-
NCT01838759	-		Completed	-	Turkey ... 展开 >> Bulent Ecevit University Hospital Zonguldak, Turkey, 67300 收起 <<
NCT00256750	-		Completed	-	-
NCT00736476	Helicobacter Pylori Infection	Phase 1	Completed	-	Germany ... 展开 >> Otto von Guericke Universität Magdeburg Magdeburg, Germany, 39120 收起 <<
NCT03096457	Leishmaniasis, Cutaneous ... 展开 >> Leishmania Braziliensis Complex Leishmaniasis, American Leishmaniasis; American, Cutaneous 收起 <<	Phase 2 Phase 3	Completed	-	Bolivia ... 展开 >> Hospital Local Palos Blancos Palos Blancos, La Paz, Bolivia, 00000 Hospital Dermatologico de Jorochito Jorochito, SC, Bolivia 收起 <<
NCT02705573	Kidney Transplantation, Mannit... 展开 >>ol 收起 <<	Phase 3	Completed	-	Austria ... 展开 >> Medical University Vienna Vienna, Austria, 1090 收起 <<
NCT00393029	Anti-p53 TCR-Gene	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Bethesda, Maryland, United States, 20892 收起 <<
NCT00355719	HIV Infections	Phase 4	Completed	-	Spain ... 展开 >> Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Sant Jaume de Calella Calella, Barcelona, Spain, 08370 收起 <<
NCT00393029	-		Completed	-	-
NCT01331525	Extensive Stage Small Cell Lun... 展开 >>g Cancer 收起 <<	Phase 2	Completed	-	United Kingdom ... 展开 >> Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Leeds Teaching Hospitals NHS Foundation Trust Leeds, United Kingdom, LS9 7TF Barts and The London NHS Trust London, United Kingdom, EC1M 6BQ Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG5 1PB Weston Park Clinical Trials Centre Sheffield, United Kingdom, S10 2SJ Southampton University Hospitals NHS Trust Southampton, United Kingdom, SO16 6YD The Clatterbridge Cancer Centre NHS Foundation Trust Wirral, United Kingdom, CH63 4JY 收起 <<
NCT00185679	Acute Myelogenous Leukemia (AM... 展开 >>L) - Relapsed, Primary Refractory Disease or Poor Risk Factors Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase Myelodysplastic Syndrome (MDS) - High and Intermediate Risk Non-Hodgkin's Lymphoma (NHL) Chronic Lymphocytic Leukemia (CLL) - Refractory 收起 <<	Phase 2	Terminated(This study was supe... 展开 >>rseded by the subsequent study IRB-15919 (NCT01050764)) 收起 <<	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT00185679	-		Terminated(This study was supe... 展开 >>rseded by the subsequent study IRB-15919 (NCT01050764)) 收起 <<	-	-
NCT03672591	-		Not yet recruiting	March 31, 2019	-
NCT01703715	-		Completed	-	United Kingdom ... 展开 >> Queens Medical Centre Nottingham, Nottinghamshire, United Kingdom, NG7 2UH 收起 <<
NCT02866721	Cystic Fibrosis	Phase 1	Recruiting	December 2020	United States, Ohio ... 展开 >> University Hospitals Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Megan Tribout, BSN, RN 216-286-0763 Megan.Tribout@UHhospitals.org Principal Investigator: James F. Chmiel, MD, MPH 收起 <<
NCT02480608	Leukemia, Myelogenous, Chronic... 展开 >>, BCR-ABL Positive 收起 <<	Phase 1 Phase 2	Completed	-	-
NCT00438425	Hyperlipidemia ... 展开 >> Cardiovascular Disease 收起 <<	Not Applicable	Completed	-	Canada, British Columbia ... 展开 >> Healthy Heart Program, St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 Canada, Ontario Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Canada, Quebec Institute on Nutraceuticals and Functional Foods and the Lipid Research Center, Laval University Hospital Research Center Quebec City, Quebec, Canada, G1V 4G2 收起 <<
NCT01132157	Healthy End S... 展开 >>tage Renal Disease 收起 <<	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Severance hospital, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 收起 <<
NCT02355418	-		Active, not recruiting	August 2019	United Kingdom ... 展开 >> University Hospital Birmingham Birmingham, West Midlands, United Kingdom, B15 2TH 收起 <<
NCT02853435	Infections, Bacterial	Phase 1	Completed	-	United States, California ... 展开 >> GSK Investigational Site Anaheim, California, United States, 92801 United States, Texas GSK Investigational Site Austin, Texas, United States, 78744 收起 <<
NCT01079806	Chronic Hepatitis B Virus, Ped... 展开 >>iatric 收起 <<	Phase 3	Completed	-	-
NCT01079806	-		Completed	-	-
NCT01573923	Liver Cirrhosis	Phase 1 Phase 2	Unknown	October 2015	China, Beijing ... 展开 >> The 302 Hospital of Chinese People's Liberation Army Recruiting Beijing, Beijing, China Principal Investigator: Hanwei Li, MD, PhD China, Gansu the First Affiliated Hospital of Lanzhou University Recruiting Lanzhou, Gansu, China Contact: Xun Li, MD, PhD Principal Investigator: Xun Li, MD China, Hainan Hainan BOAO Life infinity international anti-aging medical center Recruiting Qionghai, Hainan, China, 571434 Contact: Jiang Shu Jiang.st@hotmail.com China, Jiangsu The first people's hospital of Lianyungang Recruiting Lianyungang, Jiangsu, China, 222002 Contact: Hui Shi, MD Principal Investigator: Hui Shi, MD China, Shanghai Tongji Hospital of Tongji University Recruiting Shanghai, Shanghai, China Contact: Liming Chen, MD, PhD Principal Investigator: Jianwei Lu, PhD China, Shanxi The 323 Hospital of Chinese People's Liberation Army Recruiting Xi'an, Shanxi, China, 710054 Contact: Liming Wang, MD 86-29-84756502 wanglm@fmmu.edu.cn Principal Investigator: Liming Wang, MD 收起 <<
NCT01792635	-		Terminated(The study was termi... 展开 >>nated prematurely on 16 May 2014 due to a safety concern.) 收起 <<	-	-
NCT01929863	Diabetes Mellitus, Type 2	Phase 2	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 收起 <<
NCT02853435	-		Completed	-	-
NCT01929863	-		Completed	-	-
NCT03511950	-		Not yet recruiting	June 30, 2020	-
NCT01119846	Diabetes Mellitus, Type 2	Phase 2	Completed	-	United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 收起 <<
NCT01792635	Diabetes Mellitus, Type 2	Phase 2	Terminated(The study was termi... 展开 >>nated prematurely on 16 May 2014 due to a safety concern.) 收起 <<	-	United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 收起 <<
NCT02565628	Idiopathic Parkinson's Disease	Phase 1	Completed	-	United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 QPS-MRA, LLC (Broward Research Group) Hollywood, Florida, United States, 33024 Qps-Mra Llc South Miami, Florida, United States, 33143 QPS-MRA, LLC (Miami research Associates) South Miami, Florida, United States, 33143 QPS-MRA, LLC (MRA Clinical Research) South Miami, Florida, United States, 33143 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, New Jersey CRI Worldwide, LLC Marlton, New Jersey, United States, 08053 United States, Ohio CTI Clinical Research Center Cincinnati, Ohio, United States, 45255 收起 <<
NCT03277209	Pancreas Cancer	Phase 1	Active, not recruiting	December 2020	United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10065 United Kingdom Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom, CB2 0QQ 收起 <<
NCT01119846	-		Completed	-	-
NCT02565628	-		Completed	-	-
NCT02700958	Atherosclerosis ... 展开 >> Stable Angina Peripheral Artery Disease Contrast-induced Nephropathy 收起 <<	Not Applicable	Completed	-	Estonia ... 展开 >> Tartu University Hospital Tartu, Tartu County, Estonia, 50406 收起 <<
NCT00374322	Neoplasms, Breast	Phase 3	Completed	-	-
NCT00374322	-		Completed	-	-
NCT00239356	Schizophrenia	Phase 3	Completed	-	Canada, Ontario ... 展开 >> Local Institution Ottawa, Ontario, Canada Canada, Quebec Local Institution Sherbrooke, Quebec, Canada Croatia Local Institution Rijeka, Croatia Local Institution Zagreb, Croatia Czech Republic Local Institution Hradec Kralove, Czech Republic Local Institution Prague 6, Czech Republic France Local Institution Nantes Orvault, France Local Institution Rennes Cedex, France Local Institution Uzes, France Hungary Local Institution Budapest, Hungary Local Institution Gyor, Hungary Netherlands Local Institution Vught, Netherlands Poland Local Institution Krakow, Poland Local Institution Poznan, Poland Romania Local Institution Bucharest, Romania Russian Federation Local Institution St. Petersburg, Russian Federation South Africa Local Institution Westdene, Free State, South Africa Local Institution Johannesburg, Gauteng, South Africa Local Institution Cape Town, Western Cape, South Africa United Kingdom Local Institution Antrim, United Kingdom 收起 <<
NCT00669331	Bronchiectasis	Phase 3	Completed	-	-
NCT00669331	-		Completed	-	-
NCT02202161	Diabetes Mellitus, Type 2	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 收起 <<
NCT02940743	Cardiovascular Disease (CKD) ... 展开 >> Hyperphosphatemia 收起 <<	Not Applicable	Completed	-	United States, New York ... 展开 >> New York University School of Medicine New York, New York, United States, 10016 收起 <<
NCT00453479	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Netherlands ... 展开 >> GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Harderwijk, Netherlands, 3844 DG GSK Investigational Site Utrecht, Netherlands, 3584 CJ GSK Investigational Site Zuidlaren, Netherlands, 9471 GP 收起 <<
NCT02202161	-		Completed	-	-
NCT00239356	-		Completed	-	-
NCT02357199	Mouth Diseases ... 展开 >> Renal Insufficiency, Chronic 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Department of Odontology, Faculty of Health Sciences, University of Copenhagen Copenhagen, Denmark, DK-2200 收起 <<
NCT02130193	-		Completed	-	-
NCT01376323	Diabetes Mellitus, Type 2	Phase 2	Completed	-	United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 <<
NCT02130193	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Iowa GSK Investigational Site Iowa City, Iowa, United States, 52242 United States, Pennsylvania GSK Investigational Site Oaks, Pennsylvania, United States, 19456 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19140 United States, South Carolina GSK Investigational Site Spartanburg, South Carolina, United States, 29303 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Neu isenburg, Hessen, Germany, 63263 GSK Investigational Site Dueren, Nordrhein-Westfalen, Germany, 52349 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45359 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Leipzig, Sachsen, Germany, 04207 GSK Investigational Site Leipzig, Sachsen, Germany, 04275 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Berlin, Germany, 10789 收起 <<
NCT01734993	-		Completed	-	-
NCT00451321	Diabetes Mellitus, Type 1	Phase 2	Terminated	-	United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, California GSK Investigational Site Walnut Creek, California, United States, 94598 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20037 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32207 GSK Investigational Site Pinellas Park, Florida, United States, 33781 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 1655 United States, Michigan GSK Investigational Site Kalamazoo, Michigan, United States, 49048 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55455 United States, Mississippi GSK Investigational Site Gulfport, Mississippi, United States, 39501 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68131 United States, Ohio GSK Investigational Site Mentor, Ohio, United States, 44060 United States, South Dakota GSK Investigational Site Rapid City, South Dakota, United States, 57701 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229-4801 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4G 3E8 收起 <<
NCT01734993	Rheumatoid Arthritis	Phase 3	Completed	-	France ... 展开 >> Bordeaux, France, 33076 Montpellier, France, 34295 Nantes, France, 44035 Paris, France, 75679 Strasbourg, France, 67098 Toulouse, France, 31059 收起 <<
NCT01673490	-		Terminated(The sole investigat... 展开 >>ive site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.) 收起 <<	-	-
NCT00453479	-		Completed	-	-
NCT02114203	Phase 1 Sickle Cell	Phase 1	Completed	-	United States, Illinois ... 展开 >> University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612-5836 University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center E7E Boston, Massachusetts, United States, 02118 Boston Medical Center Boston, Massachusetts, United States, 02118 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Interfaith Medical Center Brooklyn, New York, United States, 11213 Interfaith Medical Center Brooklyn, New York, United States, 11238 United States, North Carolina UNC Hospitals' Investigational Drug Service Pharmacy Chapel Hill, North Carolina, United States, 27514 UNC School of Medicine Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 United States, Virginia Investigational Drug Services Richmond, Virginia, United States, 23298 Virginia Commonwealth University Richmond, Virginia, United States, 23298 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Italy Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 A.O.O.R Villa Sofia - V. Cervello Palermo, Italy, 90146 Netherlands Centre for Human Drug Research Leiden, Netherlands, 2333 CL United Kingdom Royal Liverpool and Broadgreen University Hospital Trust Liverpool, Merseyside, United Kingdom, L7 8XP Guy's and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Imperial College Healthcare NHS Trust London, United Kingdom, W12 0HS Central Manchester University Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Oxford University Hospitals NHS Trust Oxford, United Kingdom, OX3 7LE 收起 <<
NCT00451321	-		Terminated	-	-
NCT01673490	Prostatic Hyperplasia	Phase 4	Terminated(The sole investigat... 展开 >>ive site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.) 收起 <<	-	Vietnam ... 展开 >> GSK Investigational Site Ho Chi Minh, Vietnam 收起 <<
NCT01376323	-		Completed	-	-
NCT02114203	-		Completed	-	-
NCT00138424	BK Virus (Nephropathy)	Phase 1 Phase 2	Terminated	-	United States, Alabama ... 展开 >> University of Alabama Hospital - Nephrology Birmingham, Alabama, United States, 35249-0001 United States, California California Pacific Medical Center - Sutter Pacific Medical Foundation - Transplant Nephrology San Francisco, California, United States, 94115-1932 University of California San Francisco Medical Center at Parnassus - Organ Transplant San Francisco, California, United States, 94143-2204 United States, Colorado University of Colorado Denver Aurora, Colorado, United States, 80045-2541 United States, Illinois Northwestern University - Comprehensive Transplant Center Chicago, Illinois, United States, 60611-2927 The University of Chicago Medical Center - Kindney Trasnplant - Nephrology Chicago, Illinois, United States, 60637-1447 United States, Minnesota University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine Minneapolis, Minnesota, United States, 55455-0356 Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States, 55905-0001 United States, New Hampshire Dartmouth-Hitchcock Medical Center - Infectious Disease Lebanon, New Hampshire, United States, 03756-1000 United States, Texas Dallas Nephrology Associates - Dallas Transplant Institute Dallas, Texas, United States, 75204-6168 United States, Washington University of Washington - Medicine Seattle, Washington, United States, 98195-7110 United States, Wisconsin University of Wisconsin Hospital and Clinics - Clinical Science Center - Nephrology Madison, Wisconsin, United States, 53792-0001 收起 <<
NCT02627378	MERS-CoV Infection ... 展开 >> Refractory Hypoxemia 收起 <<	Phase 1	Completed	-	Saudi Arabia ... 展开 >> Dammam University KFHU Al-Khobar, EP, Saudi Arabia, 31952 收起 <<
NCT01172847	Healthy Volunteer	Phase 1	Completed	-	United States, Arkansas ... 展开 >> Little Rock, Arkansas, United States, 72204 收起 <<
NCT00138424	-		Terminated	-	-
NCT01172847	-		Completed	-	-
NCT02563899	Hyperhidrosis	Phase 2	Completed	-	United States, North Carolina ... 展开 >> GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78759 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 收起 <<
NCT02563899	-		Completed	-	-
NCT00802854	-		Completed	-	Korea, Republic of ... 展开 >> Chonbuk National University Hospital Deokjin-gu, Jeollabuk-do, Korea, Republic of, 561-712 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Dong-A University Medical Center (Dong-A University Hospital) Busen, Korea, Republic of, 602-715 Keimyung University Dongsan Medical Center (KUDMC) Daegu, Korea, Republic of, 700-712 Daegu fatima hospital Daegu, Korea, Republic of, 701-724 Daegu Catholic University Medical Center (DCUMC) Daegu, Korea, Republic of, 705-718 Ajou University Hospital Gyeonggi-do, Korea, Republic of, 443-721 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 120-752 Seoul Medical Center Seoul, Korea, Republic of, 131-795 Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 <<
NCT00802854	-		Completed	-	-
NCT02871570	Moderate Hepatic Impairment ... 展开 >> Normal Hepatic Function 收起 <<	Phase 1	Completed	-	United States, Florida ... 展开 >> Orlando Clincial Research Center Orlando, Florida, United States, 32809 收起 <<
NCT00725712	Neoplasms, Gastrointestinal Tr... 展开 >>act 收起 <<	Phase 2	Completed	-	United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Arizona GSK Investigational Site Scottsdale, Arizona, United States, 85258 United States, California GSK Investigational Site Los Angeles, California, United States, 90024 GSK Investigational Site Stanford, California, United States, 94305 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20007 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30309 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Montana GSK Investigational Site Billings, Montana, United States, 59101 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87131 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10021 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792 收起 <<
NCT00725712	-		Completed	-	-
NCT01028911	Alzheimer's Disease	Phase 1	Terminated(This study terminat... 展开 >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) 收起 <<	-	United States, Kansas ... 展开 >> Pfizer Investigational Site Wichita, Kansas, United States, 67207 Pfizer Investigational Site Wichita, Kansas, United States, 67211 收起 <<
NCT01887262	Peritoneal Dialysis, Continuou... 展开 >>s Ambulatory 收起 <<	Not Applicable	Completed	-	Korea, Republic of ... 展开 >> Seoul National University Hospital Clinical Trial Center Seoul, Korea, Republic of, 110-744 收起 <<
NCT01028911	-		Terminated(This study terminat... 展开 >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) 收起 <<	-	-
NCT01652885	Dermatitis, Atopic	Phase 1 Phase 2	Completed	-	United States, California ... 展开 >> Anacor Investigational Site Fremont, California, United States, 94538 Anacor Investigational Site San Diego, California, United States, 92123 United States, Indiana Anacor Investigational Site Indianapolis, Indiana, United States, 46256 United States, North Carolina Anacor Investigational Site High Point, North Carolina, United States, 27262 Anacor Investigational Site Winston-Salem, North Carolina, United States, 27104 United States, Texas Anacor Investigational Site Houston, Texas, United States, 77030 收起 <<
NCT01652885	-		Completed	-	-
NCT01285518	Diabetes Mellitus, Type 2	Phase 1	Completed	-	United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Ft. Meyers, Florida, United States, 33901 Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 收起 <<
NCT02871570	-		Completed	-	-
NCT00575159	Diabetes Mellitus, Type 1	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92161 收起 <<
NCT00635089	Eosinophilic Esophagitis	Phase 3	Completed	-	-
NCT01285518	-		Completed	-	-
NCT01577745	-		Completed	-	-
NCT01577745	Solid Tumors	Phase 1	Completed	-	United States, California ... 展开 >> Research Site Los Angeles, California, United States, 90404 United States, Connecticut Research Site New Haven, Connecticut, United States, 06513 United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Ann Arbor, Michigan, United States, 48103 United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, New York Research Site New York, New York, United States, 10002 United States, Ohio Research Site Cincinnati, Ohio, United States, 45201 Research Site Cleveland, Ohio, United States, 44105 United States, Texas Research Site Houston, Texas, United States, 77030 United States, Washington Research Site Seattle, Washington, United States, 98112 Research Site Tacoma, Washington, United States, 98405 收起 <<
NCT00635089	-		Completed	-	-
NCT01036022	Colitis, Ulcerative	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Bonheiden, Belgium, 2820 GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Gent, Belgium, 9000 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 5G2 GSK Investigational Site London, Ontario, Canada, N6A 4G5 GSK Investigational Site Vaughan, Ontario, Canada, L4L 4Y7 Canada GSK Investigational Site Quebec, Canada, G1S 4L8 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Ludwigshafen, Rheinland-Pfalz, Germany, 67067 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Leipzig, Sachsen, Germany, 04129 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Hamburg, Germany, 20148 GSK Investigational Site Hamburg, Germany, 20246 Norway GSK Investigational Site Lørenskog, Norway, 1478 GSK Investigational Site Oslo, Norway, 0514 GSK Investigational Site Oslo, Norway, N-0456 GSK Investigational Site Tønsberg, Norway, 3116 Sweden GSK Investigational Site Göteborg, Sweden, SE-416 85 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-111 86 GSK Investigational Site Stockholm, Sweden, SE-171 76 收起 <<
NCT01340586	End Stage Renal Disease	Phase 1	Completed	-	United States, Florida ... 展开 >> Orlando, Florida, United States 收起 <<
NCT02046174	Colorectal Cancers	Phase 2	Active, not recruiting	December 2020	United States, Kansas ... 展开 >> University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, New York Calvary Hospital Bronx, New York, United States, 10461 Weill Cornell Medical College/The Rogosin Institute New York, New York, United States, 10021 United States, Ohio The Ohio State University; OSU Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1228 收起 <<
NCT00575159	-		Completed	-	-
NCT01439204	Rheumatoid Arthritis	Phase 1	Completed	-	United States, Nebraska ... 展开 >> Icon Clinical Pharmacology Unit, Llc Omaha, Nebraska, United States, 68154 收起 <<
NCT00397891	-		Completed	-	-
NCT01036022	-		Completed	-	-
NCT01439204	-		Completed	-	-
NCT00397891	Alzheimer Disease	Phase 1	Completed	-	Japan ... 展开 >> Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Saitama, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan 收起 <<
NCT02951052	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 3	Active, not recruiting	February 8, 2022	-
NCT02118792	Dermatitis, Atopic	Phase 3	Completed	-	United States, Virginia ... 展开 >> Anacor Investigational Site Henrico, Virginia, United States 收起 <<
NCT00420056	Lymphoma, Mantle-Cell	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Presbyterian Hospital New York, New York, United States, 10021 Weill Medical College of Cornell University - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 <<
NCT00420056	-		Completed	-	-
NCT01340586	-		Completed	-	-
NCT01235741	Obesity	Phase 2	Terminated(Results from previo... 展开 >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) 收起 <<	-	United States, California ... 展开 >> Research Site Greenbrae, California, United States Research Site La Jolla, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Florida Research Site Winter Park, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Maryland Research Site Hyattsville, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Montana Research Site Butte, Montana, United States United States, New York Research Site New York, New York, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Austin, Texas, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Virginia Research Site Arlington, Virginia, United States Research Site Norfolk, Virginia, United States Research Site Richmond, Virginia, United States 收起 <<
NCT02287350	Pain	Phase 4	Completed	-	United States, Alabama ... 展开 >> Sheffield, Alabama, United States United States, California Stanford, California, United States United States, Missouri Saint Peters, Missouri, United States United States, Texas Dallas, Texas, United States United States, Wisconsin Milwaukee, Wisconsin, United States 收起 <<
NCT01235741	-		Terminated(Results from previo... 展开 >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) 收起 <<	-	-
NCT02287376	Migraine	Phase 4	Completed	-	United States, Florida ... 展开 >> Tampa, Florida, United States United States, New York Amherst, New York, United States 收起 <<
NCT02038764	Diabetes Mellitus, Type 1	Phase 1	Completed	-	United States, California ... 展开 >> VA San Diego Healthcare System (Drug Shipment) San Diego, California, United States, 92161 Veterans Administration San Diego Healthcare System San Diego, California, United States, 92161 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine New Haven, Connecticut, United States, 06510 Yale New Haven Hospital - Investigational Drug Services New Haven, Connecticut, United States, 06511 Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Illinois Duchossois Center for Advanced Medicine Chicago, Illinois, United States, 60637 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 University of Chicago Clinical Resource Center Chicago, Illinois, United States, 60637 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Umass Memorial Medical Center Worcester, Massachusetts, United States, 01655 University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota University Of Minnesota Fairview Pharmacy Services Minneapolis, Minnesota, United States, 55454 University Of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, Missouri Barnes- Jewish HOSP Att: Kathryn Vehe Saint Louis, Missouri, United States, 63110 Washington University - Center for Advanced Medicine Saint Louis, Missouri, United States, 63110 Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Clinical Research Unit Durham, North Carolina, United States, 27710 Duke University Health Systems (DUHS) Investigational Drug Services Durham, North Carolina, United States, 27710 收起 <<
NCT02287376	-		Completed	-	-
NCT02118792	-		Completed	-	-
NCT00365859	Autistic Disorder ... 展开 >> Behavioral Symptoms 收起 <<	Phase 3	Completed	-	-
NCT02287350	-		Completed	-	-
NCT02751424	Infections, Bacterial	Phase 1	Terminated(Study data is curre... 展开 >>ntly under review.) 收起 <<	-	Australia, South Australia ... 展开 >> GSK Investigational Site Adelaide, South Australia, Australia, 5000 收起 <<
NCT02509117	Healthy Subjects	Phase 1	Completed	-	United States, California ... 展开 >> California Clinical Trials Medical Group, Inc Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 收起 <<
NCT00365859	-		Completed	-	-
NCT02135055	Inflammatory Disorder of Immun... 展开 >>e System Sepsis 收起 <<	Phase 4	Unknown	March 2015	-
NCT02038764	-		Completed	-	-
NCT00122382	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT02332798	Schizophrenia	Phase 1	Completed	-	United States, California ... 展开 >> Collaborative Neuroscience Network, LLC. Long Beach, California, United States, 90806 收起 <<
NCT02332798	-		Completed	-	-
NCT02751424	-		Terminated(Study data is curre... 展开 >>ntly under review.) 收起 <<	-	-
NCT02509117	-		Completed	-	-
NCT02793232	Healthy Subjects	Phase 1	Completed	-	Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT03470441	Acute Myocardial Infarction ... 展开 >> STEMI 收起 <<	Phase 2	Not yet recruiting	December 2018	-
NCT02691702	-		Completed	-	-
NCT01571284	Colorectal Cancer Metastatic	Phase 3	Completed	-	-
NCT00122382	-		Completed	-	-
NCT02691702	Healthy Adult Subjects ... 展开 >> Healthy Elderly Subjects 收起 <<	Phase 1	Completed	-	United States, Florida ... 展开 >> QPS-MRA, LLC (Miami Research Associates) South Miami, Florida, United States, 33143 Qps-Mra, Llc South Miami, Florida, United States, 33143 收起 <<
NCT02750930	Diabetes Mellitus, Type 2	Phase 4	Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 <<	-	-
NCT01571284	-		Completed	-	-
NCT02750930	-		Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 <<	-	-
NCT01163253	Psoriasis	Phase 3	Terminated	-	-
NCT02793232	-		Completed	-	-
NCT02310750	Plaque Psoriasis	Phase 1	Completed	-	United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 收起 <<
NCT01439971	-		Completed	-	-
NCT01163253	-		Terminated	-	-
NCT03025880	Advanced Breast Cancer	Phase 2	Recruiting	July 2020	Spain ... 展开 >> Institut Català d'Oncologia. Hospital Universitario Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Hospital Universitario de Canarias Recruiting La Laguna, Canarias, Spain, 38320 Hospital Universitario Virgen de la Arrixaca Recruiting El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Centro Oncológico de Galicia Recruiting A Coruña, Spain, 15009 Complejo Hospitalario Universitario Reina Sofía Recruiting Cordoba, Spain, 14004 Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain, 28034 Hospital Clínico Universitario San Carlos Recruiting Madrid, Spain, 28040 Hospital Universitario Virgen de la Macarena Recruiting Sevilla, Spain, 41009 Hospital Clínico Universitario de Zaragoza "Lozano Blesa" Recruiting Zaragoza, Spain, 50009 收起 <<
NCT02205333	Advanced Solid Tumors ... 展开 >> Aggressive B-cell Lymphomas 收起 <<	Phase 1 Phase 2	Terminated(The study was termi... 展开 >>nated early at the sponsor's discretion.) 收起 <<	-	United States, Arizona ... 展开 >> Research Site Scottsdale, Arizona, United States, 85259 United States, California Research Site Sacramento, California, United States, 95817 Research Site Santa Monica, California, United States, 90404 United States, District of Columbia Research Site Washington, D.C., District of Columbia, United States, 20007 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, Nevada Research Site Las Vegas, Nevada, United States, 89169 United States, New Jersey Research Site Hackensack, New Jersey, United States, 7601 United States, North Carolina Research Site Huntersville, North Carolina, United States, 28078 United States, Oregon Research Site Portland, Oregon, United States, 97213 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 United States, Texas Research Site Houston, Texas, United States, 77030 收起 <<
NCT02637115	Metabolic Syndrome x ... 展开 >> Glucose Metabolism Disorders Dyslipidemias Obesity 收起 <<	Not Applicable	Completed	-	Belgium ... 展开 >> Cliniques universitaires Saint-Luc Brussels, Belgium, 1200 收起 <<
NCT01439971	Hemophilia A	Phase 1	Completed	-	United States, California ... 展开 >> University of California San Diego Medical Center San Diego, California, United States, 92103-8651 United States, Connecticut New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 OHSU Investigational Pharmacy Portland, Oregon, United States, 97239 Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania CTRC Philadelphia, Pennsylvania, United States, 19104 Penn Comprehensive Hemophilia Program - Center for Blood Disorders Philadelphia, Pennsylvania, United States, 19104 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, B-1070 Hungary Semmelweis Egyetem Altalanos Orvostudomanyi Kar/ I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Dipartimento di Medicina Clinica 1-Centro Regionale per le Malattie del Sangue Castelfranco Veneto (TV), Italy, 31033 Servizio Farmacia- Ospedale Castelfranco Veneto Castelfranco Veneto - Treviso, Italy, 31033 Centro Emofilia e Trombosi "Angelo Bianchi Bonomi" U.O.S. Dipartimentale per la Diagnosi e la Terapi Milano, Italy, 20122 Servizio Farmacia Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Milano, Italy, 20122 Centro Malattie Emorragiche e Trombotiche - Ematologia Vicenza, Italy, 36100 Farmacia Ospedaliera Ospedale San Bortolo Vicenza, Italy, 36100 New Zealand Christchurch Clinical Studies Trust Christchurch, New Zealand, 08011 South Africa Phoenix Pharma (Pty) Ltd Port Elizabeth, Eastern Cape, South Africa, 6001 Turkey Ege University Tip Fakultesi Izmir, Turkey, 35100 United Kingdom Royal Free Hampstead NHS Trust, Royal Free Hospital London, United Kingdom, NW3 2QG Haematology Department London, United Kingdom, W12 0HS Central Manchester Universtiy Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL 收起 <<
NCT02205333	-		Terminated(The study was termi... 展开 >>nated early at the sponsor's discretion.) 收起 <<	-	-
NCT02262754	Chronic Low Back Pain	Phase 2	Completed	-	-
NCT03090516	Alzheimer's	Phase 2 Phase 3	Recruiting	March 10, 2018	China, Jiangsu ... 展开 >> Ting Wu Recruiting Nanjing, Jiangsu, China, 210000 Contact: Ting Wu, professor 18851122018 wuting80000@126.com Contact: Wanrong Zhang, master 15851875395 zwr10010533@163.com 收起 <<
NCT02228395	-		Completed	-	-
NCT02310750	-		Completed	-	-
NCT03657030	Healthy	Phase 1	Recruiting	May 2019	United States, Texas ... 展开 >> PPD Development, LP Recruiting Austin, Texas, United States, 78744 Contact: Antonia M Davidson, MD 512-447-2985 Contact: Kristi Wheeler 512-747-4764 Kristi.Wheeler@ppdi.com 收起 <<
NCT02262754	-		Completed	-	-
NCT02228395	Healthy	Phase 1	Completed	-	United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 <<
NCT03400033	Anaemia	Phase 3	Recruiting	July 7, 2020	-
NCT02059759	Amyotrophic Lateral Sclerosis	Phase 2	Completed	-	France ... 展开 >> CHRU de Montpellier - Hôpital Gui de Chauliac Montpellier, France, 34295 收起 <<
NCT03041961	Healthy Young Men	Not Applicable	Completed	-	United Kingdom ... 展开 >> Department of Life Sciences and Medecine London, Central London, United Kingdom, SE1 9NH 收起 <<
NCT01673178	Diabetes Melliuts, Type 2	Phase 1	Completed	-	United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 Wake Internal Medicine Consultants Raleigh, North Carolina, United States, 27612 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Community Research Cincinnati, Ohio, United States, 45255 Mercy Hospital Pharmacy Cincinnati, Ohio, United States, 45255 United States, Texas Covance Clinical Research Unit Dallas, Texas, United States, 75247 收起 <<
NCT01673178	-		Completed	-	-
NCT01602341	Dermatitis, Atopic	Phase 2	Completed	-	United States, California ... 展开 >> Anacor Investigational Site Fremont, California, United States United States, Florida Anacor Investigational Site Miami, Florida, United States United States, Kentucky Anacor Investigational Site Lousiville, Kentucky, United States United States, Michigan Anacor Investigational Site Detroit, Michigan, United States United States, New Mexico Anacor Investigational Site Albuquerque, New Mexico, United States United States, New York Anacor Investigational Site Stony Brook, New York, United States United States, North Carolina Anacor Investigational Site High Point, North Carolina, United States United States, Oregon Anacor Investigational Site Portland, Oregon, United States United States, Tennessee Anacor Investigational Site Knoxville, Tennessee, United States United States, Utah Anacor Investigational Site Salt Lake City, Utah, United States United States, Virginia Anacor Investigational Site Norfolk, Virginia, United States Australia, Australian Capital Territory Anacor Investigational Site Phillip, Australian Capital Territory, Australia, 2606 Australia, New South Wales Anacor Investigational Site Kogarah, New South Wales, Australia, 2217 Australia, Queensland Anacor Investigational Site Wooloongabba, Queensland, Australia Australia, Victoria Anacor Investigational Site Box Hill, Victoria, Australia Anacor Investigational Site Parkville, Victoria, Australia Australia, Western Australia Anacor Investigational Site Fremantle, Western Australia, Australia, 6160 收起 <<
NCT02014272	Healthy Volunteers	Phase 1	Completed	-	Singapore ... 展开 >> Pfizer Investigational Site Singapore, Singapore, 188770 收起 <<
NCT01602341	-		Completed	-	-
NCT02443740	Healthy	Phase 1	Completed	-	United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 <<
NCT01369225	Alzheimer's Disease	Phase 1	Completed	-	United States, Florida ... 展开 >> MD Clinical Hallandale Beach, Florida, United States, 33009 Munroe Regional Medical Center Ocala, Florida, United States, 34471 Renstar Medical Research Ocala, Florida, United States, 34471 Trinity Care Solutions Ocala, Florida, United States, 34471 Advanced Imaging of Ocala Ocala, Florida, United States, 34481 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Maryland Foers Medical Arts Pharmacy Bethesda, Maryland, United States, 20814 CBH Health, LLC Rockville, Maryland, United States, 20850 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49048 Borgess Research Institute Kalamazoo, Michigan, United States, 49048 KNI Southwest Michigan Imaging Center, LLC Kalamazoo, Michigan, United States, 49048 United States, Missouri Millennium Psychiatric Associates, LLC Creve Coeur, Missouri, United States, 63141 DePaul Health Center-MRI Department St. Louis, Missouri, United States, 63044 United States, New Jersey Memory Enhancement Center of America, Inc. Eatontown, New Jersey, United States, 07724 Central Jersey Radiology Oakhurst, New Jersey, United States, 07755 Korea, Republic of Seoul National University Hospital, Department Neurology Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Inha University Hospital, Department of Neurology Incheon, Korea, Republic of, 400-711 Samsung Medical Center, Department of Neurology Seoul, Korea, Republic of, 1350710 Korea University Anam Hospital IRB Seoul, Korea, Republic of, 136-705 ASAN Medical Center Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center, Department of Neurology Seoul, Korea, Republic of, 143914 收起 <<
NCT02224664	Parkinson`s Disease	Phase 1	Completed	-	United States, California ... 展开 >> Orange Coast Memorial Medical Center Fountain Valley, California, United States, 92708 The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States, 92708 Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 United States, Colorado Rocky Mountain Movement Disorders Center Englewood, Colorado, United States, 80113 Davita Clinical Research Center Lakewood, Colorado, United States, 80228 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 Compass Research, LLC Orlando, Florida, United States, 32806 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, Massachusetts Massachusetts General Hospital -- FOR DRUG SHIPMENT ONLY Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Quest Research Institute Farmington Hills, Michigan, United States, 48334 United States, New Jersey PRA International Marlton, New Jersey, United States, 08053 United States, North Carolina Carolina Phase I Research, LLC Raleigh, North Carolina, United States, 27612 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Texas Neurology Consultants of Dallas, PA Dallas, Texas, United States, 75231 Walnut Hill Medical Center Dallas, Texas, United States, 75231 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT02443740	-		Completed	-	-
NCT01806896	Huntington's Disease	Phase 2	Completed	-	France ... 展开 >> Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris Cedex 13, France, 75651 收起 <<
NCT01806896	-		Completed	-	-
NCT01478607	Painful Diabetic Peripheral Ne... 展开 >>uropathy (PDPN) 收起 <<	Phase 3	Completed	-	-
NCT00335153	-		Completed	-	-
NCT01369225	-		Completed	-	-
NCT02224664	-		Completed	-	-
NCT00983437	Traumatic Brain Injury	Phase 3	Terminated(Study has been stop... 展开 >>ped by sponsor decision) 收起 <<	-	-
NCT02014272	-		Completed	-	-
NCT00145327	Osteoporosis	Phase 3	Completed	-	-
NCT00335153	Advanced Parkinson's Disease	Phase 3	Completed	-	-
NCT02280096	Multiple Sclerosis	Phase 2	Unknown	March 2016	Mexico ... 展开 >> Hospital de Especialidades, CMN Siglo XXI Mexico City, Distrito Federal, Mexico, 06725 收起 <<
NCT00145327	-		Completed	-	-
NCT02062034	Non-proliferative Diabetic Ret... 展开 >>inopathy Diabetes Mellitus Type 2 收起 <<	Phase 2	Completed	-	Mexico ... 展开 >> Cardiovascular Research Unit, University of Guadalajara Guadalajara, Jalisco, Mexico, 44340 收起 <<
NCT00983437	-		Terminated(Study has been stop... 展开 >>ped by sponsor decision) 收起 <<	-	-
NCT03493191	Acute Pain	Phase 1	Recruiting	September 2018	Australia ... 展开 >> Linear Clinical Research Limited Recruiting Nedlands, Australia Contact: Sarah Powell +61 (0) 411 062 165 spowell@linear.org.au 收起 <<
NCT03211403	Gout Hyperuri... 展开 >>cemia 收起 <<	Phase 1	Completed	-	Australia, New South Wales ... 展开 >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 收起 <<
NCT02656225	Postpartum Anemia	Phase 1 Phase 2	Unknown	August 2016	China, Guangdong ... 展开 >> the First Affiliated Hospital, Guangzhou University of Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510405 Contact: Yanfang Li, PhD +86 13928777126 gzyanfangli@hotmail.com 收起 <<
NCT00577031	Colorectal Cancer	Phase 4	Completed	-	Italy ... 展开 >> Bologna, Italy, 40138 Brescia, Italy, 25122 Cagliari, Italy, 09100 Cagliari, Italy, 09121 Caserta, Italy, 81100 Catanzaro, Italy, 88100 Cefalu, Italy, 90015 Fano, Italy, 61032 Firenze, Italy, 50139 Frattaminore, Italy, 80026 Grosseto, Italy, 58100 Ivrea, Italy, 10015 Latisana, Italy, 33053 Lecce, Italy, 73100 Legnago, Italy, 37045 Legnano, Italy, 20025 Macerata, Italy, 62100 Napoli, Italy, 80131 Negrar, Italy, 37024 Orbassano, Italy, 10043 Padova, Italy, 35128 Palermo, Italy, 90127 Palermo, Italy, 90146 Pavia, Italy, 27100 Reggio Calabria, Italy, 89100 Reggio Emilia, Italy, 42100 Rionero in Vulture, Italy, 85028 Roma, Italy, 00152 Roma, Italy, 00184 Roma, Italy, 00186 Roma, Italy, 00189 Salerno, Italy, 84131 San Giovanni Rotondo, Italy, 71013 Sondrio, Italy, 23100 Taormina, Italy, 98030 Torino, Italy, 10125 Torino, Italy, 10153 Verbania, Italy, 28921 收起 <<
NCT03680105	Critical Limb Ischemia	Phase 1	Recruiting	March 2019	United States, Texas ... 展开 >> ICON Early Phase Services Recruiting San Antonio, Texas, United States, 78209 Contact: Dennis A Ruff, MD 收起 <<
NCT00658359	Kidney Transplantation	Phase 2	Completed	-	-
NCT02291289	Colorectal Cancer	Phase 2	Suspended(Following iDMC revie... 展开 >>w of cohort 4 data a temporary recruitment halt to the whole study and a temporary halt to randomisation into cohort 4 has been undertaken) 收起 <<	December 29, 2021	-
NCT00483756	Kidney Transplantation	Phase 2	Completed	-	-
NCT03545347	Hip Fractures	Phase 2	Recruiting	December 2019	Denmark ... 展开 >> Hvidovre Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Morten Tange Kristensen 38626191 morten.tange.kristensen@regionh.dk 收起 <<
NCT01922739	Low Back Pain	Phase 3	Completed	-	-
NCT00658359	-		Completed	-	-
NCT01315314	Kidney Failure, Chronic ... 展开 >> Disorders Associated With Peritoneal Dialysis 收起 <<	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Division of Nephrology and Department of Internal Medicine, Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 收起 <<
NCT01587807	Respiratory Disorders	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Belfast, United Kingdom, BT9 6AD GSK Investigational Site Harrow, United Kingdom, HA1 3UJ 收起 <<
NCT00483756	-		Completed	-	-
NCT01922739	-		Completed	-	-
NCT03433248	Type2 Diabetes	Phase 4	Recruiting	December 1, 2020	Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Michaël JB van Baar, MD +31 20 444 4709 m.vanbaar@vumc.nl Contact: Daniël H van Raalte, MD PhD +31 20 444 0534 d.vanraalte@vumc.nl Principal Investigator: Mark HH Kramer, MD PhD Principal Investigator: Daniël H van Raalte, MD PhD 收起 <<
NCT01662804	Neuroblastoma	Phase 1	Active, not recruiting	August 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT01615185	Schizophrenia	Phase 4	Terminated	-	Taiwan ... 展开 >> Kai-Suan Psychiatric Hospital Kaohsiung, Taiwan, 802 收起 <<
NCT00629161	Parkinson Disease	Phase 2 Phase 3	Unknown	-	China, Beijing ... 展开 >> Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences Recruiting Beijing, Beijing, China, 100053 Contact: Li Gao, MD China, Shanghai Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Qin Xiao, MD Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 200032 Contact: Canxing Yuan, MD Zhongshan hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Dingfang Cai, MD doctorcn@hotmail.com Tongji Hospital of Tongji University Recruiting Shanghai, Shanghai, China, 200065 Contact: Qing Zhan, MD Shanghai Chinese Medical Hospital Recruiting Shanghai, Shanghai, China, 200071 Contact: Yi Liu, MD Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 200127 Contact: Zhenguo Liu The Sixth People＇s Hospital, Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200233 Contact: Xiaojiang Sun, MD Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 200437 Contact: Hong Zhao, MD China, Zhejiang Department of Neurology, The second people's hospital of Wenzhou Recruiting Wenzhou, Zhejiang, China, 325000 Contact: Liya Han 收起 <<
NCT00577031	-		Completed	-	-
NCT00805389	Hepatitis B	Phase 2	Completed	-	Belgium ... 展开 >> GSK Investigational Site Bruxelles, Belgium, 1200 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site La Louvière, Belgium, 7100 GSK Investigational Site Wilrijk, Belgium, 2610 Germany GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72074 GSK Investigational Site Haag, Bayern, Germany, 83527 GSK Investigational Site Muenchen, Bayern, Germany, 80636 GSK Investigational Site Muenchen, Bayern, Germany, 81241 GSK Investigational Site Regensburg, Bayern, Germany, 93053 GSK Investigational Site Wuerzburg, Bayern, Germany, 97070 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 12627 GSK Investigational Site Berlin, Germany, 13125 GSK Investigational Site Hamburg, Germany, 20253 收起 <<
NCT01322906	Liver Failure	Phase 2	Unknown	July 2012	-
NCT02334696	-		Unknown	January 2017	-
NCT01043523	-		Completed	-	-
NCT01586754	-		Unknown	May 2012	Turkey ... 展开 >> Istanbul Medeniyet University Goztepe Training and Research Hospital Istanbul, Turkey, 34000 收起 <<
NCT00830297	Hyperglycemia	Phase 2	Completed	-	Austria ... 展开 >> Medical University of Vienna, Department of Internal Medicine III Vienna, Austria, 1090 收起 <<
NCT00805389	-		Completed	-	-
NCT01043523	-		Completed	-	United States, California ... 展开 >> Palo Alto, California, United States, 94304 United States, New York New York, New York, United States, 10032 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Ohio Cinncinati, Ohio, United States, 45229 United States, Pennsylvania Hershey, Pennsylvania, United States, 17033 Italy Many Locations, Italy Japan Many Locations, Japan Singapore Many Locations, Singapore Taiwan Many Locations, Taiwan 收起 <<
NCT00736879	-		Completed	-	-
NCT01525550	Well-differentiated Pancreatic... 展开 >> Neuroendocrine Tumor 收起 <<	Phase 4	Completed	-	-
NCT00452140	Metastatic Breast Cancer ... 展开 >> Advanced Breast Cancer 收起 <<	Phase 2	Terminated(company focus on ot... 展开 >>her projects) 收起 <<	-	Austria ... 展开 >> Study site, Austria France Study site, France Germany Study sites, Germany Italy Study site, Italy Spain Barcelona, Spain 收起 <<
NCT03422172	HIV Infections	Phase 1	Active, not recruiting	April 28, 2020	China, Zhejiang ... 展开 >> GSK Investigational Site Hangzhou, Zhejiang, China, 310000 China GSK Investigational Site Beijing, China, 100069 GSK Investigational Site Shanghai, China, 201508 收起 <<
NCT01462175	Neoplasms	Phase 1	Completed	-	Australia, Victoria ... 展开 >> Melbourne, Victoria, Australia, 3000 Canada, Ontario Hamilton, Ontario, Canada, L8V 5C2 Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Montreal, Quebec, Canada, H3T 1E2 France Bordeaux, France, 33076 Lyon, France, 69373 Korea, Republic of Seoul, Korea, Republic of, 110-744 Netherlands Groningen, Netherlands, 9713 GZ 收起 <<
NCT00850642	-		Terminated	-	-
NCT00899470	Type 2 Diabetes Mellitus	Phase 1	Completed	-	United States, Nebraska ... 展开 >> Mds Pharma Services Lincoln, Nebraska, United States, 68502 收起 <<
NCT01525550	-		Completed	-	-
NCT00850642	Asthma	Phase 2	Terminated	-	Canada, Ontario ... 展开 >> GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 United Kingdom GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Leicester, Leicestershire, United Kingdom, LE3 9QP GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site Manchester, United Kingdom, M23 9QZ 收起 <<
NCT01332331	Hypertension, Pulmonary	Phase 2	Suspended(Ongoing juvenile rat... 展开 >> toxicology studies.) 收起 <<	February 1, 2019	-
NCT01342952	Hypertension, Pulmonary	Phase 2	Recruiting	October 24, 2024	-
NCT01205165	Hepatitis B, Chronic	Phase 4	Completed	-	-
NCT00899470	-		Completed	-	-
NCT00348140	Alzheimer's Disease	Phase 3	Completed	-	-
NCT02436577	Bioequivalence ... 展开 >> Healthy Japanese Subjects Pharmacokinetics 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> Research Site Harrow, United Kingdom 收起 <<
NCT00348140	-		Completed	-	-
NCT02436577	-		Completed	-	-
NCT02446171	-		Completed	-	-
NCT01901471	Acute Myocardial Infarction	Phase 2	Withdrawn	October 2015	France ... 展开 >> CH Pays d'Aix Aix-en-Provence, France, 13616 Clinique de La Fourcade Bayonne, France, 64100 CHU Hopital Cardiologique Louis Pradel Bron, France, 69677 Hôpital Gabriel Montpied Clermont-ferrand, France, 63003 Chu Hopital Du Bocage Dijon, France, 21034 Chu Hopital A Michallon Grenoble, France, 38043 Hopital St Luc St Joseph Lyon, France Chu Arnaud de Villeneuve Montpellier, France, 34295 Hopital Guillaume Et Rene Laennec Nantes, France, 44093 Chu de Nimes Nimes, France, 30029 Aphp Hopital Bichat Paris, France, 75018 Centre Hospitalier de Pau PAU, France, 64011 Chu de Bordeaux Pessac, France, 33604 Hopital Charles Nicolle Rouen, France, 76031 Nouvel Hôpital Civil Strasbourg, France, 67091 Chu de Rangueil Toulouse, France, 31403 Chru de Tours Tours, France, 37044 Chu de Nancy Brabois Vandoeuvre Les Nancy, France, 54511 收起 <<
NCT01021553	Premature Ejaculation	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92120 GSK Investigational Site San Jose, California, United States, 95128 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46825 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Bala-Cynwyd, Pennsylvania, United States, 19004 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV GSK Investigational Site Utrecht, Netherlands, 3584 CJ 收起 <<
NCT03054194	Healthy Participants	Phase 1	Completed	-	United States, Texas ... 展开 >> Eisai Trial Site San Antonio, Texas, United States, 78217 收起 <<
NCT01021553	-		Completed	-	-
NCT02446171	Bioavailability ... 展开 >> Healthy Subjects 收起 <<	Phase 1	Completed	-	Germany ... 展开 >> Research Site Berlin, Germany 收起 <<
NCT01842607	Asthma	Phase 3	Completed	-	-
NCT01790620	Sepsis Septic... 展开 >> Shock Acute Kidney Injury 收起 <<	Not Applicable	Completed	-	Spain ... 展开 >> Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 收起 <<
NCT01205165	-		Completed	-	-
NCT00111800	-		Completed	-	-
NCT01240863	Chronic Pain	Phase 3	Completed	-	-
NCT00111800	Diabetes Mellitus, Type 2	Phase 2	Completed	-	-
NCT00555880	Hypotension, Orthostatic	Phase 4	Completed	-	United States, Indiana ... 展开 >> Fort Wayne Neurological Center Fort Wayne, Indiana, United States, 46805 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Minnesota VA Medical Center Minneapolis, Minnesota, United States, 55417 United States, Missouri Forest Park Neurophysiology Saint Louis, Missouri, United States, 63139 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Raleigh Neurology Associates Raleigh, North Carolina, United States, 27607 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, South Carolina Absher Neurology, PA Greenville, South Carolina, United States, 29615 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 United States, Texas Diabetes and Glandular Disease research Associates, PA San Antonio, Texas, United States, 78229 收起 <<
NCT01601821	-		Completed	-	-
NCT01601821	Inflammation	Phase 4	Completed	-	Iran, Islamic Republic of ... 展开 >> Labbafinejad Hospital Tehran, Iran, Islamic Republic of Modarres Hospital Tehran, Iran, Islamic Republic of Shariati Hospital Tehran, Iran, Islamic Republic of Taleqani Hospital Tehran, Iran, Islamic Republic of 收起 <<
NCT01842607	-		Completed	-	-
NCT00555880	-		Completed	-	-
NCT00048061	Post Menopausal Osteoporosis	Phase 3	Completed	-	-
NCT00430677	-		Terminated(Terminated due to f... 展开 >>ailure to meet the primary efficacy endpoint in the Short-term Period) 收起 <<	-	-
NCT01240863	-		Completed	-	-
NCT03107442	Systemic Lupus Erythematosus	Not Applicable	Completed	-	Spain ... 展开 >> Virgen de las Nieves University Hospital Granada, Spain, 18014 收起 <<
NCT01134055	Macular Degeneration	Phase 2	Completed	-	-
NCT01134055	-		Completed	-	-
NCT02339155	Infections, Bacterial	Phase 4	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Edgewater, Florida, United States, 32132 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 United States, Tennessee GSK Investigational Site Knoxville, Tennessee, United States, 37920 收起 <<
NCT01268566	Glioblastoma Multiforme	Phase 2	Completed	-	United States, Arizona ... 展开 >> Research Site Tucson, Arizona, United States United States, California Research Site Los Angeles, California, United States Research Site Stanford, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York, New York, United States United States, Ohio Research Site Canton, Ohio, United States United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Seattle, Washington, United States 收起 <<
NCT02339155	-		Completed	-	-
NCT00048061	-		Completed	-	-
NCT02216123	Malaria, Vivax	Phase 3	Completed	-	Brazil ... 展开 >> GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 Colombia GSK Investigational Site Cali, Colombia GSK Investigational Site Monteria, Colombia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Mae Sot, Thailand, 63110 GSK Investigational Site Tak, Thailand, 63170 Vietnam GSK Investigational Site Ho Chi Minh, Vietnam 收起 <<
NCT02293902	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT01268566	-		Completed	-	-
NCT02216123	-		Completed	-	-
NCT00430677	Systemic Lupus Erythematosus	Phase 2 Phase 3	Terminated(Terminated due to f... 展开 >>ailure to meet the primary efficacy endpoint in the Short-term Period) 收起 <<	-	-
NCT00908037	Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 <<	Phase 2	Completed	-	-
NCT02293902	-		Completed	-	-
NCT00710684	Alzheimer's Disease	Phase 2	Completed	-	-
NCT00867087	-		Completed	-	-
NCT00867087	Lymphoma, B-Cell	Phase 2	Completed	-	-
NCT00637767	Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 <<	Phase 2	Unknown	-	United Kingdom ... 展开 >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Contact Person 44-121-472-1311 Saint Bartholomew's Hospital Recruiting London, England, United Kingdom, EC1A 7BE Contact: Contact Person 44-20-7377-7000 Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Kim Orchard, MD 44-0-238-079-4118 kho@soton.ac.uk 收起 <<
NCT00710684	-		Completed	-	-
NCT00908037	-		Completed	-	-
NCT01568112	Healthy	Phase 3	Completed	-	United States, Minnesota ... 展开 >> Research Site St Paul, Minnesota, United States 收起 <<
NCT01568112	-		Completed	-	-
NCT03014674	Asthma	Phase 3	Completed	-	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Germany GSK Investigational Site Berlin, Germany, 14050 United Kingdom GSK Investigational Site Harrow, Middlesex, United Kingdom, HA1 3UJ 收起 <<
NCT03014674	-		Completed	-	-
NCT00550420	-		Terminated(Based on preliminar... 展开 >>y parent study results) 收起 <<	-	-
NCT02422797	HIV Infections	Phase 3	Active, not recruiting	August 12, 2021	-
NCT00550420	Alzheimer's Disease	Phase 3	Terminated(Based on preliminar... 展开 >>y parent study results) 收起 <<	-	-
NCT02422797	-		Active, not recruiting	-	-
NCT01262677	-		Completed	-	-
NCT01584648	Melanoma	Phase 3	Active, not recruiting	October 15, 2018	-
NCT01943864	-		Completed	-	-
NCT01584648	-		Active, not recruiting	-	-
NCT03736005	-		Not yet recruiting	May 2020	-
NCT01491932	Dyskinesias P... 展开 >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents 收起 <<	Phase 2	Completed	-	-
NCT01262677	Partial Seizures ... 展开 >> Epilepsies, Partial 收起 <<	Phase 3	Completed	-	-
NCT00428090	Alzheimer's Disease	Phase 3	Completed	-	-
NCT03630627	Healthy Volunteers	Phase 1	Recruiting	August 20, 2020	United States, California ... 展开 >> PAREXEL International Recruiting Glendale, California, United States, 91206 Contact 888-228-7425 收起 <<
NCT00428090	-		Completed	-	-
NCT00509028	-		Completed	-	-
NCT03351751	Healthy Volunteers	Phase 1	Completed	-	United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 <<
NCT00509028	Asthma	Phase 3	Completed	-	Japan ... 展开 >> Research Site Takizawa, Iwate, Japan 收起 <<
NCT01943864	Cancer	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 277-8577 GSK Investigational Site Osaka, Japan, 537-8511 GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 GSK Investigational Site Tokyo, Japan, 181-8611 收起 <<
NCT01174446	Hemophilia B	Phase 3	Completed	-	-
NCT00410202	Hepatitis B, Chronic	Phase 3	Completed	-	-
NCT01174446	-		Completed	-	-
NCT01697956	Allergic Rhinitis	Phase 3	Completed	-	United States, California ... 展开 >> Teva Investigational Site 10305 Long Beach, California, United States United States, Georgia Teva Investigational Site 10304 Stockbridge, Georgia, United States United States, Minnesota Teva Investigational Site 10300 Plymouth, Minnesota, United States United States, Pennsylvania Teva Investigational Site 10302 Normal, Pennsylvania, United States United States, Texas Teva Investigational Site 10301 New Braunfels, Texas, United States Teva Investigational Site 10303 San Antonio, Texas, United States 收起 <<
NCT02429791	HIV Infections	Phase 3	Active, not recruiting	August 13, 2021	-
NCT00410202	-		Completed	-	-
NCT02814656	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> Research Site London, United Kingdom 收起 <<
NCT02271984	Healthy	Phase 1	Completed	-	Germany ... 展开 >> Please contact the Merck KGaA Communication Center Darmstadt, Germany 收起 <<
NCT02429791	-		Active, not recruiting	-	-
NCT02271984	-		Completed	-	-
NCT00817063	Eczema	Phase 3	Completed	-	-
NCT03672513	Menopause Nut... 展开 >>ritional Intervention Bone Diseases 收起 <<	Not Applicable	Completed	-	Spain ... 展开 >> Universidad de Granada Granada, Spain, 18071 收起 <<
NCT03062761	Growth	Phase 2	Recruiting	July 2018	Finland ... 展开 >> University of Turku Children's Allergy and Asthma Clinic Active, not recruiting Turku, Finland Germany Vivantes Klinik für Geburtsmedizin, Klinikum Neukölln Recruiting Berlin, Germany Contact: Dietmar Schlembach dietmar.schlembach@vivantes.de Paediatric Practice Recruiting Bramsche, Germany Contact: Thomas Adelt thomasadelt@yahoo.de Netherlands Gelre Ziekenhuizen Active, not recruiting Apeldoorn, Netherlands Poland Poliklinika Ginekologiczno-Poloznicza Sp. z o.o. Sp.k Recruiting Białystok, Poland Contact: Marta Arciszewska-Kasprzak marta@arciszewska.eu Specjalistyczna Poradnia Medyczna Przylądek Zdrowia Recruiting Kraków, Poland Contact: Izabela Tarczoń lekarz@przyladekzdrowia.pl POLMED / Instytut Mikroekologii Recruiting Poznań, Poland Contact: Tomasz Pikula tpikula@ump.edu.pl Korczowski Bartosz, Gabinet Lekarski Recruiting Rzeszów, Poland Contact: Bartosz Korczowski korczowski@op.pl NZLA Michalkowice Jarosz i Partnerzy Spolka Lekarska Recruiting Siemianowice Śląskie, Poland Contact: Barbara Pajek michalkowice@of.pl 收起 <<
NCT02818699	Overweight Ob... 展开 >>ese 收起 <<	Not Applicable	Recruiting	January 2018	United States, Massachusetts ... 展开 >> Human Nutrition Research Center on Aging at Tufts University Recruiting Boston, Massachusetts, United States, 02111 收起 <<
NCT00817063	-		Completed	-	-
NCT01697956	-		Completed	-	-
NCT03070548	Advanced Solid Tumors	Phase 1	Completed	-	Hungary ... 展开 >> PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalohely Budapest, Hungary, 1077 收起 <<
NCT03070548	-		Completed	-	-
NCT01318993	Crohn's Disease	Phase 3	Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 <<	-	-
NCT01114620	-		Completed	-	-
NCT01316939	-		Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 <<	-	-
NCT01316939	Crohn's Disease	Phase 3	Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 <<	-	-
NCT00272779	HIV Infections	Phase 3	Completed	-	-
NCT00272779	-		Completed	-	-
NCT01114620	Influenza	Phase 4	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-8588 收起 <<
NCT00129623	Post-Menopausal Osteopenia	Phase 4	Completed	-	United States, Colorado ... 展开 >> Lakewood, Colorado, United States, 80227 United States, Florida Stuart, Florida, United States, 34996 United States, Maryland Bethesda, Maryland, United States, 20817 United States, Michigan Detroit, Michigan, United States, 48236 United States, Missouri St Louis, Missouri, United States, 63110 United States, Nebraska Omaha, Nebraska, United States, 68131 United States, New Mexico Albuquerque, New Mexico, United States, 87106 United States, Ohio Cincinnati, Ohio, United States, 45224 United States, Oregon Portland, Oregon, United States, 97213 United States, Texas Amarillo, Texas, United States, 79124 United States, Virginia Norfolk, Virginia, United States, 23502 Richmond, Virginia, United States, 23294 收起 <<
NCT00129623	-		Completed	-	-
NCT03397641	Atrial Fibrillation	Phase 1	Completed	-	United Kingdom ... 展开 >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS 收起 <<
NCT00793871	Gastrointestinal Neoplasms, Ga... 展开 >>strointestinal Stromal Tumors 收起 <<	Phase 4	Completed	-	China, Jiangsu ... 展开 >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 收起 <<
NCT01362348	Macular Degeneration	Phase 2	Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 <<	-	United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85014 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Georgia GSK Investigational Site Decatur, Georgia, United States, 30030 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Houston, Texas, United States, 77030 France GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 <<
NCT01318993	-		Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 <<	-	-
NCT00793871	-		Completed	-	-
NCT00768989	HIV	Phase 2	Terminated(Efficacy endpoint m... 展开 >>et, but overall experimental dosing regimen not considered optimal to support further clinical development in this population.) 收起 <<	-	United States, Arizona ... 展开 >> Southwest Center For HIV/AIDS Phoenix, Arizona, United States, 85006 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06510 United States, District of Columbia Dupont Circle Physicians Group Washington, District of Columbia, United States, 20009 United States, Florida Orlando Immunology Center Orlando, Florida, United States, 32803 United States, New York The Aaron Diamond AIDS Research Center New York, New York, United States, 10016 United States, Ohio University Of Cincinnati Cincinnati, Ohio, United States, 45267 United States, Texas Tarrant County Infectious Disease Associates Ft Worth, Texas, United States, 76104 Therapeutic Concepts, P.A. Houston, Texas, United States, 77004 Diversified Medical Practices, P.A. Houston, Texas, United States, 77057 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Capital Federal, Buenos Aires, Argentina, 1264 Local Institution Mar Del Plata, Buenos Aires, Argentina, B7600CTO Local Institution Rosario, Santa Fe, Argentina, 2000 France Local Institution Nantes Cedex 01, France, 44035 Local Institution Paris Cedex 10, France, 75475 Local Institution Paris Cedex 20, France, 75970 收起 <<
NCT00768989	-		Terminated(Efficacy endpoint m... 展开 >>et, but overall experimental dosing regimen not considered optimal to support further clinical development in this population.) 收起 <<	-	-
NCT00897390	Type 2 Diabetes Mellitus	Phase 1	Completed	-	United States, Nebraska ... 展开 >> Mds Pharma Services Lincoln, Nebraska, United States, 68502 收起 <<
NCT02463435	Severe Obesity	Not Applicable	Completed	-	Brazil ... 展开 >> Unidade de Pesquisa Clínica do Hospital das Clínicas/UFG Goiânia, Goiás, Brazil, 74605-020 收起 <<
NCT01362348	-		Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 <<	-	-
NCT02593539	Activated PI3K-delta Syndrome	Phase 2	Recruiting	December 11, 2019	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT01240915	Colitis, Ulcerative	Phase 2	Completed	-	-
NCT01001169	-		Completed	-	-
NCT00897390	-		Completed	-	-
NCT02691325	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 <<
NCT00420199	Active Rheumatoid Arthritis	Phase 3	Completed	-	Belgium ... 展开 >> Local Institution Bruxelles, Belgium, 1200 Local Institution Yvoir, Belgium, 5530 Germany Local Institution Berlin, Germany, 14059 Local Institution Berlin, Germany, BE-10117 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Sweden Local Institution Stockholm, Sweden, 171 76 United Kingdom Local Institution London, Greater London, United Kingdom, SE19RT Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA 收起 <<
NCT01001169	Influenza	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Tokyo, Japan, 157-8535 收起 <<
NCT03358407	Inflammatory Bowel Diseases	Phase 1	Recruiting	September 16, 2019	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT01240915	-		Completed	-	-
NCT00420199	-		Completed	-	-
NCT03262272	End Stage Renal Disease ... 展开 >> Inflammation 收起 <<	Not Applicable	Recruiting	December 21, 2018	France ... 展开 >> AIDER-Lapeyronie Recruiting Montpellier, France, 34295 Contact: Jean Paul Cristol, Professor +33 4 67 33 83 15 jp-cristol@chu-montpellier.fr Contact: Laetitia Barbe +33 6 30 17 80 37 laetitia.barbe@hemotech.fr 收起 <<
NCT02229227	-		Completed	-	-
NCT01845922	Refeeding Syndrome	Phase 4	Unknown	February 2014	Denmark ... 展开 >> Rigshospitalet Recruiting Copenhagen ø, Denmark, 2100 Contact: Irene Wessel, MD, Phd 004535458322 Sub-Investigator: Katrine B. Dester, M.S. student Sub-Investigator: Henrik Carlsen, M.S. student Sub-Investigator: Martine D. Hansen, M.S. student 收起 <<
NCT02410343	Growth Hormone Deficiency	Phase 3	Terminated(Business decision)	-	-
NCT02410343	-		Terminated(Business decision)	-	-
NCT03169790	Non Hodgkin Lymphoma	Phase 1 Phase 2	Not yet recruiting	March 2019	-
NCT02772016	Thalassemia	Early Phase 1	Unknown	-	China, Guangdong ... 展开 >> the first affiliated hospital of Guangzhou University of Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510405 Contact: Yanfang Li, PhD +86-20-36598857 gzyanfangli@hotmail.com 收起 <<
NCT03426995	Arthritis, Rheumatoid	Phase 1	Recruiting	July 29, 2019	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00534313	Psoriatic Arthritis	Phase 2	Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 <<	-	-
NCT00534313	-		Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 <<	-	-
NCT01920594	Surgical Procedures	Phase 2	Completed	-	United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35233 United States, California GSK Investigational Site Los Angeles, California, United States, 90048 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109-5864 United States, Minnesota GSK Investigational Site Rochester, Minnesota, United States, 55905 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 308902 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 United States, Virginia GSK Investigational Site Charlottesville, Virginia, United States, 22908 GSK Investigational Site Richmond, Virginia, United States, 23298 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Quebec GSK Investigational Site Quebec City, Quebec, Canada, G1V 4G5 收起 <<
NCT02204371	Telangiectasia, Hereditary Hem... 展开 >>orrhagic 收起 <<	Phase 2	Terminated(The study was termi... 展开 >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) 收起 <<	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30912-3135 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5B 1W8 收起 <<
NCT02204371	-		Terminated(The study was termi... 展开 >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) 收起 <<	-	-
NCT02229227	Diabetes Mellitus, Type 2	Phase 3	Completed	-	-
NCT00555906	Multiple Myeloma	Phase 2	Completed	-	United States, Illinois ... 展开 >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110-1093 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York Presbyterian, Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Czech Republic Vseobecna fakultni nemocnice v Praze Praha 2, Czech Republic, 12808 Germany Universitaetsklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik Mainz, Germany, 55131 收起 <<
NCT00555906	-		Completed	-	-
NCT03287310	Asthma	Phase 1	Recruiting	September 24, 2019	Germany ... 展开 >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Berlin, Germany, 14050 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Harrow, Middlesex, United Kingdom, HA1 3UJ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting London, United Kingdom, NW10 7EW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Manchester, United Kingdom, M23 9QZ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT01920594	-		Completed	-	-
NCT02179918	Advanced Solid Tumors	Phase 1	Completed	-	United States, California ... 展开 >> Research Administration Office Los Angeles, California, United States, 90095 Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States, 90095 UCLA Hematology-Oncology Clinic Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 United States, Connecticut Smilow Cancer Center at Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06510 United States, Texas South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 <<
NCT03069989	Idiopathic Pulmonary Fibrosis	Phase 1	Active, not recruiting	May 23, 2019	United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, SW3 6HP GSK Investigational Site London, United Kingdom, WC1E 6JF GSK Investigational Site London, United Kingdom 收起 <<
NCT03136380	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	Japan ... 展开 >> GSK Investigational Site Tokyo, Japan, 162-0053 收起 <<
NCT00979602	Influenza	Phase 3	Completed	-	-
NCT03447314	Neoplasms	Phase 1	Recruiting	February 14, 2020	United States, Missouri ... 展开 >> GSK Investigational Site Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Recruiting Dallas, Texas, United States, 75230 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Washington GSK Investigational Site Recruiting Tacoma, Washington, United States, 98405 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Not yet recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Not yet recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03709706	Neoplasms	Phase 2	Not yet recruiting	April 22, 2021	-
NCT00979602	-		Completed	-	-
NCT02179918	-		Completed	-	-
NCT01035749	Influenza	Phase 2	Completed	-	Estonia ... 展开 >> GSK Investigational Site Tartu, Estonia, 50106 Slovakia GSK Investigational Site Cifer, Slovakia, 919 43 GSK Investigational Site Dolny Kubin, Slovakia, 026 01 GSK Investigational Site Dunajska Streda, Slovakia, 929 01 GSK Investigational Site Nova Dubnica, Slovakia, 018 51 GSK Investigational Site Nove Mesto nad Vahom, Slovakia, 915 01 GSK Investigational Site Puchov, Slovakia, 020 01 GSK Investigational Site Ruzomberok, Slovakia, 034 01 GSK Investigational Site Trencin, Slovakia, 911 01 收起 <<
NCT00490568	-		Terminated(Based on preliminar... 展开 >>y parent study results) 收起 <<	-	-
NCT00490568	Alzheimer's Disease	Phase 3	Terminated(Based on preliminar... 展开 >>y parent study results) 收起 <<	-	-
NCT03590613	Autoimmune Diseases	Phase 1	Active, not recruiting	September 21, 2018	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 收起 <<
NCT02216097	-		Terminated(The study stopped b... 展开 >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) 收起 <<	-	-
NCT01347866	Advanced Cancer	Phase 1	Terminated(Refer to Detailed D... 展开 >>escription for documentaion of Termination Statement.) 收起 <<	-	United States, California ... 展开 >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095-6984 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica, California, United States, 90404 UCLA Santa Monica Hematology Oncology Santa Monica, California, United States, 90404 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 MUSC, Investigational Drug Services Charleston, South Carolina, United States, 29425 MUSC Health East Cooper Mount Pleasant, South Carolina, United States, 29464 MUSC Specialty Care-North North Charleston, South Carolina, United States, 29406 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Italy Ospedale San Raffaele Milano, Italy, 20132 Spain Hospital General Vall d'Hebron Barcelona, Spain, 08035 收起 <<
NCT01035749	-		Completed	-	-
NCT03359473	Cachexia	Phase 2	Recruiting	November 3, 2019	United States, California ... 展开 >> GSK Investigational Site Not yet recruiting Torrance, California, United States, 90502 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Florida GSK Investigational Site Recruiting Jacksonville, Florida, United States, 32216 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, North Carolina GSK Investigational Site Recruiting High Point, North Carolina, United States, 27262 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, South Carolina GSK Investigational Site Recruiting Spartanburg, South Carolina, United States, 29303 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Germany GSK Investigational Site Recruiting Frankfurt, Hessen, Germany, 60596 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Grosshansdorf, Schleswig-Holstein, Germany, 22927 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03245619	Pancreatitis, Acute Necrotizin... 展开 >>g 收起 <<	Phase 1	Terminated(Sponsor decision pe... 展开 >>nding review of data.) 收起 <<	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 0GG 收起 <<
NCT02216097	Post-Traumatic Stress Disorder	Phase 2	Terminated(The study stopped b... 展开 >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) 收起 <<	-	United States, New York ... 展开 >> Clinical and Translational Science Institute (CTSI) New York, New York, United States, 10016 NYU CTSI Research Pharmacy (Drug Shipment Address) New York, New York, United States, 10016 NYU School of Medicine New York, New York, United States, 10016 收起 <<
NCT03457727	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT01347866	-		Terminated(Refer to Detailed D... 展开 >>escription for documentaion of Termination Statement.) 收起 <<	-	-
NCT01773408	Myelogenous Leukemia, Acute	Phase 1	Completed	-	United States, California ... 展开 >> USC Norris Cancer Center Los Angeles, California, United States, 90033 United States, New York New York Medical College Valhalla, New York, United States, 10595 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Texas Cancer Therapy & Research Ctr; Dept Institute for Drug Development San Antonio, Texas, United States, 78229 Australia, Victoria Peter Maccallum Cancer Centre Melbourne, Victoria, Australia, 3000 Canada, Ontario University Health Network; Princess Margaret Hospital; Medical Oncology Dept Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology Montreal, Quebec, Canada, H3T 1E2 France Institut J Paoli I Calmettes; Onco Hematologie 2 Marseille, France, 13273 Italy Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpigh Bologna, Emilia-Romagna, Italy, 40138 Korea, Republic of Seoul National Uni Hospital; Dept. of Internal Medicine/Hematology/Oncology Seoul, Korea, Republic of, 03080 Asan Medical Center Seoul, Korea, Republic of, 05505 United Kingdom The Beatson West of Scotland Cancer Centre; Cancer Clinical Trials Unit Glasgow, United Kingdom, G12 0YN 收起 <<
NCT03544281	Multiple Myeloma	Phase 2	Recruiting	November 28, 2022	United States, Alabama ... 展开 >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02633098	Colorectal Cancer ... 展开 >> Bowel Cancer 收起 <<	Phase 2	Recruiting	February 28, 2024	United Kingdom ... 展开 >> Kent Oncology Centre, Maidstone Hospital Recruiting Barming, Kent, United Kingdom, ME16 9QQ Contact: Mark Dr Hill 01622 225041 mehill@nhs.net Contact: Lisa Tribe 01622 227098 ltribe@nhs.net Medway Maritime Hospital Not yet recruiting Gillingham, Kent, United Kingdom, ME7 5NY Barking, Havering and Redbridge University Hospitals NHS Trust Recruiting Barking, United Kingdom Contact: Nirooshun Dr Rajendran 01708 435000 ext 3615 nirooshun.rajendran@bhrhospitals.nhs.uk Contact: Alison Ray 01708 435000 ext 3615 alison.ray@bhrhospitals.nhs.uk Ashford & St Peters Hospital NHS Foundation Trust Recruiting Chertsey, United Kingdom Contact: Pasha Mr Nisar 01932 722318 pasha.nisar@asph.nhs.uk Contact: Victoria Frost 01932 723534 victoria.frost@asph.nhs.uk St George's University Hospitals NHS Fundation Trust Recruiting London, United Kingdom, SW17 0RE Contact: Yolanda Augustin, MBBS, MRCP,MSc, FRCR 02087255722 yaugusti@sgul.ac.uk Principal Investigator: Andrew Rawmell, MA, MD, FRCS Plymouth Hospitals NHS Trust Not yet recruiting Plymouth, United Kingdom, PL6 8DH Contact: Clare Miss Adams clare.adams2@nhs.net Contact: Abigail Patrick abigail.patrick1@nhs.net Shrewsbury and Telford Hospital NHS Trust Recruiting Shrewsbury, United Kingdom Contact: Jon Mr Lacy-Colson 01743 261000 ext 1460 jon.lacy-colson@sath.nhs.uk Contact: Sally Potts 01743 261000 ext 1692 收起 <<
NCT02723955	Cancer	Phase 1	Recruiting	May 18, 2020	United States, California ... 展开 >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00612456	-		Completed	-	-
NCT01229436	Dupuytren's Contracture	Phase 3	Completed	-	Denmark ... 展开 >> Pfizer Investigational Site Copenhagen, Denmark, 1402 K Pfizer Investigational Site Silkeborg, Denmark, 8600 France Pfizer Investigational Site Montpellier cedex 5, France, 34295 Pfizer Investigational Site Nice, France, 06000 Pfizer Investigational Site Paris, France, 75016 Pfizer Investigational Site Paris, France, Cedex 15 75908 Germany Pfizer Investigational Site Bad Neustadt, Germany, 97616 Pfizer Investigational Site Berlin, Germany, 10627 Pfizer Investigational Site Bonn, Germany, 53123 Pfizer Investigational Site Muenster, Germany, 48149 Pfizer Investigational Site Nurnberg, Germany, 90471 Pfizer Investigational Site Tubingen, Germany, 72076 Hungary Pfizer Investigational Site Miskolc, Hungary, 3526 Italy Pfizer Investigational Site Sesto San Giovanni, Milano, Italy, 20099 Pfizer Investigational Site Modena, Italy, 41124 Pfizer Investigational Site Savona, Italy, 17100 Spain Pfizer Investigational Site Elche, Alicante, Spain, 03203 Pfizer Investigational Site Hospitalet De Llobregat, Barcelona/ Spain, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08022 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Málaga, Spain, 29010 Sweden Pfizer Investigational Site Malmö, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, SE 118 83 Pfizer Investigational Site Uppsala, Sweden, 751 85 United Kingdom Pfizer Investigational Site Derby, United Kingdom, DE22 3NE Pfizer Investigational Site Glasgow, United Kingdom, G4 0SF Pfizer Investigational Site Norwich, United Kingdom, NR4 7UY Pfizer Investigational Site Southampton, United Kingdom, SO16 6YD 收起 <<
NCT00612456	Macular Degeneration	Phase 2	Completed	-	-
NCT01727791	Healthy Lactating Women	Phase 4	Completed	-	Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT01229436	-		Completed	-	-
NCT03044353	Amyloidosis	Phase 2	Suspended(Pending data review.... 展开 >>) 收起 <<	September 23, 2021	United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02115 United Kingdom GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site London, United Kingdom, NW10 7EW 收起 <<
NCT01727791	-		Completed	-	-
NCT00457002	Venous Thrombosis ... 展开 >> Pulmonary Embolism 收起 <<	Phase 3	Completed	-	-
NCT01607372	Asthma and Rhinitis	Phase 2	Completed	-	Canada, Ontario ... 展开 >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 收起 <<
NCT00457002	-		Completed	-	-
NCT03027726	Overweight Children With Type ... 展开 >>2 Diabetes Risk 收起 <<	Not Applicable	Completed	-	Spain ... 展开 >> Pediatric Endocrinology Unit of the University Hospital of Araba (HUA) Vitoria-Gasteiz, Araba, Spain, 01009 收起 <<
NCT01712061	-		Completed	-	-
NCT01920555	Treatment Resistant Depression	Phase 2	Completed	-	United States, California ... 展开 >> Stanford University Palo Alto, California, United States, 94304 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 收起 <<
NCT01712061	Diabetic Nephropathy	Phase 2	Completed	-	-
NCT02257359	Embryo Transfer	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT01920555	-		Completed	-	-
NCT01009060	Schizophrenia	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Garden Grove, California, United States, 92845 GSK Investigational Site Los Angeles, California, United States, 90073 GSK Investigational Site National City, California, United States, 91950 GSK Investigational Site Sacramento, California, United States, 95817 GSK Investigational Site San Diego, California, United States, 92102 GSK Investigational Site Torrance, California, United States, 90502 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46222 United States, Maryland GSK Investigational Site Catonsville, Maryland, United States, 21228 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 GSK Investigational Site Jamaica Plain, Massachusetts, United States, 02130 United States, New Jersey GSK Investigational Site Mount Laurel, New Jersey, United States, 08054 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10032 United States, North Carolina GSK Investigational Site Butner, North Carolina, United States, 27509 收起 <<
NCT01009060	-		Completed	-	-
NCT00853112	Hypertension, Pulmonary	Phase 2	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00349895	Coronary Artery Disease ... 展开 >> Coronary Artery Stenosis 收起 <<	Phase 4	Completed	-	Austria ... 展开 >> Medizinische Universitätsklinik Graz, Austria, 8036 Belgium OLV Ziekenhuis Aalst Aalst, Belgium, 9300 AZ Middelheim Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Belgium, 2650 Virga Jesse Ziekenhuis Hasselt, Belgium, 3500 France Hôpital Henri Mondor Creteil, France, 94010 Germany Herzzentrum Bad Krozingen Bad Krozingen, Germany, 79189 Herz- und Diabeteszentrum Nordrhein-Westfalen Bad Oeynhausen, Germany, 32545 Internistische Klinik Dr. Müller Munich, Germany, 81379 Netherlands Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ Amphia Ziekenhuis Breda, Netherlands, 4818 CK Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 GD United Kingdom Kings College Hospital London, United Kingdom, SE5 9RS John Radcliflfe Hospital Oxford, United Kingdom, OX3 9DU 收起 <<
NCT00968526	Influenza	Phase 3	Completed	-	Belgium ... 展开 >> GSK Investigational Site Wilrijk, Belgium, 2610 收起 <<
NCT02903966	Colitis, Ulcerative	Phase 2	Recruiting	May 7, 2019	United States, California ... 展开 >> GSK Investigational Site Recruiting Moreno Valley, California, United States, 92555 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Terminated Oceanside, California, United States, 92056 GSK Investigational Site Recruiting San Diego, California, United States, 92115 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Louisiana GSK Investigational Site Not yet recruiting Marrero, Louisiana, United States, 70072 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Michigan GSK Investigational Site Recruiting Chesterfield, Michigan, United States, 48047 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting Great Neck, New York, United States, 11021 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Washington GSK Investigational Site Not yet recruiting Seattle, Washington, United States, 98195 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Germany GSK Investigational Site Recruiting Ulm, Baden-Wuerttemberg, Germany, 89081 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Frankfurt, Hessen, Germany, 60431 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Kiel, Schleswig-Holstein, Germany, 24105 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1105 AZ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Poland GSK Investigational Site Recruiting Katowice, Poland, 40-660 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Ksawerow, Poland, 95-054 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Wroclaw, Poland Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Russian Federation GSK Investigational Site Recruiting Rostov-on-Don, Russian Federation, 344091 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting St Pertersburg, Russian Federation, 196247 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Stavropol, Russian Federation, 355018 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Ufa, Russian Federation, 450071 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Sweden GSK Investigational Site Recruiting Stockholm, Sweden, SE-171 76 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Stockholm, Sweden, SE-182 88 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Uppsala, Sweden, SE-752 37 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Stockport, Cheshire, United Kingdom, SK2 7JE Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Belfast, United Kingdom, BT16 1RH Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Dudley, United Kingdom, DY1 2HQ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Edgbaston, Birmingham, United Kingdom, B15 2GW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT00853112	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT02603172	Amyloidosis	Phase 1	Terminated(A new study will be... 展开 >> initiated in order to specifically investigate cardiac safety) 收起 <<	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 <<
NCT00968526	-		Completed	-	-
NCT02738931	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT00424294	-		Terminated(See Detailed Descri... 展开 >>ption field) 收起 <<	-	-
NCT02027857	Brain Electrical Impedance; ... 展开 >> Non-invasive Intracranial Pressure 收起 <<	Not Applicable	Unknown	June 2015	China, Shaanxi ... 展开 >> Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University Not yet recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu Shijie, M.D.,Ph.D. 086-29-84773307 hushijie@fmmu.edu.cn Contact: Fei Zhou, M.D.,Ph.D. 086-13992888996 feizhou@fmmu.edu.cn Principal Investigator: Hu Shijie, M.D.,Ph.D. 收起 <<
NCT00424294	Arthritis, Rheumatoid	Phase 2	Terminated(See Detailed Descri... 展开 >>ption field) 收起 <<	-	-
NCT02964507	Neoplasms	Phase 2	Recruiting	June 1, 2020	-
NCT02682979	-		Completed	-	Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 收起 <<
NCT02542813	Postpartum Hemorrhage	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 <<
NCT02381769	Alcoholic Liver Disease	Not Applicable	Completed	-	India ... 展开 >> Institute of Liver & Biliary Sciences New Delhi, Delhi, India, 110070 收起 <<
NCT03393975	Congenital Thrombotic Thromboc... 展开 >>ytopenic Purpura 收起 <<	Phase 3	Active, not recruiting	January 21, 2021	United Kingdom ... 展开 >> University College London Hospitals London, Greater London, United Kingdom, NW1 2PG 收起 <<
NCT03728816	-		Recruiting	September 30, 2020	China, Shanghai ... 展开 >> Ruijin Hospital Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Jieming QU, Ph.D., M.D. 0086-021-64370045 jmqu0906@163.com Principal Investigator: Jieming QU, Ph.D., M.D. Principal Investigator: Jing ZHANG, Ph.D., M.D. 收起 <<
NCT02246699	Overweight and Obese Volunteer... 展开 >>s. 收起 <<	Not Applicable	Completed	-	France ... 展开 >> Clinical Nutrition Center Naturalpha (CNCN) Lille, France, 59120 收起 <<
NCT03398421	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT02802501	Malaria, Vivax	Phase 3	Recruiting	November 29, 2019	Indonesia ... 展开 >> GSK Investigational Site Recruiting Jakarta, Indonesia, 10430 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02925546	Heart Failure, Congestive	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT03159442	Chronic Obstructive Pulmonary ... 展开 >>Disease - COPD 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 <<
NCT01978951	Chronic Kidney Disease	Not Applicable	Completed	-	Thailand ... 展开 >> Bhumirajanagarindra Kidney Institute Bangkok, Thailand, 10400 收起 <<
NCT02799264	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT03574142	Healthy Subjects	Phase 1	Completed	-	China ... 展开 >> Research Site Beijing, China, 100029 收起 <<
NCT02289365	Radiodermatitis	Phase 2	Unknown	December 2016	Taiwan ... 展开 >> Departmant of Radiotherapy, Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan, 80756 Department of Radiation Oncology, China Medical University Hospital Taichung, Taiwan Department of Oncology, Taipei Verterans General Hospital Taipei, Taiwan, 11217 收起 <<
NCT00381394	Leishmaniasis, Visceral	Phase 2	Completed	-	India ... 展开 >> GSK Investigational Site Muzaffarpur, India, 842001 GSK Investigational Site Muzaffarpur, India GSK Investigational Site Patna, India, 800007 收起 <<
NCT03045887	Asthma	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 <<
NCT01766882	End Stage Renal Failure	Not Applicable	Completed	-	United States, Michigan ... 展开 >> University Dialysis Unit Ann Arbor, Michigan, United States, 48104 University of Michigan Dialyisis Unit Livonia, Michigan, United States, 48152 收起 <<
NCT01413074	End Stage Renal Disease	Phase 4	Terminated	-	China, Guangdong ... 展开 >> The First Affiliated Hospital , Sun Yet-Sen University Guangzhou, Guangdong, China, 510080 China, Shanghai Shanghai Changzheng Hospital Shanghai, Shanghai, China, 200003 Ruijin Hospital,Shanghai Jiaotong University , School of Medicine Shanghai, Shanghai, China, 200025 Huashan Hospital ,Fudan University Shanghai, Shanghai, China, 200040 Renji Hospital , Shanghai Jiaotong University , School of Medicine Shanghai, Shanghai, China China, Zhejiang The First Affiliated Hospital , Zhejiang University, School of Medicine Hangzhou, Zhejiang, China, 310003 Hangzhou Hospital of Tranditional Chinese Medicine Hangzhou, Zhejiang, China, 310007 收起 <<
NCT02639975	Glaucoma	Phase 1	Completed	-	-
NCT02245022	HIV Pregnancy	Phase 2 Phase 3	Active, not recruiting	December 2018	South Africa ... 展开 >> Desmond Tutu HIV Foundation Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda 收起 <<
NCT02956746	Human Rabies	Phase 1 Phase 2	Completed	-	United States, Florida ... 展开 >> inVentiv Clinical Research Facility, 1951 NW 7th Ave. Suit 450 Miami, Florida, United States, 33136 收起 <<
NCT01599286	Propionic Acidemia, Type I and... 展开 >>/or Type II Methylmalonic Acidemia Carbamoyl-Phosphate Synthase I Deficiency Disease Ornithine Carbamoyltransferase Deficiency 收起 <<	Phase 2	Recruiting	December 2019	United States, California ... 展开 >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Rebecca Signer, MS, LCGC 310-206-6581 RSigner@mednet.ucla.edu Principal Investigator: Derek Wong, MD Lucile Packard Children's Hospital at Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Thu Quan, MBA, HCM 650-736-8166 tquan@stanford.edu Principal Investigator: Gregory M Enns, MD United States, Colorado The Children's Hospital of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Curtis Coughlin, MS, MBe, CGC 303-724-2310 curtis.coughlin@childrenscolorado.org Contact: James Weisfeld-Adams, MD 303-724-2310 james.weisfeld-adams@childrenscolorado.org Principal Investigator: James Weisfeld-Adams, MD United States, District of Columbia Children's National Medical Center Recruiting Washington, D.C., District of Columbia, United States, 20010 Contact: Nicholas Ah Mew, MD 202-476-5863 nahmew@childrensnational.org Contact: Katie Rice, MPH, CCRP 202-621-0062 krice3@childrensnational.org Principal Investigator: Nicholas Ah Mew, MD United States, Massachusetts Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02115 Contact: Vera Anastasoaie 617-355-7346 vera.anastasoaie@childrens.harvard.edu Contact: Kyla Almeida, RN, BSN 617-919-4126 kyla.almeida@childrens.harvard.edu Principal Investigator: Gerard T Berry, MD United States, New York Mount Sinai School of Medicine Recruiting New York, New York, United States, 10029 Contact: Luca Fierro, MS, CGC 212-659-1477 luca.fierro@mssm.edu Principal Investigator: George Diaz, MD United States, Ohio University Hospitals Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Audrey Lynn, PhD 216-844-7124 audrey.lynn@uhhospitals.org Contact: Kimberly Wallis, MS, LGC 216-983-0844 kimberly.wallis@uhhospitals.org Principal Investigator: Shawn McCandless, MD United States, Pennsylvania The Children's Hospital of Philadelphia (CHOP) Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Genevieve Nesom 267-426-1368 nesomg@email.chop.edu Principal Investigator: Can Ficicioglu, MD, PhD University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Angela Leshinski, MBA, RD, LDN 412-692-5232 angela.leshinski@chp.edu Principal Investigator: Gerard Vockley, MD, PhD 收起 <<
NCT03515291	Myocardial Fibrosis	Phase 2	Not yet recruiting	August 2020	-
NCT02231021	Type 2 Diabetes Mellitus	Phase 4	Recruiting	November 2018	Korea, Republic of ... 展开 >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Principal Investigator: Kun-Ho Yoon, MD, PhD Sub-Investigator: Yoon-Hee Choi, MD, PhD Sub-Investigator: Hye-Kyung Yang, MD 收起 <<
NCT01302938	Overactive Bladder	Phase 4	Terminated(Stop date for rando... 展开 >>mization 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.) 收起 <<	-	United States, California ... 展开 >> Mytrus, Inc. San Francisco, California, United States, 94104 University of California San Francisco San Francisco, California, United States, 94121 收起 <<
NCT03741283	Aging Malnutr... 展开 >>ition Drug Prescribing 收起 <<	Not Applicable	Recruiting	December 15, 2020	Denmark ... 展开 >> Amager & Hvidovre Hospital Recruiting Hvidovre, Region Hovedstaden, Denmark, 2650 Contact: Aino L Andersen, Msc 0045 24616108 Aino.leegaard.andersen@regionh.dk Contact: Morten B Houlind, Msc 0045 28 83 85 63 morten.baltzer.houlind@regionh.dk 收起 <<
NCT01553058	Psoriasis Car... 展开 >>diovascular Disease 收起 <<	Phase 4	Completed	-	United States, California ... 展开 >> University of California, Davis Health System Sacramento, California, United States, 95816 United States, Colorado The University of Colorado Denver, Colorado, United States, 80045 United States, Maryland National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 United States, New York Buffalo Medical Group Buffalo, New York, United States, 14221 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19140 United States, Texas Menter Dermatology Research Institute Dallas, Texas, United States, 75246 Center for Clinical Studies Houston, Texas, United States, 77004 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 收起 <<
NCT01410227	Von Willebrand Disease	Phase 3	Completed	-	-
NCT01410227	-		Completed	-	-
NCT01876212	Metastatic Melanoma	Phase 2	Active, not recruiting	June 6, 2019	United States, Pennsylvania ... 展开 >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 收起 <<
NCT01553058	-		Completed	-	-
NCT01302938	-		Terminated(Stop date for rando... 展开 >>mization 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.) 收起 <<	-	-
NCT01624792	Chronic Obstructive Pulmonary ... 展开 >>Disease Muscle Wasting 收起 <<	Not Applicable	Active, not recruiting	April 2019	United States, Texas ... 展开 >> Texas A&M University College Station, Texas, United States, 77843 收起 <<
NCT02128698	Bariatric Surgery Candidate	Not Applicable	Completed	-	Germany ... 展开 >> Department of General, Visceral, and Transplant Surgery, University Hospital of Tübingen Tübingen, Germany, 72076 收起 <<
NCT01866592	-		Completed	-	-
NCT01988181	Intradialytic Hypotension ... 展开 >> End Stage Renal Failure on Dialysis 收起 <<	Not Applicable	Completed	-	Canada, Alberta ... 展开 >> Alberta Health Services Southern Alberta Renal Program Calgary, Alberta, Canada, T2N 2T9 收起 <<
NCT01476501	Sub-optimal Vitamin D Status ... 展开 >> Bone Disease Diabetic Nephropathy 收起 <<	Phase 2	Unknown	December 2015	Canada, Alberta ... 展开 >> Clinical Research Unit, University of Alberta Edmonton, Alberta, Canada, T6G 0K2 收起 <<
NCT02811887	Liver Cirrhosis, Alcoholic	Not Applicable	Recruiting	December 2018	Denmark ... 展开 >> Bispebjerg Hospital, Department of Physical and Occupational Therapy Recruiting Copenhagen, Denmark, 2400 Contact: Marius Henriksen, PT, PhD +4535312251 marius.henriksen@regionh.dk 收起 <<
NCT02702765	Wilsons Disease	Not Applicable	Recruiting	February 2020	Denmark ... 展开 >> Department of Hepatology and Gastroenterology, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Jessica Björklund, Research-year student 004560748993 jebjoe@rm.dk 收起 <<
NCT01866592	Psoriasis Car... 展开 >>diovascular Disease 收起 <<	Phase 4	Completed	-	United States, California ... 展开 >> University of California, Davis Health System Sacramento, California, United States, 95816 United States, Colorado University of Colorado Denver, Colorado, United States, 80045 United States, Maryland National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 United States, New York Buffalo Medical Group Buffalo, New York, United States, 14221 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Menter Dermatology Research Institute Dallas, Texas, United States, 75246 Center for Clinical Studies Houston, Texas, United States, 77004 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 收起 <<
NCT00397722	Social Phobia	Phase 2	Completed	-	-
NCT03039777	-		Completed	-	Saudi Arabia ... 展开 >> New jeddah clinic Hospital Jeddah, Saudi Arabia 收起 <<
NCT02876952	Myocardial Infarction	Not Applicable	Recruiting	June 2018	Spain ... 展开 >> Department of Physical Education and Sport. Faculty of Education and Sport-Physical Activity and Sport Section. University of the Basque Country Recruiting Vitoria-gasteiz, Araba/álava, Spain, 01007 Contact: SARA MALDONADO-MARTIN, PhD sara.maldonado@ehu.eus Sub-Investigator: Juan Jose GOIRIENA, PhD 收起 <<
NCT03466073	Community-acquired Pneumonia	Phase 1 Phase 2	Recruiting	February 28, 2019	Australia, Queensland ... 展开 >> Cairns Hospital Recruiting Cairns, Queensland, Australia, 4870 Contact: Michelle Gosley +61 7 42266547 michelle.gosley@health.qld.gov.au Principal Investigator: GRAHAM SIMPSON, MD Australia, Victoria Box Hill Hospital Recruiting Box Hill, Victoria, Australia, 3128 Contact: Irina Shinkarsky +61 3 90949515 irina.shinkarsky@monash.edu Principal Investigator: Francis Thien, MD Footscray Hospital Recruiting Footscray, Victoria, Australia, 3011 Contact: SUE CASANELIA +61 3 83456804 sue.casanelia@wh.org.au Principal Investigator: ANNE MARIE SOUTHCOTT, MD Sub-Investigator: MATTHEW HORDERN, MD Sub-Investigator: LIN MO, MD Sub-Investigator: LAUREN NG, MD Sub-Investigator: SANJIWIKA WASGEWATTA, MD Royal Melbourne Hospital Recruiting Melbourne, Victoria, Australia, 3052 Contact: Joan Patterson +61 3 93422181 joan.patterson@mh.org.au Principal Investigator: JOE SASADEUSZ, MD Sub-Investigator: CARLY HUGHES, MD Sub-Investigator: OULI XIE, MD Sub-Investigator: SADID KHAN, MD Sub-Investigator: SHIO YEN, MD New Zealand Waikato Hospital Recruiting Hamilton, New Zealand, 3240 Contact: Sandra Hopping +64 7 839 8899 sandra.hopping@waikatodhb.health.nz Principal Investigator: Catherina Chang, MD Sub-Investigator: Miriam Bennett, MD Wellington Hospital Recruiting Wellington, New Zealand, 6021 Contact: Marina DZHELALI +64 4 9185117 marina.dzhelali@ccdhb.org.nz Principal Investigator: Paul Taylor, MD 收起 <<
NCT01703624	Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 <<	Phase 2	Completed	-	United Kingdom ... 展开 >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ 收起 <<
NCT00157157	Hemophilia A	Phase 3	Completed	-	-
NCT00157157	-		Completed	-	-
NCT03775109	Alcoholic Hepatitis	Phase 2	Recruiting	December 2019	United Kingdom ... 展开 >> Blackpool Teaching Hospitals Not yet recruiting Blackpool, United Kingdom Contact: Peter Isaacs University Hospitals Bristol NHS Foundation Trust Not yet recruiting Bristol, United Kingdom Contact: Anne McCune Cambridge University Hospitals NHS Foundation Trust Not yet recruiting Cambridge, United Kingdom Contact: Michael Allison Derby Teaching Hospitals NHS Foundation Trust Not yet recruiting Derby, United Kingdom Contact: Andrew Austin Glasgow Royal Infirmary, Greater Glasgow & Clyde Not yet recruiting Glasgow, United Kingdom, G4 0SF Contact: Ewan Forrest Leeds Teaching Hospitals NHS Trust Not yet recruiting Leeds, United Kingdom Contact: Richard Parker Aintree University Hospital Not yet recruiting Liverpool, United Kingdom Contact: Cyril SIEBERHAGEN Royal Liverpool and Broadgreen University Hospitals NHS Trust Not yet recruiting Liverpool, United Kingdom Contact: Paul Richardson Imperial College Healthcare NHS Foundation Trust Recruiting London, United Kingdom, W2 1NY Contact: Mark Thursz 020 3312 5359 Chelsea and Westminster Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: Matthew Foxton King's College Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: Vishal Patel Royal Free London NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: David Patch The Newcastle Upon Tyne Hospitals NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom Contact: Steve Masson Nottingham University Hospitals NHS Trust Not yet recruiting Nottingham, United Kingdom Contact: Stephen Ryder John Radcliffe Hospital, Oxford University NHS Foundation Trust Not yet recruiting Oxford, United Kingdom, OX3 9DU Contact: Jeremy Cobbold Plymouth Hospitals NHS Trust Not yet recruiting Plymouth, United Kingdom Contact: Ashwin Dhanda Sheffield Teaching Hospitals NHS Foundation Trust Not yet recruiting Sheffield, United Kingdom Contact: Amer Al-Joudeh University Hospital Southampton NHS Foundation Trust Not yet recruiting Southampton, United Kingdom Contact: Mark Wright 收起 <<
NCT01785082	Liver Failure	Phase 3	Completed	-	Germany ... 展开 >> Dept. of General-, Visceral- and Graft Surgery, Charité Campus Virchow-Hospital Berlin, Germany, 13353 Dept. of General- and Visceral Surgery, Jena University Hospital Jena, Germany, 07747 Clinic and Policlinic for Visceral-, Graft-, Thorax- and Vascular Surgery, Leipzig University Hospital Leipzig, Germany, 04103 Clinic and Policlinic for General- Visceral- and Graft Surgery, Würzburg University Hospital Würzburg, Germany, 97080 收起 <<
NCT00751452	-		Unknown	September 2009	France ... 展开 >> Etienne MERLIN Recruiting Clermont-Ferrand, France, 63003 收起 <<
NCT02488044	Arginase I Deficiency ... 展开 >> Hyperargininemia 收起 <<	Phase 1 Phase 2	Active, not recruiting	February 2019	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Florida University of Florida Gainesville, Florida, United States, 32611 United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas UTSW Dallas, Texas, United States, 75390 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Portugal Centro Hospitalar S. Joao Porto, Portugal United Kingdom Great Ormond Street Hospital London, United Kingdom 收起 <<
NCT03025152	Gastric Cancer ... 展开 >> Gastrointestinal Disease 收起 <<	Not Applicable	Recruiting	July 2020	China, Jiangxi ... 展开 >> Jiangxi University of Traditional Chinese Medicine Recruiting Nanchang, Jiangxi, China, 330004 Contact: Xu Zhou +8618780085060 zhouxu_ebm@hotmail.com Contact: Xiaofan Chen +86079187118012 841347982@qq.com 收起 <<
NCT00269087	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Kodaira, Japan, 187-0002 GSK Investigational Site Kyoto, Japan, 612-0026 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tokyo, Japan, 164-0012 收起 <<
NCT03282682	Hypogonadism, Male ... 展开 >> Physical Activity Testosterone Deficiency 收起 <<	Not Applicable	Recruiting	December 31, 2018	Slovakia ... 展开 >> Comenius University in Bratislava, Faculty of physical education and sport Recruiting Bratislava, Slovakia, 814 69 Contact: Michal Kralik +421 910272863 michal.kralik@uniba.sk 收起 <<
NCT03378531	Arginase I Deficiency ... 展开 >> Hyperargininemia 收起 <<	Phase 2	Recruiting	June 2021	United States, California ... 展开 >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Gregory Enns, MD Principal Investigator: Gregory Enns, MD United States, Florida University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Roberto Zori, MD Principal Investigator: Roberto Zori, MD United States, Michigan Children'sf Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Robert Conway, MD Principal Investigator: Robert Conway, MD United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: George Diaz, MD Principal Investigator: George Diaz, MD United States, Texas UTSW Recruiting Dallas, Texas, United States, 75390 Contact: Markey McNutt, MD Principal Investigator: Markey McNutt, MD Canada, Ontario The Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Andreas Schultze, MD Principal Investigator: Andreas Schultze, MD 收起 <<
NCT03067961	Salmonella Typhi Infection	Not Applicable	Active, not recruiting	August 15, 2019	United Kingdom ... 展开 >> Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom, OX3 7LE 收起 <<
NCT01644396	-		Completed	-	-
NCT01644396	Moderate to Severe Plaque Psor... 展开 >>iasis 收起 <<	Phase 4	Completed	-	Russian Federation ... 展开 >> Site Reference ID/Investigator# 67547 Ekaterinburg, Russian Federation, 620076 Site Reference ID/Investigator# 78433 Kazan, Russian Federation, 420012 Site Reference ID/Investigator# 67542 Moscow, Russian Federation, 107076 Site Reference ID/Investigator# 67546 Saratov, Russian Federation, 410028 Site Reference ID/Investigator# 78417 Smolensk, Russian Federation, 214018 Site Reference ID/Investigator# 78413 St. Petersburg, Russian Federation, 190013 Site Reference ID/Investigator# 67545 St. Petersburg, Russian Federation, 194044 收起 <<
NCT00537654	Prostatic Hyperplasia	Phase 1	Completed	-	United States, Indiana ... 展开 >> GSK Investigational Site Evansville, Indiana, United States, 47714 United States, Texas GSK Investigational Site Austin, Texas, United States, 78752 收起 <<
NCT03483090	Osteoarthritis, Knee	Phase 2	Recruiting	July 30, 2020	Australia, Queensland ... 展开 >> University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Recruiting Morayfield, Queensland, Australia, 4506 Contact: Jessica Baird +61 7 5456 3797 trials@usc.edu.au Contact: Georgina Street +61 7 5456 3798 gstreet@usc.edu.au Principal Investigator: Susan Thackwray University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Recruiting Sippy Downs, Queensland, Australia, 4556 Contact: Jessica Baird +61 7 5456 3797 trials@usc.edu.au Contact: Georgina Street +61 7 5456 3798 gstreet@usc.edu.au Principal Investigator: Susan Thackwray Australia, South Australia CSIRO Nutrition and Health Research Clinic Recruiting Adelaide, South Australia, Australia, 5000 Contact: Bianca Benassi-Evans Australia, Victoria Emeritus Research Recruiting Camberwell, Victoria, Australia, 3124 Contact: Edwin Young +61 3 950 96166 edwinyoung@emeritusresearch.com Contact: Teresa Ringeri +61 3 950 96166 teresaringeri@emeritusresearch.com Principal Investigator: Andrew Ostor 收起 <<
NCT03525678	Multiple Myeloma	Phase 2	Recruiting	June 30, 2020	-
NCT03169959	Type 2 Diabetes Mellitus	Phase 1	Completed	-	United States, Maryland ... 展开 >> Research Site Baltimore, Maryland, United States, 21225 收起 <<
NCT03395704	Hereditary Hemochromatosis	Phase 2	Recruiting	December 2018	United States, Arkansas ... 展开 >> Investigative Site Recruiting North Little Rock, Arkansas, United States, 72117 United States, California Investigative Site Recruiting Palo Alto, California, United States, 94305 Investigative Site Recruiting Rialto, California, United States, 92377 Investigational Site Recruiting San Diego, California, United States, 91942 United States, Michigan Investigative Site Recruiting Wyoming, Michigan, United States, 49519 United States, Mississippi Investigative Site Recruiting Jackson, Mississippi, United States, 39216 United States, New York Investigative Site Recruiting East Setauket, New York, United States, 11733 Investigative Site Recruiting Manhasset, New York, United States, 11030 Investigative Site Recruiting New York, New York, United States, 10029 United States, Texas Investigative Site Recruiting Dallas, Texas, United States, 75246 Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Investigative Site Recruiting Houston, Texas, United States, 77058 Investigative Site Recruiting San Antonio, Texas, United States, 78215 United States, Washington Investigative Site Recruiting Seattle, Washington, United States, 98104 Australia, New South Wales Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Queensland Investigative Site Recruiting Brisbane, Queensland, Australia, 4120 Investigative Site Recruiting Herston, Queensland, Australia, 4029 Australia, Victoria Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 France Investigative Site Recruiting Bondy, France, 93140 Investigative Site Recruiting Orléans, France, 45000 Investigative Site Recruiting Pessac, France, 33604 Investigative Site Recruiting Rennes Cedex 9, France, 35033 United Kingdom Investigative Site Recruiting Bradford, England, United Kingdom, BD9 6RJ Investigative Site Recruiting Newcastle Upon Tyne, England, United Kingdom, NE7 7DN Investigative Site Recruiting Portsmouth, England, United Kingdom, PO6 3LY 收起 <<
NCT02729051	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	-
NCT02660736	Diabetes Mellitus, Type 2	Phase 1	Completed	-	United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 <<
NCT01304927	Male Infertility	Phase 2 Phase 3	Completed	-	Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark, 2100 收起 <<
NCT03493386	Anaemia	Phase 1	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 <<
NCT02966834	Cholestasis	Phase 2	Recruiting	April 1, 2020	-
NCT03136991	Cardiovascular Disease	Phase 1	Completed	-	United States, California ... 展开 >> Research Site Glendale, California, United States, 91206 收起 <<
NCT03472742	-		Recruiting	July 31, 2021	Japan ... 展开 >> Niigata University Medical & Dental Hospital Recruiting Niigata, Japan, 951-8510 Contact: Division of Gastroenterology and Hepatology 收起 <<
NCT02041299	Iron Overload ... 展开 >> Sickle Cell Disease Other Anemias 收起 <<	Phase 4	Recruiting	September 2019	-
NCT02832362	Common Cold	Phase 1	Completed	-	Canada, Quebec ... 展开 >> GSK Investigational Site Quebec City, Quebec, Canada, G1P 0A2 收起 <<
NCT03511105	Healthy Volunteers	Phase 1	Recruiting	February 3, 2019	Germany ... 展开 >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03019042	Gastrointestinal Disease	Not Applicable	Active, not recruiting	December 2019	China, Jiangxi ... 展开 >> Jiangxi University of Traditional Chinese Medicine Nanchang, Jiangxi, China, 330004 收起 <<
NCT03555890	Rhinitis	Phase 1	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 收起 <<
NCT00350415	Ulcerative Colitis	Phase 3	Completed	-	-
NCT03393806	Asthma	Phase 2	Recruiting	October 10, 2019	France ... 展开 >> GSK Investigational Site Not yet recruiting Brest Cedex, France, 29609 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Marseille, France, 13015 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Montpellier cedex 5, France, 34295 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1105 AZ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Wythenshawe, Greater Manchester, United Kingdom, M23 9LT Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Leicester, Leicestershire, United Kingdom, LE3 9QP Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Liverpool, Merseyside, United Kingdom, L7 8XP Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Birmingham, United Kingdom, B9 5SS Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Bradford, United Kingdom, BD9 6RJ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Edgbaston, United Kingdom, B15 2GW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03288064	Athletic Performance ... 展开 >> Oxidative Stress Inflammation 收起 <<	Not Applicable	Completed	-	Greece ... 展开 >> School of Physical Education and Sport Science, University of Thessaly Trikala, Thessaly, Greece, 42100 收起 <<
NCT03329547	Infections, Bacterial	Phase 1	Withdrawn(Change in commercial... 展开 >> strategy) 收起 <<	February 2, 2018	-
NCT03677596	Leukemia Prec... 展开 >>ursor b-Cell Lymphoblastic Leukemia-Lymphoma ACUTE LYMPHOBLASTIC LEUKEMIA 收起 <<	Phase 4	Not yet recruiting	May 16, 2025	-
NCT01820494	Growth and Tolerance Infant St... 展开 >>udy 收起 <<	Not Applicable	Completed	-	United States, Maryland ... 展开 >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Michigan Children's Hospital of Detroit Detroit, Michigan, United States, 48201 United States, Nebraska Children's Hospital Omaha, Nebraska, United States, 68114 收起 <<
NCT03329573	Anxiety Disorders	Phase 1	Completed	-	China ... 展开 >> GSK Investigational Site Shanghai, China, 201508 收起 <<
NCT00258050	Neoplasms, Breast	Phase 1	Completed	-	United States, New Hampshire ... 展开 >> GSK Investigational Site Lebanon, New Hampshire, United States, 03756 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599 收起 <<
NCT02666287	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 <<
NCT03149848	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom 收起 <<
NCT02478463	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Active, not recruiting	September 10, 2019	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21287-5554 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 收起 <<
NCT03562117	Infections, Bacterial	Phase 1	Recruiting	April 10, 2019	United States, Florida ... 展开 >> GSK Investigational Site Recruiting Miami, Florida, United States, 33136 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Orlando, Florida, United States, 32809 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03299049	HIV Infections	Phase 3	Active, not recruiting	March 11, 2022	-
NCT02893488	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 1	Completed	-	United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 <<
NCT02924688	Asthma	Phase 3	Active, not recruiting	February 21, 2019	-
NCT03562195	Asthma	Phase 3	Recruiting	April 2, 2021	China, Guangdong ... 展开 >> GSK Investigational Site Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China, Jilin GSK Investigational Site Not yet recruiting Changchun, Jilin, China, 130041 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China, Xinjiang GSK Investigational Site Not yet recruiting Urumqi, Xinjiang, China, 830054 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China, Zhejiang GSK Investigational Site Recruiting Wenzhou, Zhejiang, China, 323027 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China GSK Investigational Site Not yet recruiting Guangzhou, China, 511400 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Shanghai, China Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02802514	Diabetes Mellitus	Phase 4	Terminated	-	United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02114 收起 <<
NCT03316131	Asymptomatic Hyperuricemia	Phase 2	Completed	-	United States, California ... 展开 >> Research Site Glendale, California, United States, 91206 United States, Maryland Research Site Baltimore, Maryland, United States, 21225 收起 <<
NCT02578953	Prostatic Hyperplasia	Phase 1	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 <<
NCT02899026	Polymyalgia Rheumatica	Phase 3	Withdrawn(GSK decision to retu... 展开 >>rn rights to sirukumab to Janssen and discontinue sirukumab development in polymyalgia rheumatica.) 收起 <<	August 26, 2021	-
NCT03266172	Autoimmune Diseases	Phase 1	Recruiting	November 13, 2018	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Nottingham, United Kingdom, NG11 6JS Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02837380	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 1	Completed	-	China ... 展开 >> GSK Investigational Site Shanghai, China, 200030 收起 <<
NCT01377571	Diarrhea Feve... 展开 >>r Nausea Vomit Irritability 收起 <<	Phase 2	Completed	-	Vietnam ... 展开 >> Preventive Medicine center Thanh Son, Phu Tho, Vietnam 收起 <<
NCT02502812	Cardiovascular Disease	Phase 1	Completed	-	India ... 展开 >> GSK Investigational Site Telangana, India, 500 013 收起 <<
NCT02794519	Asthma	Phase 2	Withdrawn(This study has suspe... 展开 >>nded participant recruitment.) 收起 <<	October 4, 2016	United States, California ... 展开 >> GSK Investigational Site Long Beach, California, United States, 90808 United States, Florida GSK Investigational Site Aventura, Florida, United States, 33180 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45231 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23225 GSK Investigational Site Richmond, Virginia, United States, 23229 Spain GSK Investigational Site Alcorcón (Madrid), Spain, 28922 GSK Investigational Site Gerona, Spain, 17005 GSK Investigational Site Santiago De Compostela. La Coruña., Spain, 15706 收起 <<
NCT03639311	HIV Infections	Phase 2	Not yet recruiting	November 30, 2020	United States, Florida ... 展开 >> GSK Investigational Site Not yet recruiting Fort Lauderdale, Florida, United States, 33316 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Not yet recruiting Dallas, Texas, United States, 75246 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT02751294	Malaria, Vivax	Phase 1	Completed	-	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 <<
NCT03417830	Amyloidosis	Phase 1	Terminated(Change in benefit/r... 展开 >>isk profile.) 收起 <<	-	Sweden ... 展开 >> GSK Investigational Site Uppsala, Sweden, SE-751 85 GSK Investigational Site Uppsala, Sweden, SE-751 收起 <<
NCT02706535	Drug Interactions	Phase 1	Completed	-	United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 <<
NCT03250689	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Active, not recruiting	December 3, 2018	United Kingdom ... 展开 >> GSK Investigational Site Dundee, United Kingdom, DD1 9SY 收起 <<
NCT03345407	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Active, not recruiting	January 10, 2019	-
NCT03575962	HIV Infections	Phase 1	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Nottingham, United Kingdom, NG11 6JS 收起 <<
NCT03408392	Infections, Bacterial	Phase 1	Completed	-	South Africa ... 展开 >> GSK Investigational Site Bloemfontein, Free State, South Africa, 9300 收起 <<
NCT02698553	Depressive Disorder, Major	Phase 1	Completed	-	China ... 展开 >> GSK Investigational Site Shanghai, China, 200030 收起 <<
NCT00549679	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Estonia ... 展开 >> GSK Investigational Site Tallinn, Estonia, 13419 Finland GSK Investigational Site Tampere, Finland, 33520 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Berlin, Germany, 10717 GSK Investigational Site Hamburg, Germany, 22291 Netherlands GSK Investigational Site Hoorn, Netherlands, 1624 NP GSK Investigational Site Horn, Netherlands, 6085 NM GSK Investigational Site Veldhoven, Netherlands, 5504 DB Russian Federation GSK Investigational Site Barnaul, Russian Federation, 656 045 GSK Investigational Site Moscow, Russian Federation, 105 077 GSK Investigational Site St. Petersburg, Russian Federation, 197022 GSK Investigational Site Yaroslavl, Russian Federation, 150003 Slovakia GSK Investigational Site Bratislava, Slovakia, 826 06 GSK Investigational Site Kosice, Slovakia, 041 90 GSK Investigational Site Martin, Slovakia, 036 59 收起 <<
NCT01124318	Atopic Dermatitis	Phase 2 Phase 3	Completed	-	Russian Federation ... 展开 >> Moscow Dermatovenerologic Clinical Dispensary № 1 Moscow, Russian Federation, 119071 Moscow State University of Medicine and Dentistry Moscow, Russian Federation, 127473 收起 <<
NCT03000686	Healthy Volunteers	Phase 1	Recruiting	June 14, 2019	Germany ... 展开 >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03258762	Toxoplasmosis	Phase 1	Completed	-	Australia, Victoria ... 展开 >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 收起 <<
NCT03697824	Neoplasms	Phase 2	Not yet recruiting	July 17, 2022	-
NCT03286842	HER2-ve Metastatic Breast Canc... 展开 >>er Germline BRCA1/2 Mutations Somatic BRCA1/2 Mutations 收起 <<	Phase 3	Recruiting	November 30, 2020	-
NCT03055195	Dermatitis, Atopic	Phase 2	Terminated(Study reached pre-d... 展开 >>etermined futility criteria following interim analysis. No safety concerns were noted.) 收起 <<	-	-
NCT03132740	-		Recruiting	June 1, 2019	China, Guangdong ... 展开 >> Zhujiang Hospital of The Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Chihua Fang, MD (+86)2062782568 s_mountain@126.com Contact: Qingshan Chen, MM (+86)2062782568 s_mountain@126.com 收起 <<
NCT03557281	Tuberculosis	Phase 2	Not yet recruiting	September 13, 2020	-
NCT02723786	Kidney Transplantation (Status... 展开 >> Post) 收起 <<	Phase 2	Recruiting	November 23, 2018	Spain ... 展开 >> GSK Investigational Site Not yet recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting L'Hospitalet de Llobregat, Spain, 08907 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Cardiff, United Kingdom, CF14 4XW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Edinburgh, United Kingdom, EH16 4SA Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Glasgow., United Kingdom, G51 4TF Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Newcastle upon Tyne., United Kingdom, NE7 7DN Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Oxford, United Kingdom, OX3 7LE Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT01733901	Coronary Heart Disease	Not Applicable	Unknown	July 2015	China, Jiangsu ... 展开 >> First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210000 Principal Investigator: Qijun Shan, Professor Principal Investigator: Zhijian Yang, Professor Principal Investigator: Chun Chen, Professor Principal Investigator: Xiujuan Zhou, Professor Sub-Investigator: Weichong Qian, Professor Sub-Investigator: Zhenhua Dai, Doctor Sub-Investigator: Jie Gen, Master Sub-Investigator: Zhongxia Zhou, Master Sub-Investigator: Min Qiu, Doctor 收起 <<
NCT03132649	-		Recruiting	June 1, 2019	China, Guangdong ... 展开 >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Chihua Fang, MD (+86)2062782568 s_mountain@126.com Contact: Qingshan Chen, MM (+86)2062782568 s_mountain@126.com 收起 <<
NCT03534752	-		Recruiting	April 1, 2020	Switzerland ... 展开 >> Lausanne University Hospitals Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: F , MD 收起 <<
NCT01610232	Healthy	Phase 1	Completed	-	Brazil ... 展开 >> Optics Group from Physics Institute of São Carlos (IFSC), University of São Paulo (USP) São Carlos, São Paulo, Brazil, 369 收起 <<
NCT03479892	Metabolism and Nutrition Disor... 展开 >>der Obesity 收起 <<	Phase 1	Recruiting	May 4, 2019	United States, Texas ... 展开 >> Novo Nordisk Investigational Site Recruiting San Antonio, Texas, United States, 78209 收起 <<
NCT02012361	Ischemia	Phase 1	Completed	-	United States, Florida ... 展开 >> UF Health Gainesville, Florida, United States, 32610 收起 <<
NCT01433562	Breast Cancer	Phase 2 Phase 3	Completed	-	Indonesia ... 展开 >> Surgery-Oncology Division, Department of Surgery, Faculty of Medicine, University of Airlangga / Dr. Soetomo Hospital Surabaya, East Java, Indonesia, 60286 收起 <<
NCT03672994	-		Recruiting	March 30, 2019	United Kingdom ... 展开 >> NIHR Leicester Biomedical Research Centre - Respiratory, Glenfield Hospital Recruiting Leicester, Leicestershire, United Kingdom, LE3 9QP Contact: Amisha Singapuri, Bsc Hons 01162583370 ext 3072 amisha.singapuri@uhl-tr.nhs.uk Contact: Wadah Ibrahim, MBBS, MRCP 01162583370 wadah.ibrahim@uhl-tr.nhs.uk 收起 <<
NCT03725436	Advanced Malignant Solid Neopl... 展开 >>asm Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Estrogen Receptor Positive HER2/Neu Negative Metastatic Malignant Solid Neoplasm Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8 Recurrent Breast Carcinoma TP53 wt Allele Unresectable Malignant Solid Neoplasm 收起 <<	Phase 1	Not yet recruiting	July 26, 2023	United States, Texas ... 展开 >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Funda Meric-Bernstam 713-563-1930 Principal Investigator: Funda Meric-Bernstam 收起 <<
NCT03372603	Cough	Phase 2	Active, not recruiting	April 22, 2019	United Kingdom ... 展开 >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7BL GSK Investigational Site Cottingham, United Kingdom, HU16 5JQ GSK Investigational Site North Shields, United Kingdom, NE29 8NH 收起 <<
NCT02245932	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Not Applicable	Completed	-	Netherlands ... 展开 >> Maastricht University Medical Center Maastricht, Limburg, Netherlands 收起 <<
NCT00707239	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00940017	Aspergillosis ... 展开 >> Candidemia 收起 <<	Phase 4	Completed	-	United States, Connecticut ... 展开 >> Pfizer Investigational Site Hartford, Connecticut, United States, 06102 收起 <<
NCT00707239	Pneumonia, Bacterial	Phase 2	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00359177	Vomiting	Phase 1	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Gainesville, Florida, United States, 32608 GSK Investigational Site Orlando, Florida, United States, 32809 收起 <<
NCT00940017	-		Completed	-	-
NCT02752867	Cognitive Impairment	Not Applicable	Recruiting	April 2018	China, Beijing ... 展开 >> Department of Neurology,Dongfang Hospital,Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100078 Contact: Yunling Zhang, PhD,MD 86 10 67689634 收起 <<
NCT02475655	HIV Infections	Phase 2	Completed	-	United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 UCSD Antiviral Research Center CRS San Diego, California, United States, 92103 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Missouri Washington University Therapeutics (WT) CRS Saint Louis, Missouri, United States, 63110-1010 United States, New York Weill Cornell Chelsea CRS New York, New York, United States, 10010 Weill Cornell Uptown CRS New York, New York, United States, 10065 University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester, New York, United States, 14642 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 Case Clinical Research Site Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence, Rhode Island, United States, 02906 United States, Tennessee Vanderbilt Therapeutics (VT) CRS Nashville, Tennessee, United States, 37204 收起 <<
NCT02481466	Cardiovascular Diseases ... 展开 >> Hypercholesterolemia Type 2 Diabetes Metabolic Syndrome 收起 <<	Not Applicable	Recruiting	December 2022	Canada, British Columbia ... 展开 >> Healthy Heart Lipid Clinic, St. Paul's Hospital Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Principal Investigator: Jiri Frohlich, MD Canada, Manitoba Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Not yet recruiting Winnipeg, Manitoba, Canada, R3T 6C5 Contact: Peter Jones, PhD Principal Investigator: Peter Jones, PhD Canada, Ontario Risk Factor Modification Centre, St. Michael's Hospital Recruiting Toronto, Ontario, Canada, M5C 2T2 Contact: David J Jenkins, MD PhD 416-867-7475 David.jenkins@utoronto.ca Contact: Dorothea A Faulkner, PhD 416-360-4000 ext 48175 FaulknerD@smh.ca Principal Investigator: David J Jenkins, MD PhD Sub-Investigator: Cyril Kendall, PhD Sub-Investigator: Robert Josse, MD Sub-Investigator: Lawrence Leiter, MD Sub-Investigator: John Sievenpiper, MD PhD Sub-Investigator: Anish Kirpalani, MD Canada, Quebec Institute of Nutraceuticals and Functional Foods, Laval University Recruiting Quebec City, Quebec, Canada, G1V 4G2 Contact: Benoit Lamarche, PhD Principal Investigator: Benoit Lamarche, PhD 收起 <<
NCT03418896	Hypogonadism ... 展开 >>Calcium Disorder Renal Disease 收起 <<	Not Applicable	Recruiting	December 31, 2019	Denmark ... 展开 >> Department of Growth and Reproduction, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Li Juel Mortensen, MD +4535459456 Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Martin Blomberg Jensen, MD +4535451865 blombergjensen@gmail.com Principal Investigator: Martin Blomberg Jensen, MD 收起 <<
NCT01226563	Acute Myocardial Infarction ... 展开 >> Congestive Heart Failure ST-Elevation Myocardial Infarction 收起 <<	Not Applicable	Completed	-	-
NCT03657186	Overweight We... 展开 >>ight Loss 收起 <<	Not Applicable	Recruiting	August 2019	Germany ... 展开 >> Analyze & Realize Recruiting Berlin, Germany, 10369 Contact: Udo Bongartz, Dr. med. Barbara Grube Recruiting Berlin, Germany, 10709 Contact: Barbara Grube Jörg Förstermann Recruiting Berlin, Germany, 14059 Contact: Jörg Förstermann 收起 <<
NCT02552888	Chronic Kidney Disease	Phase 2	Completed	-	United States, Louisiana ... 展开 >> Tulane School of Medicine New Orleans, Louisiana, United States, 70112 收起 <<
NCT02256124	Neurofibromatosis Type 1	Phase 2 Phase 3	Recruiting	July 2019	Belgium ... 展开 >> University Hospital Leuven Recruiting Leuven, Belgium, B-3000 Contact: Eric Legius, MD, PhD +3216345903 eric.legius@uzleuven.be Contact: Ellen Plasschaert, MSc +3216345903 ellen.plasschaert@uzleuven.be Sub-Investigator: Ellen Plasschaert, MSc Principal Investigator: Eric Legius, MD, PhD Netherlands Erasmus Medical Center Recruiting Rotterdam, South Holland, Netherlands, 3015CN Principal Investigator: Marie-Claire Y de Wit, MD, PhD Sub-Investigator: Myrthe Ottenhoff, MD, MSc Spain Hospital Sant Joan de Deu Recruiting Barcelona, Spain Contact: Hector Salvador Hernandez, Dr. 收起 <<
NCT03036800	Obesity Weigh... 展开 >>t Loss Diabetes Mellitus 收起 <<	Phase 4	Recruiting	January 2021	Ireland ... 展开 >> St Vincent's University Hospital Recruiting Dublin, Ireland Contact: Carel Le Roux, Prof 0171 66 831 carel.leroux@ucd.ie Principal Investigator: Carel LeRoux, Prof Sub-Investigator: Donel O'Shea, Prof United Kingdom NHS Greater Glasgow and Clyde West Glasgow Ambulatory Care Hospital Not yet recruiting Glasgow, United Kingdom Contact: Mike Lean, Prof 0141 201 8604 mike.lean@glasgow.ac.uk University Hospitals of Leicester NHS Trust, Leicester General Hospital Recruiting Leicester, United Kingdom Contact: Melanie Davies, Prof 0116 258 6481 melanie.davies@uhl-tr.nhs.uk Sub-Investigator: David Webb, Dr University Hospital Aintree Recruiting Liverpool, United Kingdom Contact: John Wilding, Prof 0151 529 5899 J.P.H.Wilding@liverpool.ac.uk Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Contact: Barbara McGowan, Dr 020 7188 1912 barbara.mcGowan@gstt.nhs.uk 收起 <<
NCT01723007	Hypercholesterolemia ... 展开 >> Overweight 收起 <<	Not Applicable	Completed	-	Brazil ... 展开 >> Department of Public Health-DSC-FM School of Medicine, Federal University of Amazon-UFAM Manaus-AM, Amazon, Brazil, 69000000 Department of Public Health-DSC, School of Medicine-FM, University of Aamazon-UFAM Manaus, Amazon, Brazil, 69000000 收起 <<
NCT03686618	Pancreatitis, Acute	Phase 2	Not yet recruiting	November 1, 2019	United States, New Hampshire ... 展开 >> Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 收起 <<
NCT02210806	Asthma	Phase 2	Completed	-	United States, California ... 展开 >> Amphastar Site 0001 San Jose, California, United States, 95117 United States, Oregon Amphastar Site 0025 Medford, Oregon, United States, 97504 United States, Texas Amphastar Site 0030 New Braunfels, Texas, United States, 78130 Amphastar Site 0032 San Antonio, Texas, United States, 78229 收起 <<
NCT03658512	-		Recruiting	February 1, 2028	Germany ... 展开 >> University of Tuebingen, Internal medicine IV Recruiting Tuebingen, Germany, 72074 Contact: Andreas Fritsch, Prof, MD +49 7071 29 ext 82711 andreas.fritsche@med.uni-tuebingen.de Principal Investigator: Andreas Fritsche, MD 收起 <<
NCT02606097	Gastrointestinal Stromal Tumou... 展开 >>r (GIST) 收起 <<	Phase 2	Unknown	-	Taiwan ... 展开 >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Chun-Nan Yeh, MD 886-3-3281200 ext 3219 yehchunnan@gmail.com 收起 <<
NCT00778622	Type 2 Diabetes Mellitus	Phase 4	Completed	-	China, Beijing ... 展开 >> Local Institution Beijing, Beijing, China, 100028 Local Institution Beijing, Beijing, China, 100034 Local Institution Beijing, Beijing, China, 100044 Local Institution Beijing, Beijing, China, 100088 Local Institution Beijing, Beijing, China, 100730 Local Institution Beijing, Beijing, China, 101100 Local Institution Beijing, Beijing, China, 200016 China, Guangdong Local Institution Guangdong Province, Guangdong, China, 510180 Local Institution Guangdong Province, Guangdong, China, 528000 Local Institution Guangdong, Guangdong, China, 510180 China, Shanghai Local Institution Shanghai, Shanghai, China, 200003 Local Institution Shanghai, Shanghai, China, 200092 Local Institution Shanghai, Shanghai, China, 201100 Local Institution Shanghai, Shanghai, China, 201200 收起 <<
NCT01935804	Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders 收起 <<	Phase 2	Completed	-	Saudi Arabia ... 展开 >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Makkah, Saudi Arabia, 21589 收起 <<
NCT02164552	-		Unknown	December 2014	Saudi Arabia ... 展开 >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Recruiting Jeddah, Makkah, Saudi Arabia, 21589 Contact: Veronica B Orbacedo, BSc 0096612640000 ext 25574 vorbacedo@yahoo.com Contact: Ramia Al-sobhi, BSc 0096612640000 ext 25528 ceor@kau.edu.sa Sub-Investigator: Ahmed Y Ali, MD Sub-Investigator: Ghazi Y Refai, MD Sub-Investigator: Mohammed H Qari, FRCPA Sub-Investigator: Heba S Kary, MD 收起 <<
NCT02728453	Diabetes Mellitus Type 2	Phase 4	Active, not recruiting	April 2019	Germany ... 展开 >> Hannover Medical School Hannover, Germany, 30625 收起 <<
NCT02059811	Hypertension ... 展开 >>Chronic Kidney Disease 收起 <<	Not Applicable	Completed	-	United States, North Carolina ... 展开 >> Stedman Nutrition and Metabolism Center, Center for Living Durham, North Carolina, United States, 27705 收起 <<
NCT00778622	-		Completed	-	-
NCT03008954	Overweight Ob... 展开 >>esity 收起 <<	Not Applicable	Completed	-	Czechia ... 展开 >> Hradec Králové Hradec, Czechia, 500 00 Charles University Prague, Czechia, 121 08 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy Federico University Hospital Naples, Italy, 80131 Policlinico Umberto I Rome, Italy, 00161 收起 <<
NCT03021291	Overweight and Obesity	Not Applicable	Completed	-	United States, California ... 展开 >> Arternis Institute for Clinical Research San Diego, California, United States, 92103 Clinical Trial Investigators Tustin, California, United States, 92780 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Westside Center for Clinical Research Jacksonville, Florida, United States, 32205 United States, Louisiana Pennington Biomedical Research Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Cornell Weill Medical College New York, New York, United States, 10065 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Aventiv Research Columbus, Ohio, United States, 43213 United States, Pennsylvania Geisinger Health System Danville, Pennsylvania, United States, 17822 United States, Texas Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Czechia Health & Care SRO Prague, Czechia, 182 00 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy IRCCS Policlinico San Donato Milan, Italy, 20097 University of Rome Rome, Italy, 00186 Spain University of Navarra Pamplona, Spain, 31008 收起 <<
NCT03283267	Hyperkalemia	Phase 1	Completed	-	Hong Kong ... 展开 >> Research Site Hong Kong, Hong Kong 收起 <<
NCT02922140	Acute Coronary Syndrome	Not Applicable	Unknown	August 2017	Egypt ... 展开 >> Ain Shams University Cairo, Egypt 收起 <<
NCT03249181	HIV-1-infection ... 展开 >> Pregnancy Related 收起 <<	Phase 3	Active, not recruiting	March 2021	South Africa ... 展开 >> University of Cape Town Cape Town, Western Cape, South Africa Uganda Infectious Diseases Institute Kampala, Uganda 收起 <<
NCT01435382	Hypercholesterolemia ... 展开 >> Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Maryland PAREXEL International - Baltimore Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 收起 <<
NCT01389596	-		Completed	-	-
NCT03039205	Platelet Aggregation ... 展开 >> Adenosine Coronary Artery Disease Kidney Dysfunction Antiplatelet Therapy 收起 <<	Phase 2	Recruiting	December 15, 2018	Brazil ... 展开 >> Instituto do Coração (InCor) - Hospital das Clínicas da FMUSP Recruiting Sao Paulo, Brazil Contact: André Franci, M.D. 55 11 2661-5850 收起 <<
NCT02525497	Kidney Failure,Chronic	Not Applicable	Unknown	December 2017	China, Beijing ... 展开 >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: ZHOU Jianhui, Doctor +86 010 66935462 china_pd@126.com Contact: CHEN Xiangmei, Doctor +86 010 66935462 xmchen301@126.com 收起 <<
NCT01712074	Alzheimer's Disease	Phase 2	Terminated(The study was termi... 展开 >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) 收起 <<	-	-
NCT01473407	Chronic Kidney Disease ... 展开 >> Chronic Renal Failure 收起 <<	Phase 3	Completed	-	-
NCT01389596	Epilepsy, Partial Seizures	Phase 3	Completed	-	-
NCT01473420	Chronic Renal Failure ... 展开 >> Chronic Kidney Disease 收起 <<	Phase 3	Completed	-	-
NCT01473407	-		Completed	-	-
NCT01473420	-		Completed	-	-
NCT02552602	HIV	Not Applicable	Unknown	February 2016	-
NCT00570063	Schizophrenia	Phase 2	Terminated	-	United States, California ... 展开 >> California Clinical Trials Medical Group, Inc. Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Telecare-Cresta Loma Lemon Grove, California, United States, 91945 California Clinical Trials Medical Group Paramount, California, United States, 90723 LaPaz Geropsychiatric Center Paramount, California, United States, 90723 California Clinical Trials Medical Group San Diego, California, United States, 92123 United States, Connecticut Connecticut Mental Health Center-Yale University, Clinical Neuroscience Research Unit New Haven, Connecticut, United States, 06519 United States, New Jersey CRI Worldwide, LLC Willingboro, New Jersey, United States, 08046 United States, Oklahoma St. Anthony Hospital Oklahoma City, Oklahoma, United States, 73101 IPS Research Company Oklahoma City, Oklahoma, United States, 73103 收起 <<
NCT03528681	Hyperkalemia	Phase 3	Not yet recruiting	October 7, 2019	-
NCT01712074	-		Terminated(The study was termi... 展开 >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) 收起 <<	-	-
NCT00425061	Asthma	Phase 2	Completed	-	-
NCT01435382	-		Completed	-	-
NCT00531752	Attention Deficit Hyperactivit... 展开 >>y Disorder 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Bay Area Research Institute Lafayette, California, United States, 94549 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 United States, Illinois The University of Illinois at Chicago, Institute for Juvenile Research Chicago, Illinois, United States, 60608 United States, Massachusetts Massachusetts General Hospital, ADHD Program Cambridge, Massachusetts, United States, 02138 United States, New York New York University School of Medicine New York, New York, United States, 10010 United States, Virginia NeuroScience, Inc Herndon, Virginia, United States, 20170 收起 <<
NCT00425061	-		Completed	-	-
NCT00570063	-		Terminated	-	-
NCT02875834	Hyperkalemia	Phase 3	Completed	-	-
NCT00886821	Diabetes Mellitus, Type 2	Phase 1	Completed	-	United States, Florida ... 展开 >> Cetero Research Miami Gardens, Florida, United States, 33169 United States, Texas Cetero Research - San Antonio San Antonio, Texas, United States, 78229 收起 <<
NCT00531752	-		Completed	-	-
NCT02072824	Partial Onset Seizures	Phase 3	Completed	-	-
NCT00886821	-		Completed	-	-
NCT02072824	-		Completed	-	-
NCT02800967	Hypertension ... 展开 >>Overweight 收起 <<	Not Applicable	Unknown	June 2017	Serbia ... 展开 >> Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade Belgrade, Serbia, 11000 收起 <<
NCT02355769	-		Completed	-	Poland ... 展开 >> Military Institute of Medicine Warsaw, Mazovia, Poland, 04-141 收起 <<
NCT01994291	Macular Edema, Diabetic	Phase 2	Terminated	-	-
NCT01312909	Smoking Cessation	Phase 4	Completed	-	-
NCT01994291	-		Terminated	-	-
NCT00528879	Type 2 Diabetes	Phase 3	Completed	-	-
NCT03355079	Cancer-related Malnutrition	Phase 4	Recruiting	July 2020	France ... 展开 >> Hôpital Cochin Recruiting Paris, France, 75014 收起 <<
NCT01879839	Renal Failure Chronic Contrast... 展开 >> Induced 收起 <<	Phase 4	Completed	-	Germany ... 展开 >> University Hospital of Cologne Cologne, Germany, 50937 收起 <<
NCT02650193	Non-metastatic Breast Cancer	Phase 2	Completed	-	Hungary ... 展开 >> CRU Hungary Kft.,CRU Early Phase Unit, Miskolci Semmelweis Kórház és Egyetemi Oktató Kórház Miskolc, BAZ Megye, Hungary, 3529 Debreceni Egyetem Klinikai Központ, ÁOK, Onkológiai Klinika Debrecen, Hajdú-bihar Megye, Hungary, 4032 Országos Onkológiai Intézet Budapest, Hungary, 1122 Spain Hospital Universitario Arnau de Vilanova Lleida, Cataluna, Spain, 25198 Hospital Universitario de Fuenlabrada, Servicio de oncologia Fuenlanbrada, Madrid, Spain, 28942 START Madrid - CIOCC, Unidad de fases 1 planta 3, Hospital Universitario HM Sanchinarro Madrid, Spain, 28050 Hospital Arnau de Vilanova. planta 6, unidad de Oncología Valencia, Spain, 46015 收起 <<
NCT00528879	-		Completed	-	-
NCT02657759	HYPERCHOLESTEROLEMIA	Not Applicable	Unknown	May 2016	France ... 展开 >> Biofortis Recruiting Saint-Herblain, France, 44800 Contact: Patrice CHAUVEAU + 33 (0)2 40 20 45 65 patrice.chauveau@mxns.com Principal Investigator: David GENDRE, M.D. 收起 <<
NCT02244164	Type 2 Diabetes ... 展开 >> Incretinomimetics Pancreas 收起 <<	Not Applicable	Recruiting	-	Belgium ... 展开 >> Gastroenterology Department Erasme Hospital Recruiting Brussels, Belgium, 1070 Contact: Vincent Huberty, MD +3225553715 vincent.huberty@erasme.ulb.ac.be 收起 <<
NCT02650193	-		Completed	-	-
NCT02757625	ICU Sedation	Phase 3	Completed	-	Japan ... 展开 >> Asahikawa Medical University Hospital Asahikawa, Hokkaido, Japan, 078-8510 Hyogo Prefectural Kobe Children's Hospital Kobe, Hyogo, Japan, 650-0047 Shikoku Medical Center for Children and Adults Zentsuji, Kagawa, Japan, 765-8507 Osaka Women's and Children's Hospital Izumi, Osaka, Japan, 594-1101 Osaka Medical College Hospital Takatsuki, Osaka, Japan, 569-8686 Jichi Medical University Hospital Shimotsuke, Tochigi, Japan, 329-0498 Juntendo University Hospital Bunkyo-ku, Tokyo, Japan, 113-8431 Tokyo Metropolitan Children's Medical Center Fuchu, Tokyo, Japan, 183-8561 University Hospital, Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Okayama University Hospital Okayama, Japan, 700-8558 Osaka City General Hospital Osaka, Japan, 534-0021 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 收起 <<
NCT02007512	Breast Cancer	Phase 2	Active, not recruiting	March 29, 2019	-
NCT01312909	-		Completed	-	-
NCT02007512	-		Active, not recruiting	-	-
NCT01440049	-		Completed	-	-
NCT02757625	-		Completed	-	-
NCT02956447	Hyperprolactinemia ... 展开 >> Hypogonadism 收起 <<	Phase 2	Recruiting	February 2021	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Isabella McDonald 617-726-8484 mghkisspeptinresearch@partners.org 收起 <<
NCT01440049	-		Completed	-	-
NCT03591471	Henoch-Schönlein Purpura Nephr... 展开 >>itis 收起 <<	Phase 1 Phase 2	Recruiting	December 2018	China, Henan ... 展开 >> Children's Hospital, The First Affiliated Hospital of HUTCM Recruiting Zhengzhou, Henan, China, 450000 Contact: Ying Ding, Director +86-13503840642 dingying3236@sina.com Contact: Xia Zhang, secretary +86-13838276039 zhangxia_125@163.com Principal Investigator: Ying Ding, Director The First Affiliated Hospital of Henan University of Traditional Chinese Medicine Recruiting Zhengzhou, Henan, China, 450000 Contact: Ying Ding, MD +86-371-66221361 dingying3236@sina.com Contact: Xia zhang, MD +86-371-13213210370 ardar123@sina.com Principal Investigator: Jiansheng Li, MD 收起 <<
NCT02540252	-		Active, not recruiting	April 2017	Denmark ... 展开 >> University Hospital of Copenhagen, Hvidovre Hvidovre, Copenhagen, Denmark, 2650 收起 <<
NCT02027987	Traumatic Brain Injury	Phase 1	Unknown	December 2016	China, Shaanxi ... 展开 >> Institute of Neurosurgery, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu S Jie, M.D., Ph.D. 086 029 84773307 hushijie@fmmu.edu.cn Contact: Fei Zhou, M.D., Ph.D. 086 029 13992888996 feizhou@fmmu.edu.cn Principal Investigator: Hu S Jie, M.D., Ph.D. 收起 <<
NCT00054132	-		Completed	-	-
NCT00054132	Recurrent Breast Carcinoma ... 展开 >> Stage IV Breast Cancer 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> UCSF Medical Center-Mount Zion San Francisco, California, United States, 94115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT02418650	Healthy	Phase 1	Completed	-	United Kingdom ... 展开 >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS 收起 <<
NCT00797108	-		Completed	-	-
NCT01889238	Advanced, Androgen Receptor Po... 展开 >>sitive Triple Negative Breast Cancer 收起 <<	Phase 2	Active, not recruiting	June 30, 2019	-
NCT02303392	Prolymphocytic Leukemia ... 展开 >> Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia 收起 <<	Phase 1	Recruiting	December 31, 2018	United States, Ohio ... 展开 >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer C. Woyach, MD 614-293-8165 Jennifer.Woyach@osumc.edu Principal Investigator: Jennifer Woyach, MD United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Deborah Stephens, DO Principal Investigator: Deborah Stephens, DO 收起 <<
NCT02976246	Vitamin K Supplementation ... 展开 >> Endstage Renal Disease Cardiovascular Disease Bone Disease 收起 <<	Phase 2 Phase 3	Recruiting	August 2020	Denmark ... 展开 >> Holbaek Hospital Not yet recruiting Holbaek, Denmark, 4300 Contact: Marianne Berthelsen, MDS mbte@regionsjaelland.dk Zealand University Hospital Recruiting Roskilde, Denmark, 4000 Contact: Karin Levy-Schousboe, phd student +45 23351803 kshb@regionsjaelland.dk Contact: Peter Marckmann, MDS +45 23351228 pmar@regionsjaelland.dk 收起 <<
NCT00797108	Pneumonia, Bacterial	Phase 2	Completed	-	United States, California ... 展开 >> eStudySite, Inc. Chula Vista, California, United States, 91911 Sharp Chula Vista Medical Center Chula Vista, California, United States, 91911 eStudySite, Inc. Oceanside, California, United States, 92056 Tri-City Medical Center Oceanside, California, United States, 92056 United States, Illinois Medical Arts Associates, Ltd Moline, Illinois, United States, 61265 Trinity Medical Center Rock Island, Illinois, United States, 61201 United States, Minnesota Infectious Disease Minneapolis Limited Minneapolis, Minnesota, United States, 55422 United States, Ohio Summa Health System Akron, Ohio, United States, 44304 Summa Health System Akron, Ohio, United States, 44309 Summa Health System Akron, Ohio, United States, 44310 United States, Utah Utah Valley Pulmonary Clinic Provo, Utah, United States, 84604 Utah Valley Regional Medical Center Provo, Utah, United States, 84604 Australia, Queensland Infection Management Services, Building 17, Level 1 Brisbane, Queensland, Australia, 4102 Canada, Ontario Hamilton Health Sciences - General Site Hamilton, Ontario, Canada, L8L 2X2 Hamilton Health Sciences- McMaster Site Hamilton, Ontario, Canada, L8N 3Z5 Hamilton Health Sciences - Henderson Site Hamilton, Ontario, Canada, L8V 1C3 Korea, Republic of Asan Medical Center, Division of Infectious Diseases Seoul, Korea, Republic of, 138-736 Poland Oddzial Chorob Wewnetrznych i Gastroenterologii Bialystok, Poland, 15-003 Oddzial Chorob Pluc Brzesko, Poland, 32-800 Kliniczny Oddzial Gruzlicy i Chorob Pluc Krakow, Poland, 30-901 Oddzial Kliniczny Pulmonologii i Alergologii Lodz, Poland, 90-153 Oddzial Pulmonologiczny III Poznan, Poland, 60-569 Oddzial Pulmonologiczny Proszowice, Poland, 32-100 II Oddzial Chorob Wewnetrznych Warszawa, Poland, 03-401 收起 <<
NCT01728922	Clinically Isolated Syndrome ... 展开 >> Multiple Sclerosis 收起 <<	Phase 1 Phase 2	Completed	-	Ireland ... 展开 >> St Vincent's University Hospital Dublin, Dublin 4, Ireland 收起 <<
NCT01006122	-		Completed	-	-
NCT00565812	Osteoarthritis	Phase 2	Completed	-	-
NCT01889238	-		Active, not recruiting	-	-
NCT00942968	Cancer	Phase 4	Completed	-	-
NCT02366637	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Terminated(Study terminated on... 展开 >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 <<	-	United Kingdom ... 展开 >> Medicines Evaluation Unit Ltd Wythenshawe, Manchester, United Kingdom, M23 9QZ Nottingham University Hospital NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Respiratory Medicine, Bradford Institute of Health Research Bradford, United Kingdom, BD9 6RJ 收起 <<
NCT01006122	Excessive Daytime Sleepiness ... 展开 >> Narcolepsy 收起 <<	Phase 2	Completed	-	United States, Arizona ... 展开 >> Pfizer Investigational Site Phoenix, Arizona, United States, 85006 Pfizer Investigational Site Phoenix, Arizona, United States, 85051 Pfizer Investigational Site Tucson, Arizona, United States, 85712 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90048 Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Brandon, Florida, United States, 33511 Pfizer Investigational Site St. Petersburg, Florida, United States, 33707 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30342 Pfizer Investigational Site Macon, Georgia, United States, 31201 United States, Illinois Pfizer Investigational Site Vernon Hills, Illinois, United States, 60061 United States, Kentucky Pfizer Investigational Site Crestview Hills, Kentucky, United States, 41017 Pfizer Investigational Site Louisville, Kentucky, United States, 40217 United States, Mississippi Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39401 Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39402 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Dublin, Ohio, United States, 43017 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19114 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19139 United States, South Carolina Pfizer Investigational Site Columbia, South Carolina, United States, 29201 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78731 Pfizer Investigational Site Houston, Texas, United States, 77063 收起 <<
NCT02014792	-		Completed	-	United Kingdom ... 展开 >> King's College London London, United Kingdom, SE1 9NH King's College Hospital London, United Kingdom, SE5 9RS Guy's and St Thomas' Hospital London, United Kingdom 收起 <<
NCT00942968	-		Completed	-	-
NCT02366637	-		Terminated(Study terminated on... 展开 >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 <<	-	-
NCT02484768	Restless Legs Syndrome	Phase 2	Withdrawn(as per GCP sponsor/c... 展开 >>ompany decision) 收起 <<	-	-
NCT00431236	Nausea and Vomiting, Chemother... 展开 >>apy-Induced 收起 <<	Phase 3	Completed	-	-
NCT01821131	Above Optimal Plasma LDL Conce... 展开 >>ntrations 收起 <<	Not Applicable	Active, not recruiting	September 2018	Canada, Manitoba ... 展开 >> Asper Clinical Research Institute Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario Glycemic Index Laboratories Inc. Toronto, Ontario, Canada, M5C 2N8 收起 <<
NCT03693300	Non-small Cell Lung Cancer (NS... 展开 >>CLC) 收起 <<	Phase 2	Not yet recruiting	December 30, 2022	United States, Tennessee ... 展开 >> Research Site Not yet recruiting Knoxville, Tennessee, United States, 37920 France Research Site Not yet recruiting Saint Priest en Jarez, France, 42270 United Kingdom Research Site Not yet recruiting Leeds, United Kingdom, LS9 7TF 收起 <<
NCT02655315	Parkinson Disease	Phase 2	Recruiting	February 2021	Austria ... 展开 >> Medizinische Universitat Innsbruck Recruiting Innsbruck, Austria Principal Investigator: Werner Poewe, MD, PhD Czechia Univerzita Karlova V Praze Recruiting Prague, Czechia Principal Investigator: Evzen Ruzicka, MD,PhD Charles University Recruiting Praha, Czechia Principal Investigator: Evzen Ruzicka, MD France CHU Pellegrin Recruiting Bordeaux, France Principal Investigator: Wassilios Meissner, MD,PhD Hôpital Wertheimer Recruiting Bron, France Principal Investigator: Stéphane Thobois, MD,PhD Hôpital Montpied Recruiting Clermont-Ferrand, France Principal Investigator: Frank Durif, MD,PhD Hôpital Salengro, CHRU Recruiting Lille, France CHU la TIMONE Recruiting Marseille, France Principal Investigator: Alexandre Eusebio, MD, PhD AP-HP, Hôpital Pitié-Salpêtrière Recruiting Paris, France Principal Investigator: Jean-Christophe Corvol, MD, PhD CHU de Strasbourg, Hôpital de Hautepierre Recruiting Strasbourg, France Principal Investigator: Christine Tranchant, MD,PhD Chu Purpan Recruiting Toulouse, France Principal Investigator: Olivier Rascol, MD,PhD Germany University Hospital, Saarland University Not yet recruiting Homburg, Germany Principal Investigator: Stefanie Behnke, MD Christian-albrechts universität zu kiel Recruiting Kiel, Germany Principal Investigator: Daniela Berg, MD,PhD Klinik und Poliklinik für Neurologie der Universitätsmedizin Rostock Recruiting Rostock, Germany Principal Investigator: Uwe Walter, MD,PhD Netherlands Acadamic central center, Amsterdam Recruiting Amsterdam, Netherlands Principal Investigator: Rob De Bie, MD Radboud university medical center Recruiting Nijmegen, Netherlands Principal Investigator: Bart Post, MD Portugal Centro Hospitalar e universitario de Coimbra Not yet recruiting Coimbra, Portugal Principal Investigator: Cristina Januario, MD Centro Hospitalar do Alto Ave Recruiting Guimarães, Portugal Principal Investigator: Miguel Gago, MD Centro Hospitalar Lisboa Norte Not yet recruiting Lisbon, Portugal Principal Investigator: Joaquim Ferreira, MD Spain Hospital Clinic Universitari de Barcelona Recruiting Barcelona, Spain Principal Investigator: Eduard Tolosa, MD,PhD Hospital de Bellvitge Not yet recruiting Barcelona, Spain Principal Investigator: Matilde Calopa, MD,Phd Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain Principal Investigator: Jaime Kulisevsky, MD,PhD United Kingdom Cambridge University Hospital Not yet recruiting Cambridge, United Kingdom Principal Investigator: Paul Worth, MD University of Glasgow Terminated Glasgow, United Kingdom Newcastle University Not yet recruiting Newcastle, United Kingdom Principal Investigator: David Burn, MD,PhD 收起 <<
NCT03710408	Dehydration	Not Applicable	Not yet recruiting	March 1, 2020	Denmark ... 展开 >> Aalborg University Hospital Not yet recruiting Aalborg, Denmark, 9000 Contact: Mathias B Danielsen, MD +4597664190 Maad@rn.dk 收起 <<
NCT02737306	Graft Vs Host Disease	Phase 2	Recruiting	December 2019	United States, Florida ... 展开 >> University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 United States, Illinois Loyola University Medical Center Cardinal Bernardin Cancer Center Recruiting Maywood, Illinois, United States, 60153 United States, Michigan Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55409 United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Transplant Institute Methodist Hospital Recruiting San Antonio, Texas, United States, 78229 United States, West Virginia West Virginia University Medicine Recruiting Morgantown, West Virginia, United States, 26506 收起 <<
NCT01845012	End Stage Renal Disease	Not Applicable	Terminated(Study has been prem... 展开 >>aturely halted because of failure of patient recruitment.) 收起 <<	-	Belgium ... 展开 >> Cliniques universitaires St Luc Bruxelles, Belgium, 1200 France ECHO Angers Angers, France, 49055 CTMR Saint Augustin Bordeaux, France, 33000 CHPC Cherbourg, France, 50102 CHU Grenoble Grenoble, France, 38043 ANIDER Le Petit Quevilly, France, 76143 AURAL Lyon, France, 69008 Hospices Civils de Lyon - Hôpital Edouard Herriot Lyon, France, 69437 AGDUC Meylan Meylan, France, 38240 AURA - Paris Paris, France, 75015 Hospices Civils de Lyon - Centre Hospitalier Lyon Sud Pierre-benite, France, 69495 ECHO Nantes Reze, France, 44402 Centre Hospitalier de Vichy Vichy, France, 03201 收起 <<
NCT01107665	Stage III Melanoma ... 展开 >> Stage IV Melanoma Unresectable Melanoma 收起 <<	Phase 2	Active, not recruiting	January 2019	United States, California ... 展开 >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 收起 <<
NCT00107718	Melanoma	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90089 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Santa Monica, California, United States, 90404-2104 United States, Connecticut GSK Investigational Site New Haven, Connecticut, United States, 06520 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32209 GSK Investigational Site Miami Beach, Florida, United States, 33140 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Lutherville-Timonium, Maryland, United States, 21093 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Ohio GSK Investigational Site Toledo, Ohio, United States, 43614-5809 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213-2584 Australia, New South Wales GSK Investigational Site Waratah, New South Wales, Australia, 2298 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site South Brisbane, Queensland, Australia, 4101 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 收起 <<
NCT02374619	Muscle Damage ... 展开 >> Oxidative Stress 收起 <<	Not Applicable	Completed	-	-
NCT01290458	Muscle Damage ... 展开 >> Oxidative Stress Hemolysis 收起 <<	Not Applicable	Completed	-	Greece ... 展开 >> University of Thessaly Trikala, Greece, 42100 收起 <<
NCT00206232	Heart Failure	Phase 4	Completed	-	United States, Texas ... 展开 >> Baylor College of Medicine Heart Clinic Houston, Texas, United States, 77030 收起 <<
NCT00565812	-		Completed	-	-
NCT03756324	Mastitis Acute Female	Phase 2 Phase 3	Not yet recruiting	March 31, 2021	China ... 展开 >> Beijing Hospital of Traditional Chinese Medicine Not yet recruiting Beijing, China Contact: Dongxiao Zhang Morningdong@163.com Beijing University of Chinese Medicine Third Affiliated Hospital Not yet recruiting Beijing, China Contact: Xiaohua Pei 0086-10-52075224 pxh_127@163.com Contact: Xinyan Jin 0086-10-52075224 20170941260@bucm.edu.cn Tongzhou Maternal & Child Health Hospital of Beijing Not yet recruiting Beijing, China Contact: Lihui Shi 0086-10-81580191 sup118@aliyun.com 收起 <<
NCT03315221	Subjects in Need of a Human Mi... 展开 >>lk Fortifier (HMF) Growth Tolerance Safety 收起 <<	Phase 2 Phase 3	Recruiting	November 2021	France ... 展开 >> CHRU Nancy - Maternité regionale Universitaire A. Pinard Recruiting Nancy, France Contact: Jean Michel Hascoët, PI Germany Universitätskinderklinik der Otto-v.-Guericke Universität Not yet recruiting Magdeburg, Germany Contact: Ralf Böttger, PI United Kingdom Saint-Peter's Hospital NHS Foundation Trust Recruiting Chertsey, United Kingdom Contact: Peter Reynolds, PI Norfolk and Norwich NHS Foundation Trust Not yet recruiting Norwich, United Kingdom Contact: Paul Clarke, PI 收起 <<
NCT03610334	Healthy Volunteers	Phase 1	Recruiting	July 2019	France ... 展开 >> Centre d'Investigation Clinique - Centre de Pharmacologie Clinique et d'Evaluations Thérapeutiques (CIC-CPCET) Recruiting Marseille, France, 13385 Contact: Christine Audebert, MD 491384641 ext +33 christine.audebert@ap-hm.fr Contact: Laurence Attolini, PhD 491388003 ext +33 laurence.attolini@ap-hm.fr Principal Investigator: Christine Audebert, MD Sub-Investigator: Marie-Noelle Lefebvre, MD Sub-Investigator: Frank Rouby, MD 收起 <<
NCT00549744	Asthma	Phase 2	Completed	-	New Zealand ... 展开 >> GSK Investigational Site Wellington, New Zealand, 6035 South Africa GSK Investigational Site George, Eastern Cape, South Africa, 6529 GSK Investigational Site Bloemfontein, South Africa, 9301 收起 <<
NCT00281684	Toothache	Phase 2	Completed	-	Italy ... 展开 >> GSK Investigational Site Verona, Veneto, Italy, 37134 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 110-768 United Kingdom GSK Investigational Site Croydon, Surrey, United Kingdom, CR7 7YE GSK Investigational Site Leeds, United Kingdom, LS2 9NG GSK Investigational Site Manchester, United Kingdom, M13 9WL 收起 <<
NCT02178592	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 3	Active, not recruiting	December 31, 2019	-
NCT00569062	Depressive Disorder, Major	Phase 2	Terminated(Negative data from ... 展开 >>a GSK PoC study in RA combined with evidence of greater sensitivity of toll-like receptor pathways to p38 inhibition.) 收起 <<	-	Estonia ... 展开 >> GSK Investigational Site Tartu, Estonia, 50417 India GSK Investigational Site Bangalore, India, 560029 GSK Investigational Site Bangalore, India, 560034 GSK Investigational Site Ludhiana, India, 141001 GSK Investigational Site Manipal,, India, 576 104 GSK Investigational Site Mumbai, India, 400010 GSK Investigational Site Pune, India, 411004 Russian Federation GSK Investigational Site Moscow, Russian Federation, 107076 GSK Investigational Site Moscow, Russian Federation, 115522 GSK Investigational Site Moscow, Russian Federation, 119992 GSK Investigational Site Moscow, Russian Federation, 123367 GSK Investigational Site Nizhny Novgorod, Russian Federation, 603115 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation GSK Investigational Site St.Petersburg, Russian Federation, 193167 收起 <<
NCT01641393	Exocrine Pancreatic Insufficie... 展开 >>ncy: Cystic Fibrosis 收起 <<	Phase 3	Completed	-	-
NCT02461992	-		Completed	-	-
NCT03558503	Bladder Cancer ... 展开 >> Urothelial Carcinoma Urothelial Carcinoma Bladder 收起 <<	Phase 2	Recruiting	September 2020	United States, Arizona ... 展开 >> Mayo Clinic Not yet recruiting Phoenix, Arizona, United States, 85054 Contact: Mark Tyson, MD Tyson.Mark@mayo.edu Contact: Christina Mihok Mihok.Christina@mayo.edu United States, Arkansas Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Richard Emanuel D'Anna, MD 501-219-8900 alturodoc@hotmail.com Contact: Katie O'Brien 501.219.8900 ext 2002 katie@arkansasurology.com United States, California Tower Urology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Arnold Cinman, MD 310-854-9898 cinman5676@towerurology.com Contact: Shiblee Nomanee 310854-9898 ext 168 nomanees@towerurology.com UCLA - University of California, Los Angeles Not yet recruiting Los Angeles, California, United States, 90095 Contact: Chamie Karim, MD 310-206-8183 kchamie@mednet.ucla.edu Contact (310)794-5929 Providence Medical Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jennifer Linehan, MD 520-440-5142 Jennifer.Linehan@providence.org Contact: Kelly Garver 310-582-7456 Garverk@JWCI.ORG United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Michael O'Donnell, MD 319-356-2421 michael-odonnell@uiowa.edu Contact (319)384-5458 United States, Maryland John Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21218 Contact: Max Kates, MD 410-550-3506 Mkates@jhmi.edu Contact 410-955-6850 United States, Michigan University of Michigan Comprehensive Cancer Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Alon Weizer, MD 734-647-8903 aweizer@med.umich.edu United States, Nebraska Adult & Pediatric Urology, PC Recruiting Omaha, Nebraska, United States, 68114 Contact: Trainer Andrew, MD 402-399-7894 atrainer@adultpediatricuro.com Contact: Kim Ganzel 402-397-7894 research@adultpediatricuro.com United States, New York Manhattan Medical Research Recruiting New York, New York, United States, 10016 Contact: Huang William, MD Contact: Carmela Graci-Pipitone 917-409-3919 cgpipitone@manhattanmedicalresearch.com Weill Cornell Medical College Not yet recruiting New York, New York, United States, 10065 Contact: Douglas Scherr, MD 212-746-5788 dss2001@med.cornell.edu Contact: Thomas Flynn 212.746.4739 thf3001@med.cornell.edu Montefiore Medical Center (Albert Einstein) Not yet recruiting New York, New York, United States, 10461 Contact: Alexander Sankin, MD 718-920-4531 asankin@montefiore.org Contact 347-842-1715 Western New York Urology Associates Recruiting New York, New York, United States, 14225 Contact: Kent Chevli, MD kchevli@wnyurology.com Contact: Stephanie Malczewski 716-844-5553 smalczewski@wnyurology.com United States, North Carolina The University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27572 Contact: Angela Smith, MD 919-966-8217 angela_smith@med.unc.edu Contact 919-537-3505 United States, Oregon Oregon Urology Not yet recruiting Springfield, Oregon, United States, 97477 Contact: Bryan Mehlhaff, MD 541-284-5509 investigator@oregonurology.com Contact: Stephanie Kerns 541-284-5508 stephanie@oregonurology.com United States, Pennsylvania Penn State Hershey State College Not yet recruiting Hershey, Pennsylvania, United States, 17033 Contact: Jay Raman, MD 717-531-8887 jraman@hmc.psu.edu Contact: Kathleen Lehman (717) 531-5930 klehman3@hmc.psu.edu United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 Contact: Neil Shore, MD 843-839-1679 Nshore@gsuro.com Contact: Lindsey Rabon 843-839-1679 LRabon@atlanticurologyclinics.com United States, Texas Urology San Antonio Not yet recruiting Fredericksburg, Texas, United States, 78233 Contact: Daniel Saltzstein, MD 210-617-4116 saltzstein@urologysa.com Contact: Kethsaly Salinas 210-617-4116 kethsaly.Salinas@urologysa.com Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: Seth Lerner, MD 713-798-4001 slerner@bcm.edu; godoy@bcm.edu Contact 713-798-8514 Israel Carmel Medical Center Not yet recruiting Haifa, Israel, 3436212 Contact: Boris Fridman, MD 972-537176389 BORISFR@clalit.org.il Contact: Hilla Cohen 972-544753731 HillaCo@clalit.org.il Rabin Medical Center Not yet recruiting Petah tikva, Israel, 49372 Contact: Yaron Erlich, CM yarone@clalit.org.il Contact: Natali Oginets 972-542003783 nataliog@clalit.org.il Sheba Medical Center Not yet recruiting Ramat Gan, Israel, 52621 Contact: Menahem Laufer, MD Contact: Efrat Ezra 972-545446438 Efrat.Ezra@sheba.health.gov.il 收起 <<
NCT00390845	Pain, Neuropathic	Phase 2	Completed	-	Australia, New South Wales ... 展开 >> GSK Investigational Site Broadmeadow, New South Wales, Australia, 2292 GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44789 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 Russian Federation GSK Investigational Site Moscow, Russian Federation, 117292 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Solihull, West Midlands, United Kingdom, B91 2JL GSK Investigational Site Liverpool, United Kingdom, L9 7LJ GSK Investigational Site London, United Kingdom, W12 0NN GSK Investigational Site London, United Kingdom, WC1X 8LD 收起 <<
NCT01817166	Multiple Sclerosis	Phase 3	Recruiting	January 2022	France ... 展开 >> CHU d'Amiens - Hôpital Nord Not yet recruiting Amiens Cedex 1, France, 80054 Sub-Investigator: Olivier Godefroy, MD, PhD Sub-Investigator: Abdullatif Al Khedr, MD CHU de Lyon - Hôpital Pierre Wertheimer Recruiting Bron, France, 69677 Sub-Investigator: Christian Confavreux, MD, PHD Sub-Investigator: Sandra Vukusic, MD, PhD CHU de Caen - Hôpital Côte de Nacre Recruiting Caen Cedex 9, France, 14033 Sub-Investigator: Gilles Defer, MD, PhD Sub-Investigator: Nathalie Derache Belpalme, MD CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Recruiting Clermont Ferrand, France, 63003 Sub-Investigator: Pierre Clavelou, MD, PhD Sub-Investigator: Frédéric Thaite, MD CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91100 Sub-Investigator: Ivania Patry, MD Clinique des Cèdres - Capio Not yet recruiting Cornebarrieu, France, 31700 Sub-Investigator: Claude Mekies, MD CHU de Dijon Recruiting Dijon, France, 21079 Sub-Investigator: Thibault Moreau, MD, PhD CHU de Martinique - Hôpital Pierre Zobda-Quitman Not yet recruiting Fort-de-France, France, 97261 Sub-Investigator: Philippe Cabre, MD CHU de Grenoble - Hôpital A Michallon Recruiting Grenoble, France, 38043 Sub-Investigator: Olivier Casez, MD CHRU de Lille - Hôpital Roger Salengro Recruiting Lille, France, 59037 Sub-Investigator: Patrick Vermersch, MD, PhD Sub-Investigator: Hélène Zephyr, MD Sub-Investigator: Olivier Outteryck, MD CHU de Limoges - Hôpital Dupuytren Recruiting Limoges, France, 87042 Sub-Investigator: Laurent Magy, MD, PhD Sub-Investigator: Alexis Montcuquet, MD Groupe Hospitalier de l'Institut Catholique de Lille Recruiting Lomme Cedex, France, 59462 Sub-Investigator: Patrick Hautecoeur, MD Sub-Investigator: Cécile Donzé-Parret, MD CHU de Montpellier - Hôpital Gui de Chauliac Recruiting Montpellier, France, 34295 Sub-Investigator: William Camu, MD, PhD Sub-Investigator: Bertrand Carlander, MD Sub-Investigator: Mahmoud Charif, MD Sub-Investigator: Pierre Labauge, MD, PhD CHU de Nancy - Hôpital Central Recruiting Nancy, France, 54035 Sub-Investigator: Marc Debouverie, MD, PhD Sub-Investigator: Sophie Pittion-Vouyovitch, MD CHU de Nantes - Hôtel-Dieu Recruiting Nantes, France, 44093 Sub-Investigator: Sandrine Wiertlewski, MD Sub-Investigator: David Laplaud, MD CHU de Nice - Hôpital Pasteur Recruiting Nice, France, 06002 Sub-Investigator: Christine Lebrun-Fresnay, MD CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Eric Thouvenot, MD, PhD Sub-Investigator: Giovanni Castelnovo, MD APHP - Hôpital Saint-Antoine Not yet recruiting Paris Cedex 12, France, 75571 Sub-Investigator: Bruno Stankoff, MD, PhD Sub-Investigator: Claire Giannesini, MD MAILLART Elisabeth - La Pitié Salpétrière Not yet recruiting Paris, France, 75013 Contact: MAILLART Elisabeth, PH Fondation Ophtalmologique Adolphe Rothschild Recruiting Paris, France, 75019 Sub-Investigator: Olivier Gout, MD CH de Pau Not yet recruiting Pau, France, 64000 Sub-Investigator: Mickaël Bonnan, MD CH de Perpignan - Hôpital Saint Jean Recruiting Perpignan, France, 66046 Sub-Investigator: Nicolas Gaillard, MD Sub-Investigator: Anais Dutray, MD CH de Cornouaille - Site Quimper - Hôpital Laennec Recruiting Quimper, France, 29107 Sub-Investigator: Marc Coustans, MD CHU de Reims - Hôpital Maison Blanche Recruiting Reims, France, 51092 Sub-Investigator: Ayman Tourbah, MD CHU de Rennes - Hôpital PontChaillou Recruiting Rennes, France, 35033 Sub-Investigator: Gilles Edan, MD, PhD Sub-Investigator: Emmanuelle Le Page, MD Sub-Investigator: Véronique Deburghgraeve, MD CHU de Rouen - Hôpital Charles Nicolle Recruiting Rouen, France, 76031 Sub-Investigator: Didier Hannequin, MD, PhD Sub-Investigator: Bertrand Bourre, MD CH de Poissy - Saint-Germain-en-Laye Recruiting Saint-Germain-en-Laye, France, 78100 Sub-Investigator: Olivier Heinzlef, MD CH de Saumur Recruiting Saumur Cedex, France, 49403 Sub-Investigator: Richard Devy, MD CHRU de Strasbourg - Hôpital Civil Recruiting Strasbourg Cedex, France, 67091 Sub-Investigator: Jérôme De Sèze, MD, PhD CHRU de Toulouse - Hôpital Purpan Recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: David Brassat, MD, PhD CHRU de Tours - Hôpital Bretonneau Recruiting Tours, France, 37044 Sub-Investigator: Philippe Corcia, MD, PhD Sub-Investigator: Anne-Marie Guennoc, MD CH de Versailles - Hôpital Mignot Recruiting Versailles, France, 78000 Sub-Investigator: Fernando Pico, MD, PhD Sub-Investigator: Chantal Nifle, MD CH de Vichy - Jacques Larin Not yet recruiting Vichy, France, 03207 Sub-Investigator: Renato Colamarino, MD 收起 <<
NCT02424539	Rhinitis, Allergic, Perennial ... 展开 >>and Seasonal 收起 <<	Phase 4	Completed	-	China, Fujian ... 展开 >> GSK Investigational Site Xiamen, Fujian, China, 361003 China, Guangdong GSK Investigational Site Shenzhen, Guangdong, China, 518038 China, Hunan GSK Investigational Site Changsha, Hunan, China, 410005 GSK Investigational Site Changsha, Hunan, China, 410011 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 China, Shanxi GSK Investigational Site Taiyuan, Shanxi, China, 030016 China, Zhejiang GSK Investigational Site Wenzhou, Zhejiang, China, 323027 China GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China GSK Investigational Site Changsha, China GSK Investigational Site Chongqing, China, 400014 GSK Investigational Site Fuzhou, China, 350025 GSK Investigational Site Hangzhou, China, 310052 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200092 GSK Investigational Site Shanghai, China, 200127 收起 <<
NCT02891837	Acute Lung Injury	Phase 3	Recruiting	October 2019	-
NCT02975726	Liver Cirrhosis ... 展开 >> Ascites 收起 <<	Not Applicable	Active, not recruiting	February 2019	Canada, Manitoba ... 展开 >> Health Sciences Centre Winnipeg, Manitoba, Canada, R3E 3P4 收起 <<
NCT00048165	Heart Transplantation	Phase 4	Completed	-	-
NCT02518724	Physical Performance ... 展开 >> Rhabdomyolysis 收起 <<	Not Applicable	Unknown	December 2016	Israel ... 展开 >> Sheba medical center Tel-Hashomer, Ramat- Gan, Israel 收起 <<
NCT02461992	Hemophilia A	Phase 1	Completed	-	China ... 展开 >> Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital Beijing, China, 100032 Hematology Department,Beijing Children's Hospital, Capital Medical University Beijing, China, 100045 收起 <<
NCT03714685	Healthy Males	Phase 1	Not yet recruiting	April 2019	-
NCT03315741	Bronchiolitis Obliterans ... 展开 >> Graft Vs Host Disease 收起 <<	Phase 1	Recruiting	March 31, 2020	United States, California ... 展开 >> Stanford University School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Joe L Hsu, MD, MPH 650-725-9536 joehsu@stanford.edu Contact: Efthymia I Matthaiou, PhD 650-497-6766 ematth@stanford.edu Principal Investigator: Joe L Hsu, MD, MPH 收起 <<
NCT02262169	Non-Bleeding Peptic Ulcers	Phase 3	Recruiting	March 2019	Indonesia ... 展开 >> Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Udayana Sanglah General Hospital Recruiting Denpasar, Bali, Indonesia, 80114 Contact: IDN Wibawa Prof. DR. Dr., SpPD-KGEH agusbobwibawa@yahoo.com Principal Investigator: IDN Wibawa Prof. DR. Dr., SpPD-KGEH Sub-Investigator: Nyoman Purwadi dr., Sp.PD-KGEH Sub-Investigator: I Gusti Agung Suryadarma dr., Sp.PD-KGEH Sub-Investigator: I Ketut Mariadi dr., Sp.PD Sub-Investigator: Gde Somayana dr., Sp.PD Sub-Investigator: Putu Prathiwi Primadharsini dr., M. Biomed, Sp.PD Sub-Investigator: Anak Agung Ayu Ngurah Susraini dr., Sp.PA (K) Sub-Investigator: Herman Saputra dr., Sp.PA (K) 收起 <<
NCT00569803	Transplantation	Phase 1	Completed	-	United States, Texas ... 展开 >> Ppd Development Austin, Texas, United States, 78744 收起 <<
NCT00859898	Type 2 Diabetes Mellitus	Phase 3	Completed	-	-
NCT03709680	Solid Tumors ... 展开 >>Ewing Sarcoma Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma 收起 <<	Phase 1	Not yet recruiting	September 27, 2023	-
NCT00048165	-		Completed	-	-
NCT00859898	-		Completed	-	-
NCT00950859	Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 <<	Phase 2	Completed	-	-
NCT03678259	Systemic Amyloidosis	Phase 1	Recruiting	October 1, 2021	United States, Tennessee ... 展开 >> University of Tennessee Medical Center Recruiting Knoxville, Tennessee, United States, 37920 Contact: Jonathan Wall, Ph.D. 收起 <<
NCT00569803	-		Completed	-	-
NCT03367195	Gastroesophageal Reflux Diseas... 展开 >>e (GERD) 收起 <<	Phase 3	Active, not recruiting	December 2018	Indonesia ... 展开 >> Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Padjajaran Dr. Hasan Sadikin Hospital Bandung, Indonesia Division of Gastroenterology Department of Internal Medicine Faculty of Medicine, University of Indonesia Dr. Cipto Mangunkusumo National General Hospital Jakarta, Indonesia, 10430 Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Diponegoro Dr. Kariadi Hospital Semarang, Indonesia Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Airlangga Dr. Soetomo Hospital Surabaya, Indonesia Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Gadjah Mada Dr. Sardjito Hospital Yogyakarta, Indonesia 收起 <<
NCT02738502	Maternal-fetal Infection Trans... 展开 >>mission 收起 <<	Phase 2	Recruiting	February 2020	France ... 展开 >> Hôpital Antoine Béclère Recruiting Clamart, France, 92140 Principal Investigator: Véronique Chambrin, MD Hôpital Louis Mourier Recruiting Colombes, France, 92700 Sub-Investigator: Laurent Mandelbrot, MD Principal Investigator: Françoise Meier, MD Hôpital Sud Francilien Recruiting Corbeil-essonnes, France, 91106 Principal Investigator: Amélie Chabrol, MD Hôpital Bicêtre Recruiting Le Kremlin Bicêtre, France, 94275 Principal Investigator: Delphine Peretti, MD Hôpital la Pitié Salpétrière Recruiting Paris, France, 75013 Principal Investigator: Roland Tubiana, MD 收起 <<
NCT02502006	Healthy	Phase 1	Recruiting	September 2020	United States, Pennsylvania ... 展开 >> Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Katherine N Theken, PharmD, PhD 215-573-9592 ktheken@pennmedicine.upenn.edu Contact: LaVenia Banas, RN 215-662-4652 banas@pennmedicine.upenn.edu 收起 <<
NCT00950859	-		Completed	-	-
NCT00392925	-		Completed	-	-
NCT03649412	Autoimmune Diseases	Phase 1	Recruiting	April 24, 2019	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Nottingham, United Kingdom, NG11 6JS Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT03340935	Malignant Neoplasm ... 展开 >> Cancer 收起 <<	Not Applicable	Recruiting	June 30, 2018	Italy ... 展开 >> Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Claudio Vernieri, M.D., Ph.D. +39 02 23903066 claudio.vernieri@istitutotumori.mi.it 收起 <<
NCT03324685	Drug Interactions	Phase 1	Completed	-	United States, Florida ... 展开 >> Research Site Daytona Beach, Florida, United States, 32117 收起 <<
NCT00392925	Overweight Ob... 展开 >>esity 收起 <<	Phase 2	Completed	-	United States, Florida ... 展开 >> Research Site Deland, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Minnesota Research Site Edina, Minnesota, United States United States, Montana Research Site Butte, Montana, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Oregon Research Site Portland, Oregon, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Washington Research Site Olympia, Washington, United States 收起 <<
NCT01609894	Postnatal Growth Disorder ... 展开 >> Neurodevelopment 收起 <<	Not Applicable	Unknown	-	Canada, Ontario ... 展开 >> Faculty of Health Science, McMaster Children's Hospital Recruiting Hamilton, Ontario, Canada, L8S 4K1 Contact: Christoph Fusch, MD, PhD, FRCPC +1 905 521 2100 ext 75721 fusch@mcmaster.ca Principal Investigator: Christoph Fusch, MD, PhD, FRCPC Sub-Investigator: Niels Rochow, MD Sub-Investigator: Gerhard Fusch, PhD Sub-Investigator: Salhab el Helou, MD, FRCPC Sub-Investigator: Sabiha Ahmad Sub-Investigator: Akshdeep Singh Bhatia Sub-Investigator: Klaus Wutzke, PhD 收起 <<
NCT01942122	Endometrioma ... 展开 >>Visual Analogue Pain Scale: Moderate or Severe Pain 收起 <<	Phase 2 Phase 3	Recruiting	February 2019	Indonesia ... 展开 >> Yasmin Clinic, Dr. Cipto Mangunkusumo Hospital (Kencana) Recruiting Jakarta Pusat, Jakarta, Indonesia, 10430 Contact: Kanadi Sumapraja, SpOG(K), MD +6221 3928720 kanadisuma@yahoo.com Contact: Budi Wiweko, SpOG(K), MD +6221 39831098 wiwekobudi@yahoo.co.id Sub-Investigator: R. Muharam, SpOG(K), MD Sub-Investigator: Andon Hestiantoro, SpOG(K), MD Sub-Investigator: Budi Wiweko, SpOG(K), MD Sub-Investigator: Herbert Situmorang, SpOG(K), MD Sub-Investigator: Gita Pratama, SpOG(K), MD Sub-Investigator: Achmad K Harzif, SpOG, MD Sub-Investigator: Mila Maidarti, SpOG, MD Sub-Investigator: Vita Silvana, SpOG, MD Department of Obstetrics and Gynecology, RSUP Persahabatan Recruiting Jakarta Pusat, Jakarta, Indonesia Contact: Botefilia, SpOG (K), MD +62214891708 botefilia@yahoo.com Principal Investigator: Botefilia, SpOG (K), MD Sub-Investigator: Zakia, SpOG, MD Sub-Investigator: Devi Marischa, SpOG, MD Department of Obstetrics and Gynecology RSUP Fatmawati Recruiting Jakarta, Indonesia Contact: Agus S As'adi, SpOG (K), MD +62217501524 agus_surur_asadi@yahoo.com Principal Investigator: Agus S As'adi, SpOG (K), MD Sub-Investigator: Luky S Syahbana, SpOG (K), MD Sub-Investigator: Malvin, SpOG (K), MD 收起 <<
NCT02629250	Femoral Fractures	Not Applicable	Recruiting	March 2017	China, Guangdong ... 展开 >> Guangzhou First People's Hospital Recruiting Guangzhou, Guangdong, China, 510180 Contact: Xiangcai Ruan, MD, PHD 86-20-81048306 xc_ruan@hotmail.com Principal Investigator: Xiangcai Ruan, MD, PHD Sub-Investigator: Bin Zheng, MD, Msc Sub-Investigator: Jingjing Tang, MD Sub-Investigator: Wei Liu, MD Sub-Investigator: Chengxiang Lu, MD, Msc 收起 <<
NCT02638142	-		Recruiting	December 2020	Italy ... 展开 >> Ospedale Madonna della Navicella Recruiting Chioggia, Venezia, Italy Contact: Roberto Valle, MD Principal Investigator: Roberto Valle, MD Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Giorgio Vescovo, MD Principal Investigator: Giorgio Vescovo, MD University of Rome La Sapienza Recruiting Roma, Italy, 00189 Contact: Salvatore Di Somma, MD +3906.33775581 salvatore.disomma@uniroma1.it Principal Investigator: Salvatore Di Somma, MD Department of Internal Medicine, Cardiovascular Diseases Unit Recruiting Siena,, Italy, 53100 Contact: Alberto Palazzuoli, MD +39577585363 palazzuoli2@unisi.it Principal Investigator: Alberto Palazzuoli, MD Sub-Investigator: Gaetano Ruocco, MD 收起 <<
NCT03058458	Healthy Volunteers ... 展开 >> Asthma 收起 <<	Phase 1	Completed	-	United Kingdom ... 展开 >> Investigator Site Harrow, United Kingdom 收起 <<
NCT02445560	Aging	Not Applicable	Completed	-	United States, Florida ... 展开 >> UF Food Science and Human Nutrition Department Gainesville, Florida, United States, 32611 UF/IFAS Extension Office Marion County Ocala, Florida, United States, 34470 收起 <<
NCT03640312	Hypertension	Phase 2	Not yet recruiting	December 1, 2021	-
NCT03010813	Colorectal Neoplasms ... 展开 >> Urologic Neoplasms Urologic Diseases Nasopharyngeal Neoplasms Oropharyngeal Neoplasms Oral Neoplasms Hypopharyngeal Neoplasms Laryngeal Neoplasms ENT Diseases 收起 <<	Not Applicable	Completed	-	China ... 展开 >> Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, China 收起 <<
NCT01525238	-		Completed	-	-
NCT01525238	Type 2 Diabetes Mellitus	Phase 1	Completed	-	United States, Alabama ... 展开 >> The Children Hospital Of Alabama Birmingham, Alabama, United States, 35233 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Nemours Childrens Hospital Orlando, Florida, United States, 32827 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Louisiana Lsuhsc-Shreveport Shreveport, Louisiana, United States, 71103 United States, Missouri Childrens Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Women And Children'S Hopsital Of Buffalo Buffalo, New York, United States, 14222 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Mercy Children'S Hospital Toledo, Ohio, United States, 43608 United States, Pennsylvania Children'S Hospital Of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children'S Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Methodist Le Bonheur Hlthcare Memphis, Tennessee, United States, 38103 United States, Texas Christus Santa Rosa Childrens Hospital San Antonio, Texas, United States, 78207 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44150 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Veracruz, Mexico, 91910 收起 <<
NCT02221804	Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) Muscle Atrophy 收起 <<	Not Applicable	Unknown	May 2016	United Kingdom ... 展开 >> Royal Brompton & Harefield NHS Foundation Trust Recruiting London, United Kingdom, SW3 6NP Contact: Sara Kladidis, MB BS MRCP 02073518029 s.kladidis@rbht.nhs.uk Principal Investigator: Michael Polkey, FRCP PhD 收起 <<
NCT02145988	Diabetes Peri... 展开 >>pheral Arterial Disease 收起 <<	Phase 2 Phase 3	Terminated(Recruitment rate is... 展开 >> unexpectedly too low (insufficient number of eligible patients).) 收起 <<	-	Indonesia ... 展开 >> Department of Internal Medicine, Faculty of Medicine, University of Udayana/Sanglah Hospital Denpasar, Bali, Indonesia Department of Internal Medicine, RSUD Wangaya Denpasar, Bali, Indonesia 收起 <<
NCT01662999	Type 2 Diabetes Mellitus	Phase 1	Completed	-	United States, Nebraska ... 展开 >> Icon Clinical Pharmacology Omaha, Nebraska, United States, 68154 收起 <<
NCT03418415	Type 2 Diabetes Mellitus ... 展开 >> Renal Denervation 收起 <<	Not Applicable	Recruiting	January 2022	China, Jiangsu ... 展开 >> Zhongda Hospital, Southeast University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Gao-Jun Teng, MD +86 25 83272121 gjteng@seu.edu.cn Contact: Tao Pan, PhD +86-15850651223 15850651223@126.com 收起 <<
NCT00414609	Myocardial Infarction	Phase 3	Completed	-	-
NCT00414609	-		Completed	-	-
NCT01508936	-		Completed	-	-
NCT01285323	Eosinophilic Asthma	Phase 3	Completed	-	-
NCT01662999	-		Completed	-	-
NCT01285323	-		Completed	-	-
NCT02359032	Healthy Volunteers	Phase 1	Completed	-	United Kingdom ... 展开 >> Site GB44001 Harrow, United Kingdom, HA1 3UJ 收起 <<
NCT01508936	Eosinophilic Asthma	Phase 3	Completed	-	-
NCT01270464	-		Completed	-	-
NCT00673387	Overweight Ob... 展开 >>esity 收起 <<	Phase 2	Completed	-	-
NCT01270464	Eosinophilic Asthma	Phase 3	Completed	-	-
NCT01287039	Eosinophilic Asthma	Phase 3	Completed	-	-
NCT03667183	Eating Disorder ... 展开 >> Female Adolescents 收起 <<	Not Applicable	Completed	-	-
NCT03374033	Infant, Very Low Birth Weight	Not Applicable	Recruiting	July 30, 2022	Italy ... 展开 >> Ospedale G. Salesi Recruiting Ancona, Italy, 60123 Contact: Virgilio P. Carnielli, MD, PhD 00390715962045 v.carnielli@univpm.it Contact: Chiara Biagetti, MD 00390715962014 chiara.biagetti@ospedaliriuniti.marche.it 收起 <<
NCT02302456	Immediate Postpartum Hemorrhag... 展开 >>e 收起 <<	Phase 3	Completed	-	France ... 展开 >> Angers University Hospital Angers, France, 49933 收起 <<
NCT01287039	-		Completed	-	-
NCT01766050	Transplant Rejection	Phase 4	Completed	-	United States, Texas ... 展开 >> Healthcare Discoveries, Llc D/B/A Icon Development Solutions San Antonio, Texas, United States, 78209 收起 <<
NCT00673387	-		Completed	-	-
NCT01766050	-		Completed	-	-
NCT01610492	Glomerulonephritis, Membranous	Phase 2	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Exeter, Devon, United Kingdom, EX2 5DW GSK Investigational Site Stevenage, Hertfordshire, United Kingdom, SG1 4AB GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, United Kingdom, G11 6NT GSK Investigational Site Manchester, United Kingdom, M13 9WL GSK Investigational Site Reading, United Kingdom, RG1 5AN GSK Investigational Site Salford, United Kingdom, M6 8HD GSK Investigational Site Whitechapel, London, United Kingdom, E1 1BB 收起 <<
NCT00372112	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	Australia, New South Wales ... 展开 >> GSK Investigational Site Camperdown, New South Wales, Australia, 2050 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Bulgaria GSK Investigational Site Ruse, Bulgaria, 7000 GSK Investigational Site Sofia, Bulgaria, 1431 GSK Investigational Site Sofia, Bulgaria, 1606 Germany GSK Investigational Site Weinheim, Baden-Wuerttemberg, Germany, 69469 GSK Investigational Site Hannover, Niedersachsen, Germany, 30159 GSK Investigational Site Geesthacht, Schleswig-Holstein, Germany, 21502 Netherlands GSK Investigational Site Breda, Netherlands, 4819 EV GSK Investigational Site Hoorn, Netherlands, 1624 NP New Zealand GSK Investigational Site Auckland, New Zealand, 1005 GSK Investigational Site Tauranga, New Zealand Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Iasi, Romania, 700506 收起 <<
NCT01230021	Congenital Bleeding Disorder ... 展开 >> Congenital FXIII Deficiency 收起 <<	Phase 3	Completed	-	United States, Massachusetts ... 展开 >> Novo Nordisk Investigational Site Boston, Massachusetts, United States, 02115 United States, Michigan Novo Nordisk Investigational Site Detroit, Michigan, United States, 48201 United States, Minnesota Novo Nordisk Investigational Site Minneapolis, Minnesota, United States, 55404 United States, Ohio Novo Nordisk Investigational Site Columbus, Ohio, United States, 43205 Israel Novo Nordisk Investigational Site Petach Tikva, Israel, 49100 United Kingdom Novo Nordisk Investigational Site Birmingham, United Kingdom, B4 6NH Novo Nordisk Investigational Site Leicester, United Kingdom, LE1 5WW Novo Nordisk Investigational Site Manchester, United Kingdom, M13 9WL Novo Nordisk Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP Novo Nordisk Investigational Site Reading, United Kingdom, RG1 5AN 收起 <<
NCT02917772	Carcinoma, Renal Cell ... 展开 >> Clear-cell Metastatic Renal Cell Carcinoma 收起 <<	Phase 2	Recruiting	July 2021	-
NCT01230021	-		Completed	-	-
NCT01610492	-		Completed	-	-
NCT01760967	Sepsis	Phase 4	Completed	-	Japan ... 展开 >> Tohoku University Sendai, Miyagi, Japan, 9808574 收起 <<
NCT00372112	-		Completed	-	-
NCT01439373	Hepatitis C, Chronic	Phase 2	Completed	-	United States, California ... 展开 >> GSK Investigational Site Anaheim, California, United States, 92801 GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site Coronado, California, United States, 92118 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Oceanside, California, United States, 92056 United States, Florida GSK Investigational Site Miramar, Florida, United States, 33025 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89109 United States, Oklahoma GSK Investigational Site Tulsa, Oklahoma, United States, 74104 United States, Texas GSK Investigational Site Houston, Texas, United States, 77004 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 收起 <<
NCT02722044	-		Completed	-	-
NCT02722044	Rheumatoid Arthritis	Phase 3	Completed	-	United States, Michigan ... 展开 >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Medication Management, LLC Greensboro, North Carolina, United States, 27408 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Altoona Center for Clinical Research, PC Duncansville, Pennsylvania, United States, 16635 United States, Texas Austin Regional Clinic, PA Austin, Texas, United States, 78731 Accurate Clinical Management Houston, Texas, United States, 77004 Accurate Clinical Research, Inc. Houston, Texas, United States, 77034 收起 <<
NCT00819234	Obesity	Phase 2	Completed	-	-
NCT03356977	Atopic Dermatitis	Phase 4	Recruiting	February 23, 2019	-
NCT01439373	-		Completed	-	-
NCT00486863	Schistosomiasis	Phase 2	Completed	-	Philippines ... 展开 >> Research Institute for Tropical Medicine - Health Compound Muntinlupa City, National Capital Region, Philippines, 1781 收起 <<
NCT00486863	-		Completed	-	-
NCT00927082	Hepatitis B, Chronic	Phase 4	Completed	-	-
NCT03539601	Atopic Dermatitis	Phase 4	Recruiting	May 25, 2020	United States, Arkansas ... 展开 >> Dermatology Trial Associates Recruiting Bryant, Arkansas, United States, 72022 United States, California California Dermatology & Clinical Research Institute Recruiting Encinitas, California, United States, 92024 United States, Florida Park Avenue Dermatology Recruiting Orange Park, Florida, United States, 32073 Forward Clinical Trials, Inc. Recruiting Tampa, Florida, United States, 33624 United States, Kentucky DS Research Recruiting Louisville, Kentucky, United States, 40241 United States, North Carolina M3-Wake Research, Inc. Recruiting Raleigh, North Carolina, United States, 27612 United States, Texas Arlington Research Center Inc Recruiting Arlington, Texas, United States, 76011 United States, Virginia Virginia Clinical Research, Inc Recruiting Norfolk, Virginia, United States, 23502 收起 <<
NCT01286779	Hemophilia B	Phase 3	Completed	-	-
NCT01376167	Malaria, Vivax	Phase 2	Completed	-	Bangladesh ... 展开 >> GSK Investigational Site Bandarban, Bangladesh Brazil GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 GSK Investigational Site Porto Velho, Rondônia, Brazil, 76812-329 Cambodia GSK Investigational Site Oddar Meancheay Province, Cambodia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia India GSK Investigational Site Bikaner, India GSK Investigational Site Chennai, India, 600016 GSK Investigational Site Lucknow, India, 226003 GSK Investigational Site Secunderabad, India, 500 003 Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Philippines GSK Investigational Site Rio Tuba, Bataraza, Philippines, 5306 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Tak, Thailand, 63110 收起 <<
NCT00395018	Hepatitis B, Chronic	Phase 3	Completed	-	-
NCT00819234	-		Completed	-	-
NCT00395018	-		Completed	-	-
NCT00927082	-		Completed	-	-
NCT03160976	Subcutaneous Fat	Not Applicable	Not yet recruiting	October 25, 2017	Brazil ... 展开 >> Federal University of Health Science of Porto Alegre Not yet recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90050170 Contact: Rodrigo DM Plentz, PhD 55 51 998419044 roplentz@yahoo.com.br 收起 <<
NCT02653339	Rhinitis, Allergic, Perennial	Not Applicable	Unknown	August 2018	China, Beijing ... 展开 >> Peking Union Medical College Hospital traditional Chinese medicine department Not yet recruiting Beijing, Beijing, China, 100730 Contact: Xiaoyang Zhang, Doctor (+86)13910769068 zhangxymz@163.com 收起 <<
NCT00371150	Hepatitis B Infection	Phase 4	Completed	-	-
NCT00371150	-		Completed	-	-
NCT01376167	-		Completed	-	-
NCT02964429	Kidney Failure,Chronic ... 展开 >> Renal Insufficiency,Chronic Kidney Disease, End-Stage Kidney Insufficiency 收起 <<	Not Applicable	Completed	-	Czech Republic ... 展开 >> Interní oddělení Strahov VFN Praha, Czech Republic, 169 00 Praha 6 收起 <<
NCT03460652	ADHD	Phase 3	Recruiting	March 2019	United States, Arkansas ... 展开 >> Woodland International Research Recruiting Little Rock, Arkansas, United States, 72211 Contact: Lacey Earls 501-221-8681 lacey@woodlandintlresearchgrp.com Principal Investigator: Jim Aukstuolis, MD United States, Colorado MCB Clinical Research Centers Recruiting Colorado Springs, Colorado, United States, 80910 Contact: Nichole Gonzalez 719-634-6576 ngonzalez@mcbcrc.com Principal Investigator: Andrew Sedillo, MD United States, Florida Meridien Research Recruiting Bradenton, Florida, United States, 34201 Contact: Margaret Bell 941-756-8680 mbell@meridienresearch.net Principal Investigator: Andrew Cutler, MD Clinical Neuroscience Solutions, Inc. Recruiting Jacksonville, Florida, United States, 32256 Contact: Sandeep Jandir 904-281-5757 sjandir@cnshealthcare.com Principal Investigator: Nandita Jones, MD Innovative Clinical Research, Inc. Recruiting Lauderhill, Florida, United States, 33319 Contact: Kadian Watson 954-990-6326 kwatson@segaltrials.com Principal Investigator: Rishi Kakar, MD Meridien Research Recruiting Maitland, Florida, United States, 32751 Contact: Sondra Chapman 407-644-1165 schapman@meridienresearch.net Principal Investigator: Andrea Marraffino, MD Clinical Neuroscience Solutions, Inc. Recruiting Orlando, Florida, United States, 32801 Contact: Rebecca Klipper 407-425-5100 rklipper@cnshealthcare.com Principal Investigator: Robert Molpus, MD United States, Illinois Capstone Clinical Research Recruiting Libertyville, Illinois, United States, 60048 Contact: Kelly Burns 847-549-7214 kburns@capstoneclinical.com Principal Investigator: Michael Greenbaum, MD United States, Kansas Psychiatric Associates Recruiting Overland Park, Kansas, United States, 66211 Contact: Glynis Murphy, PhD 913-438-8221 research@murphyclinic.com Principal Investigator: William Murphy, MD United States, Nevada Center for Psychiatry and Behavioral Medicine, Inc. Recruiting Las Vegas, Nevada, United States, 89128 Contact: Jordan Karbins 702-838-0742 jordankabins@gmail.com Principal Investigator: Ann Childress, MD United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact: Vania Dasilva 856-753-7335 vdasilva@hritrials.com Principal Investigator: Howard Hassman, MD United States, Ohio Neuro-Behavioral Clinical Research Recruiting Canton, Ohio, United States, 44718 Contact: Natalie Kuemerle 330-493-1118 nkuemerle@nb-cr.com Principal Investigator: Shishuka Malhotra, MD Midwest Clinical Research Center, LLC Recruiting Dayton, Ohio, United States, 45417 Contact: Rebecca Vernon 937-424-1050 rvernon@midwestclinical.com Principal Investigator: Otto Dueno, MD United States, Oregon Oregon Center for Clinical Investigations, Inc. Recruiting Portland, Oregon, United States, 97214 Contact: Christina Friesen 503-276-6224 christina.friesen@occi.org Principal Investigator: Beal Essink, MD Oregon Center for Clinical Investigations, Inc. Recruiting Salem, Oregon, United States, 97301 Contact: Emily Valdez 503-540-0100 emily.valdez@occi.org Principal Investigator: Drissana Tran, MD United States, Tennessee Clinical Neuroscience Solutions, Inc. Recruiting Memphis, Tennessee, United States, 38119 Contact: Kelly Iskiwitz, BS 901-843-1045 kiskiwitz@cnshealthcare.com Principal Investigator: Valerie Arnold, MD United States, Texas FutureSearch Trials Recruiting Austin, Texas, United States, 78731 Contact: Erin Ashmore 214-369-2600 ext 109 erina@fstrials.com Principal Investigator: Michael Downing, MD Bayou City Research, Ltd. Recruiting Houston, Texas, United States, 77007 Contact: Kathy Harpst 832-251-7000 ext 302 Principal Investigator: Matthew Brams, MD Houston Clinical Trials Recruiting Houston, Texas, United States, 77098 Contact: Janice Roggenkamp 713-527-8448 jroggenkamp@houstonclintrials.com Principal Investigator: Alain Katic, MD 收起 <<
NCT01286779	-		Completed	-	-
NCT01789970	-		Completed	-	-
NCT01789970	Low Back Pain	Phase 3	Completed	-	-
NCT02860312	End Stage Renal Disease on Hem... 展开 >>odialysis 收起 <<	Not Applicable	Not yet recruiting	May 2019	-
NCT02947568	-		Recruiting	December 2019	Hungary ... 展开 >> 2nd Department of Medicine and Nephrological Center Recruiting Pécs, Baranya, Hungary, 7624 Contact: Gergo A Molnar, MD, PhD +3672536050 gergo.molnar@aok.pte.hu Contact: Eszter Sélley, MD +3672536050 eszter.selley@aok.pte.hu Sub-Investigator: Béla Melegh, MD Sub-Investigator: Lilla Lakner, MD Sub-Investigator: Kulcsár Imre, MD Sub-Investigator: Bene Judit, MD Principal Investigator: István Wittmann, MD 收起 <<
NCT00976560	Depressive Disorder, Major	Phase 2	Completed	-	United States, Illinois ... 展开 >> GSK Investigational Site Hoffman Estates, Illinois, United States, 60169 GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, New York GSK Investigational Site New York, New York, United States, 10128 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 Bulgaria GSK Investigational Site Pazardzhik, Bulgaria, 4400 GSK Investigational Site Plovdiv, Bulgaria, 4000 GSK Investigational Site Ruse, Bulgaria GSK Investigational Site Sofia, Bulgaria, 1113 Estonia GSK Investigational Site Tartu, Estonia, 50417 Germany GSK Investigational Site Huettenberg, Hessen, Germany, 35625 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Achim, Niedersachsen, Germany, 28832 GSK Investigational Site Westerstede, Niedersachsen, Germany, 26655 GSK Investigational Site Bielefeld, Nordrhein-Westfalen, Germany, 33647 GSK Investigational Site Dresden, Sachsen, Germany, 01097 GSK Investigational Site Berlin, Germany, 10629 Russian Federation GSK Investigational Site Moscow, Russian Federation, 107076 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Samara, Russian Federation, 443016 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation 收起 <<
NCT00976560	-		Completed	-	-
NCT00048074	Post Menopausal Osteoporosis	Phase 3	Completed	-	-
NCT01163851	Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 <<	Phase 1	Completed	-	United States, Arizona ... 展开 >> Premier Research Group, Limited Peoria, Arizona, United States, 85381 Dedicated Phase 1, Inc. Phoenix, Arizona, United States, 85013 Premier Research Group Limited Phoenix, Arizona, United States, 85027 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 收起 <<
NCT00048074	-		Completed	-	-
NCT01890473	Rheumatoid Arthritis	Phase 1	Completed	-	-
NCT01890473	-		Completed	-	-
NCT03693287	Infant,Premature ... 展开 >> Parenteral Nutrition Growth 收起 <<	Phase 3	Not yet recruiting	May 30, 2021	-
NCT02210091	Hemophilia A	Phase 3	Completed	-	-
NCT00256867	Diabetes Mellitus, Type 2	Phase 3	Completed	-	-
NCT01163851	-		Completed	-	-
NCT02210091	-		Completed	-	-
NCT00381238	-		Completed	-	-
NCT00381238	Alzheimer's Disease	Phase 2	Completed	-	United States, Arizona ... 展开 >> GSK Investigational Site Litchfield Park, Arizona, United States, 85340 GSK Investigational Site Phoenix, Arizona, United States, 85006 GSK Investigational Site Sun City, Arizona, United States, 85351 United States, Massachusetts GSK Investigational Site Belmont, Massachusetts, United States, 02478 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4H 1R3 收起 <<
NCT02400333	Bioavailability ... 展开 >> Healthy Subjects 收起 <<	Phase 1	Completed	-	Germany ... 展开 >> Research Site Berlin, Germany 收起 <<
NCT03617393	-		Recruiting	December 1, 2020	China, Shanghai ... 展开 >> Ruijin Hospital Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Jieming QU, Ph.D., M.D. +86 18317030297 jmqu0906@163.com 收起 <<
NCT00759564	Pneumonia	Phase 1	Completed	-	United States, Indiana ... 展开 >> Centurion Clinical Research Indianapolis, Indiana, United States, 46260 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, 1070 收起 <<
NCT02400333	-		Completed	-	-
NCT00366080	Narcolepsy	Phase 2	Terminated(Study was terminate... 展开 >>d based on the interim results of a futility test.) 收起 <<	-	Austria ... 展开 >> GSK Investigational Site Innsbruck, Austria, A-6020 GSK Investigational Site Vienna, Austria, A-1190 Finland GSK Investigational Site Espoo, Finland, 02980 Germany GSK Investigational Site Regensburg, Bayern, Germany, 93053 GSK Investigational Site Schwalmstadt, Hessen, Germany, 34613 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44789 GSK Investigational Site Berlin, Germany, 14050 Netherlands GSK Investigational Site Leiden, Netherlands, 2333 CL Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Barcelona, Spain, 08036 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB3 8RE GSK Investigational Site Edinburgh, United Kingdom, EH3 6HP GSK Investigational Site London, United Kingdom, W1G 6BF 收起 <<
NCT00759564	-		Completed	-	-
NCT01175135	Schizophrenia	Phase 2	Completed	-	-
NCT00256867	-		Completed	-	-
NCT03034967	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 2	Completed	-	-
NCT01192191	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 811-2201 GSK Investigational Site Fukuoka, Japan, 819-8555 GSK Investigational Site Fukushima, Japan, 964-0871 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 001-0901 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 070-8644 GSK Investigational Site Hyogo, Japan, 651-0073 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 310-0015 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kagawa, Japan, 760-0073 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 981-8563 GSK Investigational Site Miyagi, Japan, 984-8560 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-0832 GSK Investigational Site Nagano, Japan, 390-8601 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Osaka, Japan, 530-0012 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Toyama, Japan, 930-0194 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 <<
NCT00967902	Coronary Artery Lesions	Phase 2	Completed	-	Australia, New South Wales ... 展开 >> John Hunter Hospital Newcastle, New South Wales, Australia, 2300 收起 <<
NCT03305419	Autoimmune Diseases	Phase 1	Recruiting	October 22, 2018	United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 <<
NCT01175135	-		Completed	-	-
NCT01192191	-		Completed	-	-
NCT02927457	Lupus Erythematosus, Cutaneous	Phase 1	Completed	-	Germany ... 展开 >> GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Wuppertal, Nordrhein-Westfalen, Germany, 42283 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 10117 收起 <<
NCT01475461	Type 2 Diabetes Mellitus	Phase 2	Completed	-	-
NCT01517373	Diabetes Mellitus, Type 2	Phase 2	Completed	-	-
NCT00993967	-		Completed	-	-
NCT00993967	Freidreich's Ataxia	Phase 3	Completed	-	Austria ... 展开 >> Universitätsklinik Innsbruck Innsbruck, Austria Belgium Hôpital Erasme - Univeristé Libre de Bruxelles Bruxelles, Belgium, 1070 France Hôpital de la Salpétrière - INSERM U679, Neurologie et Thérapeutique expérimentale Paris, France, 75651 Germany HELIOS Klinikum Berlin Berlin, Germany, 13125 Neurologische Universitätsklinik und Ploklinik - Universitätsklimikum Bonn Bonn, Germany, 53105 Klinik II, Neuropädiatrie und Muskelerkrankungen - Universitätsklinik Freiburg Freiburg, Germany, 79106 Zentrum für Neurologische Medizin Göttingen, Germany, 37073 UKE Hamburg Neuropädiatrie - Zentrum für Frauen, Kinder und Jugendmedizin Hamburg, Germany, 20246 Neurologische Klinik - Klinikum Grosshadern München, Germany, 81377 Neurologische Universitätsklinik und Poliklinik Tübingen, Germany, 72076 Netherlands University medical Center Groningen Groningen, Netherlands, 9700 RB 收起 <<
NCT01475461	-		Completed	-	-
NCT02669589	Acute Kidney Injury	Phase 4	Recruiting	March 2021	Germany ... 展开 >> University Hospital Aachen Recruiting Aachen, Germany, D-52074 Klinikum Augsburg Recruiting Augsburg, Germany, D-86156 HELIOS Klinikum Bad Saarow, Dept. of Intensive Care Recruiting Bad Saarow, Germany, D-15526 Charité Berlin, Dept. of Anesthesiology and Intensive Care Medicine Recruiting Berlin, Germany, 10117 Charité Berlin CCM, Medical Department, Division of Nephrology Recruiting Berlin, Germany, D-10117 Charité Berlin CCV, Medical Department, Division of Nephrology Recruiting Berlin, Germany, D-13353 Evangelisches Klinikum Bethel gGmbH Recruiting Bielefeld, Germany, D-33617 Universitätsklinikum Knappschaftskrankenhaus Bochum Recruiting Bochum, Germany, D-44892 University Hospital Bonn, Dept.of Anesthesiology and Intensive Care Medicine Recruiting Bonn, Germany, D-53127 University Hospital Duesseldorf, Dept. of Anaesthesiology Recruiting Duesseldorf, Germany, D-40225 University Hospital Düsseldorf, Dept. of Nephrology Recruiting Düsseldorf, Germany, D-40225 University Hospital Erlangen Recruiting Erlangen, Germany, D-91054 University Hospital Essen, Dept. for Nephrology Recruiting Essen, Germany, D-45122 University Hospital Frankfurt, Dept. of Anesthesiology, Intensive-Care Medicine and Pain Therapy Recruiting Frankfurt, Germany, D-60590 University Hospital Gießen, Dept. of Anesthesiology and Intensive Care Recruiting Gießen, Germany, D-35392 University Medicine Greifswald Recruiting Greifswald, Germany, D-17475 University Medical Center Göttingen, Dept. for Anesthesiology Recruiting Göttingen, Germany, D-37075 University Hospital Halle, Dept. of Anesthesiology and Intensive Care Recruiting Halle (Saale), Germany, D-06120 University Medical Center Hamburg-Eppendorf, Dept. of Intensive Care Recruiting Hamburg, Germany, D-20246 University Hospital Heidelberg, Dept. of Anesthesiology Recruiting Heidelberg, Germany, D-69120 University Hospital Jena, Dept. of Anesthesiology and Intensive Care Medicine Recruiting Jena, Germany, D-07747 University Hospital Schleswig-Holstein, Campus Kiel, Dept. for Anaesthesiology and Intensive Care Withdrawn Kiel, Germany, D-24105 Klinikum Köln-Merheim, Medizinische Klinik I Recruiting Köln, Germany, D-51109 Universitätsklinikum Leipzig Recruiting Leipzig, Germany, D-04103 Universitätsmedizin Mainz Recruiting Mainz, Germany, D-55131 University Hospital Muenster Recruiting Muenster, Germany, D-48149 Technical University of Munich University Hospital, Dept. for Anaesthesiology Recruiting München, Germany, D-81675 Klinikum Nürnberg Recruiting Nürnberg, Germany, D-90419 University Hospital Regensburg, Dept. of Surgery Recruiting Regensburg, Germany, D-93042 Municipal Hospital Solingen, Dept. for Nephrology and General Internal Medicine Recruiting Solingen, Germany, D-42653 University Hospital Tuebingen Recruiting Tuebingen, Germany, D-72076 收起 <<
NCT02932618	Von Willebrand Disease	Phase 3	Recruiting	May 29, 2020	-
NCT01517373	-		Completed	-	-
NCT02578004	-		Completed	-	Tunisia ... 展开 >> Latifa KHLIFI Sousse, Tunisia, 4000 收起 <<
NCT00964158	-		Completed	-	-
NCT00856843	Colonoscopy	Phase 3	Completed	-	United States, Alabama ... 展开 >> University of South Alabama Mobile, Alabama, United States, 36693 United States, Florida Jupiter Research Jupiter, Florida, United States, 33458 Miami Research Associates Miami, Florida, United States, 33143 United States, Indiana Indiana University Medical Center Indianapolis, Indiana, United States, 46202 United States, New York Long Island GI Research Group Great Neck, New York, United States, 11023 收起 <<
NCT01342211	-		Completed	-	-
NCT01342211	Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 <<	Phase 2	Completed	-	-
NCT02683746	Diabetes Mellitus, Type 2	Phase 3	Completed	-	-
NCT00964158	Influenza	Phase 3	Completed	-	Spain ... 展开 >> GSK Investigational Site Bilbao, Spain, 48013 GSK Investigational Site Burgos, Spain, 09005 GSK Investigational Site Madrid, Spain, 28046 GSK Investigational Site Móstoles/Madrid, Spain, 28935 GSK Investigational Site Sevilla, Spain, 41013 收起 <<
NCT03184987	Asthma	Phase 3	Active, not recruiting	June 24, 2019	Japan ... 展开 >> GSK Investigational Site Gifu, Japan, 509-6134 GSK Investigational Site Gunma, Japan, 372-0831 GSK Investigational Site Gunma, Japan, 373-0807 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Kagawa, Japan, 762-8550 GSK Investigational Site Kanagawa, Japan, 236-0004 GSK Investigational Site Kyoto, Japan, 607-8062 GSK Investigational Site Okinawa, Japan, 901-2121 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 157-0066 GSK Investigational Site Tokyo, Japan, 169-0073 GSK Investigational Site Toyama, Japan, 937-0042 收起 <<
NCT00856843	-		Completed	-	-
NCT02683746	-		Completed	-	-
NCT03775538	Parkinson Disease ... 展开 >> Movement Disorders Neuro-Degenerative Disease Nervous System Diseases Brain Diseases 收起 <<	Phase 1 Phase 2	Recruiting	September 30, 2020	Finland ... 展开 >> Helsinki University Hospital Not yet recruiting Helsinki, Finland, 00029 Contact: Filip Scheperjans, Ph.D, MD +358 (0)50-4284113 parkinson.tutkimus@gmail.com Sweden Skåne University Hospital Not yet recruiting Lund, Sweden, 221 85 Contact: Håkan Widner, Ph.D, MD +46 (0)46-17 14 25 Hakan.Widner@med.lu.se Contact: Gesine Paul-Visse, Ph.D, MD +46 (0)46-17 77 66 Gesine.Paul-Visse@med.lu.se Karolinska University Hospital Recruiting Stockholm, Sweden, 14186 Contact: Per Svenningsson, Ph.D, MD +46 8 585 87271 per.svenningsson@ki.se Contact: Lisa Hainke +46 8 585 84710 lisa.hainke@sll.se 收起 <<
NCT00658320	Kidney Transplantation	Phase 3	Completed	-	Japan ... 展开 >> Novartis Pharma K.K., Japan Tokyo, Japan, 106-8618 收起 <<
NCT03669757	Psoriasis Vulgaris	Phase 1	Recruiting	February 2019	Germany ... 展开 >> Investigational Site Recruiting Schwerin, Mecklenburg-Vorpommern, Germany, 19055 Investigational Site Recruiting Hamburg, Germany, 20095 收起 <<
NCT00742885	Influenza	Phase 2	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-8588 GSK Investigational Site Tokyo, Japan, 204-8585 收起 <<
NCT01642407	-		Completed	-	-
NCT00658320	-		Completed	-	-
NCT03189225	Diabetes Mellitus	Not Applicable	Completed	-	United Kingdom ... 展开 >> Diabetes Centre, Heartlands Hospital Birmingham, United Kingdom, B9 5SS NHS Lothian Edinburgh, United Kingdom, EH16 4SA Highland Diabetes Institute Inverness, United Kingdom, IV2 3JH 收起 <<
NCT02938520	HIV Infections	Phase 2 Phase 3	Active, not recruiting	July 7, 2022	-
NCT01642407	Pulmonary Arterial Hypertensio... 展开 >>n Hypertension, Pulmonary 收起 <<	Phase 4	Completed	-	Japan ... 展开 >> Kitasato University Hospital Sagamihara, Kanagawa, Japan, 252-0375 Osaka University Hospital Suita, Osaka, Japan, 565-0871 Toho University Omori Medical Center Ota-ku, Tokyo, Japan, 143-8541 National Center for Child Health and Development Setagaya-ku, Tokyo, Japan, 157-8535 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 收起 <<
NCT02378506	Arthritis, Rheumatoid	Phase 3	Completed	-	Bulgaria ... 展开 >> MHAT Plovdiv Plovdiv, Bulgaria, 4000 DCC "Aleksandrovska" EOOD Sofia, Bulgaria, 1431 UMHAT "Sv. Ivan Rilski" EAD, Sofia Sofia, Bulgaria, 1612 Medical Center - "New rehabilitation center" EOOD Stara Zagora, Bulgaria, 6000 Croatia Chc Rijeka Rijeka, Croatia, 51000 Medicinski Centar Kuna Peric Zagreb, Croatia, 10000 Germany Centrum für innovative Diagnostik und Therapie Frankfurt/Main, Hessen, Germany, 60528 Rheumaforschung - Studienambulanz Dr. Wassenberg Ratingen, Nordrhein-westfalen, Germany, 40882 Schlosspark-Klinik, Innere Medizin II, Rheumatologie Berlin, Germany, 14059 Medizinische Hochschule Hannover Hannover, Germany, 30625 Immunologisches Zentrum Vogelsang-Gommern GmbH Vogelsang-Gommern, Germany, 39245 Greece Rheumatology Department Rion Patras, Achaia, Greece, 26500 University Hospital of Heraklion Heraklion, Crete, Greece, 71110 Rheumatology Unit Thessaloniki, Greece, 56429 Hungary Qualiclinic Kft. Budapest, Hungary, 1036 Pest Megyei Flor Ferenc Korhaz Kistarcsa, Hungary, 2143 Szabolcs-Szatmar-Bereg megyei Nyiregyhaza, Hungary, 4400 Poland Krakowskie Centrum Medyczne sp. Z.O.O Krakow, Poland, 31-501 NZOZ Lecznica MAK-MED s.c. Nadarzyn, Poland, 05-830 Prywatna Praktyka Lekarska Prof. UM dr hab.med. Pawel Hrycaj Poznan, Poland, 61-397 Reumatika-Centrum Reumatologii Warszawa, Poland, 02-691 Serbia Institute of Rheumatology Belgrade, Beograd, Serbia, 11000 Slovakia Reumatologicka ambulancia Bratislava, Slovakia, 841 04 AAGS, s.r.o. Dunajska Streda, Slovakia, 929 01 Reumatologicka ambulancia, MUDr. Zuzana Cizmarikova, s.r.o. Poprad, Slovakia, 058 01 REUMEX s.r.o. Rimavska Sobota, Slovakia, 979 01 REUMA-GLOBAL s.r.o. Trnava, Slovakia, 917 01 Reumatologicka ambulancia Zilina, Slovakia, 010 01 South Africa Panorama Medical Centre Panorama, Cape Town, South Africa, 7500 Wits Clinical Research CMJAH Clinical Trial Site Parktown, Johannesburg, South Africa, 2193 St. Augustines Hospital Durban/Berea, Kwazulu-natal, South Africa, 4001 收起 <<
NCT02082977	Cancer	Phase 1	Terminated(The maximal dose an... 展开 >>d schedule attained with GSK2816126 has shown insufficient evidence of clinical activity, and does not justify further clinical investigation) 收起 <<	-	United States, Illinois ... 展开 >> GSK Investigational Site Chicago, Illinois, United States, 60611 United States, New York GSK Investigational Site New York, New York, United States, 10021 France GSK Investigational Site Villejuif cedex, France, 94805 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT GSK Investigational Site Southampton, United Kingdom, SO16 6YD 收起 <<
NCT02287779	Non-Alcoholic Steatohepatitis	Phase 1	Completed	-	United States, Tennessee ... 展开 >> New Orleans Center for Clinical Research Knoxsville, Tennessee, United States, 37920 收起 <<
NCT01411215	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	China, Chongqing ... 展开 >> Daping Hospital Chongqing, Chongqing, China, 400038 China, Fujian Fujian Provincial Hospital Fuzhou, Fujian, China, 350001 China, Gansu Lanzhou University Second Hospital Lanzhou, Gansu, China, 730030 China, Guangdong The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China, 510405 China, Heilongjiang No. 199 Haerbin, Heilongjiang, China, 150001 China, Hunan The Second Xiangya Hospital of Central South University Changsha, Hunan, China, 410011 China, Inner Mongolia The First Affiliated Hospital of Baotou Medical College Baotou, Inner Mongolia, China, 014010 China, Jiangsu Jiangsu Province Hospital/Department of Rheumatology Nanjing, Jiangsu, China, 210029 Affiliated Hospital of Nantong University Nantong, Jiangsu, China, 226001 China, Shanxi The Second Hospital of Shanxi Medical University Taiyuan, Shanxi, China, 030001 China, Sichuan Si Chuan Huaxi Hospital/Rheumatology Department Chengdu, Sichuan, China, 610041 China Baotou Central Hospital Baotou city, China Shanghai Changning Guanghua Integrative Medicine Hospital Beijing, China, 200052 Shanghai Jiaotong University Affiliated Third People's Hospital Shanghai, China, 201900 Xinjiang Uygur Autonomous Region People's Hospital Urumqi, China, 830001 收起 <<
NCT00742885	-		Completed	-	-
NCT02287779	-		Completed	-	-
NCT00985673	Influenza	Phase 2	Completed	-	United States, Georgia ... 展开 >> GSK Investigational Site Stockbridge, Georgia, United States, 30281 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Fort Worth, Texas, United States, 76135 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 4J6 收起 <<
NCT03754920	Fasting	Not Applicable	Active, not recruiting	September 9, 2019	China, Shanghai ... 展开 >> Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200030 收起 <<
NCT02378506	-		Completed	-	-
NCT00989235	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT00989235	-		Completed	-	-
NCT01714817	Lupus Nephritis	Phase 3	Completed	-	-
NCT01411215	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT02698046	Heart Failure	Phase 3	Unknown	October 2016	Brazil ... 展开 >> Division of Cardiology, Department of Internal Medicine Recruiting Ribeirao Preto, Sao Paulo, Brazil, 14000-000 Contact: Jaqueline RS Gentil, Master +551633154577 jaqueline.gentil@usp.br Contact: Marcus V Simoes, PhD +551636022791 Sub-Investigator: Marcus Vinícius Simões, PhD Sub-Investigator: Pedro V Schwartzmann, PhD Sub-Investigator: Eduardo EV Carvalho, Master Sub-Investigator: Luciana P Seabra, Master Sub-Investigator: Júlio C Crescêncio, PhD Sub-Investigator: Lourenço Gallo Junior, PhD 收起 <<
NCT00471237	Osteoporosis	Phase 2	Terminated(Terminated for futi... 展开 >>lity by sponsor after a pre-planned interim review of data) 收起 <<	-	-
NCT00985673	-		Completed	-	-
NCT01342926	Atrophy, Geographic	Phase 2	Completed	-	-
NCT01342926	-		Completed	-	-
NCT02036346	Colorectal Resection ... 展开 >> Ileostomy 收起 <<	Not Applicable	Completed	-	Greece ... 展开 >> University Hospital of Larissa Larissa, Thessaly, Greece, 41110 收起 <<
NCT00471237	-		Terminated(Terminated for futi... 展开 >>lity by sponsor after a pre-planned interim review of data) 收起 <<	-	-
NCT01396148	Gastrointestinal Stromal Tumor... 展开 >>s 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Czechia Fakultni nemocnice Brno Brno, Czechia, 613 00 FN Brno Brno, Czechia, 625 00 Masarykuv onkologicky ustav Brno, Czechia, 656 33 France CHU de La Timone, Hopital enfants Marseille cedex 5, France, 13385 Hopital d'Enfants de la Timone Marseille cedex 5, France, 13385 Hopital de la Timone Marseille cedex 5, France, 13385 收起 <<
NCT01802112	Constipation	Not Applicable	Completed	-	Spain ... 展开 >> San Antonio Catholic University of Murcia Guadalupe, Murcia, Spain, 30107 收起 <<
NCT01396148	-		Completed	-	-
NCT02193815	Psoriasis Vulgaris	Phase 1	Completed	-	Germany ... 展开 >> Bioskin GmbH Hamburg, Germany, 20095 收起 <<
NCT01714817	-		Completed	-	-
NCT02193815	-		Completed	-	-
NCT01684215	-		Completed	-	-
NCT00090519	Diabetic Retinopathy	Phase 3	Completed	-	-
NCT01684215	Neoplasms Bre... 展开 >>ast Neoplasms 收起 <<	Phase 2	Completed	-	Japan ... 展开 >> Aichi Cancer Center Hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan, 003-0804 Kumamoto Shinto General Hospital Kumamoto-city, Kumamoto, Japan, 862-8655 Saitama Cancer Center Kita-adachi-gun, Saitama, Japan, 362-0806 National Cancer Center Hospital Chuo-Ku, Tokyo, Japan, 104-0045 Chiba Cancer Center Chiba, Japan, 260-8717 National Hospital Organization Shikoku Cancer Center Ehime, Japan, 791-0280 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Hiroshima City Hiroshima Citizens Hospital Hiroshima, Japan, 730-8518 Iwate Medical University Hospital Iwate, Japan, 020-8505 Hakuaikai Medical Corporation Sagara Hospital Kagoshima, Japan, 892-0833 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Kumamoto City Hospital Kumamoto, Japan, 862-8505 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization Osaka National Hospital Osaka, Japan, 540-0006 收起 <<
NCT01512160	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT00090519	-		Completed	-	-
NCT00159783	-		Completed	-	-
NCT01512160	Post-surgical Dental Pain	Phase 2	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	United States, Texas ... 展开 >> Pfizer Investigational Site Austin, Texas, United States, 78744 收起 <<
NCT00903617	-		Completed	-	-
NCT00903617	Dyslipidaemias	Phase 2	Completed	-	United States, Florida ... 展开 >> GSK Investigational Site Pembroke Pines, Florida, United States, 33026 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46260 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Minnesota GSK Investigational Site Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina GSK Investigational Site Statesville, North Carolina, United States, 28677 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45246 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78205 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 United States, Washington GSK Investigational Site Olympia, Washington, United States, 98502 GSK Investigational Site Seattle, Washington, United States, 98104 收起 <<
NCT01336621	Epilepsy	Phase 3	Completed	-	-
NCT00159783	Bipolar Disorder	Phase 3	Completed	-	-
NCT01336621	-		Completed	-	-
NCT02319148	Healthy Volunteers	Phase 1	Completed	-	Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 <<
NCT03274648	BehçEt Disease	Not Applicable	Not yet recruiting	January 2018	-
NCT02268045	Diffuse Large B-cell Lymphoma	Phase 3	Completed	-	-
NCT02319148	-		Completed	-	-
NCT01529346	Postoperative Dental Pain	Phase 2	Completed	-	United States, Texas ... 展开 >> Central Texas Oral Surgery Associates Austin, Texas, United States, 78705 Premier Research Group Limited Austin, Texas, United States, 78705 PPD Development, LP Austin, Texas, United States, 78744 收起 <<
NCT00643201	Venous Thrombosis	Phase 3	Completed	-	-
NCT01366521	Asthma	Phase 2	Completed	-	United States, North Carolina ... 展开 >> GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Estonia GSK Investigational Site Tallinn, Estonia, 13619 GSK Investigational Site Tartu, Estonia, 51014 France GSK Investigational Site Marseille cedex 20, France, 13915 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pessac Cedex, France, 33604 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60596 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Berlin, Germany, 14050 收起 <<
NCT01529346	-		Completed	-	-
NCT02621931	Migraine	Phase 3	Completed	-	-
NCT00559585	Rheumatoid Arthritis (RA)	Phase 3	Completed	-	-
NCT02621931	-		Completed	-	-
NCT01366521	-		Completed	-	-
NCT02037321	-		Unknown	December 2017	Canada, Ontario ... 展开 >> Toronto 3-D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 收起 <<
NCT02629861	-		Completed	-	-
NCT00404768	Obstetric Labour, Premature	Phase 2	Completed	-	-
NCT00559585	-		Completed	-	-
NCT00404768	-		Completed	-	-
NCT02341482	Healthy	Phase 1	Completed	-	United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 <<
NCT00643201	-		Completed	-	-
NCT01577381	Age-Related Maculopathy	Phase 2	Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT02629861	Migraine	Phase 3	Completed	-	-
NCT02341482	-		Completed	-	-
NCT01577381	-		Terminated(See termination rea... 展开 >>son in detailed description.) 收起 <<	-	-
NCT01819922	Healthy	Phase 1	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT02261961	Sarcopenia Ag... 展开 >>ing Immune Function 收起 <<	Not Applicable	Active, not recruiting	September 30, 2019	United States, Arkansas ... 展开 >> Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR North Little Rock, Arkansas, United States, 72114-1706 收起 <<
NCT00663702	Arthritis, Rheumatoid	Phase 3	Completed	-	-
NCT01819922	-		Completed	-	-
NCT01147809	Thrombocytopaenia	Phase 2	Completed	-	-
NCT00663702	-		Completed	-	-
NCT01147809	-		Completed	-	-
NCT02689414	Abdominal Aortic Aneurysm ... 展开 >> Peripheral Artery Disease Carotid Artery Stenosis 收起 <<	Not Applicable	Completed	-	Estonia ... 展开 >> Tartu University Hospital Tartu, Tartu County, Estonia, 50406 收起 <<
NCT00313144	Alpha1-antitrypsin Deficiency	Phase 4	Terminated(Study terminated ea... 展开 >>rly due to Aralast being phased out of the market.) 收起 <<	-	United States, California ... 展开 >> Adupa Rao, MD San Marino, California, United States, 91108 收起 <<
NCT01840059	Cardiac Failure	Phase 2	Completed	-	United Kingdom ... 展开 >> Royal Brompton Hospital London, United Kingdom, SW3 6NP 收起 <<
NCT00313144	-		Terminated(Study terminated ea... 展开 >>rly due to Aralast being phased out of the market.) 收起 <<	-	-
NCT00736879	Type 2 Diabetes Mellitus	Phase 3	Completed	-	-
NCT01925274	-		Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 <<	-	-
NCT01438424	Hepatitis B Virus ... 展开 >> HBV 收起 <<	Phase 2	Completed	-	-
NCT02631473	HIV	Phase 1	Suspended(Study is on hold whi... 展开 >>lst a grant application for further funding is put together) 收起 <<	-	United Kingdom ... 展开 >> St Stephen's Centre London, United Kingdom, SW10 9NH 收起 <<
NCT02373202	Rheumatoid Arthritis	Phase 3	Completed	-	Japan ... 展开 >> Investigational Site Number 392010 Asahi-Shi, Japan Investigational Site Number 392001 Asahikawa-Shi, Japan Investigational Site Number 392070 Beppu-Shi, Japan Investigational Site Number 392036 Chiba-Shi, Japan Investigational Site Number 392083 Chuo-Ku, Japan Investigational Site Number 392004 Fukui-Shi, Japan Investigational Site Number 392039 Fukuoka-Shi, Japan Investigational Site Number 392030 Ichinomiya-Shi, Japan Investigational Site Number 392002 Iizuka-Shi, Japan Investigational Site Number 392019 Kagoshima-Shi, Japan Investigational Site Number 392066 Kamakura-Shi, Japan Investigational Site Number 392050 Kato-Shi, Japan Investigational Site Number 392037 Kawachi-Nagano-Shi, Japan Investigational Site Number 392099 Kawasaki-Shi, Japan Investigational Site Number 392013 Kitakyushu-Shi, Japan Investigational Site Number 392097 Kochi-Shi, Japan Investigational Site Number 392065 Kushiro-Shi, Japan Investigational Site Number 392026 Matsuyama-Shi, Japan Investigational Site Number 392034 Miyagi-Gun, Japan Investigational Site Number 392076 Nagoya-Shi, Japan Investigational Site Number 392080 Nagoya-Shi, Japan Investigational Site Number 392046 Narashino-Shi, Japan Investigational Site Number 392059 Oita-Shi, Japan Investigational Site Number 392062 Okayama-Shi, Japan Investigational Site Number 392027 Osaki-Shi, Japan Investigational Site Number 392049 Sagamihara-Shi, Japan Investigational Site Number 392014 Sapporo-Shi, Japan Investigational Site Number 392041 Sapporo-Shi, Japan Investigational Site Number 392073 Sapporo-Shi, Japan Investigational Site Number 392006 Sasebo-Shi, Japan Investigational Site Number 392021 Sendai-Shi, Japan Investigational Site Number 392022 Sendai-Shi, Japan Investigational Site Number 392033 Sendai-Shi, Japan Investigational Site Number 392071 Sendai-Shi, Japan Investigational Site Number 392029 Shizuoka-Shi, Japan Investigational Site Number 392023 Takaoka-Shi, Japan Investigational Site Number 392003 Tomakomai-Shi, Japan Investigational Site Number 392074 Urasoe-Shi, Japan Investigational Site Number 392079 Urayasu-Shi, Japan Investigational Site Number 392048 Yokohama-Shi, Japan 收起 <<
NCT02373202	-		Completed	-	-
NCT01925274	Metastatic Colorectal Cancer	Phase 2	Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 <<	-	United States, California ... 展开 >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 收起 <<
NCT02969044	Rheumatoid Arthritis	Phase 2	Completed	-	-
NCT01147523	Fatty Liver S... 展开 >>teatohepatitis 收起 <<	Phase 2	Completed	-	Greece ... 展开 >> Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital Thessaloniki, Greece, 54642 收起 <<
NCT00893789	-		Terminated(Study has been stop... 展开 >>ped by sponsor decision.) 收起 <<	-	-
NCT01970865	ALK-positive Non Small Cell Lu... 展开 >>ng Cancer (NSCLC) and ROS1-positive NSCLC 收起 <<	Phase 2	Active, not recruiting	February 19, 2019	-
NCT01438424	-		Completed	-	-
NCT00893789	Traumatic Brain Injury	Phase 3	Terminated(Study has been stop... 展开 >>ped by sponsor decision.) 收起 <<	-	-
NCT01536379	Transplantation, Organ	Phase 2	Completed	-	United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site London, United Kingdom, SE1 9RT 收起 <<
NCT00910962	-		Completed	-	-
NCT00910962	Acute Coronary Syndrome	Phase 2	Completed	-	-
NCT02969044	-		Completed	-	-
NCT01970865	-		Active, not recruiting	-	-
NCT01536379	-		Completed	-	-
NCT02189005	Diabetes Mellitus ... 展开 >> Pre-Diabetes Hyperglycemia Metabolic Syndrome 收起 <<	Phase 3	Completed	-	India ... 展开 >> Dia Care- Diabetes Care and Hormone Clinic Ahmedabad, Gujarat, India, 380015 St. Johns College and Hospital Bangalore, Karnataka, India, 560034 Totall Diabetes and Hormone Institution Indore, Madhya Pradesh, India, 452010 Bhatia Hospital Mumbai, Maharashtra, India, 411007 Inamdar Multispeciality Hospital Pune, Maharashtra, India, 411040 Diabetes Care Centre Jaipur, Rajasthan, India, 302018 收起 <<
NCT01276288	Diabetes Mellitus, Type 2	Phase 1	Completed	-	Germany ... 展开 >> 1245.42.1 Boehringer Ingelheim Investigational Site Neuss, Germany 收起 <<
NCT01779635	Acute Kidney Injury ... 展开 >> Hemorrhage Coagulopathy 收起 <<	Not Applicable	Completed	-	Singapore ... 展开 >> National University Hospital Singapore, Singapore, 119228 收起 <<
NCT01276288	-		Completed	-	-
NCT00795704	-		Completed	-	-
NCT00189098	Chronic Otitis Media	Not Applicable	Completed	-	Netherlands ... 展开 >> Wilhelmina Children Hospital, University Medical Center Utrecht Utrecht, Netherlands, 3508AB 收起 <<
NCT00189098	-		Completed	-	-
NCT03183245	Renal Failure ... 展开 >> End Stage Renal Disease Hemodialysis Vascular Access 收起 <<	Phase 3	Recruiting	December 2023	United States, Arizona ... 展开 >> Arizona Kidney Disease and Hypertension Center (AKDHC) Recruiting Phoenix, Arizona, United States, 85012 University of Arizona Recruiting Tucson, Arizona, United States, 85724 United States, California Sharp Memorial Recruiting Fresno, California, United States, 92123 University of California, Irvine Recruiting Irvine, California, United States, 92868 University of CA, San Diego - LaJolla VA Hospital Recruiting La Jolla, California, United States, 92161 Alliance Research Recruiting Laguna Hills, California, United States, 92653 VA Long Beach Healthcare System Recruiting Long Beach, California, United States, 90822 UCLA Not yet recruiting Los Angeles, California, United States, 90025 University of Southern California Recruiting Los Angeles, California, United States, 90033 Cedars Sinai Recruiting Los Angeles, California, United States, 90048 UC Davis Not yet recruiting Sacramento, California, United States, 95817 Balboa Nephrology Recruiting San Diego, California, United States, 92123 UCSF Recruiting San Francisco, California, United States, 94143 Mills Peninsula Hospital Not yet recruiting San Mateo, California, United States, 94401 Olive View- UCLA Medical Center Not yet recruiting Sylmar, California, United States, 91342 United States, Florida Mount Sinai Medical Center Recruiting Miami, Florida, United States, 33140 Tampa General Hospital Recruiting Tampa, Florida, United States, 33606 United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 United States, New Jersey Rutgers University Recruiting Newark, New Jersey, United States, 07103 Overlook Medical Center Recruiting Summit, New Jersey, United States, 07901 United States, North Carolina Surgical Specialists of Charlotte Recruiting Charlotte, North Carolina, United States, 28207 United States, Wisconsin Medical College of Wisconsin Not yet recruiting Milwaukee, Wisconsin, United States, 53226 收起 <<
NCT01689272	End-stage Renal Disease	Phase 4	Completed	-	Kazakhstan ... 展开 >> Republican Scientific Center for Emergency Medicine Astana, Kazakhstan, 010000 收起 <<
NCT03481920	Pancreatic Ductal Adenocarcino... 展开 >>ma Pancreatic Cancer 收起 <<	Early Phase 1	Recruiting	August 2019	Spain ... 展开 >> Hospital Universitario Fuenlabrada Recruiting Fuenlabrada, Madrid, Spain Contact: Laura Medina Rodriguez, MD 0034916006162 lauramaria.medina@salud.madrid.org Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Jaimen Feliu Batle, MD, PhD Hospital Ramon y Cajal Recruiting Madrid, Spain Contact: Carmen Guillen Ponce, MD, PhD 收起 <<
NCT02600559	Otitis Media	Phase 3	Completed	-	United States, California ... 展开 >> Email Otonomy Central Contact for Trial Locations San Diego, California, United States, 92121 收起 <<
NCT03158363	Immobilization, Tonic ... 展开 >> Fasting Endotoxemia Metabolism 收起 <<	Not Applicable	Completed	-	Denmark ... 展开 >> Institute for Clinical MEdicine Aarhus, Denmark, 8000 收起 <<
NCT00515463	-		Completed	-	-
NCT01385917	-		Unknown	December 2018	France ... 展开 >> Myology Institute Recruiting Paris, France Contact: Laurent Servais, MD 01 42 16 66 47 l.servais@institut-myologie.org Principal Investigator: Laurent SERVAIS, MD United Kingdom Great ormond Street Hospital & University College London Hospital Recruiting London, United Kingdom, WC1N 1EH Contact: Francesco Muntoni, Pr, HD +44 1 02079052111 f.muntoni@ich.ucl.ac.uk 收起 <<
NCT01077349	Shock	Not Applicable	Completed	-	France ... 展开 >> Groupe Hospitalier Pitié-Salpêtrière Paris, France, 75013 收起 <<
NCT01954290	Acute Cerebrovascular Accident... 展开 >> Cerebral Edema 收起 <<	Phase 2	Withdrawn(Investigator is leav... 展开 >>ing the institution.) 收起 <<	-	-
NCT01527110	Influenza, Human	Phase 3	Completed	-	Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 816-0864 GSK Investigational Site Kanagawa, Japan, 247-8533 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 985-8506 GSK Investigational Site Okayama, Japan, 700-8557 GSK Investigational Site Osaka, Japan, 581-0011 GSK Investigational Site Shizuoka, Japan, 432-8002 收起 <<
NCT00106639	Kidney Transplantation	Phase 2	Completed	-	United States, California ... 展开 >> Pfizer Investigational Site Los Angeles, California, United States, 90057 Pfizer Investigational Site Los Angeles, California, United States, 92356 Pfizer Investigational Site Palo Alto, California, United States, 94304 Pfizer Investigational Site San Diego, California, United States, 92123 Pfizer Investigational Site San Francisco, California, United States, 94115 Pfizer Investigational Site San Francisco, California, United States, 94143-0780 Pfizer Investigational Site Stanford, California, United States, 94305 United States, Colorado Pfizer Investigational Site Denver, Colorado, United States, 80262 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60611 United States, Louisiana Pfizer Investigational Site New Orleans, Louisiana, United States, 70112 United States, Missouri Pfizer Investigational Site St. Louis, Missouri, United States, 63110-1092 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 United States, New Jersey Pfizer Investigational Site Livingston, New Jersey, United States, 07039 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 Pfizer Investigational Site New York, New York, United States, 10029 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97210 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75204 Pfizer Investigational Site Dallas, Texas, United States, 75246 United States, Virginia Pfizer Investigational Site Richmond, Virginia, United States, 23298 United States, Wisconsin Pfizer Investigational Site Milwaukee, Wisconsin, United States, 53226 收起 <<
NCT02030834	Non-Hodgkins Lymphoma (NHL) Pa... 展开 >>tients, With CD19+B Cell Lymphomas 收起 <<	Phase 2	Active, not recruiting	January 2020	United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT00095498	Rheumatoid Arthritis	Phase 2	Completed	-	-
NCT02042066	Hypertension, Resistant to Con... 展开 >>ventional Therapy 收起 <<	Phase 1	Unknown	-	Israel ... 展开 >> Hadassah Medical Organization Not yet recruiting Jerusalem, Israel, 91120 Contact: Ayelet Shauer, MD +972-2-6776564 aye.shauer@gmail.com Principal Investigator: Ayelet Shauer, MD Sub-Investigator: David Libovitz, Professor Sub-Investigator: Ido Ben-Dov, MD Sub-Investigator: Shmuel Hen, MD Sub-Investigator: Amir Orlev, MD 收起 <<
NCT02264860	HIV-1 Infection	Not Applicable	Recruiting	December 2018	United States, Georgia ... 展开 >> Ponce De Leon Center Recruiting Atlanta, Georgia, United States, 30308 Contact: Vincent Marconi, MD 404-616-0673 vcmarco@emory.edu Principal Investigator: David M Guidot, MD 收起 <<
NCT02035358	Metastatic Renal Cell Carcinom... 展开 >>a Metastatic Clear-cell Renal Cancer Recurrent Renal Cell Carcinoma Refractory Renal Cell Carcinoma Metastatic Kidney Cancer 收起 <<	Phase 1	Unknown	-	United States, Iowa ... 展开 >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Maryland John Hopkins University Baltimore, Maryland, United States, 21205 United States, Utah Univeristy of Utah Salt Lake City, Utah, United States, 84112 收起 <<
NCT00106639	-		Completed	-	-
NCT03142529	Chronic Kidney Failure ... 展开 >> End-Stage Kidney Disease 收起 <<	Phase 1 Phase 2	Recruiting	October 15, 2018	China, Guangdong ... 展开 >> Guangdong Provincial Hospital of Traditional Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510006 Contact: Kun Bao baokun@aliyun.com 收起 <<
NCT03305549	Acute Kidney Injury	Not Applicable	Enrolling by invitation	January 1, 2020	United States, California ... 展开 >> UCSF Medical Center Moffitt-Long Hospital San Francisco, California, United States, 94143 收起 <<
NCT03046186	-		Recruiting	June 2017	Denmark ... 展开 >> Hvidovre University Hospital Recruiting Hvidovre, Please Select, Denmark, 2650 Contact: Maria S Svane 38626357 Maria.Saur.Svane@regionh.dk Principal Investigator: Sten Madsbad, MD, DMSc 收起 <<
NCT01842386	Anticytokine Autoantibody-Asso... 展开 >>ciated Diseases Disseminated Non-Tuberculous Mycobacteria Chronic Mucocutaneous Candidiasis Pulmonary Alveolar Proteinosis (PAP) 收起 <<	Phase 1	Active, not recruiting	January 1, 2025	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT00095498	-		Completed	-	-
NCT01308671	Coronary Artery Disease	Not Applicable	Unknown	April 2016	China ... 展开 >> General Hospital of Chinese People's Armed Police Forces Recruiting Beijing, China, 100039 Contact: Hui Liang Liu, Doctor 86-01-88276531 lhl518@vip.sina.com Contact: Yu Jie Wei, Master 86-01-88276707 weiyujie6980@sina.com Principal Investigator: Hui Liang Liu, Doctor Principal Investigator: Yu Jie Wei, Master Sub-Investigator: Jie Sun, Master 收起 <<
NCT01527110	-		Completed	-	-
NCT00515463	Low Bone Mineral Density ... 展开 >> Osteopenia Osteoporosis 收起 <<	Phase 3	Completed	-	-
NCT03049670	-		Not yet recruiting	March 1, 2018	-
NCT01282853	Peptic Ulcer ... 展开 >>Hemorrhage 收起 <<	Not Applicable	Completed	-	Taiwan ... 展开 >> Far Eastern Memorial Hospital New Taipei city, Taiwan, 22060 收起 <<
NCT01352182	Severe Sepsis ... 展开 >> Septic Shock 收起 <<	Phase 1 Phase 2	Completed	-	United States, Ohio ... 展开 >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 收起 <<
NCT03315923	Progressive Multiple Sclerosis	Phase 2 Phase 3	Not yet recruiting	May 1, 2019	Iran, Islamic Republic of ... 展开 >> Kashani Hospital Not yet recruiting Isfahan, Iran, Islamic Republic of, 8174673461 Contact: Masoumeh Cheshmavar, M.D. +98 913 109 3877 m.cheshmavar65@gmail.com Contact: Shervin Badihian, M.D. +98 913 303 3036 shervin.badihian@gmail.com 收起 <<
NCT02300571	-		Recruiting	January 2018	Italy ... 展开 >> Fondazione del Piemonte per l'Oncologia Recruiting Candiolo, Italy, 10060 Contact: Luisa Gioeni, PharmD +39011993 ext 3959 luisa.gioeni@ircc.it Sub-Investigator: Fabrizio Carnevale Schianca, MD Sub-Investigator: Daniela Caravelli, MD Sub-Investigator: Dario Sangiolo, MD Sub-Investigator: Susanna Gallo, MD Sub-Investigator: Valentina Coha, MD Sub-Investigator: Giovanni Grignani, MD Sub-Investigator: Delia Rota Scalabrini, MD Sub-Investigator: Marco Fizzotti, MD Ospedale Regina Margherita Not yet recruiting Torino, Italy, 10126 Contact: Massimo Berger, MD +39011.313 ext 5360 massimoberger@gmail.com Principal Investigator: Franca Fagioli, MD Sub-Investigator: Elena Vassallo, MD Sub-Investigator: Massimo Berger, MD Sub-Investigator: Francesca Nesi, MD Sub-Investigator: Paola Quarello, MD 收起 <<
NCT01382758	-		Completed	-	United States, Colorado ... 展开 >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 收起 <<
NCT01456104	Melanoma	Phase 1	Active, not recruiting	October 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT01575249	-		Unknown	June 2016	Romania ... 展开 >> "Bagdasar-Arseni" Emergency Hospital Not yet recruiting Bucharest, Romania, 041915 Contact: ALEXANDRU N MISCHIE, MD 0040723708050 alexandru_mischie@yahoo.com Principal Investigator: ALEXANDRU N MISCHIE, MD Principal Investigator: CRINA SINESCU, MD FESC FACC 收起 <<
NCT01493024	Hyperkalemia ... 展开 >>Chronic Kidney Disease Kidney Dysfunction 收起 <<	Phase 2	Completed	-	United States, Arizona ... 展开 >> Southwest Clinical Research Institute Tempe, Arizona, United States, 85284 United States, California West Coast Clinical Trials Costa Mesa, California, United States, 92626 United States, Florida Riverside Clinical Research Edgewater, Florida, United States, 32132 Elite Research Institute, Inc. Miami, Florida, United States, 33169 Compass Research Phase 1, LLC Orlando, Florida, United States, 32806 Lakeview Medical Research Summerfield, Florida, United States, 34491 United States, Kansas Johnson County Clin-Trials Lenexa, Kansas, United States, 66219 United States, Texas Southwest Houston Research, Ltd Houston, Texas, United States, 77099 Renal Associates, P.A. San Antonio, Texas, United States, 78215 收起 <<
NCT00808795	Radiocontrast-Induced Nephropa... 展开 >>thy Chronic Kidney Disease Diabetes Mellitus 收起 <<	Phase 3	Completed	-	Iran, Islamic Republic of ... 展开 >> Tehran Heart center Tehran, Iran, Islamic Republic of, 1411713138 收起 <<
NCT01018017	Diabetes Mellitus, Type 2	Phase 2	Completed	-	Germany ... 展开 >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 收起 <<
NCT02837861	Protein Feeding in Post-trauma... 展开 >>tic Injury Patients 收起 <<	Early Phase 1	Recruiting	January 31, 2021	United States, Massachusetts ... 展开 >> Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Peter A Burke, MD 617-414-8056 peter.burke@bmc.org Contact: Myriam Castagne, BS 617-638-8622 mycastag@bu.edu 收起 <<
NCT02011789	Hypercholesterolemia	Not Applicable	Completed	-	United States, California ... 展开 >> USDA Western Human Nutrition Research Center Davis, California, United States, 95616 收起 <<
NCT02907502	Healthy	Not Applicable	Recruiting	December 2026	Germany ... 展开 >> Dr Von Hauner Children's hospital Recruiting Munich, Germany, 80337 Principal Investigator: Berthold Koletzko, Professor Spain Hospital Universitari Joan 23 de Tarragona. Universitat Rovira i Virgili. Recruiting Tarragona, Spain Principal Investigator: Ricardo Closa-Monasterolo, Professor Principal Investigator: Joaquín Escribano, Professor 收起 <<
NCT01724424	Sepsis	Phase 1	Completed	-	United Kingdom ... 展开 >> University of Aberdeen Aberdeen, Scoltand, United Kingdom, AB25 2ZD 收起 <<
NCT03700580	Diabetic Foot ... 展开 >> Neuropathy, Diabetic Foot Ulcer 收起 <<	Phase 2	Completed	-	Brazil ... 展开 >> Unidade de Referência Secundária (URS) Padre Eustáquio, do Distrito Sanitário Noroeste da Secretaria Municipal e Saúde de Belo Horizonte. Belo Horizonte, Minas Gerais, Brazil, 30720-100 收起 <<
NCT02649140	Urolithiasis	Not Applicable	Unknown	March 2016	China, Guangdong ... 展开 >> Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510230 Contact: Guohua Zeng, Ph.D and M.D +86 13802916676 gzgyzgh@vip.tom.com Principal Investigator: Guohua Zeng, Ph.D and M.D Sub-Investigator: Zhou Yang 收起 <<
NCT01493024	-		Completed	-	-
NCT02100930	Neuroblastoma	Not Applicable	Recruiting	March 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Kushner, MD 212-639-6793 Contact: Nai-Kong Cheung, MD, PhD 646-888-2313 Principal Investigator: Brian Kushner, MD 收起 <<
NCT02837094	Type 1 Diabetes	Phase 1	Recruiting	December 31, 2018	United Kingdom ... 展开 >> Cardiff and Vale University Health Board Recruiting Cardiff, United Kingdom, CF14 4XW Contact: Alexandra Howell +44 (0)29 20746710 ext 46710 HowellA4@cardiff.ac.uk 收起 <<
NCT02923193	Peripheral Arterial Disease	Not Applicable	Recruiting	January 2021	-
NCT03621384	-		Completed	-	Indonesia ... 展开 >> dr. Cipto Mangunkusumo Hospital Jakarta Pusat, DKI Jakarta, Indonesia, 10430 收起 <<
NCT01780168	-		Recruiting	December 31, 2022	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 <<
NCT02957877	Endstage Renal Disease	Phase 4	Unknown	May 2018	Hong Kong ... 展开 >> Alice Ho Miu Ling Nethersole Hospital Recruiting Hong Kong, Hong Kong Contact: Steve Siu-Man Wong, MBChB, FRCPC (852) 26892000 stevesmwong@gmail.com 收起 <<
NCT01372176	Critical Illness ... 展开 >> Intensive Care (ICU) Myopathy Muscle Wasting Loss of Physical Function Mechanical Ventilation 收起 <<	Phase 4	Completed	-	Denmark ... 展开 >> Department of Intensive Care, Rigshospitalet Copenhagen, Denmark, 2100 收起 <<
NCT02272530	-		Unknown	December 2018	Germany ... 展开 >> University Hospital Duesseldorf Recruiting Duesseldorf, Germany, 40225 Contact: Miriam Cortese-Krott, PhD Miriam.Cortese@uni-duesseldorf.de Contact: Georg Wolff Georg.Wolff@med.uni-duesseldorf.de 收起 <<
NCT01855048	Healthy Volunteers ... 展开 >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus 收起 <<	Phase 1	Completed	-	Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 <<
NCT02343016	-		Unknown	June 2015	Italy ... 展开 >> Bambino Gesù Hospital and Research Institute Not yet recruiting Rome, Italy, 00165 Contact: Anna Francesca Scolari, MD afrancesca.scolari@opbg.net Principal Investigator: Anna Francesca Scolari 收起 <<
NCT01446055	Critical Limb Ischemia ... 展开 >> Peripheral Arterial Disease Buerger's Disease 收起 <<	Phase 1 Phase 2	Unknown	April 2013	China, Beijing ... 展开 >> Xuan Wu Hospital Not yet recruiting Beijing, Beijing, China Contact: Yongquan Gu, MD 13910002909 gu-yq@263.net Principal Investigator: Yongquan Gu, MD 收起 <<
NCT01525225	Type 2 Diabetes Mellitus	Phase 1	Terminated(Release of Post Mar... 展开 >>keting Requirement for this study. Terminated November 2013.) 收起 <<	-	United States, Arkansas ... 展开 >> Osborne Research Center Little Rock, Arkansas, United States, 72201 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Missouri The Children'S Mercy Hospital And Clinics Kansas City, Missouri, United States, 64108 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Promedica Toledo Childrens Hospital Toledo, Ohio, United States, 43606 United States, Pennsylvania Childrens Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 收起 <<
NCT02175654	Colorectal Neoplasms ... 展开 >> Metastatic Disease 收起 <<	Phase 2	Terminated(The trial was prema... 展开 >>turely closed due to lack of accrual) 收起 <<	-	Spain ... 展开 >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain, 28046 收起 <<
NCT01525225	-		Terminated(Release of Post Mar... 展开 >>keting Requirement for this study. Terminated November 2013.) 收起 <<	-	-
NCT02579265	Hospitalized Neonates and Infa... 展开 >>nts, Expected to Require Parenteral Nutrition for 28 Days 收起 <<	Phase 3	Recruiting	October 2019	United States, California ... 展开 >> Lucile Packard Children's Hospital Recruiting Palo Alto, California, United States, 94304 Contact: Katherine McCallie, MD UC San Diego Medical Center Recruiting San Diego, California, United States, 92103 Contact: Jae H Kim, MD, PhD Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Brian Lane, MD United States, Connecticut Yale - New Haven Children's Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Orly Levit, MD United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2991 Contact: Daniel T Robinson, MD United States, Massachusetts Boston Children's Hospital Withdrawn Boston, Massachusetts, United States, 02115 United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198-1205 Contact: Ann Anderson Berry, MD, PhD United States, New York Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Contact: Joanne Lai, MD Steven & Alexandra Cohen Children's Medical Center of NY Active, not recruiting New York, New York, United States, 11040 United States, Oklahoma The Children's Hospital at OU Medical Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Kimberly Ernst, MD United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Maria R Mascarenhas, MBBS Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jeffrey A Rudolph, MD United States, Tennessee Vanderbilt Children's Hospital Recruiting Nashville, Tennessee, United States, 37345 Contact: William Walsh, MD United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Amy B Hair, MD 收起 <<
NCT03418181	Kidney Failure ... 展开 >> Dialysis 收起 <<	Not Applicable	Recruiting	March 2, 2019	United Kingdom ... 展开 >> East and North Hertfordshire NHS Trust (incorporating Mount Vernon Cancer Centre) Recruiting Stevenage, United Kingdom, SG1 4AB Contact: Dr Enric Vilar 收起 <<
NCT01140295	Colonoscopy Preparation	Phase 4	Terminated	-	United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT01140295	-		Terminated	-	-
NCT02117635	Ischaemic Stroke ... 展开 >> Cerebral Infarction Hemiparesis Arm Paralysis 收起 <<	Phase 2	Completed	-	United Kingdom ... 展开 >> Queen Elizabeth Hospital Birmingham, United Kingdom NHS Southern General Hospital Glasgow, United Kingdom, G51 4TF Kings College Hospital London, United Kingdom University College London Hospital London, United Kingdom Royal Victoria Infirmary Newcastle, United Kingdom Nottingham City Hospital Nottingham, United Kingdom SalfordRoyal NHS Foundation Trust Salford, United Kingdom Royal Hallamshire Hosptial Sheffield, United Kingdom Southampton Hospital Southampton, United Kingdom 收起 <<
NCT02018081	Intensive Care Unit Syndrome ... 展开 >> Community-acquired Pneumonia 收起 <<	Phase 4	Completed	-	France ... 展开 >> University Hospital Toulouse Toulouse, France, 31059 收起 <<
NCT01224496	Myelodysplastic Syndrome (MDS)... 展开 >> Aplastic Anaemia (AA) Myelofibrosis (MF) Thalassemia Intermedia 收起 <<	Phase 1 Phase 2	Completed	-	Singapore ... 展开 >> Singapore General Hospital Singapore, Singapore, 169608 收起 <<
NCT03191409	-		Recruiting	June 30, 2019	China, Shaanxi ... 展开 >> First Affiliated Hospital of Xi'an Jiaotong University Recruiting XI'an, Shaanxi, China, 710061 Contact: Ming Zhang, Ph.D 18991232265 zmmri@163.com First affiliated hospital of Xi'an Jiaotong University Recruiting Xi'an, Shaanxi, China, 710061 Contact: Ming Zhang, Ph.D 18991232265 zmmri@163.com Principal Investigator: Dun Ding, MD 收起 <<
NCT01680211	Prediabetes H... 展开 >>yperlipidemia 收起 <<	Not Applicable	Completed	-	India ... 展开 >> Srinivasa Clinic & Diabetic Care Center Bangalore, Karnataka, India, 560050 收起 <<
NCT02388139	-		Unknown	June 2017	Romania ... 展开 >> Cardiology Departament "IBCV" Hospital Recruiting Iasi, Romania, 700503 Contact: Alexandru Burlacu, MD alburlacu@yahoo.com Principal Investigator: Alexandru Burlacu, MD 收起 <<
NCT01797341	Kidney-Pancreas Transplantatio... 展开 >>n 收起 <<	Phase 3	Completed	-	Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 收起 <<
NCT00463463	Non-Hodgkin's Lymphoma	Phase 3	Unknown	-	Israel ... 展开 >> Soroka Universuty Medical Center Recruiting Beer Sheva, Israel, 84101 Contact: Itai Levi, MD 972-8-6403325 etail@clalit.org.il 收起 <<
NCT00775476	Systemic Lupus Erythematosus	Phase 1 Phase 2	Suspended(Funds from original ... 展开 >>NIH grant, AT4332, have been exhausted. While new funding is thought with revised study design, no new patients will be recruited.) 收起 <<	June 2019	United States, New York ... 展开 >> SUNY Upstate Medical University Syracuse, New York, United States, 13210 收起 <<
NCT02534961	Hepatocellular Carcinoma	Phase 4	Unknown	December 2017	Taiwan ... 展开 >> Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 112 Contact: Chien-Wei Su, MD & PhD 886228712121 ext 3352 cwsu2@vghtpe.gov.tw 收起 <<
NCT00197522	Breast Neoplasms	Phase 1	Completed	-	Canada, Ontario ... 展开 >> Hamilton Health Sciences Hamilton, Ontario, Canada, M8V 1C3 收起 <<
NCT02106182	Nocturia Beni... 展开 >>gn Prostatic Hyperplasia 收起 <<	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Bucheon St.Mary's Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-818 Ajou University Hospital Suwon, Gyeonggi-do, Korea, Republic of, 443-380 Pusan Natonal University Hospital Busan, Korea, Republic of, 602-739 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Hanyang University Hospital Seoul, Korea, Republic of, 133-792 Soon Chun Hyang University Hospital Seoul, Korea, Republic of, 140-887 收起 <<
NCT02065245	Aging Frailty	Phase 1 Phase 2	Active, not recruiting	December 2020	United States, Florida ... 展开 >> ISCI/University of Miami Miller School of Medicine Miami, Florida, United States, 33136 收起 <<
NCT00001941	HTLV-I Infection ... 展开 >> T Cell Leukemia 收起 <<	Phase 1 Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01916317	Operable Breast Cancer	Phase 3	Active, not recruiting	December 2023	India ... 展开 >> Dr. B Barooha Cancer Institute Guwahati, Assam, India, 781016 All India Institute of Medical Science New Delhi, Delhi, India, 110029 Gujarat Cancer & Research Institute (GCRI) Ahmedabad, Gujarat, India, 380 016 Malabar Cancer Centre Kannur, Kerela, India, 670103 Kolhapur Cancer Centre PVT LTD Kolhapur, Maharashtra, India, 416008 Tata Memorial Centre Mumbai Mumbai, Maharashtra, India, 400012 Sterling Multi Speciality Hospital Pune, Maharashtra, India, 411044 Shree Siddhivinayak Ganapti Cancer Hospital Sangli Sangli, Maharashtra, India, 416410 North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS) Shillong, Meghalaya, India, 793012 Basavatarakam Indo- American Cancer Hospital Hyderabad, Telangana, India, 500034 Max Super Speciality Hospital Delhi, India, 110092 收起 <<
NCT03660748	Obesity	Early Phase 1	Recruiting	September 1, 2019	Canada, Ontario ... 展开 >> GI Labs Recruiting Toronto, Ontario, Canada, M5C2N8 Contact: Adish Ezatagha, MSc 416 861-9782 ext 208 aezatagha@gilabs.com Contact: Alexandra L Jenkins, PhD / RN 416 861-9782 ext 200 alexandrajenkins@gilabs.com 收起 <<
NCT02189850	Colonoscopy	Phase 2	Completed	-	United States, Arkansas ... 展开 >> Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States United States, Georgia Children's Center for Digestive Health Care Atlanta, Georgia, United States United States, Louisiana Delta Research Partners Bastrop, Louisiana, United States United States, Mississippi Gastrointestinal Associates Jackson, Mississippi, United States United States, New York University of Buffalo Pediatric Associates Buffalo, New York, United States 收起 <<
NCT00519168	-		Completed	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT01973192	-		Completed	-	United States, Indiana ... 展开 >> Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis Children's Hospital St. Louis, Missouri, United States, 63110 Australia, Victoria The Royal Children's Hospital Melbourne, Victoria, Australia Australia Telethon Kids Institute West Perth, Australia, 6872 收起 <<
NCT00095147	Rheumatoid Arthritis	Phase 3	Completed	-	-
NCT00001941	-		Completed	-	-
NCT01794858	Pancreatitis	Phase 2	Withdrawn	-	United States, New York ... 展开 >> NYU Medical Center New York, New York, United States, 10016 收起 <<
NCT00095147	-		Completed	-	-
NCT01183897	Neuroblastoma	Phase 2	Active, not recruiting	August 2019	United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT00502593	Influenza	Phase 2	Completed	-	Spain ... 展开 >> GSK Investigational Site Blanes (Girona), Spain, 17300 GSK Investigational Site L'Eliana, Valencia, Spain, 46183 GSK Investigational Site Paiporta, Valencia, Spain, 46200 GSK Investigational Site Quart De Poblet, Valencia, Spain, 46930 GSK Investigational Site Valencia, Spain, 46008 GSK Investigational Site Valencia, Spain, 46011 GSK Investigational Site Valencia, Spain, 46024 收起 <<
NCT00582985	Cancer Neopla... 展开 >>sm Metastasis 收起 <<	Phase 1	Completed	-	United States, Arizona ... 展开 >> Scottsdale, Arizona, United States, 85260 United States, California Santa Monica, California, United States, 90404 United States, New York Buffalo, New York, United States, 14263 United States, North Carolina Durham, North Carolina, United States, 27705 收起 <<
NCT03639519	Cardiothoracic Surgery	Phase 4	Recruiting	August 15, 2019	Egypt ... 展开 >> Galaa Military Medical Complex Recruiting Cairo, Sheraton, Egypt, 11651 Contact: Tamer M Ayed, MD Principal Investigator: Tamer M Ayed, MD Principal Investigator: Walid R Abdelfattah, MSc Principal Investigator: Nehal A Hassan, MSc Principal Investigator: Fathi M Aboushareb, MSc Principal Investigator: Nourhane A Ibrahim, MSc Principal Investigator: Kareem E Eltoukhy, MSc Principal Investigator: Romel B Barsoum, MSc Principal Investigator: Maged A Mohamed, MSc Principal Investigator: George S Hanna, BSc 收起 <<
NCT00924170	Adult T-Cell Leukemia (ATL)	Phase 1 Phase 2	Active, not recruiting	January 1, 2019	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01608347	Recurrent Miscarriage	Phase 4	Completed	-	-
NCT01846117	Oxidative Stress ... 展开 >> Inflammation Aging Pain 收起 <<	Phase 1 Phase 2	Completed	-	Canada, Saskatchewan ... 展开 >> Saskatoon Centre for Patient-Oriented Research Saskatoon, Saskatchewan, Canada, S7K 0M7 收起 <<
NCT01111266	Kidney Disease	Not Applicable	Completed	-	Germany ... 展开 >> Georg-Haas Dialysezentrum der PHV Gießen, Hessen, Germany, 35392 收起 <<
NCT00654316	TB	Phase 1	Completed	-	United Kingdom ... 展开 >> Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom, OX3 7LJ 收起 <<
NCT02084550	Ulcerative Colitis	Not Applicable	Active, not recruiting	September 2017	Denmark ... 展开 >> Department of Surgery P, Aarhus University Hospital Aarhus C, Denmark, 8000 收起 <<
NCT01868490	Cholangiocarcinoma	Phase 1 Phase 2	Unknown	May 2016	Thailand ... 展开 >> Siriraj Clinical Research Center, Siriraj Hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Contact: Adisak Wongkajornsilp, M.D. Ph.D. +66892017568 adisak.won@mahidol.ac.th Contact: Siriluk Suddhichupaiboon, R.N +66896775663 siriluk.sud@mahidol.ac.th Principal Investigator: Adisak Wongkajornsilp, M.D. Ph.D. 收起 <<
NCT00853411	Asthma	Not Applicable	Withdrawn(Terminated by Invest... 展开 >>igator due to lack of eligible subjects.) 收起 <<	-	-
NCT02387203	Pseudomyxoma Peritonei ... 展开 >> Appendiceal Neoplasms 收起 <<	Phase 2	Recruiting	December 2021	United States, Maryland ... 展开 >> Mercy Medical Center Recruiting Baltimore, Maryland, United States, 21202 收起 <<
NCT00965094	Chronic Renal Failure	Phase 4	Completed	-	Israel ... 展开 >> Novartis Investigative Site Haifa, Israel, 31096 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Tel-Aviv, Israel, 64239 收起 <<
NCT00965094	-		Completed	-	-
NCT00007345	Cutaneous T Cell Lymphoma ... 展开 >> Peripheral T Cell Lymphoma 收起 <<	Phase 2	Completed	-	United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, Arkansas University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope National Cancer Center Duarte, California, United States, 91010 Mercy General Hospital Sacramento, California, United States, 95819 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007-2197 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 Australia Royal Adelaide Hospital Adelaide, Australia Peter MacCallum Cancer Centre Melbourne, Australia Sir Charles Gairdner Hospital Perth, Australia 收起 <<
NCT00696410	-		Completed	-	-
NCT00924170	-		Active, not recruiting	-	-
NCT00696410	Heart Failure ... 展开 >> Cardiomyopathies 收起 <<	Phase 1	Completed	-	United States, Michigan ... 展开 >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 收起 <<
NCT00007345	-		Completed	-	-
NCT00502593	-		Completed	-	-

CAS号	57-13-6
分子式	CH₄N₂O
分子量	60.055

别名	尿素 ;Carbonyl diamide;Ureophil
运输	蓝冰

尿素 /Urea {[allProObj[0].p_purity_real_show]}

Urea 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Urea 质控信息

Urea 临床研究

Urea 实验方案

Urea 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

尿素 /Urea {[allProObj[0].p_purity_real_show]}

Urea 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Urea 质控信息

Urea 临床研究

Urea 实验方案

Urea 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Urea 纯度/质量文件产品仅供科研